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The importance of health and quality health care in people’s daily lives is widely 
recognised. Physicians play a key role in delivering quality health care and improved 
patient outcomes. However, the evidence regarding physicians’ decision making and 
their perception of quality of health care delivery and its influencers is inconclusive. The 
overall aim of this thesis is to increase the understanding of quality in health care delivery 
and the factors that influence it from a physician’s perspective. This aim is fulfilled by 
conducting three interlinked research projects. 
The first research project comprises a systematic review of the literature that identifies 
the factors, contexts and theoretical underpinnings influencing physician decision 
making. The synthesis of 160 studies reveals two main categories of influencing factors. 
The first is ‘Contexts’, which refers to the set of circumstances or facts surrounding a 
particular event or situation. The second category is ‘Interventions’, which are the 
techniques, processes or actions introduced to create changes in how physicians make 
decisions while performing their clinical duties. Although extant literature provides ample 
evidence on factors influencing physician decision making the link to quality in health 
care is under researched.   
In the second research project, the author explores how physicians construct quality of 
health care delivery by means of investigating 162 clinical cases with 27 repertory gird 
interviews that yield eleven key constructs representing a classification of physicians’ 
conception of quality.  
The third research project examines physicians’ perceptions of enablers and barriers to 
quality in health care delivery, employing semi-structured interviews. Findings indicate 
that physician’s effort in delivering quality health care is largely influenced by factors 
affecting behavioural control (freedom to act).  
This research makes five contributions to knowledge. First, a novel classification of 
factors influencing physician decision making when prescribing is developed, providing 
new understanding of the link between these factors and quality of health care. Second, 
the systematic review shows an innovative application of factor analysis to structure the 
findings of a complex phenomenon. Third, the study presents a new conceptualisation 
of physicians’ construction of quality in health care. Fourth, the research provides a 
categorization of physicians’ perceived enablers and barriers to quality health care and 
the mechanisms by which they operate. Finally, this research develops a theoretically-
grounded and empirically-informed conceptual model that incorporates three hitherto 
separate domains: agency, planned behaviour, and decision theories. This model 
provides a new integrated lens to better understand the complexities influencing quality 
in health care delivery.  
This study also makes two significant contributions to practice. First, the findings have 
helped initiate a transformation in the pharmaceutical industry’s business model, 
evolving from business-to-person to business-to-business. Second, the findings serve 
as a catalyst to drive organizational changes at Norway’s largest emergency hospital. As 
a result, a national debate was initiated, involving the Prime Minister and Minister of 
Health, on how hospital emergency care can best be provided at a national level.  
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This section provides a list of abbreviations for the reader. The intention is to 
provide a quick reference for commonly used abbreviations used throughout the 
review to enhance readability and accuracy of interpretations. 
AHUS Akershus University Hospital 
ANV Average normalized variance 
APO The Audit Project Odense 
AT Agency Theory 
B2B Business-to-business 
B2P Business-to-person 
BIPAP Bi-level positive airway pressure 
BMD Bone mineral density 
CDSS Computerised clinical decision support systems 
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DBA Doctor of Business Administration 
Df Degrees of freedom (statistics) 
Dr Doctor 
DTC Direct-to-customer (patient) 
DTP Direct-to-physician 
EBSCO Online research database 
EFPIA European Federation of Pharmaceutical Industries and 
Associations 
EMBASE International biomedical database (Excerpta Medica 
Database) 
ER Emergency room 
ERIC Education Resource Information Centre 






GP General practitioner (physician) 
GWTG Get With The Guidelines 
HCO Health-care organization 
HCP Health care professional (nurse, physician, etc.) 
HMO Health maintenance organization 
HTA Health technology assessment 
ICU Intensive care unit 
ID Identification 
IOM Institute of Medicine 
KOL Key opinion leader 
LMI Norwegian Pharmaceutical Industry Associations 
xx 
MATCH Management of Atherothrombosis With Clopidogrel in High-
Risk Patients 
MEDLINE Database with health information from the National Library 
of Medicine 
Mix Mixture 
NHS National Health Services (UK) 
NOK Norwegian crowns 
NSAID Non-steroidal anti-inflammatory analgesic 
NV Normalized variance 
NVIVO Qualitative data analysis computer package from QSR 
International 
OR Odds ratio (statistics) 
PCP Pneumocystis pneumonia 
PCT Personal Construct Theory 
PDA Personal digital assistant 
PDL Preferred drug list 
Prof Professor 
PROQUEST Online research database 




RGT Repertory grid interview technique 
ROW Rest of the World 
RQ Research question 
SAPS Simplified Acute Physiology Score (severity of disease 
classification system) 
Sig Significance (statistics) 
SPSS Statistical package for social sciences 
SSRI Selective serotonin reuptake inhibitor 
TPB Theory of Planned Behaviour 
TRA Theory of reasoned action 
USD United States dollar 
VAR Variance 
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GLOSSARY OF TERMS 
This section provides a glossary of terms for the reader. The intention is to 
provide a definition of commonly used terms used throughout the review to 
enhance readability and accuracy of interpretations. 
Academic detailing: visits by academic peers imparting scientific information in 
an objective and balanced manner. 
Academic literature: scholarly and often peer reviewed publications including a 
variety of media such as a theses, books articles and abstracts. 
Age:  age of a physician or patient in years.  
Agency Theory: the basis for agency is that one party (principal) delegates work 
to another (agent), and Agency Theory is concerned with two problems occurring 
in agency relationships (Eisenhardt, 1989). The first problem relates to conflict of 
interest (moral hazard) and the second to risk sharing (adverse selection). 
Attitude: represents an individual's degree of like or dislike for something thus 
affecting their ‘propensity’ to behave in certain ways. 
Audit: evaluation of a person, organization, system or process; often involving 
feedback. 
Behaviour: an observable action taken by an individual. For example, 
prescribing a medicine, reading a scientific article, attending to an invited 
conference. 
Biomedical: the application of the principles of biology and physiology to clinical 
medicine. 
CIMO: context, intervention, mechanism outcome framework posed by (Pawson 
et al. (2004), Pawson, 2006). 
Clinical study participation: when a physician is an investigator involved in a 
clinical study of medicines. 
Concordance: involvement of patients in decision-making to improve patient 
adherence to medical advice 
Context: a set of circumstances or facts surrounding a particular event or 
situation. 
Continuous medical education (CME): refers to a specific form of education 
that helps physicians maintain competence and learn about new and developing 
areas in their field. 
Control: the ability to purposefully direct, or suppress, change. 
Construct: the basic terms that the respondent uses to make sense of the 
elements. 
xxii 
Cost: the totalling up of expenditures associated with the decisions and their 
consequences of prescribing medicines. 
Detailing: visits by sales representatives is an important part of pharmaceutical 
promotion. 
Doctor: a qualified and certified medical doctor also denoted as physician. 
Drug:  is a legally prescribed substance that affects physiology at a functional 
level. The terms “drug” and “medicine” are used interchangeably. 
Dyad: a group of two people 
Elements: examples of the topic of interest. 
Expectation: presumed degree of probability of an occurrence. 
Experience goods: is the delivery of health care service where characteristics 
such as quality or price are difficult to ascertain before consumption, however, 
characteristics can be assessed after consumption. 
Financial incentives: include the use of increased financial accountability using 
budgets and performance-based payments. 
Formularies: committees that specify which medicines are approved for 
prescription under a set of given circumstances. 
Gender: distinguishes between male and female. 
Guideline: a statement by which to determine a course of action with the aim to 
streamline a particular process according to a set routine, based on medical 
evidence. 
Industry:  the pharmaceutical industry develops, produces, and markets 
medicines licensed for use as medications. 
Intervention: technique, process or action introduced to create change. 
Habit persistence: residues of past behaviours and experiences that leads to 
habitual rather than reasoned responses. 
Journal advertising: communication in the form of adverts used to persuade the 
readers of medical journals to prescribe the medicine being advertised 
Legal concerns: concerns about legal action, such as litigation, as a result of 
decisions made during the practice of medicine. 
Managed care: represents systems designed to finance and provide health care 
to patients enrolled in the programme with the intent to reduce cost of health care 
delivery. 
Medicine: is a legally prescribed substance that affects physiology at a functional 
level. The terms “drug” and “medicine” are used interchangeably. 
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Peer effect: the positive and negative impact of colleagues (peers) in a variety 
of choice contexts 
Personal Construct Theory: is a psychological theory of human cognition and 
personality developed by George Kelly in the 1950s. 
Physician: a qualified and certified medical doctor also denoted as physician. 
Practice type: the way the physician’s practice is organized. 
Preference: an individual’s attitude towards a set of objects in a decision-making 
process. 
Preferred drug list (PDL): a list of preferred medications based on clinical 
efficacy and safety as well as cost.  
Price: the quantity of payment given by one party to another in return for 
medicines. 
Regulation: is administrative legislation that constitutes or constrains rights and 
allocates responsibilities associated with the prescribing of medicines. 
Reimbursement: compensation for an expense associated with prescription 
medicines. 
Repertory grid: the repertory grid is a technique for identifying the ways that a 
person construes (interprets/ gives meaning to) his or her experience. 
Samples: represents free samples of medicines provided to physicians by the 
pharmaceutical industry. 
Social factors: factors that affect or direct our lifestyle through choice, such as 
religion, family, ethnicity, education and marital status.  
Social norm: the perception of what is expected from health care stakeholders 
and society in general. 
Speciality: formal medical education after medical school leading to a medical 
speciality such as internist and surgeon.  
Stakeholder: a person, group or organization that influences or can be affected 
by physician prescribing. 
Technology:  is the usage of information technology tools and techniques in the 
decision process governing physician prescribing of medicines. 
Theory of Planned Behaviour: is a theory about the link between attitude, intent, 
perceived control and behaviour. 
Theory of reasoned action: is the precursor theory to Theory of Planned 
Behaviour.  
Wallace and Wray framework (Wallace and Wray, 2006 pp. 99-100):  
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Knowledge-for-understanding: “attempting to develop theoretical and 
research knowledge from a relatively impartial standpoint. The rationale is 
to understand (rather than change) practice and policy or underlying 
ideologies”. 
Knowledge-for-critical review: “attempting to develop theoretical and 
research knowledge from an explicitly negative standpoint towards 
existing practice and policy. The rationale is to criticize and expose the 
prevailing ideology, arguing why it should be rejected and sometimes 
advocating improvement according to alternative ideology”.  
Knowledge-for-action: “attempting to develop practice-relevant 
theoretical and research knowledge, taking a positive standpoint towards 
practice and policy. The rationale is to inform efforts to bring about 
improvement within prevailing ideologies”. 
Instrumentalism: “attempting through training and consultancy, to impart 
practice knowledge and associated skills, taking a positive standpoint 
towards practice and policy. The rationale is directly to improve practice 
within the prevailing ideology”. 
Reflexive action: “practitioners attempting to develop and share their own 
practice knowledge, taking a constructively self-critical standpoint. The 
rationale is to improve their practice, either within the prevailing ideology 
or according to an alternative ideology”. 






 CHAPTER ONE: LINKING COMMENTARY 
The purpose of this Linking Commentary is to synthesize and integrate the 
scoping study and three research projects that have been completed as partial 
fulfilment of this Doctorate in Business Administration (DBA) at Cranfield School 
of Management. These projects build on each other and constitute the milestones 
required by the DBA process; see Figure 1-1 DBA milestones.  
 
Figure 1-1 DBA milestones 
The linking commentary is structured as follows. It starts by providing a structure 
of the thesis, before describing the background and motivation for the research. 
Next, it addresses the importance of the physician to the research and theoretical 
position. It then provides an overview of the research process and interlinked 
projects, followed by an overview of research methods. A summary of the key 
findings is then provided, followed by a discussion, before elaborating the 
research’s contributions to knowledge and practice. The commentary closes with 
a discussion of limitations and opportunities for further research.  
The overall aim of this thesis is to gain an understanding of quality in health care 
delivery adopting the physician’s perspective.  
Specifically, the objectives of the thesis are: 
1. To explore physicians’ decision making and prescription behaviour 
2. To identify how physicians construct and perceive quality of health care 
3. To explore the enablers and barriers to the delivery of quality health care  
1.1 Structure of the Thesis 
For purposes of clarity, a roadmap will be provided for the presentation of the 
research contributing to this thesis. The thesis is structured as follows:  
Chapter 1: Linking Commentary - Provides a synthesis and integrate the 
scoping study and three research projects. 
Chapter 2: Scoping Study – Provides a high level review of literature to identify 
relevant domains of literature and theory. 
Chapter 3: Project One (systematic review) – Provides a systematic review of 
the literature exploring factors influencing physician decision 
making employing prescribing as a proxy.  
Chapter 4: Project Two (empirical project 1) – Empirically explores how 
physicians construct quality of health care while delivering care to 
patients.  
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Chapter 5: Project Three (empirical project 2) – Empirically explores 
physicians’ perception of enablers and barriers to quality of health 
care while delivering care to patients.  
References: There are a large number of references to published work in the 
thesis. References are shown in the text by the author(s) and the 
year of publication and then listed in alphabetical order by author.   
Appendices: There are a number of appendices related to each of the individual 
projects of the thesis. Appendices for each project are presented in 
separate sections A, B and C (A=Project One, B=Project Two and 
C=Project Three).  
It is important to note that this thesis integrates stand-alone documents submitted 
as milestone requirements for the DBA. The documents have therefore been 
developed during the time period 2009 – 2013, and reflect the development of 
the author’s skills as a researcher and writer during this period. The documents 
that constitute Chapters 2 – 5 are largely unchanged; however, changes have 
been made to the projects to improve general readability of the thesis as a whole.  
1.2 Background and Motivation for the Research 
The research presented in this thesis has one overarching objective:  to develop 
the understanding of quality in health care and factors influencing it, as well as its 
contexts and the underpinning mechanisms. The finding of this thesis contributes 
to academic research, as well as providing novel insights to stakeholder groups 
in health care, with an interest in influencing its practice.  
When making policy, structural or operational changes influencing health care 
delivery, it is important that decisions are not based on mere assumption, but 
informed by quality research. The disconnection between academic management 
research and practice has been addressed by Starkey and Madan (2001) p. S3, 
who conclude that “bridging” this gap does not only require changes in the 
academic mind-set. Managers and firms also need to rethink their involvement in 
the research process”.  
Although the author of this thesis had been involved in clinical research in his 
past jobs, he had not had the opportunity to conduct research at a doctoral level. 
He wanted to become an accomplished academic for two main reasons. First, 
medicine is research driven, and as a top level executive in a health care 
organization, he felt it necessary to acquire the skills of an accomplished 
researcher. Second, as a manager, he needs research based tools and skills to 
drive change; in other words, “bridging” the gap.  
When he first embarked on the doctoral journey, the author was working for Pfizer 
as a medical director. His interest and motivation to undertake this research was 
the realization that the industry spends billions of USD every year on direct to 
physician (DTP) promotion (Gagnon and Lexchin, 2008), without sufficiently 
considering the potential consequences for overall health care outcomes. Thus, 
sparking an interest in further exploring quality in health care. The Scoping Study 
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revealed that the link between pharmaceutical promotional efforts and quality in 
health care was lacking in the literature, and calls for new promotional models for 
the pharmaceutical industry had already been advocated (Illert and Emmerich, 
2008). Speaking with top executives about his findings was discouraging. Interest 
was shown, but willingness for change was not present. He believes that this is 
partly due to the internal training of pharmaceutical managers and executives, 
where a long history of success with focus on DTP promotion is a central predictor 
of future choice (Bandura, 1986). He perceives that the current business model 
of the pharmaceutical industry does not focus on how DTP promotion contributes 
to overall health care outcomes.  
The author decided to change jobs and currently holds the position of director of 
a medical division and Chief Medical Officer at Akershus University Hospital in 
Norway. In other words, he has made the change from producer (pharmaceutical 
industry) to provider (hospital); one step closer to the patient.  In his current role, 
as a potential target customer for the pharmaceutical industry, he is invited to 
speak in fora where future industry policy and practice is being debated.  
In his current role, the author has also had the opportunity to directly influence 
how health care delivery is being organized in Norway’s largest emergency care 
hospital. He has implemented research findings which have started a debate at 
a national level, including the (former) Prime Minister and the Minister of Health, 
on how best to organize emergency care in hospitals in the country. 
The author’s interest in health care and quality can be traced back to the moment 
when he decided that he wanted to become a physician. When he was 18 years 
old, his father took him on a trip across the US, which ended with a 10 day cruise. 
On the cruise ship, the father and son shared their dinner table with a physician. 
One night, one of the guests at a neighbouring table choked on a piece of meat. 
The physician seated at the author’s table promptly got up and executed a perfect 
Heimlich manoeuvre; the piece of meat was “un-delicately” ejected from the 
unfortunate passenger. A life was saved! Witnessing this episode unfold, the 
author decided there and then that this was what he wanted to do; and at the age 
of 26, he graduated from medical school. This episode illustrates a relentless and 
genuine passion for helping and caring for patients, which represent the values 
he relies on when making choices today, whether they be personal or 
professional.  
Overall, the author is pleased with his accomplishments and with how the 
research has provided insights for his management practice within health care, 
as well as contributing to academic research in the field.  
1.3 Defining Quality in Health Care 
In this section, the reader is provided with definitions from the health care 
literature and the adopted definition employed for this research. 
Several definitions of quality can be found in the literature, but agreement on one 
grand definition of quality does not exist. Below are provided examples of 
definitions, which can be grouped into three main categories representing the 
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main approach to quality in health care: efficacy and safety, outcomes and 
systems approach.  
Patient safety has become increasingly important in health care given the number 
of identified injuries and fatalities as  a result of  preventable medical errors (Kohn 
et al., 1999). Thus, efficacy and safety is an important aspect of medical practice 
and is reflected in the examples of definitions provided below.   
“Clinically effective, personal and safe.” (Cave et al., 2008) 
“Health care should be safe, effective, patient-centred, timely, efficient and 
equitable.” (Institute of Medicine, 2001) 
Health care is designed around the provision of interventions designed to change, 
prevent or stabilize the health status of individuals or populations. The results of 
these interventions are known as health outcomes. Some definitions adopt an 
outcomes perspective, and some examples are given below.  
“The degree to which health services increase the likelihood of desired 
health outcomes and are considered consistent with current professional 
knowledge.” (Kohn et al., 1999) 
 “Medical quality is the degree to which health care systems, services and 
supplies for individuals and populations increase the likelihood for positive 
health outcomes and are consistent with current professional knowledge.” 
(American College of Medical Quality, 2010)  
“That which consistently contributes to improvement or maintenance of the 
quality and/or duration of life.” (American Medical Association, 1986) 
A systems approach to defining quality in health care takes on the task of trying 
to understand how elements and factors within the system influence one another. 
The author argues that this is a better approach to quality of healthcare as a 
scaffold on which to extend the understanding of the intrinsic complexities of 
influencers and mechanisms by which quality is affected.  Some examples are 
provided below.   
“That kind of care which is expected to maximize an inclusive measure of 
patients’ welfare, after one has taken account of the balance of expected 
gains and losses that attend the process of care in all ill parts.” 
(Donabedian, 1966, Donabedian, 1979, Donabedian, 1988, Donabedian, 
2005) 
 “Quality of care is the level of attainment of health systems’ intrinsic goals 
for health improvement and responsiveness to legitimate expectations of 
the population.” (Evans et al., 2000) 
Taking on a quality assessment perspective, (Donabedian (1979), 1988) 
proposed a model of quality comprised of three elements: structure, process and 
outcome.  
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Structure refers to stable, material characteristics (infrastructure, tools, 
technology) and the resources of the organizations that provide care and 
the financing of care (levels of funding, staffing, payment schemes, and 
incentives).  
Process is the interaction between caregivers and patients, during which 
structural inputs from the health care system are transformed into health 
outcomes. 
Outcomes can be measured in terms of health status, deaths, or disability-
adjusted life years—a measure that encompasses the morbidity and 
mortality of patients or groups of patients. Outcomes also include patient 
satisfaction or patient response. 
Donabedian’s quality model is widely used and cited in the literature concerned 
with quality in healthcare. Other notable names concerned with the topic are 
Codman and Berwick (Powell et al., 2009). Codman, a practicing surgeon in the 
early part of the last century, is generally accepted as the father of outcomes 
based medical practice after publishing a study on hospital efficiency (Codman, 
1916). Berwick, on the other hand, has focused his attention on the application 
of industrial models of quality in health care. In this thesis, the systems approach 
to quality, as proposed by Donabedian (1979), is adopted; however, it was 
chosen to widen the scope of structure to context. The argument for this choice 
is laid out in Section 1.9.1 on page 33. For the purpose of this research, a systems 
approach is adopted, and quality is defined as comprising of context, process and 
outcome. 
1.4 Importance of Physicians 
Having worked as a physician in general practice and in specialist health care as 
an anaesthesiologist, the author has had many opportunities to see and 
experience first- hand the patient-physician encounter and its challenges. The 
importance of this interaction in the delivery of quality is based on two key 
phenomena. First, patients’ access to health care requires a physician’s 
concurrence and initiative (McGuire, 2001). Second, physicians make decisions 
on behalf of patients while performing their clinical duties (Vogel et al., 2003). 
These phenomena are central to this research and subsequent parts of the thesis 
will make reference to them.  
Several stakeholders have a vested interest in influencing physician decisions, 
as they are made on behalf of patients and other stakeholders in health care. 
Initially working in the pharmaceutical industry, the author was struck by the 
debate on whether pharmaceutical promotion was information or persuasion. 
Internally in the industry it was considered information, but the seminal work of 
Hurwitz and Caves (1988) concluded that it was predominantly persuasion (i.e. 
practices designed to influence choice in favour or a particular alternative). This 
research was found to be of particular interest, as the pharmaceutical industry 
spends over 40 billion USD per year in the US alone persuading physicians to 
change their clinical decisions in favour of a particular company or brand (Gagnon 
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and Lexchin, 2008). Therefore, within the factors that affect physician decision-
making, emphasis is made in including pharmaceutical promotion.  
The literature on physicians’ prescribing is relatively abundant. However, a 
synthesis of factors influencing physician prescribing, and a coherent 
understanding of the role of context and underpinning mechanisms are missing. 
Gallan (2005), attempted such a review, but did not adopt a systematic approach 
nor frame the review as a realist synthesis. Thus, the scientific value of this work 
and its contribution to knowledge, policy and practice could be questioned. 
Physician prescribing behaviour is widely framed as choice behaviour (Lilja, 
1976, Coscelli, 2000, Venkataraman and Stremersch, 2007, Janakiraman et al., 
2008, Zerzan et al., 2011). In this thesis, therefore, physicians’ prescribing 
behaviour is adopted as a proxy for physicians’ decision making. 
Physicians engage with patients and act as expert agents. McGuire (2001) has 
written an extensive review of physician agency. This author suggests that the 
patient-physician interaction takes place in the context of information asymmetry, 
and thus uncertainty, which is suggested to be a strong driver of physician 
behaviour in a seminal work by Arrow (1963), is present. Literature on medical 
decision making is heterogeneous, and no grand theory of medical decision 
making has been formulated (Reyna, 2008). Medical decisions are made under 
uncertainty, and physicians may adopt several strategies when deciding. The 
author found the book by Payne et al. (1993) insightful, in that deciding how to 
decide is an important decision in itself. The authors claim that decision makers 
balance effort and accuracy considerations (effort-accuracy framework) and that 
this is predictive of which decision strategy is used. However, deciding on how to 
decide is not predictive of observed behaviour. In a seminal work, Ajzen (1991) 
developed the Theory of Planned Behaviour, which has later proven to have the 
highest predictive power of any behavioural theory employed in a health care 
delivery context (Godin et al., 2008). These studies significantly informed and 
motivated the research presented in this thesis, and are discussed in depth in 
subsequent chapters.   
1.5 Theoretical Positioning 
The theoretical positioning has been described in detail in the Scoping Study (see 
Chapter 2), and further detailed in Project Two, from page 169. Three hitherto 
separate theoretical domains are integrated to provide a lens to better understand 
the complexities of the phenomenon of physician decision making and their role 
in delivering quality health care (see Figure 1-2 Theoretical domains). Agency 
Theory, or more specifically physician agency, is concerned with the assumption 
of conflicting interest between a principal (patient) and an agent (physician) 
(McGuire, 2001). Conflict of interest may lead to conditions of moral hazard or 
adverse selection. Moral hazard refers to a condition where an agent will make 
decisions based on self-interest. Adverse selection refers to a condition where 
poor choices are being made due to inadequate information. The mechanism for 
both conditions is information asymmetry. Behavioural theories are abundant, but 
the Theory of Planned Behaviour has received most attention, and was found in 
a meta-analysis to have the highest predictive power of physician behaviour in 
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health care (Godin et al., 2008). Medical decisions are made under uncertainty, 
and no grand theory of medical decision making has yet been formulated (Reyna 
and Rivers, 2008). Physicians may adopt several strategies when making 
medical decisions. Rather than the decisions themselves, deciding how to decide 
(e.g. whether primarily based on judgement or closely following available 
guidelines) is important (Payne et al., 1993). 
Figure 1-2 Theoretical domains 
Agency theory, decision theory and behaviour theory form a theoretical lens in 
order to improve our understanding of quality in health care. In this section 
interlinks and the relative contribution of each of the theories employed is 
discussed.  
The author argues that Agency theory is a useful framework for understanding 
the context of physicians’ supply of effort into the delivery of health care. Agency 
theory helps understand the basis of the dyadic patient-physician relationship; 
however, it is necessary to view agency in a wider context to fully understand the 
complexities of health care delivery. Physicians make decisions on behalf of 
patients and stakeholders when performing their clinical duties and consequently, 
multiple agency relationships exist and influence physicians’ effort supplied into 
the delivery of health care. However, physicians’ exhibit a greater sense of loyalty 
to patients than to other stakeholders. Two central assumptions of Agency theory 
are relevant in in the physician-patient interaction context. First, there is a conflict 
of interest between the principal and agent. Second, information asymmetry exist 
between the agent and principal.  The information asymmetry makes it impossible 
to predict in advance physicians’ supply of effort, thus providing an opportunity 
for moral hazard to occur. Information asymmetry also implies that the physician 
does not have perfect information and adverse selection may result. Furthermore, 
information asymmetry results in uncertainty for both the principal and agent. 
Delivery of health care relies on the physician to decide the clinical content. Thus, 
Agency theory provides a useful theoretical framework to contextualise physician 
decision making 
The second theoretical framework, physician decision making is the most 









decision-making is lacking. However, the contextual framework provided by 
Agency theory indicate that decisions are made under conditions of information 
asymmetry and hence uncertainty. In addition, physicians have a variety of 
strategies to choose from when making decisions. The effort-accuracy framework 
suggested by Payne et al (2003) posits that physicians must first decide on which 
decision strategy to employ before making decisions in a clinical setting. Thus, 
the chosen strategy for decision-making influence physician supply of effort 
balanced against accuracy of decisions, and hence quality. 
It is possible to make decisions without acting on it. For example, many new 
years’ resolutions do not translate into changed behaviour. Thus, behavioural 
intent is not enough, but argued by Ajzen (1991) to be a strong predictor of actual 
behaviour. Uncertainty predicted by agency is a strong influencer of physician 
behaviour (Arrow, 1963) and may therefore influence behavioural intent.  
The theory of planned behaviour formulated by Ajzen (1991) is the behavioural 
theory with the best prediction value in health care (Godin et al., 2008). Therefore, 
the Theory of planned behaviour is the third theoretical lens employed in this 
research.  
None of the theories alone has the power to explain the complex and cloaked 
moments defining physician supply of effort into the delivery of health care.  
However, combining the theories provide a powerful theoretical lens to further our 
understanding of the complex phenomenon of quality in health care delivery. The 
relative contribution of the individual theoretical frameworks is difficult to quantify, 
as the explanatory power of the combined theoretical lens is greater than the sum 
of each individual component.  Therefore, a rank order of the individual 
frameworks contribution seems counterproductive. 
1.5.1 Conceptualization and Theoretical Underpinning 
Physicians supply effort into the delivery of health care (McGuire, 2001). Effort in 
this context is considered equal to quality of health care delivery (Ma and 
McGuire, 1997); thus, a focus on physician effort is necessary when attempting 
to extend the understanding of quality in health care delivery. Understanding 
quality in health care is not easy for three main reasons. First, medical practice 
is complex due in part to the presence of multiple principal agent relationships.  
Second, effort supplied into the delivery of health care is both unpredictable and 
un-observable. Finally, medical decisions are made under uncertainty. 
Medical practice is complex due to multiple principal agent relationships. 
Physicians must not only relate to patients, but also to other stakeholders such 
as hospital management, payers, etc., when performing their clinical duties. From 
an agency perspective, this introduces a situation defined by multiple principals. 
Agency Theory is primarily designed to deal with dyadic agent-principal 
relationships; thus, Agency Theory does not fully explicate the complexities 
inherent in the multiple principal-agent relationships that characterize health care 
delivery. It is therefore necessary to complement Agency Theory in order to fully 
understand how the supply of physician effort in health care delivery is influenced 
and how this influences quality.   
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Physician effort supplied into the delivery of health care is both un-observable 
and unpredictable. Physicians act as experts on behalf of patients and 
stakeholders when delivering health care (McGuire, 2001). The physician’s 
expert role implies that that the physician has superior knowledge, so a situation 
of information asymmetry exists. Due to information asymmetry, it is not possible 
to know what the physician knew when decisions were made. Medical decision 
making is therefore not observable, and outcomes cannot be predicted in 
advance, but only observed retrospectively.  
Health care is a service that is experienced by the patient. Both patient 
experience and clinical excellence constitute quality in health care delivery 
(McGuire, 2001). Furthermore, quality is likely to vary across physicians, as well 
as from day to day, making it difficult to predict prospectively. Thus, in addition to 
being un-observable, the effort supplied is also unpredictable. Quality in health 
care delivery is heavily dependent on the physician’s effort devoted to patient 
care. Since effort supplied by physicians is both un-observable and 
unpredictable, quality in health care delivery is therefore prospectively non-
observable and unpredictable. As such, it is necessary to employ a theoretical 
framework to better predict actual behaviour and hence quality of care 
prospectively. Godin et al. (2008) found that the Theory of Planned Behaviour 
has the highest prediction rate of the behavioural theories when applied to health 
care professionals. Thus, the Theory of Planned Behaviour is adopted to further 
extend the understanding of the supply of physicians’ efforts into the delivery of 
health care.  
It is widely stated that medical decisions are made under uncertainty (Croskerry, 
2005). Even though the physician takes on the role of the “expert”, he/she does 
not hold all available information. For example, the patient may not divulge all 
necessary information, or there is uncertainty about the effect of prescribed 
treatment; thus, medical decision making takes place under uncertainty. 
Uncertainty is described to be a strong influencer of physician behaviour (Arrow, 
1963), and physicians may adopt several heuristic strategies when making 
decisions. Therefore, it is important for physicians to choose which strategy to 
follow; in other words, deciding how to decide (Payne et al., 1993).  
In order to discuss the findings in full, a theoretical lens is employed, combining 
three hitherto separate theoretical domains; see Figure 1-2 Theoretical domains. 
First, Agency Theory, specifically physician agency (McGuire, 2001). Second, the 
Theory of Planned Behaviour. Ajzen (1991) proposed the Theory of Planned 
Behaviour (TPB), where behavioural intent is a predictor and direct precursor of 
actual behaviour. Godin et al. (2008) have shown that TPB is strongly predictive 
of actual behaviour in a health care context. The elements of TPB are shown in 
Figure 1-3 Theory of Planned Behaviour (Ajzen 1991). The final theoretical 
domain is medical decision making, specifically adaptive decision making (Payne 
et al., 1993).  
Next, the research process followed is described, including summaries of each 








Figure 1-4 Research process	
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1.6 Overview of the Research Process and Interlinked Projects 
This section describes the research process followed during the time period 
2009-2013, to conduct the research covering the Doctor of Business 
Administration (DBA) at the Cranfield School of Management.  The process is 
structured and milestone driven, with each step building on preceding work. The 
milestones are scoping study, literature review and two empirical projects, as 
shown in Figure 1-4 Research process. A summary of each of the elements is 
presented in the following subsections.  
1.6.1 Scoping Study 
The Scoping Study is a high level review of relevant literature, aimed at mapping 
literature domains and possible research gaps that might be further studied. The 
initial interest was about factors influencing physician prescribing behaviour. 
Thus, the Scoping Study is concerned with the influences on physician 
prescription behaviour from a health care value chain perspective, in order to 
identify stakeholders and points of influence.  
The literature reviewed for the Scoping Study suggests that physician education 
and training, control and regulatory measures, peer effect, promotion, price 
clinical trial participation and drug characteristics impact the quality and quantity 
of prescribing in the short term. The Scoping Study revealed that little is known 
about how factors influence prescribing behaviour. However, the Scoping Study 
found that source, message, receiver and contextual factors have all been 
postulated to have persuasive effects on the physician. Thus, the study has 
identified factors having a bearing on physician prescribing behaviour in a health 
care value chain context, but there is still a need to understand how factors affect 
physician prescription behaviour, in which contexts and with what results.   
The Scoping Study concludes that the purpose of the systematic review is to 
study literature in order to gain an understanding of the factors and contexts that 
influence physician prescribing behaviour.  
1.6.2 Project One 
As described above, the Scoping Study showed that there is still a need to 
understand how factors affect physician prescription behaviour, in which contexts 
and with what results. Therefore, a systematic review of the literature has been 
conducted with the purpose of gaining an understanding of the factors and 
contexts that influence physician prescription behaviour. Specifically the review 
identifies and maps factors and contexts having a bearing on physician decision 
behaviour when prescribing, and provides a synthesis of what is known about 
these issues. The systematic review addresses the following research question. 
RQ: What are the factors, contexts and mechanisms which influence 
physician prescribing behaviour? 
This systematic review adopted the approach outlined by Tranfield et al. (2003), 
drawing on elements taken from Huff (2009) and Fink (2010). Data extraction 
followed the methodology described by Wallace and Wray (2006). Synthesis of 
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the data adopts a realist synthesis approach, as proposed by (Pawson et al. 
(2004), Pawson (2006)), in order to ensure a strong link with practice and policy. 
Prior to conducting the review, a systematic review protocol was devised; see 
page 317 in Appendix A. The protocol is used to limit the scope of the study and 
to predefine the search strategy. The systematic search identified 3030 studies 
that, after filtering, included 160 studies for review, as shown in Figure 1-5 
Systematic review search flow chart. The review revealed two categories of 
influencers: interventions, in other words, proactive techniques, processes or 
actions introduced to create change in physician prescribing behaviour; and 
contexts, a set of circumstances or facts surrounding prescription events.   
 
Figure 1-5 Systematic review search flow chart 
Overall, this systematic review contributes to the current literature by showing 
that interventions that limit the spectrum of choice are the most effective, followed 
by face-to-face information and persuasion efforts. Furthermore, selective 
contextual factors related to the physician (habit persistence), patient (bio-
medical) and medicine attributes are important influencers of physician decision 
making when prescribing, and modulators of interventions designed to create 
change in said behaviour. Interventions limiting the spectrum of choice were 
found to be most effective. The predominant mechanism of influence was found 
to be physicians’ perception of behavioural control. However, information about 
the overall effects on outcomes was found to be missing in the reviewed literature. 
1.6.3 Project Two  
Project One revealed gaps in the understanding of how factors which influence 
physician decisions influence quality of health care delivery from a physician 
perspective. Thus, the purpose of the second project of this doctoral study is 
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concerned with exploring how physicians frame quality in health care while 
performing their clinical duties.  
Physicians, in performing their duties of patient care, can adopt several 
approaches; thus, they must decide how to decide.  Information is not equally 
shared between physicians, patients and the stakeholders. The physician has far 
more information than the patient and stakeholders, so physician decisions are 
made in the context of information asymmetry. However, physicians rarely have 
perfect information about clinical work (diagnostic, interactions, response to 
treatments), so decisions are also made under uncertainty. Physicians rely 
heavily on past experience, forming constructs that guide future choice and action 
(Ajzen, 1991 p. 203). As such, physicians’ decisions can be investigated adopting 
experiential constructivism (Jankowicz, 2004) and personal construct theory 
(Kelly, 1955).   
Physicians’ decisions are driven toward the delivery of quality of health care. 
Given physicians’ impact on quality of health care, Project Two seeks to 
understand how quality of health care is perceived by them. The following 
research question (RQ) is addressed: 
RQ: How do physicians construct quality of health care delivery in a 
hospital setting? 
A total of 27 repertory grid interviews were performed to explore how physicians 
construct quality in health care delivery. The analysis of data closely followed 
established practice in the literature, and yielded eleven key constructs. Key 
constructs were identified on the basis of assigned high importance, differentiated 
strongly and were frequently mentioned. These key constructs are 
communication, continuity of care, cooperation, correct interpretation of 
information, early diagnosis and treatment, effect of therapy, experience, 
responsibility for care provision, resource availability, and resource utilization and 
time. 
The findings from this research project provide insight into how physicians 
construct quality while performing their duties. Drawing on the findings from the 
preceding literature review (Project One) and this study, a  conceptual framework 
for quality of health care services is proposed; see page 221. Project Two 
contributes to the understanding of quality in health care delivery by providing a 
theoretically grounded and empirically informed classification of physicians’ 
conception of quality that goes beyond prior related studies. Theory in this area 
is advanced by exploring how physicians construct quality of health care delivery 
in a hospital setting. The model presented, Figure 4-5 Conceptual framework, 
integrates the study findings with elements of theory from different academic 
areas, such as medicine, economics, management and psychology.  
1.6.4 Project Three 
From Project Two emerged a static classification of physicians’ conception of 
quality. In order to extend the understanding of the dynamics of quality in health 
care, Project Three explores enablers and barriers from a physician perspective, 
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using real patient cases. Thus, Project Three adopts a dynamic approach, 
extending the  picture revealed in Project Two.  
Physicians are primarily dedicated to the process of diagnosing and treating 
patients; during this process, decisions are being made. Physician decision 
making during the process of diagnosing and treating patients has direct and 
indirect influences on the patients’ health. It is therefore important that these 
decisions are of high quality. Thus, it is of interest to understand what enablers 
and barriers of quality of health care delivery are perceived to exist.   
Physicians’ decisions are driven toward the delivery of quality of health care. 
Given the physician’s impact on quality of health care, Project Three seeks to 
extend the understanding of quality from a physician’s perception, by exploring 
enabler and barriers of quality in health care delivery. The following research 
question is addressed: 
RQ: What are the enablers and barriers physicians perceive in their role 
of providing health care? 
Each patient-physician encounter is different and forges a set of temporal 
experiences unique to each physician. In order to explore and identify enablers 
and barriers for high quality health care service delivery, a semi-structured 
interview technique was adopted to address the research question.  
Project Three revealed three important findings. First, it was revealed that 
enablers and barriers largely overlap with the constructs identified in Project Two 
(10 out of 11 constructs). In addition, two further constructs were identified in 
Project Three. Thus, the findings of Project Two were validated and extended. 
Second, the data suggest that physicians do not formally evaluate quality in 
health care delivery, but often rely on their own experience; feedback from peers 
and patients. Finally, the study showed that physicians’ efforts in delivering quality 
health care is largely influenced by factors affecting behavioural control. 
The author advances theory in this area by exploring how physicians perceive 
enablers and barriers of quality in health care delivery in a hospital setting. The 
model presented in Project Three, as illustrated in Figure 5-6 Proposed 
conceptual framework on page 279, extends the model presented in Project Two; 
see  Figure 4-5 Conceptual framework on page 221. 
In the next section, research methods employed in the research contributing to 
this thesis are presented.  
1.7 Research Methods 
In this section, the research design used in the thesis is detailed. First, the author 
states his ontological position, epistemological assumptions and, hence research 
paradigm. Next, the unit of analysis is addressed, before the methodological 
approaches for each of the interlinked projects are outlined. 
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1.7.1 Ontology, Epistemology and Research Paradigm 
Ontology is concerned with the philosophy of existence and the assumptions and 
beliefs that the researcher holds about the nature of being and existence (Blaikie, 
2007 p. 13). Having a medical background, the author entered this research 
project with a shallow realist ontological position. However, through the training 
provided by the DBA programme at Cranfield, he has learned that valuable 
information may be missed by purely relying on objective reality. Exploring quality 
in health care delivery involves looking into the complexities of the patient-
physician interaction. This is where realist and idealist ontologies meet; technical 
medicine meets with patients through the physician acting as an agent. Thus, it 
is felt that a stratified ontology is best suited for understanding the “moment of 
truth” in medicine. Blaikie (2007) p. 16, holds that “the aim of science based on 
depth realist ontology is to explain observable phenomena with reference to 
underlying structures and mechanisms”. The depth realist ontology is in line with 
this DBA researcher’s changed position, and is therefore adopted as the basis 
for this study. 
Epistemology is the theory of knowledge and the assumptions and beliefs that 
people have about the nature of knowledge. By convention, the epistemological 
assumption associated with neo-realism follows the depth realist ontology 
(Blaikie, 2007). Proponents of neo-realism hold that establishing regularities 
within phenomena or between events is only the beginning, thus rejecting the 
pattern model of explanation associated with empiricism. It is necessary to follow 
up by locating structures or mechanisms that produce the regularities (Blaikie, 
2007), p. 22. Thus, in this DBA study, the depth realist ontological position leads 
to the adoption of a neo-realism epistemology.  
Paradigms are models or frameworks that are derived from a worldview or belief 
system about the nature of knowledge and existence (Easterby-Smith et al., 2008 
pp. 57-58). Paradigms are shared by a scientific community and guide how a 
community of researchers act with regard to inquiry.  
The physician supplies effort into the delivery of health care; however, this effort 
is non-observable due in part to information asymmetry (Ma and McGuire, 1997, 
McGuire, 2001). In order to unpack the phenomenon of interest, it is therefore 
necessary to rely on physicians’ perceptions based on examples of clinical 
patient-physician interaction. Thus, an interpretive approach is necessary. The 
research paradigm is therefore that of interpretivism, as described by (Blaikie, 
2007) pp. 124-131. 
Research design must address the issue of quality assurance in addition to bias 
(Flick et al., 2004). Miles and Huberman (1994) propose to include qualitative 
criteria into the schema of quantitative criteria (objectivity, reliability and validity). 
This is an issue of trustworthiness in qualitative research, and encompasses 
credibility, transferability, dependability and confirmability (Robson, 1993 pp. 402-
407). Credibility is about demonstrating that the inquiry was carried out in a 
manner which ensures that the phenomenon of interest is accurately described. 
Transferability corresponds to external validity. Dependability is about ensuring 
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that the processes followed are clear, systematic and well documented. 
Confirmability is about ensuring an audit trail. 
The challenges of quality have been addressed in the following ways: 
 Protocols describe methods and procedures in detail 
 Description of how data was collected, analysed and transformed is 
presented 
 Researcher’s assumptions and biases are addressed 
 Audit trail is ensured by SPSS, NVIVO, Xls files, and transcripts available 
for inspection 
 Quotes are used extensively to ensure authenticity 
1.7.2 Research Strategy 
For the empirical projects, retroduction has been chosen as a research strategy. 
Retroduction, in contrast to deduction and induction, does not follow a linear logic, 
but rather constitutes a cyclic process. According to Blaikie (2007) p. 83, the 
chosen research strategy of retroduction follows from the depth realist ontology 
and epistemology of neo-realism.  
Pawson and Tilley (1994) and Layder (1993) have argued that both structures 
(contexts) and mechanisms must be incorporated in order to provide 
explanations. The aim of this research is to discover underlying mechanisms to 
explain observed regularities. Thus, the retroductive research strategy suits the 
purpose of the research and is in alignment with the researcher’s stated 
ontological position and epistemological assumptions.  
Bias is an important consideration in research strategy, as the process of 
conducting interviews might influence the responses given (Easterby-Smith et al., 
2008 p. 147). Bias is defined as any tendency which prevents unprejudiced 
consideration of a question (Kvale and Brinkmann, 2009). There are potentially a 
number of biases in this research.  The author’s own reference frame may be 
imposed on the interviewees both when asking the questions and when answers 
are provided; the author is a physician and holds views about the phenomenon 
of interest. One strategy to counteract this potential bias is the use of open ended 
questions (Project Three). The author’s own frame of reference and consequent 
perspectives will inevitably influence data collection, analysis and process of 
synthesis (James and Vinnicombe, 2002), so he has attempted to adopt a 
reflexive approach as one way that he can challenge his frame of reference and 
thereby increase the chance of recognizing the influence and limitations that 
these have on the research (Cunliffe, 2003). Reflexivity is a conscious effort to 
view the subject matter from different angles and to avoid a favoured angle a 
priori (Alvesson et al., 2008). It is important to note that adopting a reflexive 
approach does not lead to improved research outcome (Johnson and Duberley, 
2003). The author has endeavoured to maintain an awareness of these factors 
during the data collection, analysis and synthesis, as advised by Kvale and 
Brinkmann (2009), and Lofland et al. (2006).  
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1.7.3 Unit of Analysis 
According to Easterby-Smith et al. (2008) p. 103, it is important to be clear about 
the unit of analysis in advance, as this is the basis for collating the data and 
subsequent analysis. The term “unit of analysis” in this context refers to the 
distinct unit about which data is gathered. This is distinct from the level of 
analysis, which refers to a set of relationships. Together, the terms help define 
the population of this research. In this research, the unit of analysis is the 
physician-patient interaction and the level of analysis is the physician.  
Next the methodological approaches for each of the interlinked constituent 
projects of this doctoral research are discussed.  
1.7.4 Methodological Approaches for Each Project 
In this section, the methodological approaches chosen for each of the interlinked 
projects are summarized.  A multi-methodological approach, suited to the 
particulars of each individual project, is used. The different methodological 
approaches are listed below: 
Project One: Systematic review – see Section 3.2 from page 85 
Project Two: Repertory grid technique – see Section 4.3 from page 178 
Project Three:  Semi-structured interview technique – see Section 5.3 from 
page 230  
1.7.4.1 Systematic Literature Review 
The purpose of Project One is to study the literature in order to gain an 
understanding of the factors and contexts that influence physician prescription 
behaviour. Ample literature exists on the topic, so a systematic review of the 
literature is conducted. Specifically, the review will: 
 Explore and map the key issues, frameworks and theoretical 
underpinnings of physician decision behaviour  
 Investigate factors that influence physician decision behaviour when 
prescribing  
 Investigate which factors, under which contexts, may affect prescription 
behaviour, and in what ways 
Following a systematic review process to address the review question provided 
a rigorous and transparent process to identify gaps in knowledge and to frame 
the empirical research projects. Systematic literature review originated in medical 
research and is described as the process to locate and critically appraise 
scientific evidence in a transparent and replicable manner {Tranfield, 2003 #533} 
. For a detailed description of search and assessment criteria, please see 
Appendix A.1 Protocol, page 317. Applying a proven, systematic methodology to 
the literature review has resulted in a rigorous and reliable analysis of the extant 
literature to inform this study.  
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1.7.4.2 Repertory Grid Technique 
The purpose of Project Two is to explore physicians’ conception of quality. The 
effort physicians undertake in the delivery of health care is not directly observable 
due to information asymmetry. Much of what physicians do rely on tacit 
knowledge forged by years of experience. Understanding how physicians 
construct the environment in which they operate enables a glimpse into the 
hitherto un-observable. Thus, personal construct theory is adopted as the 
research strategy for this project. Repertory grid technique, based on Kelly (1955) 
personal construct theory, is used to elicit the constructs physicians use to 
characterize quality in health care.   
Repertory grid interviews, providing elements to compare and contrast, has been 
found to be a powerful tool in management research to bring out deep meanings 
and unobservable phenomena surfacing low awareness verbalization of how a 
respondent makes sense of a topic without imposing the researcher’s perspective 
(Goffin, 2002). Furthermore, the technique is useful for limiting jargon and social 
desirability (Goffin, 2002, Szwejczewski et al., 2005, Lemke et al., 2011). In this 
study, repertory grid is used to gain a deeper understanding of physicians’ 
perception of quality of health care delivery. In particular, repertory grid is used 
to identify the constructs physicians employ in characterizing quality in health 
care delivery.  
The overall advantage of the repertory grid technique is its flexibility, as it can be 
used for many different purposes (Jankowicz, 2004 p. 27). The Interview guide 
was validated and modified through the use of pilot interviews. A more detailed 
description can be found in Chapter Four, starting on page 183. 
1.7.4.3 Semi-Structured Interview Technique 
The purpose of Project Three is to extend the findings of Project Two and to gain 
a fuller understanding of quality by exploring physicians’ perception of enablers 
and barriers of quality in health care delivery. Interviews are an effective means 
to explore physicians’ experiences when delivering health care services. Kvale 
and Brinkmann (2009) p. 1,  claim that “the qualitative research interview attempts 
to understand the world from the subjects’ points of view, to unfold the meaning 
of their experiences, to uncover their lived experiences prior to scientific 
investigation”. In order to get insights about the physicians’ perceptions of 
enablers and barriers to quality in health care, semi-structured interview 
technique has been employed, as it was deemed suitable for the purpose of this 
project. Semi-structured interviews allow the researcher to both gain insights 
about the phenomenon of study, and to keep open the opportunity for the 
participant to add experiences not pre-determined in the interview guide.  
The interview guide includes an outline of topics to be covered during the 
interview (Kvale and Brinkmann, 2009 p. 130). Interview guides were validated 
and modified through the use of pilot interviews, which are described in detail in 
Chapter Five, on page 234. 
 20 
Next, a summary of the main findings and their links to existing research and 
literature are presented. 
1.8 Summary of Findings and Linkages to Existing Research 
A number of key findings emerged from the research reported in the thesis. First, 
addressing the research question of the factors that influence physician 
prescription behaviour, the systematic review revealed a novel classification, 
including two sets of factors influencing physicians’ decision making when 
prescribing. The two sets are contexts and interventions. Second, addressing the 
research question ‘how do physicians frame quality of health care delivery”, an 
empirically derived and theoretically grounded classification of how physicians 
construct quality of health care delivery emerged. Third, addressing the research 
question of enablers and barriers to quality in health, it was revealed that 
physicians’ conception of quality is closely related to enablers and barriers; and 
the mechanism by which influence on physician decision making and hence 
supply of effort into the delivery of health care was revealed.  Finally, a summary 
and conceptual framework is offered. 
The findings are presented in the following sections, and a link to existing 
research is made to contextualise the findings, pointing at where they extend or 
complement current knowledge.  
1.8.1 Factors Influencing Physician Decision Making 
Factors influencing physicians’ decision making and behaviour impact the level 
of effort supplied into the delivery of health care, and hence influence quality of 
health care offered to patients. The systematic review identified two sets of 
influencing factors: contexts (Table 1-1) and interventions (Table 1-2).  
1.8.1.1 Contexts 
Contexts are considered to be a set of circumstances or facts surrounding a 
particular event or situation. These contexts are present at the time of clinical 
decision making and modulate the level of uncertainty, so influencing physicians’ 
decisions. Characteristics of patients, physicians, practice and medicine 
attributes are all contextual factors that influence physician decisions. In general, 
the evidence of such influence is limited, but three components stand out in that 
evidence of influence is found to be high: physician habit persistence, biomedical 
factors, and efficacy and safety of medical interventions. 
Contexts are considered to be a set of circumstances or facts surrounding a 
particular event or situation. These contexts are present at the time of clinical 
decision-making and modulate the level of perceived uncertainty, thus influencing 
physicians’ decisions. Characteristics of patients, physicians, practice and 
medicine attributes are all contextual factors with a bearing on physicians’ 
decisions. Overall, the systematic review revealed that there is limited evidence 
of such influence. However, there seems to be conclusive evidence about the 
high influence physician habit persistence, biomedical factors, and efficacy and 
safety of medical interventions have on physicians’ behaviour (please see Error! 
Reference source not found.). 
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Table 1-1 Contextual factors influencing physicians when prescribing 
 
Table 1-1 describes contextual factors identified as influencers of physician 
decision making when prescribing. Four factors were identified. These factors 
have been further sub-divided into components. The mechanism column 
describes the mechanism by which influence is exerted, and its link to theory is 
captured in the “Theory” column. Evidence of influence is rated by the researcher 
on a scale low-medium-high. 
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1.8.1.1.1 Physician Habit Persistence 
Physicians, in the course of performing their clinical duties, develop certain ways 
in which to practice medicine; in other words, physicians are subject to habit 
formation while practicing. Furthermore, physicians’ established practice has 
been suggested to be subject to persistence of habit (Hellerstein, 1998, 
Alexander and Tseng, 2004, Janakiraman et al., 2008). Habit persistence in this 
context refers to choices made without cognitive involvement, and has for 
example been found to influence physicians’ decisions when prescribing (Zerzan 
et al., 2011).  Physicians typically practice medicine in a stable context (Godin et 
al., 2008), and Verplanken and Wood (2006) demonstrated that habitual 
behaviour performed in a stable context is more difficult to change. Thus, 
physician habit persistence may act as a barrier to the improvement of health 
care provision (Danzon and Furukawa, 2001). 
1.8.1.1.2 Biomedical Factors 
In general, it can reasonably be argued that the clinical practice of medicines is 
concerned with how bio-medical factors affect the physical and psychological 
wellbeing of patients. In this review, however, the quantity of literature addressing 
this very issue is limited. That said, a few publications included in the systematic 
review do address the question (Cettomai et al., 2010, Choudhry et al., 2005, 
Schneeweiss et al., 2005, Blix et al., 2011, Crawford et al., 2011).  
The limited evidence found in support of bio-medical factors as an influencer on 
physician prescribing behaviour can be argued to be because such influence is 
presumed. In fact, medical literature in general is focused on patient level bio-
medical factors as a cause of disease, focus for diagnosis and treatment, and 
ultimately lies at the core of decisions relevant to the practice of clinical medicine. 
Therefore, bio-medical factors can reasonably be argued to figure prominently 
among influencers of physician prescribing behaviour. 
1.8.1.1.3 Medicine Attributes 
Bradley (1991) found that a physician’s concern about medicines was a factor 
influencing physician prescribing behaviour. Several authors have since 
investigated the origin of these concerns, and found that efficacy and safety are 
the main constituents, so addressing the benefit-risk profile of medicines. 
Uncertainty is stated as the main driver of physician behaviour (Arrow, 1963), and 
it is therefore unreasonable to expect the benefit-risk profile of a medicine not to 
influence physician prescribing behaviour. Whilst physicians emphasise clinical 
efficacy, they seem willing to take risk under certain conditions. Thus, the benefit-
risk evaluation is dynamic and contextually contingent. 
1.8.1.2 Interventions 
Interventions are considered techniques, processes or actions introduced to 
create change. Four types of interventions were synthesised from the 160 studies 
included in the systematic review: pharmaceutical promotion, regulation and 
control, economic and non-economic factors. The four types of factors emerged 
from a factor analysis of the data. Nomenclature chosen for factors follows that 
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found in previous literature (Gallan, 2005); please se Table1-2 Interventional 
factors influencing physicians when prescribing for details. 
Table 1-2 Interventional factors influencing physicians when prescribing 
 
Table 1-2 describes interventional factors identified as influencers of physician 
decision making when prescribing. Four factors were identified. These factors 
have been further sub-divided into components. The “Effect” column describes 
the outcome of the intervention, whereas the “Mechanism” column describes the 
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mechanism by which influence is exerted, and its link to theory is captured in the 
“Theory” column. Level of influence is rated by the researcher on a scale low-
medium-high, as is the evidence of influence. 
The most effective interventions are those that influence the physician’s 
perception of control (ability to choose freely), followed by social norm (perception 
of expectation from significant others, such as family, friends and colleagues) and 
attitude formation (expression of favour or disfavour), respectively. Perception of 
control was found to be most affected by implementing choice limiting measures, 
such as formularies, preferred drug lists, managed care and reimbursement, thus 
affecting the spectrum of choice available for the physician when prescribing.  
Social norm was found to be most affected by interventions making use of bio-
medical factors, academic detailing and peer effects, respectively. Physician 
attitude toward prescribing was found to be relatively resistant to interventions, 
and consequently, the effect of pharmaceutical promotion was found to be 
modest. However, face-to-face interventions such as detailing were found to be 
more effective than less direct measures, signalling a relationship effect often 
exploited by the pharmaceutical industry. 
1.8.1.2.1 Pharmaceutical Promotion 
Detailing increases the likelihood of a particular prescription at the physician level 
(Gönül et al., 2001, Manchanda and Chintagunta, 2004). Aggregate sales or 
prescription data suggests that promotion increases prescribing (Narayanan et 
al., 2005, Narayanan et al., 2004, Rizzo, 1999, Chintagunta and Desiraju, 2005); 
this is why, traditionally, the pharmaceutical industry invests heavily in the use of 
this promotional instrument. The review showed the significant influence that 
promotion has on physician prescribing behaviour (Kremer et al., 2008). 
However, the understanding of the link between promotion and prescription is far 
from complete. The effects of promotion on physician prescribing behaviour can 
loosely fall into two categories: increased prescribing and mixed effects. Also, the 
components of contextual circumstances under which this influence is exerted 
lack solid evidence, with the exception of physician-level habit persistence, 
patient-level bio-medical factors and medicine attributes; see Section 3.4.1 on 
page 104 for further details. 
Moreover, the effect of promotion on prescription is not linear and shows 
diminishing returns (Manchanda and Chintagunta, 2004) and heterogeneity in 
physician responsiveness to promotion (Narayanan and Manchanda, 2005, 
Janakiraman et al., 2008). Diminishing returns, in this context, simply imply that 
the increased promotional investment does not produce a proportional increase 
in prescriptions. In the mixed effects category, several authors also found that 
promotion increases prescribing, but that the effect is small (Mizik and Jacobson, 
2004, Kremer et al., 2008).  
Some authors have found no significant effect of promotion on physician 
prescribing (Rosenthal et al., 2003), and others have even found a negative effect 
(Parson and Abeele, 1981). Although there exists a general consensus that 
promotion increases prescribing, the effect is modest (Kremer et al., 2008). 
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1.8.1.2.2 Regulation and Control 
The analysis of studies included in the systematic review showed that audits and 
feedback are significant factors influencing physician decisions when prescribing. 
The purpose of audits is to form an opinion on whether clinical practice reflects 
best practice. Feedback includes feedback from patients and next of kin, peers 
and own experience. Audits and feedback provided by regulators and colleagues 
give the physician summary information on clinical practice. Even though the 
evidence of audits and feed-back influence is inconclusive and level of influence 
low, audits and feed-back information serve as a means for physicians to 
evaluate their own practice. Indeed, empirical evidence from Project Three 
(Section 5.5.1.6.1 Feedback, page 247) revealed that feed-back from colleagues 
and patients is an important means for physicians to evaluate the quality of their 
practice. Prescribing reports influence the physicians’ perception or subjective 
belief of what is acceptable, both from a medical and regulatory perspective, thus 
influencing the attitude and subsequently the physicians’ behaviour when 
prescribing. 
1.8.1.2.3 Economic Factors 
Economic interventions, such as reimbursement and managed care, focused on 
limiting choice are in general more effective than those that do not limit choice. 
Price/cost of prescriptions is widely studied, but physicians in general exhibit a 
low degree of price sensitivity given they are often not held accountable for 
financial costs. However, reimbursement is an important and strong influencer of 
physician prescribing, indicating that physicians’ price sensitivity is related to the 
patient (affordability for the person) rather than at the system level (cost 
containment at the level of the organization) - i.e., at the patient level. 
Furthermore, this implies that the principal-agent relationship between physician 
and patient may be stronger than that between physician and payer.  
The review showed that balancing the triad of (economic) interests defined by the 
key stakeholders (payer, provider and patient triad) is a complex and arduous 
task. Conflict of interests may emerge within the triad of stakeholders; loyalty to 
the principal may be challenged in the context of a principal-agent relationship. 
Findings from the review indicate that assessing optimal economic decisions and 
effective resource allocation in health care is important for the resulting quality of 
health care delivered.   
1.8.1.2.4 Non-Economic Factors 
The plethora of non-economic factors influencing physician decisions when 
prescribing speaks to the complexities surrounding control of factors influencing 
quality of health care. Non-economic factors influencing physician decision 
making when prescribing have been widely investigated, but given the large 
number of factors with such potential effects, evidence of the influence of each of 
them is mostly inconclusive. However, three factors emerged from the systematic 
review as highly influential: peer influence, academic detailing and bio-medical 
factors.  
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Peers’ opinions, beliefs and practices are powerful influencers on physician 
prescription and decision making behaviour. Clinical decisions are informed by 
peer interactions and provide authoritative influence through the interchange of 
insights, thus enabling the acquisition of knowledge and experience of new drugs. 
The extent to which peers influence prescribing is related to the level of 
uncertainty associated with prescribing certain medicines.  
Academic detailing is widely stated to influence physician prescribing and is the 
most potent influencer identified in this review. However, the subtle mechanisms 
by which academic detailing exert influence on physician prescribing is not 
sufficiently covered in the literature. The review enabled the researcher to find 
that academic detailing operates through three parameters: firstly, as an 
information provision channel; secondly, enhancing peer interaction; and finally, 
academic detailing transferring and communicating guidelines, the key 
mechanism of evidence-based practice (Sackett et al., 1996).  
Bio-medical factors such as patient characteristics and disease severity are 
natural influencers of physician decision making. As noted, physician decision-
making is characterised by a great degree of uncertainty about the outcome of 
any therapeutic intervention. This means that uncertainty is consistently present. 
Uncertainty is considered the main driver for physician behaviour in general 
(Arrow, 1963).  
1.8.2 Physicians’ Conception of Quality 
The second research project of the DBA (Project Two) addresses physicians’ 
conception of quality. In this project, grounded in personal construct theory (Kelly, 
1963), 27 repertory grid interviews were conducted. The result of this project was 
an empirically-derived and theoretically-grounded classification of physicians’ 
conception of quality in health care delivery. Eleven key constructs representing 
how physicians frame the conception of quality in health care emerged; see Table 
1-3 Key constructs by quality elements and relation to theory. The significance of 
these constructs is that no such classification has yet been made available in the 
literature. Table 1-3 “Quality element” follows the model devised by Donabedian 
(1979), and is subdivided by empirically-derived constructs. The “Theory” column 
refers to the construct’s connection with theory, and “Theoretical construct” refers 
to how the empirically-derived constructs link with theoretically derived 
constructs. The last column provide links to literature references. In addition, two 
further constructs, standards of care and evaluation, were identified in Project 
Three through employing a semi-structured interview technique. 
In the following three sub-sections, these findings are briefly presented. Full 
details of the research project can be found in Chapter 4. To further categorize 
the constructs that emerged from the repertory grid, the model devised by 
Donabedian (1979) is used: structure, process and outcome (see Figure 1-6 
Elements of quality (Donabedian 1979)).  Structure refers to the attributes of the 
setting in which health care is delivered. Process refers to what is actually done 
when delivering or receiving health care. Outcome refers to the effects health 
care has on the health status of patients and populations.  
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Table 1-3 Key constructs by quality elements and relation to theory 
Quality 
element 
Construct Theory Theoretical 
construct 
Reference example
Process Communication TPB Attitude Ajzen 1991, p. 198 
Agency Risk: monitoring and 
negotiation 




TPB Control belief Ajzen 1991, p. 204 
Decision Causal vs. diagnostic 
interpretation 
Einhorn & Hogarth 1981, 
p. 65 
Continuity  TPB Control belief Ajzen 1991, p. 199 
Responsibility for 
provision of care 
TPB Control belief  & 
Social norm 
Ajzen 1991, p. 199 
Context Resource availability TPB Control belief Ajzen 1991, p. 188 
Resource utilization TPB Control belief Ajzen 1991, p. 188 
Time TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Conlon & Parks 1990, p. 
619; Eisenhart 1989, p. 70 
Cooperation TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Eisenhart 1989, p. 72 
Experience TPB Control belief Ajzen 1991, p. 203 
Agency Adverse selection Eisenhart 1989, p. 61 
Decision Habit persistence Ajzen 1989, p. 203 
Outcome Early diagnosis and 
treatment 
TPB Control belief Ajzen 1991, p. 204 
Agency Risk: random market 
effect 
Conlon & Parks 1990, p. 
610 
Effect of therapy TPB Control belief Ajzen 1991, p. 204 
Decision Reinforcement: 
positive  outcome 
feedback 




Figure 1-6 Elements of quality (Donabedian 1979) 
1.8.2.1 Process 
Process is defined as one of three elements of quality in health care (Donabedian, 
1979). In this study, five constructs emerged to comprise the process element of 
quality of health care. These constructs are: communication, correct 
interpretation, continuity of care, physician attitude and patient. 
1.8.2.1.1 Communication 
In this study, communication is found to represent an important aspect of 
physicians’ conception of quality in health care delivery, confirming previous 
research on the importance of communication on health outcomes (Jensen et al., 
2011) and the correlation between effective physician-patient communication and 
improved patient health outcomes. Stewart (1995) p. 1423, concludes that “most 
of the studies reviewed demonstrated a correlation between effective physician-
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patient communication and improved patient health outcomes”. This is further 
supported by the findings in this study, as correlation between effective physician-
patient communication and improved patient health outcomes has been 
demonstrated; see Section 4.5.3.1 on page 190. Jensen et al. (2011) further 
demonstrate that training in medical communication can improve physician 
communication skills and thus improve physician-patient interaction. 
Furthermore, a model for effective communication exists, and training based on 
the model is both suitable and effective when applied to physicians in a hospital 
setting. The study confirms previous theory and supports previous findings on the 
importance of good quality physician-patient communication. 
1.8.2.1.2 Correct Interpretation of Information 
The analysis of empirical data showed that correct interpretation of information is 
central to the process of diagnosing and deciding on the appropriate therapy. 
Focus of attention on what the physician prefers results in differential weighting 
of information features. For naturally occurring phenomena, it is not clear whether 
people do consider the likelihood of an event occurring without intervention (base 
rate) (Goldsmith, 1980). However, information that receives a causal 
interpretation is weighted more heavily in judgment than information that is 
diagnostic (Einhorn and Hogarth, 1981 p. 65). Thus, correct interpretation of 
information is found to be dependent on the physician’s preference of information 
features. 
1.8.2.1.3 Continuity of Care 
The results of this study reveal that continuity of care is an important factor 
influencing quality of health care delivery. Definitions of continuity of care are 
numerous, but are exceeded by the number of techniques used to measure 
continuity (Jee and Cabana, 2006). Saultz (2003) proposed a hierarchical 
definition of continuity, ranging from informational to longitudinal to interpersonal. 
{Freeman, 2003 #1749@@author-year} and {Haggerty, 2003 #1750@@author-
year} described continuity of care from the patient perspective. However, 
attempts at providing a uniform definition and technique for measurement of 
continuity of care has yet to be accomplished (Adler et al., 2010). Thus, as a 
global definition is lacking and numerous techniques are used to measure 
continuity, it is not surprising that the effect has been found to be variable. 
Physicians referred to the ideal continuity of care as one physician who follows 
the patient through the care process. However, it emerged from the data that this 
is not the norm. On the contrary, breach of continuity is the norm in an ever 
increasingly specialized health care service.  
Providing quality health care in an environment characterized by ever increasing 
demands on specialized disciplines makes modern medicine a complex exercise 
in logistics. For example, patients are often transferred between different medical 
services during care provision, and physicians are individuals who interact in 
different ways, etc. Health care systems evolve to account for the complexities, 
and continuity of care is challenged as a result (Adler et al., 2010).  
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This study provides confirmation of previous evidence, as it is widely stated that 
continuity is important for quality in health care delivery; however, the effect is 
found to be variable (Adler et al., 2010).  
1.8.2.1.4 Physician Attitude 
From the repertory grid data, it is revealed that physicians’ construct of quality 
includes their attitude. Physician attitude can broadly be categorized into three 
aspects: respect, humbleness and interest. Respect is suggested to be an 
element of physician attitude that may influence quality of health care provision. 
Being humble is suggested to be another element of physician attitude that may 
influence quality of health care provision by physicians. Showing interest in the 
patient and expressing empathy is another element that is suggested to influence 
quality of health care provision from a physician perspective.  
1.8.2.1.5 The Patient’s Role 
The patient plays a central role in the provision of health care. This construct did 
not meet the minimum criteria to be considered a key construct, according to the 
methods used to analyse repertory grid data. However, it is felt necessary to 
include the topic in this section in order to ensure a complete set of findings. The 
role of patients in quality of health care delivered has three aspects: firstly, 
patients exhibit state dependence; secondly, patient expectations influence 
physician decisions; and thirdly, patient delay is related to the ability to recognise 
symptoms as disease. 
Patients exhibit state dependence. In this context, state dependence is a form of 
“loyalty” to, for example, a particular physician or course of treatment. Patients 
therefore behave as if there is a cost to switching from past behavioural patterns.  
Patient expectations influence physicians’ decisions. However, the systematic 
review revealed that it is not the patients’ expectations directly, but the physicians’ 
perception of the patients’ expectations that influence decisions. The review also 
revealed that there is a gap between actual patient expectation and physician 
perceived expectation. 	
Time to diagnosis and treatment is an important factor in quality of health care 
delivery. Patients’ ability to recognize symptoms as disease is found to be a 
determining factor of time to diagnosis and hence treatment. 
1.8.2.2 Context 
The context element of quality is found to be comprised of seven constructs: 
resource availability and utilization, time, cooperation and organization, 
competency, standards of care and evaluation. 
1.8.2.2.1 Resources 
In this study, resources and resource utilization are found to be key constructs, 
as the respondents rate these factors as high. Physicians claimed that resources 
and the use of resources influence quality of health care. Resources refer to 
tangible items such as buildings, medical equipment, medicines, health care 
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professionals, etc. Physicians also claim that availability of resources is not 
enough, so appropriate utilization is also an influencer of quality.  
1.8.2.2.2 Time 
Time is an important factor in medicine, and in this study, time is related to two 
other key constructs. First, time is related to early diagnosis and treatment. In this 
context, time is the time it takes from when symptoms are recognized until 
treatment starts. Second, time is related to resources, as it is a function of 
resources available per unit time; for example, the number of physicians available 
in the emergency room (ER) at any given time will define the physician resource 
available to treat patients at that time.  
1.8.2.2.3 Cooperation and Organization 
Cooperation amongst physicians and health care workers emerged as a key 
construct. Physicians claim that quality is dependent on a team approach and its 
synergies of effect. Cooperation, therefore, is an important element in how 
physicians construct quality of health care delivery.  
1.8.2.2.4 Physician Experience 
Experience, in this research, is found to be central to quality in health care 
delivery. Physicians claim that experience has a positive influence on quality of 
health care delivery; specifically, physicians claim that more experience is better. 
In other words, the more experienced physician will be in a position to provide 
better quality health care than a less experienced colleague. 
1.8.2.2.5 Standards of Care 
With the advent of evidence based medicine, standards or clinical guidelines 
have become an increasingly important part of medicine and are often referred 
to as standards of care. Standards of medical practice also emerged as a 
significant construct of quality in health care. This is an echo of the central aspect 
of evidence based medicine (Sackett et al., 1996). Standards are also a way of 
ensuring quality control, as quality is defined by how close to the standard clinical 
medicine is being practiced. Standardized operating procedures are found to be 
an aspect of quality in this study. Procedures define the standard of care and may 
be a useful tool for quality control and improvement. 
1.8.2.2.6 Evaluation 
When asked about how they evaluate quality of health care delivery, physicians 
referred to feedback from colleagues and patients as the primary source of 
information. Being able to evaluate health care delivery is found to be a construct 
of quality in this study. From this data set, evaluation can be divided into three 
categories: measures, feedback, documentation and control.  
Measurements are an element that the data in this study suggest may influence 
quality of health care provision. Measure may be anything that is measurable, 
such as outcomes, readmission rates, hospital infection rates, etc. Feedback is 
suggested to influence quality of health care provision by the respondents in this 
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study. The feedback may be own experience, feedback from patients and next of 
kin, and outcome. Documentation and control is suggested to influence quality of 
health care provision by the respondents in this research. Evaluation is found to 
relevant in relation to quality in health care. Measurements and evaluation of 
different aspects of health care may contribute to continuous improvement, both 
on an individual as well as on a system level.  
1.8.2.3 Outcomes 
The outcome element of quality is found to be comprised of two constructs: early 
diagnosis and treatment; and effect of therapy. 
The respondents in this study claim that early diagnosis and treatment is an 
important factor influencing quality of health care delivery. Physicians also claim 
that the effect of therapy influences quality of health care, and associate effective 
therapy with quality of care. The main premise is that there is a correlation 
between the availability of effective therapy and quality of care.  
1.8.3 Enablers and Barriers to Quality of Health Care Delivery  
Project Two produced a theoretically-grounded, empirically-derived classification 
of physicians’ conception of quality in healthcare. However, information about 
enablers and barriers was missing. This project was limited in providing an 
understanding of the physicians’ role and perception of influencers of quality in 
health care.  Following from Project Two, the third project therefore looked at the 
physicians’ perspective of enablers and barriers in healthcare delivery.  
Barriers and enablers of quality health care service delivery emerged as opposite 
phenomena in this study. Thus, the presence or absence can turn a barrier into 
an enabler, and vice versa. For example, availability of time may be considered 
an enabler, and lack of time a barrier. Availability of time takes on the dimensions 
high (enabler) and low (barrier). Availability of time may therefore be considered 
an influencer, so the sub-categories of barriers and enablers in this data set may 
be considered influencers. 
There are six categories that are found to be relevant barriers and enablers: time, 
resource, competency, organization, physician and communication. The two last 
categories (physician and communication) come through as enablers, but in this 
context, all six categories are defined as barriers and enablers, based on the 
finding of the categories being mutual opposites.  
When considering the elements of quality as defined by Donabedian (1979), the 
data suggest that time, resource, competency and organization are all structural 
(context) quality elements. Physician and communication, on the other hand, are 
process elements of quality.   
A tabulated summary of the sub-categories suggested to be associated with 
quality in health care, influencers of health care and patient case validation, is 
provided in Table 1-4 Summary of findings of Project Three. The two empirical 
studies showed that physicians’ conception of quality and influencers of quality 
are identical. This is relevant because medical care belongs to the category of 
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commodities for which the product and the activity of production are identical 
(Arrow, 1963 p. 949). 
Table 1-4 Summary of findings of Project Three 






Competency Availability of necessary 
competency (knowledge, 
experience and skill) 
High - Low 
X X X 
Context 
Communication Ability to communicate, 
get and give necessary 
information in a tailored 
manner 
High - Low 
X X X 
Process 
Continuity Level of continuity of 
care 
High – Low X  X Context 
Diagnostics Ability to correctly 
diagnose patients 
without delay 
High - Low 
X X X 
Process 
Evaluation Ability to evaluate and 
learn 
High – Low X   Process 
Organization Organization of work that 
support delivery of health 
care 
High – Low 
X X X 
Context 
Patient Willingness to cooperate 
and adhere to medical 
advice given  
High - Low 




Level of experiential 
quality 
High - Low X   Outcome 
Physician 
attitude 
Ability to show and real 
interest and level of 
curiosity 
High - Low 
X X X 
Process 
Resources Availability of necessary 
technical, building and 
human resources 
High - Low 





adherence to guidelines 
High Low X   Context Process 
Therapy Ability to correctly treat 
patients without delay 
High - Low X X X Process 
Time Availability of time to do 
what is necessary 
High - Low X X X Context 
The column labelled “Quality” in the table indicates the sub-categories associated 
with how physicians conceptually frame quality in health care (derived from 
Project Two). The column labelled “Influencers of quality” indicates the sub-
categories associated with influencers (barriers and enablers) of quality in health 
care (found in Project Three). The column labelled “Patient case validation” 
indicates which sub-categories were validated from data in the 54 patient cases 
included in the data set. There are four sub-categories where the patient cases 
in the data set do not provide validation: evaluation, patient satisfaction, 
standards of care and time. Time, may be considered a subset of resource, as it 
is associated with the temporal availability of the physician as a resource in the 
delivery of health care. Thus, evaluation, standards of care and patient 
satisfaction are not validated sub-categories.  
Furthermore, the data revealed that influencers of quality in health care exert 
influence by modulating the perceived behavioural control of physicians while 
supplying effort into the delivery of health care.	
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According to the findings of Project Three, continuity of care is not considered to 
be an influencer. Furthermore, the respondents claim that discontinuity is the rule 
rather than the exception in the dataset.  
“Theoretically, one could imagine that organisational issues could have an 
impact, if for example several physicians were involved creating a breach 
of continuity in the treatment. We have to admit that breach of continuity in 
treatment is the norm in the Norwegian health care system rather than the 
exception.” (ID #: 15) 
Evaluation is not considered to be an influencer and is not validated by patient 
cases. This may indicate that evaluation is necessary for developing quality in 
health care, but does not influence quality directly. However, logically, feedback 
should provide real time learning and be a basis for experience. This researcher’s 
personal experience is that feedback is received on an infrequent basis, and may 
therefore be missed during sampling. The same arguments can be made for 
patient satisfaction; another subcategory not considered to be an influencer, and 
not validated by patient cases.  
Also, standards of care (guidelines) was found not to be an influencer. This 
finding may be due to the fact that the link between standards of care and quality 
is by way of adherence.  
“Quality is then defined as how well you managed to live up to the standard 
defined by the medical community. Decisions take place continuously and 
it is about how close to the standard you manage to practice.” (ID #: 13) 
In order to gauge adherence, it is necessary to evaluate or measure. The data in 
this study indicate that physicians do not formally measure quality. Thus, it may 
be argued that physicians do not measure guideline adherence. The results for 
standards of care, therefore, follow those of evaluation. Full details of Project 
Three can be found in Chapter 5 from page 227. 
1.9 Discussion 
In this section, the aim is to discuss what this research has revealed about the 
role of the physician in quality of health care delivery, and how it extends, support 
or otherwise existing evidence. In so doing, findings from the two empirical 
projects (Project Two and Three) are compared and integrated with the results of 
the systematic review (Project One).  
1.9.1 Elements of Quality 
Health care delivery is synonymous with medical intervention, and may be 
considered as any measure whose purpose is to improve health or alter the 
course of disease. Therefore, from a realist perspective, medical intervention 
consists of a chain of steps or processes (Pawson et al., 2004). The link between 
medical intervention as a process and quality of health care is provided by 
Donabedian (1979), who claims that quality of health care consists of three 
elements: structure, process and outcome; see Figure 1-6 Elements of quality 
(Donabedian 1979), and Section 1.3 on page 3 for a definition.   
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Pawson and Tilley (1994) argue that in order to understand the mechanism by 
which an intervention results in an outcome, it is necessary to consider the 
context under which the intervention is applied. Donabedian (1979) has 
collectively defined medical interventions as a process; one of three elements of 
health care quality. Structural elements of quality in health care are part of the 
setting under which health care is delivered, and it is therefore reasonable to 
argue that structure is a sub-set of context; see Figure 1-7 Revised quality 
elements. Below, the basis for this argument is set out. 
 
Figure 1-7 Revised quality elements 
In Project One, context emerged as a set of influencers of physician decision 
making, and three important components were revealed to be highly influential; 
see Error! Reference source not found.. Furthermore, Project Three revealed 
that bio-medical factors contextualise decision making by physicians. Diagnosis, 
signs, symptoms and disease severity across therapy areas all predict medical 
prescriptions (de Jong et al., 2009). For example, psychiatric co-morbidities in 
patients with anxiety may influence prescribing by physicians (Smolders et al., 
2007) as well as physicians’ willingness to address treatment failures (McGregor 
et al., 2007). On the basis of the systematic review and empirical findings, context 
is found to be an important element of quality.  
Donabedian (1979) defines structure in a similar way to how Pawson (2006) 
defines context, but both authors omit bio-medical factors in their definitions. This 
may in part be due to the fact that it is an integral part of the practice of medicine 
and is assumed. Nonetheless, a synthesis of extant literature and empirical 
evidence strongly suggest that bio-medical factors contextualize physician 
decision making. The findings therefore suggest that context extends beyond 
structure, and it is therefore posited that context is an important influencer of 
physician supply of effort in the delivery of health care, and that structure as 
defined by Donabedian (1979) is a sub-set of context.  
1.9.2 Ambiguity of Quality 
Although Donabedian (1979) claims that structure and process are no doubt 
related, he acknowledges that these relationships are characterized by 
complexity and ambiguity. Some scholars, for example (Ma and McGuire, 1997) 
and (McGuire, 2001), claim that that the supply of physician effort is intrinsically 
un-observable; hence, quality of health care cannot be predicted in advance, but 
only observed in retrospect. This would explain the observed ambiguity in the 
relationship between structure and process, as noted by Donabedian (1979). The 
research presented in this thesis supports this notion of ambiguity, as the 
systematic review revealed that a link between influencing factors of physician 
decision making and quality (outcomes) is missing in extant literature. 
Furthermore, from Project Two, it emerged that standards of care (guidelines) is 
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an important construct of quality. However, Project One revealed that the level of 
guideline adherence is variable (Smolders et al., 2007, Lagerlov, 2000, Chauhan 
and Mason, 2008, Nast et al., 2009, Rashidian and Russell, 2011).  In fact, it has 
been found that in some cases, more than 50% of decisions resulting in a 
prescription contradict clinical practice guidelines (Ventelou, 2010). Furthermore, 
outcomes measures of guideline implementation is largely lacking (Gill et al., 
1999). It is therefore proposed that the supply of effort by physicians when 
delivering care is not fully and accurately predictable.  
Ambiguity in the relationship between context and process is therefore dependent 
on the argument that physicians’ supply of effort in health care delivery is both 
un-observable and unpredictable. Thus, it is concluded that quality in health care 
is contingent on the unpredictable supply of un-observable physician effort. 
Herein lies the challenge for anyone hoping to understand and influence quality 
in health care.   
1.9.3 Point of Influence 
Interventions emerged as a set of factors influencing physician decision making 
in Project One, and the link to quality was found to be missing. One reason for 
this ambiguity is because the point of influence is not explicitly stated in the 
literature.  In order to address this question, the view of Pawson (2006) is 
adopted, who claims that intervention is a product of its context. Empirically, 
Project Three revealed that physicians perceive quality by what defines the 
spectrum of physicians’ choices when making decisions. Thus, the point of 
influence of interventions which emerged in Project One may reasonably be 
argued to be context; see Figure 1-8 Point of influence for interventions.  
In conclusion, it is posited that the point of influence for interventions is context.  
Hence, interventions influencing physicians’ supply of effort do so by altering the 
context under which effort is supplied. In other words, context predefines the 
spectrum of choices available to physicians when engaged in health care 
delivery. Thus, bounded decision making is the result.  
 
Figure 1-8 Point of influence for interventions 
1.9.4 Physicians’ Construction of Quality 
In this section, two aspects of physicians’ conception of quality in health care 
delivery are addressed. First, the results of the two empirical projects are 
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compared, and second, disagreement between the findings and prior research 
are discussed.  
Table 1-5 Comparison of quality constructs between Project Two and Three 




Process Communication X X TPB Attitude Ajzen 1991, p. 198 
Agency Risk: monitoring and 
negotiation 





X  TPB Control belief Ajzen 1991, p. 204 
Decision Causal vs. diagnostic 
interpretation 









for provision of 
care 
X X TPB Control belief & Social 
norm 
Ajzen 1991, p. 199 
Patient  X Agency Moral hazard & 
adverse selection 
Eisenhart 1989, p. 72 
Context Resource 
availability 
X X TPB Control belief Ajzen 1991, p. 188 
Resource 
utilization 
X  TPB Control belief Ajzen 1991, p. 188 
Time X X TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Conlon & Parks 1990, p. 





X X TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 




X X TPB Control belief Ajzen 1991, p. 203 
Agency Adverse selection Eisenhart 1989, p. 61 
Decision Habit persistence Ajzen 1989, p. 203 
Standards of 
care 
 X Decision Causal vs. diagnostic 
interpretation 
Einhorn & Hogarth 1981, 
p. 65 
Evaluation  X Decision Reinforcement: positive 
outcome feedback 
Einhorn & Hogarth 1981, 
p. 79 
Outcome Early diagnosis 
and treatment 
X X TPB Control belief Ajzen 1991, p. 204 
Agency Risk: random market 
effect 







X X TPB Control belief Ajzen 1991, p. 204 
Decision Reinforcement: positive 
outcome feedback 
Einhorn & Hogarth 1981, 
p. 79 
1.9.4.1 Comparison of Empirical Findings 
There is a close relation between influencers (enablers and barriers) and quality 
constructs. The level of investigation in both empirical projects is the patient-
physician encounter, based on real patient cases supplied by physicians taking 
part in the study. Thus, physicians’ conception of quality is linked with actual 
clinical practice, and the findings in Project Two and Three are homogenous; see 
Error! Reference source not found.. Two notable differences emerged when 
comparing constructs of physicians’ quality conception between the two empirical 
projects. First, the patient was found to be a construct in Project Three, but not in 
Project Two. The patient construct appeared in Project Two, but did not reach 
significance as per the study protocol. This was not the case in Project Three. 
Second, evaluation and standards of care emerged from Project Three as a result 
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of this topic being predefined for investigation in the protocol; see Appendix 
C.1.13 Interview Guide on page 377.  
1.9.4.2 Contradictory Findings 
Quality evidence of studies examining physicians’ conception of quality has not 
been reported in the extant literature. The constructs have previously been 
addressed separately, but not in the context of how physicians frame quality in 
health care delivery. Theoretical saturation was achieved early, at interview 17 in 
this study. It is therefore reasonable to argue that the emerging constructs reflect 
that there is strong agreement within the physician community about what 
constitutes quality in health care, which is embedded in the “medical institution” 
and practice. However, the findings are in disagreement with previous studies, 
on three points. First, the findings of cooperation and organization are not in line 
with Agency Theory. The findings of the study focus on interpersonal cooperative 
efforts between health care professionals rather than the presumed patient-
physician dyad of Agency Theory (physician agency, see Section 1.9.4.2.1). 
Second, physicians claim that experience is a construct and a strong influencer; 
however, literature is divided on whether more experienced physicians translate 
their experience into better quality of care. Third, in this study physicians 
unanimously claim that resources are lacking and that quality of care suffers as 
a consequence, but empirical studies do not support this claim.  These findings 
are now discussed in more detail.   
1.9.4.2.1 Agency 
Delivery of health care in the context of modern medicine may be considered a 
cooperative effort. According to Eisenhardt (1989) p. 72, “Agency Theory 
provides a unique, realistic and empirically testable perspective on problems of 
cooperative effort”. Thus, the principal-agent dyad may be considered a 
cooperative effort. The main tenet of Agency Theory holds that there is a conflict 
of interest between the principal and the agent. On one hand, asymmetry of 
information may drive a condition of moral hazard, and on the other, risk may 
cause adverse selection to occur. Even though the findings of this study support 
patient-physician cooperation, the main focus is on the quality of the cooperative 
effort among physicians and other health care workers. In this context, economic 
interest would drive a possible conflict of interest. However, this is not felt to be 
the case in this study due to the lack of evidence in support of this notion. 
The findings of this study suggest that how health care service delivery is 
organized may influence quality in health care. Physicians claim that health care 
service delivery should be organized so that patients have equal access, should 
ensure efficient and appropriate cooperation between different health care 
professionals providing health care according to standardised protocols, and 
should ensure a supportive work environment.  
1.9.4.2.2 Experience 
Experience emerged as a construct of physicians’ conception of quality, and the 
respondents claim that more experienced physicians are more likely to provide 
better quality care. However, in a literature review on the topic, it has been found 
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that “physicians who have been in practice longer may be at risk for providing 
lower-quality care” (Choudhry et al., 2005 p. 260). Thus, the findings in this study 
and that in the literature are contradictory.  
There may be several explanations for this finding. First, the physicians’ “toolkits” 
are created during training and may not be updated regularly (Carthy et al., 2000). 
Second, older physicians seem less likely to adopt newly proven therapies, and 
may be less receptive to new standards of care (Choudhry et al., 2005). In 
addition, practice innovations that involve theoretical shifts, such as the use of 
less invasive medical interventions (i.e., laparoscopic versus open surgical 
techniques), may take longer to adopt due to habit persistence (Coleman et al., 
1957, Coleman et al., 1959, Menzel and Katz, 1955, Kwong and Norton, 2007). 
However, when it comes to treating a particular disease, experience is an 
important indicator of quality. Studies show that physicians/hospitals that treat a 
high number of patients for a particular disease and perform large numbers of 
procedures to treat it have better results (Birkmeyer et al., 2002). Thus, 
consensus on the effect of experience on quality in the literature is therefore 
lacking. The literature points in two directions when it comes to experience. First, 
a body of evidence investigates experience at the physician level, measured by 
time in practice, and finds a paradoxical effect. Second, a body of evidence has 
examined experience in relation to specific disease and procedures, and found 
that higher numbers of patients treated reduces mortality. This may indicate that 
years in practice as a measure of experience is an inaccurate measure of 
experience.    
1.9.4.2.3 Resources 
In this study, physicians claim that increased resource availability and utilization 
will improve clinical outcomes. However, there is little evidence in the literature 
suggesting that increased resource utilization improves outcomes (Wennberg et 
al., 2002). Fisher et al. (2003) investigated whether regions with higher Medicare 
spending provide better care. The authors found that regional differences in 
Medicare spending are largely explained by the more inpatient-based and 
specialist oriented pattern of practice observed in high-spending regions, and that 
neither quality of care nor access to care appear to be better for Medicare 
enrolees in higher-spending regions (Fisher et al., 2003 p. 273). Furthermore, 
“Medicare enrolees in higher-spending regions receive more care than those in 
lower-spending regions, but do not have better health outcomes or satisfaction 
with care” (Fisher et al., 2003 p. 288).  
1.9.5 Enablers and Barriers to Quality  
Enablers and barriers of quality in health care are found to be extremes on a 
continuum; thus, they may be considered polarized limits of influencers. Project 
Two revealed key constructs representing a static picture of physicians’ quality 
conception. Project Three extend the findings revealed in Project Two by 
exploring enablers and barriers, so adopting a dynamic approach. The project 
revealed that enablers and barriers were closely linked; in fact, it was revealed 
that enablers and barriers (influencers) represent a dynamic dimension of the 
quality constructs. For example, time is both a construct of quality and an 
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influencer. Time refers to the amount of time available for a physician to spend 
on caring for a particular patient. Lack of time would be perceived as a barrier, 
and sufficient time would be perceived as an enabler of quality. Two important 
conclusions may be drawn from this example. First, time is a construct used in 
conceptualizing quality and also a factor acknowledged to influence it. Thus, there 
must exist some point along the continuum (too much time – too little time) where 
influence is exerted. This point is likely to be different from physician to physician 
and may be linked to other factors such as degree of experience. In other words, 
an experienced physician usually requires less time to get the job done than does 
an inexperienced one, and consequently, the effect of available time on 
physicians’ perception is variable. Time may also be linked to availability of 
resources and how work is organized. Second, if the time barrier did not exist, 
physicians claim that they would not do anything differently, but just more of the 
same. This suggests that perceived behavioural control is a mechanism by which 
influence on supply of effort is exerted. Furthermore, it suggests that physicians 
accept time constraints and adjust effort accordingly, thus accepting variation in 
quality. This has implications for accountability, as it is not clear whether a given 
outcome is due to physician initiated variation in effort supplied or a system driven 
variation in supply of effort.   
Physician expectancy of efficacy of medical interventions has been shown to 
influence behaviour (Denig et al., 2010). The physician takes on an expert role in 
the patient-physician dyad; and with increasing expertise, uncertainty associated 
with expectancy is reduced (McGuire, 2001). The mechanism for this reduction 
is indicated by respondents in this study to be experience of similar situations. 
Furthermore, results in this study indicate that given freedom of choice, the 
motivation may be considered constant. It could therefore be argued that 
variability in actual behaviour may be explained by the variance in perceived 
behavioural control by physicians.   
Since there is a close relation between influencers and quality constructs, it is 
concluded that physicians frame quality by the presence or absence of 
influencers on the effort supplied into the delivery of health care. 
1.9.6 Factors Influencing Physicians’ Supply of Effort  
Factors influencing physician prescribing have been widely examined. Smith 
(1977) and Gallan (2005) conducted literature reviews addressing physician 
prescription of pharmaceuticals. The research presented in this thesis differs from 
previous work on four main points. First, this research employs systematic 
literature review methodology, whereas Smith (1977) and Gallan (2005) adopt a 
non-systematic approach.  Second, the research presented in this thesis employs 
a factor analysis, thereby extending the thematic review. Third, the scope of the 
research presented in this thesis is not limited in scope to type of prescribing or 
geography; Gallan’s study was limited to outpatient prescribing in the USA. 
Fourth, the research presented in this thesis employs realist synthesis; Smith and 
Gallan did not state how the data were synthesized. Thus, this thesis presents 
the first systematic review of physician prescribing behaviour with a focus on 
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physician decision making while prescribing, identifying influencing factors and 
providing a novel classification of these factors.  
Physician habit persistence and empathy are two components of physicians’ 
characteristics that help understand the physician’s role in quality of health care 
delivery.  
In order to understand habit persistence and its implications, it is necessary to 
first define habit and to identify by which mechanism its effects are mediated. 
According to Ajzen (1987), past behaviour may reflect the impact of factors that 
influence later behaviour; however, it may not be considered a causal factor on 
its own. Thus, past behaviour cannot be assumed to be a valid measure of habit 
(Ajzen, 1991). In order to define habit as a predictive variable, it must therefore 
be defined independently of past behaviour and would capture residues of past 
behaviours (Ajzen, 1991). Attitude has been suggested to be residues of past 
experience (Campell, 1963). Thus, according to Ajzen (1991) p. 203, “the unique 
contribution of habit would lie in finding a residue of past experience that leads to 
habitual rather than reasoned response”. Habit persistence in this context does 
not fit the strict definition of habit, as it is found to be a temporal expression of 
past experience.  
Although empathy is regarded as an important element in the development of 
patient-physician relationship (Mitchell and Cormack, 1998, Dixon et al., 1999), 
evidence suggests that empathy is often lacking in modern medicine (Reynolds 
and Scott, 2000). Spiro (1992) p. 843, contends that “medical students lose some 
of their empathy as they learn science and detachment, and hospital residents 
lose the remainder in the weariness of overwork and in the isolation of the 
intensive care units that modern hospitals have become”. Furthermore, confusion 
and debate about the precise meaning of empathy exists (Reynolds, 2000, 
Mercer and Reynolds, 2002), and it is common to consider only the emotive 
aspect of empathy (Mercer and Reynolds, 2002). However, empathy is distinct 
from sympathy (Nightingale et al., 1991), and may be considered a multi-
dimensional, multi-phase construct that has several components (Reynolds, 
2000). An extensive literature review by Morse et al. (1992) summarised the 
components of empathy under four areas - emotive, moral, cognitive and 
behavioural - thus providing a conceptual framework which widens the view of 
empathy (Mercer and Reynolds, 2002).  
In this study, physicians’ conception of empathy can be illustrated by the following 
quote: “the ability to understand the patient’s situation and feel with the patient, 
ability to see the situation from the patient’s perspective and thus better 
understand the patient’s needs” (ID# 13). 
Different kinds of attitudes may be distinguished along two lines: affect and 
evaluation (Ajzen and Timko, 1986, Bagozzi, 1986, Bagozzi, 1989, Ajzen, 1991). 
There is evidence to suggest “a convergent and discriminant validity of the 
affective and evaluative measures of beliefs and attitudes” (Ajzen, 1991 p. 201). 
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1.9.7 Mechanism by Which Influence on Physician Effort is Exerted 
In this thesis, three theoretical domains are combined to form a theoretical lens 
to enable a better understanding of the complexities of quality in health care 
delivery. The research undertaken was carried out in three separate research 
projects. Project one, the systematic literature review, found that factors 
influencing physicians’ control beliefs are strong influencers of physician decision 
making when prescribing. For both contextual and interventional factors, the 
Theory of Planned Behaviour plays a central role (see Section 4.2 from page 
169), and has revealed an empirically derived and theoretically grounded 
classification of physicians’ conceptions of quality in health care. The majority of 
the constructs map to control beliefs as the central theoretical construct; see 
Table 1-3 Key constructs by quality elements and relation to theory. Project Three 
identified physicians’ perception of enablers and barriers (influencers) to quality 
in health care delivery. Influencers were found to be the same as the quality 
constructs identified in Project Two - the majority of the constructs map to control 
beliefs as the central theoretical construct; see Error! Reference source not 
found.. 
In summary, factors influencing physician decision making while prescribing, 
constructs forming physicians’ construct of quality, and enablers and barriers are 
all strongly related to control beliefs and perception of behavioural control; see 
Error! Reference source not found. and Error! Reference source not found.. 
Control of volition is an underlying assumption of TPB (Ajzen, 1991). Evidence in 
Ajzen’s study strongly suggests that perceived behavioural control is a central 
mechanism by which enablers and barriers exert influence. In an ideal world 
where barriers do not exist, physicians will not do anything differently other than 
do more of what they are already doing. Thus, the evidence indicates that 
physicians will not change what they are doing, but effort supplied by physicians 
may be influenced. It is therefore argued that “the will to act” (behavioural intent) 
is present in a clinical setting, and may be considered a constant. As such, it is 
possible for the TPB constituents, attitude and social norm, to be considered 
constant in a clinical setting.  
From a practitioner perspective and personal experience, this makes sense, as 
the drive to help others may be considered strong in the medical profession 
because there is a concern for medical ethics (Arrow, 1963). Thus, the 
combination of both intent and perceived behavioural control may be used to 
predict actual behaviour, as asserted by Ajzen (1991) p. 184. Keeping 
behavioural intent constant, the probability of actual behaviour becomes 
dependent on perceived behavioural control, which in TPB, is assumed to be 
dependent on prerequisite opportunity and resource. The availability of requisite 
opportunities and resources (e.g., time, money, skills, cooperation of others) 
collectively represent physicians’ actual control over behaviour related to health 
care service delivery (Ajzen, 1985, Ajzen, 1991 p. 182) 
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1.9.8 Role of the Physician 
The research contributing to this thesis adopts the physician’s perspective as it 
is assumed that the physician plays a central role in contributing to quality in 
health care. At this stage it is therefore natural to consider the evidence of the 
physicians’ role in this regard. In order to address the physicians’ role in health 
care, the following rhetorical question is posed: what is the physician’s role and 
how does the role influence quality in health care? The question will be answered 
by providing seven claims supported by literature and empirical findings in this 
thesis:  
1. Access to medical care requires physicians’ concurrence and initiative 
(McGuire, 2001).  
2. Physicians make decisions on behalf of patients and stakeholders in 
health care (Vogel et al., 2003). Thus, the supply of effort by physicians 
into the delivery of health care is decision making. The context of physician 
decisions is that of information asymmetry (McGuire, 2001), and hence 
uncertainty (Arrow, 1963).  
3. Habit persistence is a strong driver of physician decision making (Section 
1.8.1.1.1 from page 22).  
4. The effort supplied by physicians is unobservable (Ma and McGuire, 1997, 
McGuire, 2001) and unpredictable (Section 1.9.2 from page 34).  
5. Physician effort defines the process element of quality, and is even 
considered to be equal to quality by some scholars; for example Ma and 
McGuire (1997) and McGuire (2001).  
6. Physicians perceive quality by what defines the spectrum of choice 
available when making decisions (Section 5.5.5 from page 266).  
7. Physicians do not formally evaluate quality of effort supplied (Section 
5.5.1.6 from page 246).  
It is clear that the physician has a central role in health care, and thus plays a key 
role in quality in health care. However, there is evidence to suggest that the 
physician’s role and link to quality is ambiguous, and that if left uncontrolled, it 
could be detrimental to quality. For example, large numbers of patients are injured 
or die as a result of preventable medical errors (Kohn et al., 1999), and change 
is difficult because physicians are in a position to invoke the concept of risk 
associated with any change in service delivery (Currie et al., 2013). Change is 
needed, and the evidence presented in this thesis provides the foundation for a 
way forward. 
1.10 Contribution to Knowledge  
In this section, each contribution to scholarship from this research is presented. 
This thesis offers insights around quality in health care delivery that go beyond 
prior related studies, thus contributing to knowledge in various ways. These are 




Table 1-6 Contributions to knowledge 
Domains of 
contribution 
Extent of contribution 
What has been 
confirmed? 
What has been 
developed? 




Validity of Donabedian’s 
systems approach to quality  
Validity of TPB in a health 
care context 
Validity of Agency Theory in 
a health care context 
No uniform theory of 
medical decision making 
has been formulated 
Extension of Donabedian’s 
model of quality to include 
context (Section 5.6.1.1) 
Bio-medical contexts define 
spectre of clinical outcomes 
(Section 5.6.1.2) 
Predominant influencer of effort 
supplied by physicians  is 
perceived behavioural control 
(section 5.6.4.2) 
Multiple principals lead to 
loyalty conflicts (physicians 
remain loyal to patients on 
account of system) (Section 
3.4.4.1) 
Physician provision of decision 
effort is unpredictable (Section 
5.6.1.2) 
Established link between 
three hitherto separate 
theoretical domains: agency, 
Decision Theory and Theory 
of Planned Behaviour 
(Section 5.6.5) 
Antecedents to clinical 
outcomes (time to and 
correctness of diagnosis and 
therapy) are more reliable 
indicators of quality than 




Methods Systematic review validated 
as a method in 
management and 
organizational studies 
Repertory grid technique 




technique validated as a 
method in management and 
organizational studies 
Extending thematic synthesis 
approaches in systematic 
review by novel use of factor 





Validity of Donabedian’s 
systems approach to quality  
Validity of TPB in a health 
care context 
Validity of Agency Theory in 
a health care context 
No uniform theory of 
medical decision making 
has been formulated 




Bio-medical contexts define 
spectre of clinical outcomes 
(Section 5.6.1.2) 
TPB on its own not sufficient to 
explain phenomena of interest 
(Section 5.6)Agency on its own 
not sufficient to explain 
phenomena of interest (Section 
5.6) 
Decision Theory not sufficient 
to explain phenomena (Section 
5.6) 
 
New classification of 
influencers of physician 
decision making (contexts 
and interventions, Section 
3.4) 
Theoretically based and 
empirically derived 
classification of physicians’ 
conception of quality (Section 
4.5) 
Quality constructs identified 
as influencers (physicians 
define quality by what defines 
their spectre of choice) 
(Section 5.6.1.3) 
A categorisation of 
physicians’ perceived 
enablers and barriers to 
quality health care and the 
mechanisms by which they 
(Section 5.5.4 and 5.5.5) 
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This research makes five contributions to knowledge. First, a novel classification 
of factors influencing physician decision making when prescribing is developed, 
providing new understanding of the link between these factors and quality of 
health care (see Section 3.4). Second, the systematic review shows an innovative 
application of factor analysis to structure the findings of a complex phenomenon 
(see Section 3.3.2). Third, the study presents a new conceptualisation of 
physicians’ construction of quality in health care (see Section 4.5). Fourth, the 
research provides a categorization of physicians’ perceived enablers and barriers 
to quality health care and the mechanisms by which they operate (see Section 
5.5.4 and 5.5.5). Finally, this research develops a theoretically-grounded and 
empirically-informed conceptual model that incorporates three hitherto separate 
domains: agency, planned behaviour, and decision theories (see Section 5.6.5). 
This model provides a new integrated lens to better understand the complexities 
influencing quality in health care delivery.  
1.10.1 Classification of Factors Influencing Physician Decision 
Making when Prescribing 
The thesis provides a novel classification of factors influencing physician decision 
making when prescribing. Hitherto, no comprehensive systematic review on the 
topic has been produced. Two sets of influencing factors emerge from Project 
One: context and interventions (see Chapter 3). The research presented in this 
thesis differs from previous work on four main points. First, this research employs 
systematic literature review methodology, whereas Smith (1977) and Gallan 
(2005) adopt a non-systematic approach. Second, the research presented in this 
thesis employs a factor analysis, thereby complementing the thematic synthesis 
used in systematic review. Third, the scope of the research presented in this 
thesis is not limited in by type of prescribing or geography; Gallan’s (2005) study 
was limited to outpatient prescribing in the USA, which health care system is 
different from that of other countries. Fourth, the research presented in this thesis 
employed realist synthesis (Pawson et al., 2004) providing an degree of 
transparency and audit trial not seen in Smith (1977) and Gallan (2005). Thus, 
this thesis presents the first systematic review of physician prescribing behaviour 
with a focus on physician decision making while prescribing, identifying 
influencing factors and providing a novel classification of these factors. The aim 
of factor analysis is to determine the factors accounting for the structure between 
the variables (Fabrigar et al., 1999).  Information about the use of factor analysis 
as an approach in systematic reviews is limited. However, factor analysis has 
been used as an approach in the development of a measurement tool to assess 
the methodological quality of systematic reviews (Shea et al., 2007). 
1.10.2 Factor Analysis in Synthesising Systematic Review 
The key purpose of systematic review is to locate, critically appraise and 
synthesise the best available evidence in a particular domain (Tranfield et al., 
2003). Systematic review is useful in providing audit trial and transparency about 
the decisions made during the research process. The synthesis of the findings in 
a review, may be subject to some bias. Thus, in this thesis an innovative 
application of factor analysis to structure the findings is developed.  
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Using the data variables captured during the review, a categorical coding 
structure was constructed. Data were then evaluated using a measure of 
sampling adequacy and analysed to identify correlations between the variables 
exist to ascertain the appropriateness of the factor analysis of the data. This novel 
procedure provides additional rigour to the synthesis of the systematic review.    
1.10.3 Conceptualization of Physicians’ Construction of Quality 
The thesis provides a classification of physicians’ conception of quality.  Project 
Two (see Chapter 4) identified eleven constructs making up physicians’ 
conception of quality in health care delivery. Project Three (see Chapter 5) 
confirmed 10 of the constructs identified in Project Two, and added two further 
constructs. The constructs were categorized making use of established elements 
of quality in health care (Donabedian, 1988), thus providing granularity to the 
elements of quality; see Table 1-3 Key constructs by quality elements and relation 
to theory. Hitherto, there is no research providing an empirically-supported 
classification of how physicians frame quality in health care.	
1.10.4 Categorization of Enablers and Barriers and Mechanisms of 
Influence 
Enablers and barriers emerged from the data and were revealed to be almost 
identical to the constructs making up physicians’ conception of quality (see 
Section 5.5.4). Enablers and barriers emerged as the two poles in the quality 
constructs continua, and as key factors in explaining the degree of physician’s 
effort in providing quality health care. To date, exploration of physicians’ 
perceptions of enablers and barriers to quality in health care delivery is limited. 
The implication of this finding is that physicians define quality by what defines the 
spectrum of choice available when making decisions. 
The synthesis of data from all three projects presented in this thesis revealed a 
strong theoretical link to the Theory of Planned Behaviour; specifically control 
beliefs and perceived behavioural control into the phenomenon of physicians’ 
decision-making (see Section 5.5.5.). In the empirical research, physicians 
claimed that if barriers were not present, they would simply do more of what they 
are already doing to enhance quality in health care. Thus, empirical evidence 
suggests that the mechanism by which influence is exerted on physicians’ supply 
of effort into the delivery of health care is perceived behavioural control. This 
finding is empirical validation of the predominant mechanism (perceived 
behavioural control) revealed in Project One (see Chapter 3). 
1.10.5 Conceptual Model of Quality in Health Care 
In order to help conceptualise the complex phenomenon of influencers, contexts 
and mechanisms of quality in health care service delivery, this thesis provides an 
integrated framework grounded in constructs from Decision Theory, Agency 
Theory and the Theory of Planned Behaviour, see Figure 1-9 Conceptualization 
of physicians' role in health care delivery. The flow of the conceptual model is 
now explained. 
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The ‘moment of truth’ in medicine takes place when patient and physician interact 
(Sokol, 2010). The primary reason for this interaction is that the patient has an 
unresolved medical need. Patient-physician interaction in an agency context 
mandates patient engagement in the process of work delegation, as is evident 
from the findings of this study (see Section 4.5.4 and 5.5.2.1). When presented 
with a patient’s medical need it is the physician’s perception of this need (patient 
expectation) that is the main influencer of physician behaviour (Mangione-Smith 
et al., 1999, von Ferber et al., 2002, Hyde et al., 2005, Lado et al., 2008). In the 
agency context, the patient (principal) delegates work to the physician (agent). 
The physician supplies effort into the production of health care; however, the 
effort cannot be observed and can therefore not be predicted in advance.  
Why can effort not be predicted in advance? The patient interaction takes place 
in the context of information asymmetry and uncertainty. Since the physician is 
the “expert”, he/she holds more information than the patient, and this creates a 
situation of information asymmetry.  However, the physician is not “all knowing”, 
and thus makes decisions under conditions of uncertainty. Since it is not possible 
to know what the physician knows when deciding to supply the effort, it is also 
not possible to predict the effort in advance - but it can be observed in retrospect. 
Evidence presented in this study suggests that contextual (see Section 3.4.1 and 
5.5.1), structural (see Section 5.5.1) and procedural (see Section 5.5.2) 
influencers may determine the supply of effort by the physician in the delivery of 
health care. 
Since, according to Agency Theory, it is not possible to predict the behaviour of 
a physician in advance, the question of interest is: what influences physician 
behaviour (effort)? From the Scoping Study (see Chapter 2) and the Systematic 
Review (see Chapter 3) several theoretical frameworks were identified to 
describe behaviour, but the Theory of Planned Behaviour (TPB) is the one that is 
most widely studied and recognized to predict behaviour in a health care context 
(Godin et al., 2008).  
What is effort in this context? Physicians supply health care by diagnosing and 
treating patients when performing their duties; i.e., the physician takes a course 
of action resulting in a diagnosis and treatment. Thus, effort in the context of 
health care may be considered as the actions associated with diagnosing and 
treating patients.  
TPB holds that attitude, social norm and perceived behavioural control influence 
behavioural intent, the antecedent to actual behaviour (Ajzen, 1991). The findings 
of this study suggest that perceived behavioural control is an influencer of 
physician behaviour when delivering health care. Perceived behavioural control 
is about the freedom to act. Consider the following quote from the empirical data 
in Project Three (ID #11): 
“Interviewer: what facilitates you delivering good quality health care 
services? 
Respondent: freedom to act.” 
Interviewer: what you mean by freedom to act? 
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Respondent: that I have time, resources and a team to do the job. This is 
in line with new public management, where I believe that the most benefit 
will be achieved by giving me the freedom to act.” 
 
 
Figure 1-9 Conceptualization of physicians' role in health care delivery 
What influences the freedom to act? TPB is based on the assumption of volitional 
control, and holds that there are two levels of perceived behavioural controls: 
external and internal (Ajzen, 2002). The external level is related to external 
structural elements; for example, ‘I cannot perform the surgery because I do not 
have a scalpel’. The internal level is more abstract and relies on whether one 
believes that one can succeed when the external level is satisfied; for example, 
‘I have the scalpel, but I am not sure I am competent to perform the surgery’.   
Finally, the effort supplied into the production of health care results in an outcome 
at the patient level; however, the outcome does not influence the perceived 
behavioural control. Past behaviour, or experience in this context, is important 
because perceived behavioural control may mediate past experience on later 
behaviour (Ajzen, 1991 p. 204). Thus, outcome may influence later behaviour. 
The empirical data from Project Three (see Section 5.5.3) reveal that diagnosis 
and therapy are more reliable indicators of quality than clinical and experiential 
outcomes.  
 48 
1.11 Contributions to Management Practice 
The nature and aims of a DBA specify that a clear contribution to knowledge in 
the context of managerial practice is demonstrated, and that the potential impact 
of the research on organisational performance and/or managerial effectiveness 
is articulated.  
This research has enabled the author to make two significant contributions to 
practice in the context where he works as Director of Medical Division and Chief 
Medical Officer of Akershus University Hospital (AHUS). First, the findings have 
helped initiate discussions about the transformation of the pharmaceutical 
industry’s business model in Norway, evolving from business-to-person to 
business-to-business. Second, the findings have served as a catalyst to drive 
organizational changes in AHUS, the hospital with Norway’s largest emergency 
unit; see Table 1-7 Contributions to management practice.   
Table 1-7 Contributions to management practice  
Domains of 
contribution 
Extent of contribution 
What has been 
confirmed? 
What has been 
developed? 




Context and interventions 








are found to largely found to 
have persuasive intent  
 
Pharmaceutical business 
model is so far largely based 
on B2P 
 
Understanding and reducing 
information asymmetry in 
health care is key 
Measuring antecedent to 
clinical outcomes can reduce 
the intrinsic information 
asymmetry 
Antecedents to clinical 
outcomes introduced as 
measures of quality in 
Emergency Room 
 
Experienced physicians see 
patients first  
 
Pharmaceutical industry are 
not allowed to see physicians 
(new policy)  
 
Move to a B2B model is being 
piloted in collaboration with 
industry association 
1.11.1 Pharmaceutical Industry’s Promotion Approach 
The systematic review of the literature provided evidence that pharmaceutical 
promotion in its various forms influence physicians’ decision-making. A central 
assumption is that pharmaceutical promotion does more good than harm in terms 
of overall health care outcomes. However, for this assumption to be true, 
promotion must influence physicians to increase their effort into the delivery of 
healthcare. The systematic literature review and the two empirical projects did 
not reveal any evidence in support of this.  
Project One revealed that pharma promotional efforts influence physician 
decision-making, however a link to quality was found to be missing from extant 
literature reviewed. Project Two and Three revealed how physicians construct 
quality, what factors influences quality and the mechanism of influence. Pharma 
promotion was not revealed to be a key factor influencing quality in Project Two 
or Three, in fact it was not mentioned as a contributor to quality by any of the 
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respondents. However, provider factors were found to be strong contextual 
influencers of quality. The author therefore argues that there is a break in 
strategic and operational alignment between provider and producers in the health 
care value chain. Because of these findings, changing the pharma business 
model from direct-to-physicians promotion to business-to-business ensuring 
alignment of strategic and operational activities were embarked upon. 
The following figure explains this phenomenon. The proposed model would be 
that representatives of the pharma industry, interact on a strategic level with 
provider representatives and share their knowledge. In addition, within an 
ongoing dialogue, they discuss the best therapies for the patient population 
served by the provider. The resulting provider strategies are then acted upon by 
physicians who treat patients, observe outcomes and feed these back to the 
provider representatives, for example hospital management. Then pharma 
representatives and provider representatives jointly discuss how to improve 
patient outcomes. In this context, conversation, dialogue and exchange of best 
practice takes place at an organisational level. The proposed model aligns 
strategy and operational activities to balance levels of pharma influence and 
information. Thus, ensuring unbiased medical decision-making by physicians 
while delivering health care. 
 
Figure 1-10 Proposed and current pharma promotion models  
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As stated, the literature review revealed that the link between pharmaceutical 
promotion and clinical outcomes linked to quality of care is missing, which 
characterises the current model in most countries. What happens is that 
pharmaceutical sales representatives directly influence physicians in their-
decision making. The dialogue on a strategic level between producer and 
provider representatives are missing, thus buy passing provider governance of 
pharma influence on medical decision-making. 
Health care providers’ overarching strategy centres on maximizing value for and 
outcomes for patients whereas producers’ strategic intent is to maximize 
shareholder value. This research suggests that one way to achieve higher degree 
of alignment between providers and producers is to move away from the current 
business model adopted by the pharmaceutical industry which origins can be 
traced back to 1890 with the introduction of the “detail man” (Leffler, 1981). 
Current evidence suggest that 70 % of promotional spend is direct to physician 
and the remaining direct-to-patient (only permissible in two markets, USA and 
New Zealand). Pharmaceutical companies employ a large, but diminishing sales 
force to deliver the (direct to physician) marketing strategy. A major factor for this 
diminishing numbers is the reduced effectiveness of pharmaceutical sales forces. 
For instance, readily available clinical information through the internet, is 
questioning the traditional role of ‘information provision’ of large pharmaceutical 
field sales forces. Consequently, over the last few years we have seen the 
industry shifting its focus from large promotional expenditures into cost 
optimisation, employing multiple channels and electronic communication more 
effectively. It must be said that the target of this ‘new’ marketing approaches is 
still the physician.  
The author argues that changing the business model of pharmaceutical 
promotion from person-to-person to business-to-business is necessary. Such a 
change allows for strategic and operational alignment between health care 
providers and the producers of medicines in a health care value chain context. 
This change requires a change in the mind set of current and future 
pharmaceutical marketers from a focus on directly influencing physician decision 
making to an emphasis on aligning promotional objectives and activities with 
provider strategy for quality health care delivery. Current practices in the 
pharmaceutical industry (pharma) favour internal recruitment/promotion to 
occupy senior sales or marketing positions. The evolution of the model from a 
focus on the person to a focus on the organisation is unlikely to be realised given 
that the necessarily skill sets to articulate and implement this new paradigm is 
outside the ‘comfort zone’ of the current community of marketers in pharma. 
Thus, the author argues that a move away from the current practice of recruiting 
managers and executives with a (increasingly irrelevant) pharma sales 
background is necessary. The services industry has a long heritage of innovation 
in service contracts. The engineering sector has adopted a product-service 
systems that could be used as a template in pharma to initiate and progress the 
change in the marketing approach.  
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Is such a change possible? The author contends that it is possible to change 
established pharmaceutical promotion practices. Below a promising case 
provides evidence of this possibility. 
Based on insights that emerged from conducting this research, strict policy 
changes governing the interaction between industry and health care personnel 
have been implemented in Akershus University Hospital (AHUS). In short, the 
policy prohibits all contact in a promotional context, as pharmaceutical promotion 
is largely found to have persuasive intent. The Pharmaceutical industry’s 
persuasive efforts may influence physician decision making, and hence influence 
quality of health care delivery in ways not necessarily optimal for the patient (see 
Chapter 3). As a consequence of the policy, industry access to physicians in 
AHUS is now very limited.  
The CEO of the Norwegian Pharmaceutical Industry Association (LMI) asked for 
a meeting in August 2012 to discuss the situation. The meeting resulted in an 
agreement to investigate the possibility of piloting a new model for interaction 
between the pharmaceutical industry and physicians at AHUS. The author was 
asked to speak on the topic at the yearly LMI strategic seminar in October 2012. 
Furthermore, he was asked to address the topic at the health care regions yearly 
procurement conference in November 2012. He has collaborated with a 
representative for LMI (Pål Rydstrøm) to present to the board of directors the pilot 
project in May 2013. The presentation was well received and has resulted in a 
mandate for a pilot for a business-to-business model based on alignment of 
strategy and goals between pharma companies and the hospital. Finally, the 
author has addressed the topic at the national company conference for Glaxo 
Norway on August 6th 2013, and has been invited back by the CEO to discuss 
models for a cooperative effort within the health care industry in Norway. 
1.11.2 Hospital Management 
The evidence that emerged from this research (Project Two and Three) was 
unequivocal in suggesting that the key constructs defining quality in health care 
from a physician’s perspective are early and correct diagnosis accompanied by 
appropriate and timely treatment. Thus, it the factors influencing these key quality 
constructs are important for quality in health care. Therefore, we conclude that 
experienced physician effort should be introduced as early as possible in the 
process of providing care to patients. Placing experienced physicians 
(specialists) in the front line, that is, in the first encounters with patients improves 
accuracy of diagnosis, and appropriateness of treatment. It reduces effort needed 
in decision-making since decisions are made quick, first think and at the point of 
delivery. However, this is not how most hospitals around the world are organised. 
Often a physician in training, thus with limited experience sees the patient first. 
Typically, specialist services are provided at a later stage of clinical care.  
Time as a key quality construct, relates to the period that the physician has 
available for the patient. Thus, time is a valuable resource for physicians. 
However, time is relative and related to experience in that more experienced 
physicians typically spend less time making clinical decisions and chose 
appropriate care levels more often than their inexperienced counterparts do. 
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Thus, time relates to quality, but should be considered in combination with 
experience. Thus, more experienced physicians on the front line of the clinical 
operations not only provide earlier and correct diagnosis and treatment, but also 
increase efficiency of care delivered. For example, increased efficiency in the 
emergency room will lessen the potential for overcrowding, which has been 
associated with increased premature death (30-day mortality rates).  
Communication emerges as a key construct of how physicians construct quality. 
Clinical communication amongst physicians? is important for both arriving at a 
correct diagnosis and treatment, and for enhancing experiential quality. In fact, at 
the author’s hospital approximately 80 % of complaints from patients are related 
to communication. Thus, focusing on clinical communication training will 
influence both technical and experiential quality elements.  
Coordinated resource input emerged as a key construct of quality in health care 
delivery. Patients seldom come with only one ailment, thus a combined effort of 
experienced physicians is often necessary. Coordination of these efforts in time 
and space often bring about challenges, but can be addressed by implementing 
defined patient pathways for tailored for large patient groups such as myocardial 
infarction, heart failure, dyspnoea, chronic obstructive lung disease, etc. Thus, 
defining level of physician experience levels necessary at the different stages of 
clinical care. Clarity of necessary experience levels coupled with development 
plans ensure a match between patient need and physician experience.  
Continuity of care also emerged as a key construct in health care quality and is 
related to information integrity and efficiency of care. Continuity of care increases 
information integrity by reducing the number of information exchanges. 
Information integrity is an important aspect of patient safety. Furthermore, 
repeated questions about similar issues can be avoided, thus increasing 
confidence and experienced quality. Efficiency of care increases due to a 
reduction in duplication of efforts.    
The findings of this thesis, Project Two and Three, revealed that physicians 
construct quality of health care by saying that expertise should be provided in a 
way that facilitates early diagnosis and correct treatment. Project Three identified 
experience as a key influencer of quality related to the accuracy-effort framework 
of medical-decision making. Because of these findings managers may go about 
improving quality by ensuring that 1) quick and correct diagnosis is performed 
and that 2) appropriate and timely therapy is provided.  Therefore, these 
managerial changes were embarked upon 1) match physician experience with 
patient needs 2) ensure sufficient time for a physician to be with the patient 3) 
focus on medical communication skills in clinical practice 4) coordinate resource 
input with patient needs 5) ensure information flow and increase efficiency by 
focusing on continuity of care. Thus, this research provide a framework for 
managers to systematically examine and evaluate factors influencing quality in 
health care delivery. Below the author provides an example of a practical 
application in clinical practice. 
During 2010, Oslo and the surrounding area of the Norwegian capital (Oslo) was 
subject to a reform, including the closure of one hospital (Aker Sykehus), resulting 
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in movement of large patient populations between the remaining hospitals in the 
area. During 2011, 160 000 inhabitants were transferred from Oslo to AHUS, 
resulting in a population base of 460 000 inhabitants for the hospital, which was 
originally designed for a maximum capacity of 360 000. AHUS has become the 
largest emergency care hospital in Norway, serving approximately 10% of the 
population. These changes have resulted in “overcrowding” both in the 
emergency room (ER) and wards (Svendsen, 2012, Drabløs et al., 2012), and 
quality of health care service delivery was publicly criticized (Lunde et al., 2012, 
Holden et al., 2012), also by the county medical officer (Hvidsten, 2012). In 
addition, there has been a widespread call for change among health care 
professionals (HCPs) working in the hospital. Furthermore, it is widely stated that 
ER (Hoot and Aronsky, 2008) and ward (Forster et al., 2003) overcrowding 
influence quality of health care delivery, as evident by its impact on post 
discharge mortality rates (Richardson, 2006). Thus, the need for change was 
evident. 
The findings presented in this thesis (Project Two and Three) informed driving 
changes in how the ER services are being organized and provided in AHUS.  
Four main changes relating to the conception of quality of health care delivery by 
physicians have been implemented. First, the workload (informed by data in 
Section 4.5.3.11) of physicians has been addressed by changing working hours 
and shortening periods on call from 16 to 12 hours. Second, the number of staff 
available (informed by data in Section 5.5.1.1) in the ER follow patient volumes 
at given time of day and week; this provides a better distribution of health care 
professional (HCP) resources per patient. Third, a team based organization 
(informed by data in Section 4.5.3.3 and 5.5.1.4) pairing one physician and two 
nurses responsible for two ER examination rooms has been implemented; this 
eradicates duplication of work effort and increases the quality of communication 
between HCPs in the ER (informed by data in Section 4.5.3.1 and 5.5.2.3). 
Finally, patients are seen by an ER specialist first (as of September 2nd 2013) 
(informed by data in Section 4.5.3.7 and 5.5.1.1.2), ensuring immediate specialist 
evaluation rather than partial generic diagnosis (informed by data in Section 
4.5.3.5 and 5.5.3.1).  
The changes implemented were subject to extensive media coverage (Storvik, 
2013) and have provided a much needed reprieve from the negative media focus 
during 2012 and 2013; even the patient ombudsman publically applauded the 
changes (Bakke, 2013). The changes were also reviewed at a meeting with the 
county medical officer in June 2013, and the report was positive in that no further 
follow-up was required. These interventions were directly informed by the findings 
of this research and the in-depth insights developed in conducting the research 
projects.   
1.11.3 Policy Change 
As a result of the changes, a national debate has been initiated, involving the 
Prime Minister (Barth-Heyerdahl, 2013), Minister of Health (Bakke, 2013) and the 
Director of Health (Hallgren, 2013), on how hospital emergency care can best be 
provided at a national level. In addition to the Minister of Health, the leaders of 
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five political parties have visited the ER in AHUS to see and to get first-hand 
experience of the changes that have been implemented and how they are helping 
deliver a better care and a better experience for the patient.  
The ensuing public debate has resulted in three further indirect contributions.  
First, AHUS has been asked to participate in an advisory board to the Minister of 
Health, with the focus on ER services in Norway. Second, AHUS has been 
selected as Centre of Excellence in the region, with the provision of one million 
NOK (approximately 110 000 GBP) per year over a three year period for research 
and further development of the concept. Finally, competency requirements and a 
new specialty in emergency medicine was in the party program for two of the 
major opposition parties (Conservative party and Progress party) that were 
running for the national elections that were held on September 9th 2013. After the 
election, the Conservative and Progress parties initiated discussion leading to the 
formation of a new coalition government on October 16th 2013. The following 
sentence can be found on page 43 of the document outlining the political platform 
for the new government: “The government will implement competency criteria in 
emergency rooms and a new medical specialty in emergency medicine.” 
1.12 Implications of the Research 
In this section, implications for stakeholders in the health care value chain are 
discussed, which are payers, providers and producers. Payers refers to 
policymakers, regulators and payers. Providers refers to hospital management 
and practitioners (physicians). Producers refer to the pharmaceutical and medical 
technology industry. In addition, institutions are added, as there may be 
implications for medical education and research. Finally, implications for patients 
are also provided.  
Deriving guidelines for policy making and practice from research is in itself a 
complex phenomenon. Realist synthesis and evaluation (Pawson et al., 2004) 
emerged as an approach to synthesise ‘what works, for whom, in which 
circumstances…’. The realist synthesis methodology suggested by Pawson et al. 
(2004) is  focused on gaining insights from the respondent perspective about the 
relationship between context, intervention, mechanism and outcomes (CIMO). 
Pawson (2006) states that “the generative model calls for a more complex and 
systemic understanding of connectivity. It says that to infer a causal outcome (O) 
between two events (X and Y), one needs to understand the underlying 
generative mechanism (M) that connects them and the context (C) in which the 
relationship occurs”. Thus, intervention may be considered the trigger for change 
(Pawson, 2006 p. 27). In this context, interventions aim to change health status. 
Mechanisms describe what it is about the intervention that triggers change to 
occur. Pawson (2006) p. 23, defines mechanisms “as engines of explanation in 
realist synthesis”, as “we rely on mechanisms to tell us why interconnections 
should occur”. Employing the CIMO logic to the results in this study is of value, 
as it helps derive clear implications for policy and practice.  
The context in which this study is conducted is that of funded (e.g. prepaid) health 
care. When health care is prepaid, fee for service does not regulate demand 
(Friedman and Gould, 2007). The consequence for the physician in this context 
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is that the physician does not have mechanisms at his/her disposal to regulate 
demand (McGuire, 2001). Thus, if demand increases and resources are fixed, 
the effort per patient may decrease as a result. Evidence from this study suggests 
that physicians adjust effort into the delivery of health care in line with demand. 
Physicians therefore seem to accept variability in effort as a consequence of 
variability in demand. However, empirical data revealed that physicians’ believe 
this to result is lower quality.  
It is also possible for an employer to take advantage of a physician’s ethical 
constraints and organize health care delivery in such a way that the physician is 
forced to supply more effort to make sure the patient attains an acceptable 
outcome (McGuire, 2001 p. 61). In other words, an employer may provide limited 
resources and hope that physicians’ loyalty to patients will make the physicians 
provide the necessary effort. This case would be an example of how the health 
care service delivery is organized and resourced.  
Intervention in the CIMO context is to be understood as physician effort supplied 
into the delivery of health care, and consequently, quality in health care. The 
underlying generative mechanism is the physicians’ perception of behavioural 
control. Outcome is considered as quality in health care. Therefore, in a context 
of prepaid health care, physician effort supplied into the production of health care 
is dependent on the physicians’ perception of behavioural control of that effort. 
Therefore, the implication is that quality in healthcare is dependent on 
empowering physicians’ to make bounded decisions in a complex context. 
1.12.1 Implications for Payers 
Payers in this context refers to payers in the health care value chain, as defined 
by Burns et al. (2002). However, in addition to payers and financial 
intermediaries, policy makers and regulators are considered in this section. The 
reason for the inclusion of policymakers and regulators is that they influence and 
regulate the fiscal policies supporting the health care value chain.  
The findings of this study may be of interest to payers for three main reasons. 
First, payers by way of simple monitoring and incentives, leave a great deal of 
authority concerning diagnosis and treatment with the physician (McGuire, 2001 
p. 527). In other words, physicians are free to make clinical choices that drive the 
cost without being responsible for the financial outcome of the choice. Second, 
over reliance on medical sub-specialization and physician experience may have 
a paradoxical effect on quality of health care delivered (Choudhry et al., 2005). 
Finally, there is a lack of evidence supporting the hypothesis that more is better 
when it comes to cost of health care (Wennberg et al., 2002). In this study when 
physicians were questioned about barriers to quality in health care they revealed 
that they believe that more material and human resources equate to improved 
quality. 
1.12.2 Implications for Health Care Institutions (Providers) 
In this case, the central provider is the physician; however, in the context of 
practice characteristics, it may also be larger organizational units such as 
hospitals. For simplicity, the physician will suffice, as the review has not revealed 
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practice characteristics being a potent influencer on physician prescribing 
behaviour.  
This study provides important insights for institutions for three main reasons. 
First, the supply of physician effort is strongly linked to quality in health care 
delivery. Thus, health care organization may be able to influence quality in health 
care by considering factors influencing physicians’ supply of effort and the 
underlying mechanisms for such influence. Second, the study shows how 
institutions are organized and resourced may influence quality in health care. 
Finally, this study suggests that physician competency is an influencer of 
physicians’ supplied effort, and hence quality in health care. Thus, the importance 
of medical training should not be underestimated.  
Health care organisations would benefit from considering the findings in this study 
when: 
 Structuring medical departments 
 Deciding on resourcing 
 When controlling physician’s activities and duties 
 When planning physicians’ careers with respect to current and future 
competency needs 
It is argued that although uncertainty can be reduced, it can never be completely 
eliminated from decision-making. Therefore, most decision-making performed in 
medicine contains an irreducible intuitive element, and is thus vulnerable to these 
biases and heuristics. Given that few medical curricula overtly address the 
process of medical decision-making, both medical students and physicians 
remain vulnerable to these effects on their own (and their patients') decision-
making. Insight via education appears to be the major means by which to develop 
more advanced models of decision-making. 
A part of the interviews focused on asking respondents about what they would do 
differently if the mentioned barriers did not exist; the majority of physicians 
responded that they would do more of what they were already doing.  
“I would spend more time on diagnostics, making sure that we follow 
national and international standards for establishing diagnosis, more time 
on treatment and evaluation of effect and follow up, I would spend more 
time talking to the patients and next of kin ensuring better and more 
complete information. I would spend more time developing professionally 
and discussing cases with colleagues.” (ID #: 26) 
The consequence, as indicated in the projective questions of the semi-structured 
interviews, would be an improvement in health care service delivery in general.  
“I would probably make fewer mistakes, fewer complaints, patients would 
be more satisfied, expenses would probably decrease, things would go 
smoother, we would use less time and may be able to treat more patients. 
It would be more fun to work, less complaints from colleagues, time to 
develop as a physician.” (ID #: 15) 
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This was an unexpected finding, but quite intriguing. If physicians would simply 
do more of what they were already doing if the barriers did not exist, this reveals 
that barriers influence volition (i.e. the cognitive process of decision-making), or 
at least the perception of perceived behavioural control, at some level. 
Control of volition is an underlying assumption of the Theory of Planned 
Behaviour (TPB) (Ajzen, 1991). Evidence in this study strongly suggests that 
perceived behavioural control is a central mechanism by which enablers and 
barriers exert influence. In an ideal world where barriers do not exist, physicians 
will not do anything different other than doing more of what they are already 
doing. Thus, the evidence indicates that physicians would not change what they 
are doing, but the effort supplied by physicians would actually be affected. It is 
therefore argued that “the will to act” (behavioural intent) is present in a clinical 
setting and may be considered a constant. As such, it is possible for the TPB 
constituents, attitude and social norm, to be considered constant in a clinical 
setting.  
From a practitioner perspective and personal experience, this is plausible, as the 
drive to help others may be considered strong in the medical profession because 
there is a concern for medical ethics (Arrow, 1963). Thus, the combination of both 
intent and perceived behavioural control may be used to predict actual behaviour, 
as asserted by  Ajzen (1991) p. 184. Keeping behavioural intent constant, the 
probability of actual behaviour becomes dependent on perceived behavioural 
control, which in TPB, is assumed to be dependent on prerequisite opportunity 
and resource. The availability of requisite opportunities and resources (e.g., time, 
money, skills, cooperation of others) collectively represent physicians’ actual 
control over behaviour related to health care service delivery (Ajzen, 1985, Ajzen, 
1991 p. 182). 
1.12.3 Implications for Producers of Medicines 
The author, content that changing the business model from person-to-person to 
business-to-business is necessary. Such a change allows for strategic and 
operational alignment between health care providers and the producers of 
medicines in a health care value chain context. However, this change requires a 
change in the mind set of current and future pharmaceutical marketers. Current 
practice is internal recruitment from sales to marketing and business-to-business 
models are not necessarily within the skill set or “comfort zone” of current 
marketers. Thus, the author argue that a move away from current practice of 
recruiting managers and executives from an increasingly irrelevant salesforce 
background is necessary. 
1.13 Limitations and Future Research 
In this section the nature and limitations of this research, and opportunities for 
further research are outlined.   
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1.13.1 Nature of the Research 
This research is exploratory, and the findings should be interpreted with care 
when applied to different contexts. The primary purpose is to use existing theory 
to gain a deeper understanding of quality in healthcare, its enablers and barriers 
and the underpinning mechanisms that influence it. It integrates hitherto separate 
theoretical domains, developing a conceptual model to help guide stakeholders 
in health care when designing and implementing change. 
1.13.2 Limitations of the Study 
In this section, the limitations of this research are discussed. First, the limitations 
associated with the systematic review are addressed. Then, the limitations 
associated with the interview techniques (repertory grid technique and semi-
structured interview technique) employed in this research are outlined, and 
finally, the limitations associated with the use of mixed-methods are covered. 
1.13.2.1 Systematic Review 
In this review, every effort has been made to follow the steps designed to reduce 
bias and increase rigor and transparency by systematically searching all available 
literature and extracting relevant evidence. However, as with any academic work, 
this review has limitations associated with it.  
First, only one reviewer was employed in this systematic review, and the 
possibility for researcher bias is therefore present. By following a strict and 
predefined protocol (see Appendix A.1 from page 317) and carefully documenting 
each step, the researcher has attempted to reduce any untoward bias during the 
search, extraction and synthesis of the evidence presented in this thesis.   
Second, interventions reviewed were often based on previous research, therefore 
lacking a strong theoretical basis. The research on interventions identified in this 
review typically focus on the clinical or administrative needs for interventions. As 
no consensus on what constitutes optimal pharmaceutical consumption, and 
outcomes data on administrative interventions are lacking, it appears that the 
choice of intervention is not well grounded in theory, and at the same time, may 
be inadequately described in the literature in terms of Theory of Planned 
Behaviour, Agency Theory or decision under uncertainty. However, each study 
has been evaluated from the theoretical perspectives identified in the scoping 
study, and relevant mechanisms of influence in health care quality identified 
within the same theoretical domains.   
Finally, no restriction on study type for inclusion was made. The tendency for 
reviews published within the medical domain of the literature (approximately 
80%) is focused on randomized controlled trials as the highest standard of 
evidence quality. This positivist approach may not be the best when dealing with 
complex issues such as physician prescribing behaviour, and elements of realist 
synthesis have therefore been employed.  
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1.13.2.2 Repertory Grid and Semi-Structured Interview Technique 
Three main limitations to repertory grid technique (RGT) apply in this study. First, 
RGT is a method that is time consuming, which makes it difficult to generate large 
amounts of data and thus produce general knowledge. Second, RGT may be of 
limited use if the respondents find it difficult to understand the technique or if the 
constructs elicited are not handled in a sensitive manner (Cassell and Walsh, 
2004).  Finally, interpretation of the data may be problematic and due to the fact 
that interviews are subject to researcher bias (Goffin, 2002). 
The study was designed to capture how physicians frame quality of health care 
delivery in a hospital setting. The interview subjects in this study provided real 
patient cases where the outcome was death, either indirectly or directly caused 
by the physician being interviewed. This indicate that the respondents were both 
able and willing to tell the truth, and is therefore a testimony to the first two criteria 
suggested by  (Gottschalk et al., 1945); see Table 1-8 Checklist of criteria 
suggested by Gottschalk et al. (1945 p. 35). With respect to the third criteria, the 
researcher has been as diligent as possible to provide example quotes to 
substantiate every inference made from the data in this study. The use of low 
inference descriptors, such as quotes, is described as a strategy for improving 
the quality of qualitative research (Johnson, 1997 p. 283). Finally, Projects 1-3 
and literature have been used to corroborate the evidence presented.  
Table 1-8 Checklist of criteria suggested by Gottschalk et al. (1945 p. 35) 
# Description Checked 
1 Was the ultimate source of the detail (the primary witness) able to tell the truth? Yes 
2 Was the primary witness willing to tell the truth? Yes 
3 Is the primary witness accurately reported with regard to detail under examination? Yes 
4 Is there any external corroboration of the detail under examination? Yes 
Though qualitative research does not seek statistical generalizability, but 
generalizability to theory, there are elements that help establish the quality of the 
study. First, low inference descriptors (quotes) have been widely used. Second, 
theory triangulation (Agency Theory, Theory of Planned Behaviour and Decision 
Theory) and methods triangulation (repertory grid and semi-structured interviews) 
have been used. Finally, discussions with peers and implementation of findings 
in practice have yielded accepted changes in the way emergency medical care 
is organized on a national level. In Norway, quality in health care is a key topic in 
the national debate particularly towards the election in the fall 2013.  
One weakness of the semi-structured interview technique is that there may be a 
limited scope for the respondent to answer questions in sufficient detail or depth. 
In order to ensure sufficient detail and depth in the responses, a laddering 
approach was employed by asking follow-up questions. 
Furthermore, during the interview, the researcher may influence the way a 
respondent answers various questions, thereby biasing the responses. The 
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researcher followed the interview guide closely, and made every effort possible 
not to influence the answers provided. Open ended questions with laddering were 
employed. 
1.13.2.3 Triangulation (mixed-methods) 
As described above, in this research, a multi-methodical approach suited to the 
individual projects in this research has been employed. Even though its use goes 
back more than 100 years, it is still debated by scholars (Blaikie, 2010). 
Triangulation, also known as mixed-methods, is advocated by several scholars; 
for example, (Denzin, 1988) and (Robson, 1993). However, (Blaikie, 2010) 
argues that it is inappropriate to combine methods based on different ontological 
positions. Blaikie (2010), p. 227,  does however note that the use of mixed-
methods is of particular benefit when more than one research question is being 
addressed, as is the case in this thesis. 
1.13.3 Opportunities for Future Research 
The results from this research have highlighted many opportunities for further 
research, which are addressed in this section.  
The systematic literature review revealed a classification of factors influencing 
physician decision making. However, a deeper understanding of the link between 
contexts and interventions in determining health outcomes is an area for further 
research. 
The systematic literature review employed factor analysis and extended the 
thematic review of extant literature. Further development of research based tools 
to synthesis knowledge is an area with much potential for further work. 
The thesis provides an exemplar of the usefulness of repertory grid and semi-
structured interview techniques in exploring physician perceptions of quality in 
health care delivery based on patient-physician encounters. Their application to 
the professional service industries in general may be an area for further research.  
No grand theory of medical decision making has yet been formulated. Decision 
making in medicine is closely linked to quality; thus, medical decision making is 
an area for further theoretical research.  
The research undertaken in this thesis employed real patient-physician 
interactions to gain insight into how physicians perceive and construct quality. In 
this research, the patient is not included, and the dyadic patient-physician 
relationships is an area to be further studied in the context of the findings 
presented in this thesis.  
This study has identified how physicians frame quality in health care delivery, 
identified influencers in quality of health care service delivery, and may serve as 
a framework for further studies in this field. The model presented in this research 
will benefit from further mathematical development and prospective testing. Thus, 
further studies validating the framework presented in this thesis is warranted.   
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1.14 Chapter Summary 
In this chapter, the background and theoretical domains of the research were 
presented. The research methods and findings were discussed. The author also 
explicated the contributions of his research to knowledge and management 
practice, and the limitations of the work and directions for further research were 
highlighted. In summary, the findings of this research suggest that physicians 
construct quality in health care by defining influencers of their perceived 
behavioural control. The point of influence is the context in which effort is 
supplied; however, the link between context and process is ambiguous. The 
thesis argues for the need to be aware of the influencing factors and the 
mechanism by which these factors exert their influence on the supply of physician 
effort.  
In the next chapter, the scoping study and the research questions for the 
subsequent systematic literature review are presented. Medical and 
management literature is reviewed, and the relevance of the physician decision 




 CHAPTER TWO: SCOPING STUDY 
This Chapter is concerned with mapping out the influences on physician 
prescription behaviour from a health care value chain perspective in order to 
identify stakeholders and point of influence. 
2.1 Introduction and Background 
Health care policy is focused on addressing the general well-being of people in 
need, and in recent years, the focus on health care costs has gained momentum, 
as spend on health care is challenging budgets in most developed countries.  The 
result is emerging regulatory trends focusing on cost containment within the 
health care sector. Medicines play an important role in clinical medicine and drive 
health care costs; and cost containment measures focus on medicines, as the 
cost of medicine  accounts for a substantial portion of the total health care budget, 
typically 8 – 22 % (Legemiddelindustriforeningen, 2010). Physicians act as 
decision makers on behalf of payers and patients when administering prescription 
only medicines (Vogel et al., 2003). Influencing physician prescribing behaviour 
has thus become a key focus for regulatory measures; as a consequence, 
physician autonomy is under pressure and changes in physician prescribing 
behaviour can be observed. However, evidence as to the outcome of these 
changes is sadly lacking (Bradley, 1991, Smith, 1977).  
The pharmaceutical industry invests heavily in marketing,  using 20 – 40 % of 
revenue (Gagnon and Lexchin, 2008), and most of these investments are 
directed to the physician, who acts as the decision maker on behalf of patients 
and payers when administering prescription medicines (Vogel et al., 2003). 
However, as yet, the overall effect of pharmaceutical marketing is inconclusive, 
having generated a heated debate. Furthermore, requests for information from 
the pharmaceutical industry are declining rapidly, and conversely, the use of the 
internet as a channel for information is rapidly increasing; in 2009, 86 % of 
physicians in Europe and 89 % of physicians in the US used internet as a source 
of information in professional practice (Gucio-Pabia, 2010). The industry is 
currently facing patent expiry and loss of exclusivity on several “block buster” 
medicines, creating a revenue vacuum until the industry pipeline can fill the gap 
in 2012 and beyond. Many of the large companies are undergoing restructuring 
in order to meet future demands and high investor expectations. In addition to 
restructuring the biopharmaceutical industry, strategies are focused in the 
direction of: strategic alliance, merger and acquisitions, strengthening corporate 
social responsibility in the biopharmaceutical industry, pricing and 
reimbursement, and the rise of e-health. Given the current fiscal situation in many 
countries, there is an increasing cost containment focus by authorities, as health 
care expenditure is on the rise. Furthermore, strict regulatory and control 
measures for direct-to-physician promotion by the pharmaceutical industry are 
widely implemented. These factors collectively impact on the playing field for the 
industry and signal a need for change. The need for new promotional models is 
evident, and the difficulty will not be to identify the right initiatives - but to change 
from the current model to a new one (Illert and Emmerich, 2008). The changing 
environment has sparked the pharmaceutical industry to change the way it 
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interacts with physicians. Industry sales forces are shrinking across markets and 
the search for new and cost effective promotional channels is intense. Being on 
the receiving end of heavy marketing investments, the physician is subject to 
promotional instruments possibly affecting prescribing behaviour.  
The phenomenon of interest in this study is factors and contexts having a bearing 
on physician prescription behaviour from a health care value chain perspective. 
The chapter starts by providing a contextual backdrop from a value chain 
perspective, more specifically using the health care value chain as a framework 
for defining its boundaries, stakeholders and decision points. Second, the thesis 
goes on to describe physician interaction with stakeholders in the health care 
value chain from an agency perspective.  Next, the theoretical framework and 
underpinnings of medical decision making are addressed.  Then, the study 
addresses the factors having a bearing on physician prescribing behaviour. 
Following this, it goes on to address the theoretical framework and underpinnings 
of persuasion in order to provide an understanding of how influencing factors 
affect prescribing behaviour. Finally, the study offers a conclusion and poses a 
suggestion for further research.  
2.2 Health Care Value Chain  
In this section, the contributions and definitions of the health care value chain are 
considered in order to delineate the boundaries that identify stakeholders and 
decision makers. This will aid in the understanding of prevailing market dynamics 
within the health care sector. First of all: what is a value chain? According to   
Porter, the term means the whole production chain from raw material to product 
consumed by the end user (Porter 1980;Porter 1985, pp.33-61). Inherent to the 
definition, there are two value chains: one firm internal and one across firms. As 
health care is a complex function lacking vertical integration from raw material to 
end product, it may be useful to consider the health care sector from a value chain 
perspective.  
Two authors are central to the understanding of the health care sector from a 
value chain perspective.  {Burns, 2002 #64@@author-year} and {Burns, 2005 
#63@@author-year}   have contributed to the study of the health care value chain 
in the US, and (Stremersch (2008), Stremersch and van Dyck (2009)) have added 
a European and marketing research applications perspective to the framework. 
Burns et al. (2002) relied mostly on informants from a broad sample of firms 
collected over a period of three and one-half years. The information was gathered 
via personal interviews of informants spanning a wide range of functional areas, 
in the period between January 1998 and June 2001. (Stremersch and van Dyck, 
2009) identified marketing decision areas in the life sciences by conducting a 
literature search of academic literature and personal interviews of life science 
marketing practitioners. This led to the identification of three main areas of life 
science marketing decision areas: life science marketing, health care payer and 
provider, and marketing academics. However, from a competition-theoretical 
perspective, value chains may have limited applicability outside manufacturing 
firms,  as linear input-output activities do not adequately represent reality (Hunt, 
2002) p. 281.  
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Figure 2-1 Health care value chain (adopted from Stremersch 2008) 
The health care value chain consists of two sides: payer and delivery 
(Stremersch, 2008), as in Figure 2-1 Health care value chain (adopted from 
Stremersch 2008). As most funds spent in health care originate from government 
agencies, this represents the largest part of the payer side of the value chain 
(Burns et al., 2002) p. 15. However, financial intermediaries such as insurance 
companies may also play an important role. The delivery side is represented by 
producers and product intermediaries. Producers in this context are the 
pharmaceutical industry, and product intermediaries are represented by: 
wholesalers, pharmacies and buying organizations (Stremersch, 2008). Both 
sides meet in the middle at the provider level, represented by hospitals and 
physicians (Stremersch, 2008). However,  Burns et al. (2002) also place 
pharmacies at the provider level.  
Stakeholders in the supply chain contest access to and control over three critical 
flows: products, money and information (Burns et al., 2002) p. 18. From a payer 
and public policy perspective, there are three different policy inputs regulating 
medicines: public health (quality, safety and efficacy), health care (financing and 
reimbursement of medicines), and industrial policy (Permanand, 2006) p. 4. From 
a delivery perspective, competitive forces prevail. Clark’s theory of effective 
competition makes competition a dynamic state in pursuit of increased profit 
rather than focusing on a static state of profit maximization (Hunt, 2002) p. 262. 
Alderson’s functionalist theory argues that the firms’ pursuit of profit is to fulfil the 
primary goal of survival (Hunt, 2002) p. 264. According to Hunt, competition may 
be considered as an evolutionary and disequilibrium-provoking process (Hunt, 
2002) p. 251.  
Thus, it can be argued that the two sides of the health care value chain are driven 
by different logics in the contest for flow of products, money and information. 
Understanding these market dynamics is important, as it forms the basis for 
organization and measures designed to influence decisions within the health care 
value chain. Ultimately, this may result in influence on the physician level and 
consequently, may have a bearing on physician prescribing behaviour. 
So, how does the market dynamic effect physician prescribing behaviour? 
Although no direct empirical evidence can be found, there are clues within the 
academic literature. Consolidation and integration efforts (horizontal and vertical) 
within the health care sector have for the most part failed miserably (Burns et al., 
2002) p. 5; this leaves organizations to interact with each other in a manner often 
termed business-to-business (B2B) (Brennan et al., 2007) pp.2-6. However, it is 
the individual that has deciding capacity and is motivated by a complex 
combination of personal and organizational objectives, and at the same time, 
constrained by ethics and policies; thus, it is the specific individual and not the 
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abstract organization that is the target for persuasive efforts (Webster and Wind, 
1972). It has been widely stated that the physician is the decision maker on behalf 
of payers and patients (McGuire, 2001, Vogel et al., 2003) and that 70 % of 
pharmaceutical promotional spend is directed at the physician (Gagnon and 
Lexchin, 2008). Even though organizations play an important role in the health 
care value chain, they control process, availability and price of products. 
However, the physician retains authority and decision control over outcomes, 
even though the spectrum of outcomes may have been preselected by B2B 
marketing efforts. 
2.3 Agency 
Due to the low level of vertical integration, it is clear that work is delegated within 
the value chain; thus, it is natural to consider agency relationships. Agency 
Theory and, more specifically, physician agency is interesting, as it illuminates 
the contextual framework of the payer-physician-patient interaction and is 
suggestive of factors, practice and organization having a bearing on physician 
prescribing behaviour.  
This section will start by addressing the theoretical framework and underpinnings 
of agency and agency relationships. Then, physician agency will be covered in 
detail, including: uncertainty, informational asymmetry, moral hazard, adverse 
selection, and ethical and legal constraints. 
2.3.1 Theoretical Framework 
In an intellectual project for understanding, Eisenhardt (1989) has undertaken a 
thorough review of agency and Agency Theory. The basis for agency is that one 
party (principal) delegates work to another (agent), and Agency Theory is 
concerned with two problems occurring in agency relationships (Eisenhardt, 
1989). The first problem relates to conflict of interest (moral hazard) and the 
second to risk sharing (adverse selection).  Studies of agency relations date back 
to the early sixties, and the seminal work performed by Arrow (1963) is central in 
defining the difference in attitudes toward risk from an economic perspective. 
From the same perspective, Ross (1973) and Jensen and Meckling (1976) 
introduce the concept of different goals and division of labour.  {Mitnick, 1986 
#358@@author-year} and {Mitnick, 1994 #359@@author-year} takes on a 
political science perspective and challenges the positivist views presented by 
Arrow (1963) and Ross (1973), arguing that the  central problem with Agency 
Theory is the lack of consensus as to what the agency problem really is all about. 
Moral hazard and adverse selection lie at the core of Agency Theory, and both 
presume a conflict of interest between agent and principal (Mitnick, 1994).   Moral 
hazard occurs when a person is insulated from risk and behaves differently than 
he/she would if exposed to the risk (Arrow, 1963). Adverse selection refers to a 
situation when undesired results occur on the bases of the principal and agent 
having different information (asymmetry of information) (Arrow, 1963). From the 
health care value chain perspective, physician agency is of importance because 
it may have a bearing on prescription behaviour, as detailed in the health 
economic domain of literature, and this is addressed in further detail below. 
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2.3.2 Physician Agency 
Uncertainty is the most important factor influencing physician behaviour (Arrow, 
1963) and has been addressed in the context of physician agency. In an 
intellectual project for understanding, (McGuire, 2001) has provided a 
comprehensive review of the topic from a health economic perspective. 
Interestingly, the author concludes that economic models often ignore uncertainty 
and informational asymmetry inherent in modern health care (McGuire, 2001) p. 
496. Perfect physician agency may exist if agent and principal have the same 
information; however, no demand on the quality of information is made. Thus, 
perfect agency can be based on imperfect information (Mitnick, 1994). According 
to Eisenhardt (1989), moral hazard refers to the lack of effort by the agent, and 
adverse selection refers to the misinterpretation of ability by the agent. 
Asymmetry of information concerning these two aspects may be considered an 
advantage and if used inappropriately, may be unbeneficial to the principal.  
The physician may play the role of agent for several principals in the health care 
value chain. First and foremost, the physician is an agent on behalf of the patient. 
Asymmetry of information regarding diagnosis and treatment options is a natural 
consequence of the physicians’ extensive training and resulting expertise. This 
training is complex, time consuming and costly, creating a situation where it is not 
possible for a patient to correctly verify quality or utility of health care provided. It 
has been argued that only about 25 % of patients would be reasonably well 
informed about the care they receive (McGuire, 2001) p. 465. Physician agency 
may also exist with payers and/or employers as principals. Given the potential 
complexity of physician agency with several simultaneous principals, physician 
loyalty will be under pressure and may be influenced by shifting power between 
principals, thus having a bearing on patient health. However, the authority of the 
physician is still strong and plays a central role in any decisions related to medical 
care (McGuire, 2001) p. 463. Given the central role of the physician in medical 
decisions, it is important to further address aspects of moral hazard and adverse 
selection in this context. 
Moral hazard is said to take place when an individual not fully exposed to a risk 
would behave differently than if fully exposed to the risk (Gaynor and Gertler, 
1995). Both physician and patients are insulated from the financial realities of 
medical decisions (Illert and Emmerich, 2008), and thus subject to forces of moral 
hazard. Therefore, both the physician and the patient may engage in behaviour 
motivated by self-interest.  The physician may drive demand beyond what would 
be the case if exposed to the financial risk implicit in making the decision 
(McGuire, 2001) p. 503. A physician may influence quantity of care in three ways: 
set the level of non-contactable input (quality), influence patient preference and 
physician induced demand (McGuire, 2001) p.503-519. Increasing quality may 
increase cost, and changing patient preference in accordance with physicians’ 
self-interest may have the same effect. Physician induced demand will occur if 
the physician uses his/her “superior” knowledge to his/her benefit, driving the use 
of health care resources to a higher level than would be the case if information 
was symmetric between agent and principal (McGuire, 2001) p. 503. On the other 
hand, the patient may seek to engage in behaviour driving the consumption of 
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health care.  A patient may, for example, simply opt for taking a pill for high 
cholesterol rather than engaging in lifestyle changing behaviour such as exercise 
and healthy eating. Thus, patient preference may impact demand for health care 
services from physicians. 
Moral hazard, as illustrated above, is but one outcome of the agency problem. 
Physician agency may also have an impact on public policy through mechanisms 
of adverse selection.  In certain circumstances, it will be impossible to know what 
the physician did or knew (Pauley, 1978). This extreme form of informational 
asymmetry may lead to uninformed decisions by the principal, and consequently, 
adverse selection (McGuire, 2001) p. 498.  
Behaviour motivated by self-interest of the agent lies at the heart of the agency 
problem. The physician is an “experience good” (Gaynor 1994); consequently, a 
patient will not know the quality of care before having experienced the care 
provided by the physician. McGuire (2001) p.502 argues that learning is slow, 
and as a consequence, the reward for quality is likely to be inadequate.  Thus, 
the physician may be given room to adjust quality as an input factor (effort) 
according to prevailing motivations, including self-interest. Furthermore, credible 
evidence suggests that compensation arrangements with high degree of revenue 
sharing reduces physician effort (Gaynor and Gertler, 1995). 
Since the introduction of the Hippocratic Oath in 4th century BC, ethics have 
played a central role in the practice of medicine. Physicians have autonomy in 
decision making on the basis of an understanding that they will act in the best 
interest of their patients (Arrow, 1963). However, it has been argued that 
managed care may threaten the physicians’ loyalty to the patient (McGuire, 2001) 
p. 520. The physician is an agent for both the patient and the payer, potentially 
resulting in a loyalty conflict and cognitive dissonance. A payer can take 
advantage of the ethical constraints, imposing payment systems that force the 
physician to personally take on more of the effort to attain an acceptable outcome 
for the patient (Ma and McGuire, 1997).  
In addition to ethics, legislation also plays a central role in the practice of 
medicine. Legal constraints limit choices, but may also drive behaviour, leading 
to the practice of defensive medicine; which occurs when a physician practices 
medicine to protect himself/herself against litigation (Danzon, 2000). The practice 
of defensive medicine may drive demand for care more than would otherwise be 
the case.   
2.3.3 Summary 
At the heart of Agency Theory lays the conflict of interest concept between agent 
and principal.  However, conflict of interest may also be present between 
simultaneous principals, further complicating physician agency by influencing 
physician loyalty and possibly impacting patient health. Uncertainty and 
asymmetry of information play a central role in influencing physician behaviour 
and can negatively impact public policy decisions and outcomes through adverse 
selection. Furthermore, physicians may drive health care demand by changing 
quality of service, influencing patient preference and using asymmetry of 
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information to drive demand for care. Ethical and legal constraints of decision 
choices exist, and may be exploited by both agent and principal in addition to 
motivating the practice of defensive medicine. Thus, Agency Theory and, more 
specifically, physician agency illuminate the contextual framework of the payer-
physician-patient interaction and are suggestive of factors of practice and 
organization having a bearing on physician prescribing behaviour. That said, 
academics investigating physician agency have largely ignored uncertainty and 
informational asymmetry when modelling and investigating physician agency, 
thus weakening the arguments. 
2.4 Decision Making 
Several factors influence decision making, and understanding these factors helps 
in understanding the decision making process and potential outcomes. Because 
medical decisions have an impact on patients’ health, they should be of high 
quality (Klein, 2005). However, medical practice is complex and time is often 
limited, leading to use of shortcuts to decisions, or heuristics. Unfortunately, the 
use of heuristics also brings with it some pitfalls (Klein, 2005). Despite being 
highly trained, doctors are prone to making mistakes (Bornstein and Emler, 
2001); cognitive biases may detract from the use of logical and statistical decision 
heuristics (Hershberger et al., 1994). This research will address the theoretical 
aspects of decision making before considering factors that influence decision 
making in the context of clinical practice. Further, it will address heuristics of 
medical problem solving and decision making. Finally, a summary will be offered.  
2.4.1 Theoretical Framework  
Decision making is important in medical practice, and because health outcomes 
are probabilistic, most decisions are made under conditions of uncertainty 
(Kaplan and Frosch, 2005). Medical science has not yet solved the uncertainty 
surrounding many medical decisions (Gillett, 2004) and is the least developed 
aspect of evidence-based practice (Spring, 2008). Furthermore, uncertainty has 
been characterized as the most important factor influencing physician behaviour 
(Arrow, 1963). Thus, uncertainty is central to Decision Theory concerned with 
medical decision making.  
Decision theories are developed to explain decisions under three main conditions 
of consequence of choice: certainty, risk and uncertainty. Decision under 
certainty applies when all decisions will lead to only one consequence. Decision 
under risk applies when a choice will have one of several possible consequences 
and the probabilities of the consequences are known (Heylighen, 2010). Contrary 
to decision under risk, decision under uncertainty applies when a choice will have 
one of several possible consequences, but the probabilities of the consequences 
are not known. Furthermore, decision theories fall into two main categories: 
normative or prescriptive theories are based on idealized situations where a 
decision can be fully rational and all probabilities calculated; and descriptive 
theories work on the principle that people do not necessarily follow axioms and 
thus describe what people do rather than focus on optimality. Evidence-based 
medicine is concerned with integrating individual clinical expertise and the best 
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external evidence (Sackett et al., 1996), and works on the basis of known 
probabilities (Kaplan and Frosch, 2005). However, in a knowledge-for-critical 
evaluation project, Greenfield et al. (2007) address the usefulness of the results 
of randomized controlled trials for clinical and policy application. The authors 
conclude that the evidence includes patients who may have minimal benefit and 
that generalization to patients excluded from the study may result in 
overtreatment. Thus, it may be argued that the axioms of evidence-based 
medicine may be invalid in individual treatment decisions, and consequently, 
normative decision theories explaining decisions under risk may be not be 
applicable in medical decision making. Further support is provided by (Eddy, 
1994) in that clinicians often disagree about appropriate action in similar clinical 
situations. In addition, there is evidence to support large geographical variations 
in the use of health care (Wennberg et al., 2002, 2004) and that this variation 
does not result in the same variation in patient outcomes (Fisher et al., 2003, 
2003). This leaves descriptive theories as a possible framework for medical 
decision making. However, evidence based theories are not abundant and the 
lack thereof to support medical decision making has led to clinical approaches 
and decision tools being based on assumptions - and these assumptions have 
been challenged by behavioural research (Reyna and Rivers, 2008). Modern 
theories supported by empirical evidence differ in their views of risky decision 
making, behavioural change, health promotion and medical decision making 
(Reyna and Rivers, 2008). Three such theories have recently been gaining 
recognition:  theory of reasoned action and its extension the Theory of Planned 
Behaviour, the trans-theoretical model and fuzzy trace theory.  
2.4.1.1 Theory of Reasoned Action and the Theory of Planned Behaviour 
The theory of reasoned action states that intent is the best indicator of motivation 
to act (Fishbein, 2008) and is concerned with what determines intention. Intention 
to perform a certain action is a function of two factors: attitude and subjective 
norm (perception of importance) (Fishbein, 2008). Determinants of attitude have 
been identified as: evaluation of belief and strength of belief (O'Keefe, 2002) 
p.103-104. Perceived lack of ability may have an impact on intention to perform 
an action, and in 1991, Ajzen revised the theory and in so doing, added a third 
factor, perceived behavioural control, leading to the Theory of Planned Behaviour 
(Ajzen, 1991).   
2.4.1.2 The Trans-Theoretical Model 
The trans-theoretical model is concerned with strategies or process for change 
and originally contained four stages of change; pre-contemplation, 
contemplation, action and maintenance (Prochaska and DiClemente, 1987). The 
work of Prochaska and DiClemente (1987) was based on the need for behaviour 
change models having a bearing on health, with special focus on addiction. This 
change model has led to goal setting as an accepted method to improve 
performance and has been operationalized through practice guidelines within the 
context of medical decision making (Prochaska, 2008).  
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2.4.1.3 Fuzzy Trace Theory and Adaptive Decisions Making 
The fuzzy trace theory is based on the finding that  people rely on the gist of 
information, its bottom line meaning, as opposed to verbatim details in judgement 
and decision making (Reyna, 2008). Thus, fuzzy trace theory lends itself to 
explaining why detailed information about risk does not necessarily support 
medical decisions. However, fuzzy trace theory is at odds with the central 
assumption of evidence-based medicine, that decisions made by computation 
are superior to those made by intuition (Spring, 2008). Important aspects of 
decision need not be conscious, and subjective perception of reality shapes 
decision making (Reyna and Rivers, 2008). Decision making by medical experts 
often relies on intuitive gist processing and pattern recognition (Lorenz et al., 
2005). However, decision tasks vary in complexity and the limited processing 
capabilities of the decision maker make the adoption of adaptive decision 
strategies imperative. As no one theory will suffice to cover all eventualities 
(Reyna and Rivers, 2008), the work of (Payne et al., 1993) still stands as a 
credible seminal work having greatly contributed to the understanding of adaptive 
decision processes. The framework for adaptive decision behaviour distinguishes 
between decision strategies and problem solving; decision strategies are 
generally reserved for diffuse problems and problem solving lends itself more to 
an hypothetico-deductive approach (Payne et al., 1993) p.60. This concept is 
translated to clinical practice by (Elstein and Schwarz, 2002). Furthermore, the 
adaptive decision framework relies on trade-offs between cognitive effort and 
accuracy. Thus, the fundamentals of adaptive decision making are that 
individuals decide how to decide.  
2.4.1.4 Heuristics 
Human decision behaviour is a contingent form of information processing, and 
different decision strategies may be used to suit the situation (Payne et al., 1993) 
p.9.  Heuristics may be considered mental short cuts reducing decision effort 
(Shah and Oppenheimer, 2008). Focus on decision effort follows the assumption 
that cognitive effort is limited (Payne et al., 1993) p.73. However, decision effort 
is not the only part of the heuristic; it is also important to consider the accuracy of 
the strategy to yield a good decision, and hence the effort-accuracy framework 
was posited by (Payne et al., 1993) p.72. Unfortunately, the use of heuristics also 
brings with it some pitfalls (Klein, 2005, Tversky and Kahneman, 1974). Despite 
being highly trained, doctors are prone to making mistakes (Bornstein and Emler, 
2001) and cognitive biases may detract from the use of logical and statistical 
decision heuristics (Hershberger et al., 1994).  
In a seminal paper, Tversky and Kahneman (1974) showed that people rely on a 
limited number of heuristic principles, reducing the complexity of decision making. 
The authors describe heuristics and biases employed for making decisions under 
uncertainty. According to Tversky and Kahneman (1974), the main heuristics 
employed when making decisions under uncertainty are: representativeness, 
availability and adjustment & anchoring. Klein (2005) identified five pitfalls in 
decisions about prescribing: representativeness heuristic, availability heuristic, 
overconfidence, confirmatory bias and illusory correlation. These pitfalls have 
already been described by Tversky and Kahneman (1974) and do not represent 
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anything but a rejuvenation of the debate set in a prescription context. However, 
the notion is further supported by (Poses and Anthony, 1991), but the authors 
use the term ‘inappropriate use of heuristics’.  Furthermore, Payne et al. (1993) 
pp.193-216 identified the lack of knowledge and execution of heuristics as a 
pitfall. Thus, is can be argued that identifying an appropriate decision strategy 
and executing within the given context are central to successful decision making.  
The representativeness heuristic (Kahneman and Tversky, 1979) is an 
assumption that something seemingly similar to other things in a category is a 
part of that category (Klein, 2005).   It is important to be aware of base rate 
occurrence and not weighting information inappropriately. The availability 
heuristic builds on the principle of the ease with which information can be 
accessed and gives too much weight to information that is easily available (Payne 
et al., 1993) pp. 201-207. In many situations, estimates are made from a starting 
point - and this is known as anchoring  {Tversky, 1974 #534@@author-year}. If 
necessary adjustments are not made, then anchoring bias may occur as a 
decision is based on incomplete reasoning due to lack of baseline information.  
Even though heuristics are available, inappropriate use may lead to mistakes 
(Poses and Anthony, 1991), and it is important to consider why this may be the 
case. Confidence relies on representativeness of the prediction with disregard for 
predictive accuracy (Tversky and Kahneman, 1974). According to Klein (2005), 
most people are more confident about judgments than they ought to be and may 
be contextually influenced by an individual’s attitude, leading to overconfidence 
or illusion of validity(Tversky and Kahneman, 1974, Crano and Prislin, 2006).  
According to Tversky and Kahneman (1974), illusory correlation is a pitfall of the 
availability heuristic. How frequently two events occur together will influence the 
associative bond between them (Payne et al., 1993, Tversky and Kahneman, 
1974). Klein (2005) defines this simply as: “Illusory correlation is the tendency to 
perceive two events as causally related, when in fact the connection between 
them is coincidental or even non-existent.”  
Tversky and Kahneman (1974) argue that adjustment and anchoring bias may 
occur as a consequence of subjective probability distribution and hence violate 
the logic of statistical prediction.  The fact that people do not appear to follow logic 
and statistical theory of prediction leads to intuitive judgement (Poses and 
Anthony, 1991) that sometimes leads to severe and systematic errors 
(Kahneman and Tversky, 1973). 
In conclusion, decision under uncertainty is based on the use of a limited number 
of heuristics designed to reduce the effort of judgement, but this may reduce the 
accuracy of the decision and lead to errors (Kahneman and Tversky, 1973, 
Tversky and Kahneman, 1974, Poses and Anthony, 1991, Payne et al., 1993, 
Hershberger et al., 1994). 
2.4.2 Medical Decision Making and Prescribing Behaviour 
From the literature, it is evident that complex decisions are based on the use of 
a limited set of heuristics to reduce the effort associated with decision making. 
Medical decisions are designed to have effects on patient health, and hence the 
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quality of these decisions is important. Supported by the positivist ontology of 
evidence based medicine, most medical decisions are probabilistic in nature and 
occur under uncertainty (Elstein and Schwarz, 2002). Given the potential high 
risk to patient health and complex nature of modern medicine, factors affecting 
the quality of medical decisions need to be understood. Medicines play an 
important role in modern medicine (Hemminki, 1975) and their use as a 
therapeutic intervention is widespread.  
The work of (Bradley, 1991) represents the only identified comprehensive 
literature review on decision making and prescribing behaviour linking the 
observed effects and moderators highlighted thus far to the theory of decision 
making. At first glance, it may seem that the author adopts a neutral stance 
legitimate for a knowledge-for-understanding project, but adopts a negative 
stance criticising the rash introduction of interventions to curb cost without the 
understanding of how decisions are affected. In short, Bradley (1991) concludes 
that the understanding of prescribing behaviour requires study of the underlying 
decision process. This author argues that policy change may have untoward 
effects on patients if it is made without an understanding of current decision 
patterns.  This sentiment is later echoed by others (Sketris et al., 2009), further 
underlining the need for more research on the topic.  
 
Taking a broader view, McKinlay et al. (1996) found that the variability in medical 
decision making by physicians was not entirely accounted for by prescriptive 
theory and thus conclude that non-medical factors such as patient characteristics, 
physician characteristics and practice setting may play an important role in 
influencing physician prescribing behaviour. The notion of the authors is 
supported in a more recent literature review by (Hajjaj et al., 2010) and by the 
work of Gill et al. (1999), reporting that only 51 % of interventions introduced to 
change physician prescribing behaviour had an effect, and that no difference 
could be found across interventions. Finally, Bornstein and Emler (2001) found 
that physician clinical reasoning is vulnerable to biases and that formal processes 
may aid in improving decision quality by focusing on the most relevant 
information. The overall finding is that how factors influence physician decision 
making is a phenomenon poorly understood. In conclusion, more studies may 
lead to better decisions and healthier patients (Poses and Anthony, 1991). 
In an interesting study, employing a grounded theory approach, on the decision-
making process leading to appendectomy, Larsson et al. (2004) developed a 
model suggesting that the decision is made based on the interplay between an 
assessment of the patient’s condition and contextual characteristics. The authors 
did not strictly follow Glaser’s advice on theoretical sampling, thus limiting the 
depth of findings from the study and consequent conclusion. However, the study 
indicates that contextual factors may have a bearing on medical decisions, fully 
in line with the previous discussion on agency and agency relationships. 
According to Miller (1989), decision control involves direct influence over 
outcomes, but the range of outcomes are typically preselected; on the other hand, 
process control involves indirect influence over outcomes. Process for deciding 
on diagnosis and therapy intervention is grounded in evidence based medicine, 
 73 
and the individual physician has only indirect influence over process outcomes. 
The process will guide the decision making, but intuitive judgements are still 
made (Kahneman and Tversky, 1973, Poses and Anthony, 1991) within the 
bounds of decision and process control.  
2.4.3 Shared Decision Making 
Shared decision making is being advocated as the preferred method for decision 
making in medical care. In an intellectual project for knowledge generation, 
(Charles et al., 1997) identified four characteristics of shared decision-making in 
the medical encounter: both physician and patient must be involved, both parties 
share information, consensus regarding preferred treatment must be built, and 
that agreement on implementation is reached. The approach outlined by Charles 
et al. (1997) will reduce the informational asymmetry between patient and 
physician and is denoted by others as the informed treatment decision model 
(Gafni et al., 1998). In an attempt to ascertain difference in patient outcome 
between the informed treatment decision model and the physician as a perfect 
agent for the patient, Gafni et al. (1998) investigated adjuvant chemotherapy 
versus no adjuvant chemotherapy in patients with early stage breast cancer. The 
authors concluded that both approaches result in the same outcome. However, 
the distinction between the two agency approaches is delegation (perfect 
physician agency) versus retention of authority (informed treatment decision 
model) (Gafni et al., 1998). Nevertheless, even though shared decision making 
models are advocated, implementation remains limited in practice (Barratt, 2008). 
2.4.4 Summary 
Decision making in medicine is performed under uncertainty. However, no 
general theory of medical decision has been formulated, but the theory of 
reasoned action and its extension the Theory of Planned Behaviour is the most 
studied theoretical framework informing on the topic of physician cognition 
leading to decision behaviour. In addition, Agency Theory plays a central role in 
defining contextual contributors to the decision making process. Despite being 
highly trained, doctors are prone to making mistakes, and cognitive biases may 
detract from the use of logical and statistical decision heuristics. Given the 
multidimensional theoretical framework having a bearing on medical decision 
making, deciding how to decide is central.  
2.5 Physician Prescribing Behaviour 
Hemminiki (1975a) investigated the literature on factors affecting the prescription 
of medicines.  In this knowledge-for-understanding intellectual project, the author 
found that education, colleagues, patients, promotion, expectations and demands 
from society, and physician characteristics affect the prescribing of medicines.   
Kremer et al. (2008) and Venkataraman and Stremersch (2007) have in addition 
identified the attributes of medicine and price. Anderson et al (2006) show that 
clinical trial participation may affect prescribing behaviour. Expectations and 
demands from patients and society, and searches on physician characteristics 
yield no relevant recent literature and are omitted from this study.  
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2.5.1 Factors Affecting Prescribing Behaviour 
2.5.1.1 Education 
Hemminki (1975) summarizes the few studies on the effect of education that are 
available (Lee et al., 1965, Joyce, 1970, Becker et al., 1972). There appears not 
to be any difference in prescribing patterns for graduates from different schools; 
however, it has been shown that higher postgraduate qualifications result in lower 
rate of prescription of any kind. Hemminki (1975) concludes that there is evidence 
to suggest that there is a link between education and quality of prescribing.  
More recently, Carroll et al. (2007) investigated educational interventions and 
regulatory policies on trainee perceptions of the pharmaceutical industry. The 
authors performed a literature search using Medline and bibliographies or review 
articles of relevant studies. Articles published before 1991 were excluded. The 
review suggests that well-designed seminars, role playing and focused curricula 
can affect trainee attitudes and behaviour. However, whether the effect is 
sustainable over time is still unknown (Carroll et al., 2007).  
Ellison et al. (2009) investigated post-activity Continuing Medical Education 
(CME) evaluation surveys. The background for the survey was the concerns 
raised around possible bias in commercially supported CME activities. The 
authors concluded that 93 % of physicians participating claimed to perceive no 
bias. 
Ross and Loke (2009) performed a systematic review of literature, investigating 
whether educational interventions improve prescribing by medical students and 
junior doctors. The authors searched MEDLINE, EMBASE, Educational 
Resource Information Centre, British Education Index, PsycINFO, CINAHL, 
TIMELIT, Cochrane Trials Database and grey literature. 3189 studies were 
identified for initial screening and 22 studies were included in the review. The 
WHO Good prescribing Guide is the most widely tested and has demonstrated 
efficacy. However, the authors concluded that further work is needed to produce 
high-quality intervention (Ross and Loke, 2009). 
2.5.1.2 Promotion 
In addition to observed effects of promotion, moderators of these effects have 
been investigated by several authors (De Laat et al., 2002, Hurwitz and Caves, 
1988, Kremer et al., 2008, Leffler, 1981, Manchanda and Honka, 2005, Mizik and 
Jacobson, 2004, Smith, 1977, Venkataraman and Stremersch, 2007, Windmeijer 
et al., 2006). However, most of the information on the topic of promotional 
efficiencies and moderators has been summarized in an intellectual project for 
understanding by Kremer et al. (2008). The authors conducted a meta-analysis 
including 58 studies with the aim to formulate generalisations about the 
effectiveness of pharmaceutical promotion. In summary, Kremer et al. (2008) 
concluded that statistically significant moderators of observed effects measured 
at any level of demand are: marketing instrument, disease category and price. 
Venkataraman and Stremersch (2007) found that the attribute of medicines, 
effectiveness and side effects may be a significant moderator of effect, and 
contrasts with the findings of Kremer et al. (2008). Perhaps one of the most 
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important findings of Kremer et al. (2008) is that of endogeneity, the correlation 
between a variable and its error term1 (Bijmolt et al., 2005). The authors note that 
this correlation significantly influences the effectiveness of promotional 
instruments; thus, it can be argued that endogeneity of marketing decisions is a 
key moderator of effect, a notion supported by Bijmolt et al. (2005). In conclusion, 
it is found that effectiveness of DTP pharmaceutical promotion is moderated by 
price, endogeneity of promotional investments, disease category and attribute of 
medicines. In other words, that pharmaceutical promotion at the physician level 
positively affects sales of medicines. Changes in physician prescribing behaviour 
can therefore be considered as an effect.  
2.5.1.3 Price and Price Sensitivity at the Physician Level 
At first glance, it appears that there is wide consensus in the literature on the fact 
that promotion lowers price sensitivity at the physician level (Kremer et al., 2008, 
Manchanda et al., 2005, Rizzo, 1999). However, others have found that 
physicians demonstrate a basic lack of price sensitivity (Gönül et al., 2001). This 
is supported by the fact that physician awareness of price is in general low (Ryan 
et al., 1990, 1992, 1996).  
2.5.1.4 Colleagues 
Nair et al. (2006) investigated the asymmetric peer effects in physician 
prescribing behaviour and the role of the opinion leader. Using detailed individual-
level prescription data along with self-reported social network information, the 
authors investigated peer effects. The authors found significant and robust peer 
effects across model specifications. However, no direct data of information 
shared is available; furthermore, information regarding sales force is not 
available. The characteristic of this study is that of an experiment without a control 
group, thus limiting the value and generalizability. 
2.5.1.5 Control and Regulatory Measures 
Taking on an intellectual project for knowledge describing the regulatory 
environment in Europe from a health economic perspective,  Permanand (2006) 
p.4 found that  there are three different policy inputs regulating medicines: public 
health (quality, safety and efficacy), health care (financing and reimbursement of 
medicines), and industrial policy. 
Due to market imperfections created by asymmetry of information central to the 
supply-demand dynamic, regulation is warranted (Permanand, 2006). So, does it 
work? It has been shown that control measures can influence drug consumption, 
at least for short periods (Hemminki, 1975). Information regarding safety may also 
have an effect on consumption of medicines (Venkataraman and Stremersch, 
2007).  
                                            
1 Error term is the difference between the actual and the predicted value of the independent 
variable in a regression model. 
 76 
From a practitioner perspective, the experience is congruent with the findings of 
(Hemminki, 1975); however, for most medicines regulated though cost 
containment measures, the price sensitivity at the physician level seems to play 
a part if loyalty to the patient is challenged.  
2.5.1.6 Drug Characteristics 
Venkataraman and Stremersch (2007) empirically analyse the moderator effect 
of the attributes of medicines (safety and efficacy) on the effect of marketing 
activities (detailing and meetings); this is the first and thus far the only study to 
take this perspective. The authors employed physician-level panel data, drug 
approval database and clinical trial reports in the econometric model analysis. 
The main finding of the study is the responsiveness of physicians’ decision 
making to marketing efforts, and patient request depends upon the attributes of 
the medicine. 
2.5.1.7 Participation in Clinical Trials 
There is limited evidence that participation in clinical trials impacts prescribing 
behaviour. However, in a cohort study, it was found that conducting a trial 
sponsored by a pharmaceutical company had no significant impact on physicians’ 
adherence to international treatment recommendations, but increased their use 
of the trial sponsor’s drugs (Andersen et al., 2006).    
2.5.2 Summary 
The literature reviewed in order to conduct this scoping study suggests that 
physician education and training, control and regulatory measures, peer effect, 
promotion and drug characteristics impact the quality and quantity of prescribing 
in the short term. How these factors affect prescribing behaviour is largely 
unknown. Thus, factors having a bearing on physician prescribing behaviour in a 
health care value chain context have been identified, but there is still a need to 
understand how factors affect physician prescription behaviour, and in which 
contexts and with what results.   
2.6 Influence and Persuasion 
Leffler (1981) and Hurwitz and Caves (1988) address the role of pharmaceutical 
promotion. Leffler (1981) argues that the pharmaceutical promotion has an 
informational role. On the other hand, Hurwitz & Caves (1988) argue strongly for 
a persuasive role. In support of Hurwitz and Caves (1988), Manchanda et al. 
(2005) and Mizik and Jacobson (2004) found evidence of brand persistence late 
in the product lifecycle, suggesting a persuasive role; persuasion is defined as a 
successful attempt to influence. According to O'Keefe (2002) p.2, the definition of 
persuasion lacks a clear consensus, but still acknowledges the definition 
provided by (Simons, 1976) p.21: “Human communication designed to influence 
others by modifying their beliefs, values  or attitudes”.  
In a comprehensive review of the literature on persuasion, O'Keefe (2002) 
identifies three theoretical constructs used to explain persuasion effects: 
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cognitive dissonance theory, elaboration likelihood model, and theory of 
reasoned action and its extension the theory of planed behaviour.  
2.6.1 Theoretical Framework 
2.6.1.1 Cognitive Dissonance Theory 
The cognitive dissonance theory was developed in the 1950’s by Leo Festinger 
and is concerned with the uncomfortable feeling due to simultaneous and 
conflicting ideas and the hardwired drive to reduce this discomfort (Festinger, 
1957).  Festinger labelled this uncomfortable feeling as dissonance and its 
converse as consonant. Dissonance can vary from non-existent to high, and 
consequently, the pressure to reduce it will vary accordingly. The magnitude of 
dissonance is related to the relative proportions of dissonance and consonant 
elements, and to the importance assigned to the elements (O'Keefe, 2002) pp.77-
100.Thus, the persuader can influence any one or both of these dimensions by 
using various techniques and ultimately influence decision making. Dissonance 
theory does not represent a universal theory of persuasion, but provides ideas 
for further investigation. 
2.6.1.2 Theory of Reasoned Action & Theory of Planned Behaviour 
The theory of reasoned action (TRA) is concerned with what determines intention. 
Intention to perform a certain action is a function of two factors: attitude and 
subjective norm (perception of importance). Determinants of attitude have been 
identified as: evaluation of belief and strength of belief (O'Keefe, 2002) pp.103-
109. Perceived lack of ability may have an impact on intention to perform an 
action; in 1991, Ajzen revised the theory, and in so doing added a third factor, 
perceived behavioural control, leading to the Theory of Planned Behaviour (TPB).  
Persuasive efforts from a TRA perspective can take three forms: changing the 
attitudinal component, changing the normative component or the relative 
difference between the two (O'Keefe, 2002) p.109.  
2.6.1.3 Elaboration Likelihood Model 
Elaboration likelihood model (ELM) was developed by Petty & Cacioppo and is 
concerned with persuasion as a consequence of how likely a receiver is to think 
about the message received (O'Keefe, 2002) p.137. ELM is a dual process model 
consisting of two routes to persuasion: central and peripheral. The central path 
involves a high level of elaboration or cognitive effort, and the peripheral part 
involves a low level of elaboration and cognitive effort. Elaboration is defined by 
O'Keefe (2002) p.138 as engaging in issue-relevant thinking. Although the term 
high low is used categorically, the degree of elaboration is a continuum. The 
central pathway to persuasion requires extensive elaboration and thoughtful 
examination of issue-relevant information (O'Keefe, 2002) p.139. Consequently, 
the peripheral pathway requires less cognitive effort and is thought to be based 
on the use of simple decision rules or heuristics. Two factors have been found to 
affect the degree of elaboration: motivation and ability. High degree of elaboration 
is not likely to occur if the individual is not motivated, and the same applies if 
ability is lacking (O'Keefe, 2002) pp.141-142. Motivation is affected by personal 
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relevance and the need for cognition; unmotivated individuals are less likely to 
engage in elaboration than motivated individuals, whereas some individuals 
enjoy cognitive exercises and are more likely to engage in elaboration. Ability is 
affected by distraction and prior knowledge, and a distractive stimulus may 
detract from engaging in elaboration. If the individual has prior knowledge, then 
it is considered easier for him/her to engage in elaboration (O'Keefe, 2002) p.144.   
2.6.2 Factors Having a Bearing on Persuasion 
Furthermore, O’Keefe (O'Keefe, 2002) pp. 181-264 identified three factors having 
a bearing on persuasion: source factors, message factors, and receiver & context 
factors. Source characteristics can have complex and interrelated effects having 
direct or indirect effects on persuasion. Message characteristics have not been 
shown to have a convincing effect one way or the other. However, persuasive 
effects may be dependent on receiver and contextual factors (O'Keefe, 2002) 
p.260. The findings of O'Keefe (2002) have largely been supported by Cialdini 
(2007) work on influence and persuasion.  
2.6.3 Persuasion and Health Care Professionals’ Behaviour 
In a systematic review of health care professionals’ intentions and behaviours, 
Godin et al. (2008) included studies that aimed to predict health care 
professionals' intentions and behaviours with a clear specification of relying on a 
social cognitive theory. The cognitive factors most consistently associated with 
prediction of health care professionals' intentions and behaviours were 
documented. This study shows that the theory most often used as reference was 
the Theory of Reasoned Action (TRA) or its extension the Theory of Planned 
Behaviour (TPB); and the authors suggest that the TPB appears to be an 
appropriate theory to predict behaviour, whereas other theories better capture the 
dynamic underlying intention (Godin et al., 2008). Finally, the authors provide a 
hypothetical framework for studying health care professionals’ intentions and 
behaviours, as illustrated in Figure 2. The framework has explanatory power, as 
it provides a simple and credible explanation. Furthermore, it is not overly 
complex. However, it lacks testability and as such may not be internally 
consistent.  
 
Figure 2-2 Hypothesized theoretical framework (Godin et al 2008) 
 79 
In a study designed to examine factors affecting antibiotic prescribing in a 
managed care setting, the authors found that behavioural intention was 
significantly correlated with both attitude and subjective norms, but was not 
predictive of actual prescribing behaviour (Lambert et al., 1997). The authors thus 
posit that it is possible that prescribing behaviour is influenced by non-
psychological factors. Furthermore, physician autonomy is challenged and it can 
be argued that a system-level approach may be needed to yield a descriptive 
model of physician prescription decisions.    
2.6.4 Summary 
O'Keefe (2002) identified three theoretical models of persuasion: cognitive 
dissonance theory, ELM, TRA and its extension the TPB. All of the theories 
provide explanatory models for persuasion, but TRA & TPB are the ones that 
have received the most credible attention and undergone extensive empirical 
testing (O'Keefe, 2002) p.130 in a health care setting. Godin et al. (2008) found 
that TRA and TPB lacked granularity and hypothesized a modified TPB 
framework for the study of health care professionals’ behaviour. However, 
Lambert et al. (1997) argue that psychological factors alone may not explain 
observed behaviour in the context of a health care value chain. 
2.7 Conclusion  
Evidence based medicine plays a central role in modern health care, and in 
recent years, health care costs have soared. Evidence needed to justify treatment 
interventions has also come under scrutiny from several fronts. Both patient and 
physician are insulated from the economic realities of treatment decisions, thus 
creating a need for control by payers. Hence, the autonomy of the physician to 
make treatment decisions has purposely been limited. The pharmaceutical 
industry is under duress due to patent expiry on “block buster” medicines and 
limited efficiency of pharmaceutical promotion. In addition, the request for 
information from the industry by physicians is rapidly declining and the search for 
new and effective channels of communications is intense.  
Four general conclusions emerge from the literature reviewed in this chapter. 
First, the health care value chain welfare framework is helpful in identifying 
stakeholders and areas of decision within the health care sector. Stakeholders in 
the supply chain contest access to and control over three critical flows: products, 
money and information. Furthermore, it is clear that the physician plays a central 
role and retains direct influence over outcomes, but the range of outcomes is 
typically preselected. Second, Agency Theory and physician agency are central 
to understanding the context of structure and organization having a bearing on 
physician prescribing behaviour. Third, no grand theory of medical decision 
making has yet been formulated, but consensus exists around medical decisions 
being made under conditions of uncertainty. TRA & TPB have been extensively 
empirically tested and provide a credible framework for physician cognition in this 
context. Decision under uncertainty is based on the use of a limited number of 
heuristics designed to reduce the effort of judgement, but this may reduce the 
accuracy of the decision and lead to errors. Thus, deciding how to decide still 
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plays a central role. Fourth, physician education and training, control and 
regulatory measures, peer effect, promotion, price, clinical trial participation and 
drug characteristics impact the quality and quantity of prescribing in the short 
term. How these factors affect prescribing behaviour is largely unknown. 
However, source, message, receiver and contextual factors have all been 
postulated to have persuasive effects. Evidence suggests that source, receiver 
and context factors may have persuasive effects, but no such clarity exists with 
regards to message content. 
In conclusion, the following citation from an editorial on the complexities of 
physician prescribing behaviour still holds true: “At this critical juncture in the 
evolution of pharmaceuticals and health care, the time has come for much more 
systematic study of the myriad factors that affect what physicians prescribe for 
their patients” (Naylor, 2004) p. 106. 
Thus, the scoping study has identified the theoretical underpinning and factors 
having a bearing on physician prescribing behaviour in a health care value chain 
context, but there is still a need to understand how these factors affect physician 
prescription behaviour, in which contexts, and with what results.   
Therefore, the proposed focus for the systematic review is to study literature in 
order to gain an understanding of the factors that influence physician prescription 
behaviour. 
Specifically, the review will: 
 Explore and map the key issues, frameworks and theoretical 
underpinnings of physician decision behaviour  
 Investigate factors that influence physician decision behaviour when 
prescribing  
 Investigate which factors, under which contexts may affect prescription 
behaviour and in what ways  
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 CHAPTER THREE: PROJECT ONE  
The first chapter, the linking commentary, provided a synthesis of the entire 
research presented in this thesis. This and subsequent chapters examine specific 
areas in more detail, starting with a systematic literature review addressing the 
gap identified in Chapter Two, the Scoping Study. Specifically, this chapter 
reviews the relevant literature concerning factors influencing physician decision 
making when prescribing. The chapter discusses contextual and interventional 
factors, employing a theoretical lens, combining three hitherto separate theories; 
agency, decision and behaviour. A brief review of the three theoretical domains 
is presented to address how they contribute in shaping this research. The 
research question derived from the emergent gap in literature is presented.   
3.1 Introduction 
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001), and that payer driven 
public policy is at odds with strategies employed by the pharmaceutical industry 
(Hurwitz and Caves, 1988, Leffler, 1981, McGuire, 2001) within the context of a 
health care value chain (Stremersch, 2008, Stremersch and van Dyck, 2009). 
Furthermore, it is widely recognized that because medical decisions have an 
impact on patients’ health, they should be of high quality (Klein, 2005). Factors 
influencing physician prescribing behaviour have been widely stated, but the 
linkage between these factors and evidence of how and under which 
circumstances (contexts) influence is exerted remains unanswered (Bornstein 
and Emler 2001; Bradley 1992).  
The profit maximising hypothesis central to Agency Theory predicts that 
physicians act in a manner motivated by financial self-interest (Gaynor and 
Gertler 1995;McGuire 2001). Asymmetry of information may perpetuate self-
interest behaviour in a manner not beneficial to either side of the value chain and 
thus lead to poor decisions being made on behalf of the principal (Eisenhardt 
1989;McGuire 2001). Loyalty issues having a bearing on patient health may arise 
consequently. The practice of medicine is further complicated by the context of 
ethical and legal constraints on decision choices (Ma and McGuire 1997;McGuire 
2001).  
There appears to be consensus that decision making in medicine is performed 
under uncertainty (Bornstein and Emler, 2001, Elstein, 1999, Elstein and 
Schwarz, 2002, Payne et al., 1993, Reyna and Rivers, 2008, Spring, 2008). 
However, no general theory of medical decision has been formulated, but the 
theory of reasoned action is the most studied theoretical framework informing on 
the topic of physicians’ decision behaviour (Reyna, 2008). Given the complexities 
of medical decision making and that no grand theoretical framework exists, 
deciding how to decide is central (Payne et al., 1993). Despite being highly 
trained, doctors are prone to making mistakes, and cognitive biases may detract 
from the use of logical and statistical decision heuristics (Hershberger et al., 
1994). In summary, there is a lack of contextually sensitive evidence informing 
medical decision processes.  
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The purpose of the review is to systematically examine the literature in order to 
gain an understanding of the factors and contexts that influence physician 
prescription behaviour. Specifically, the review identifies and maps factors and 
contexts having a bearing on physician decision behaviour when prescribing, and 
provide a synthesis of what is known about these issues.  
The model used for this systematic review is as outlined by Tranfield et al. (2003), 
drawing on elements taken from Huff (2009) and Fink (2010). Data extraction 
followed the methodology described by Wallace and Wray (2006). Synthesis of 
the data adopts a realist synthesis approach, as proposed by (Pawson et al., 
2004) and (Pawson, 2006), in order to ensure a strong link with practice and 
policy. 
This systematic review is structured as follows. It starts with an overview of the 
methodology employed in the review. Then a comprehensive descriptive analysis 
of the evidence is provided before offering a realist synthesis informing practice 
and policy. Following the realist synthesis, key gaps in the literature are 
presented. Next follows a brief overview of central theoretical constructs before 
a framework proposal is offered. Then, stakeholder perspectives are addressed 
before next steps and suggestions for future research are proposed.    
Key findings of the review are summarised in tabular form. Table 3-1 Summary 
of systematic review – interventions, highlights the findings related to 
interventional factors having a bearing on physician prescribing behaviour. Table 
3-2 Summary of systematic review – contexts, highlights the findings related to 
the contextual factors identified in the systematic review.  
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3.2 Research Methodology 
3.2.1 Objectives & Scope 
The purpose of the review is to study the literature in order to gain an 
understanding of the factors and contexts that influence physician prescription 
behaviour. 
Specifically, the review will: 
 Identify and map factors and contexts having a bearing on physician 
decision behaviour when prescribing  
The scope of the review is highlighted in Table 3-3 Scope of systematic review. 
Table 3-3 Scope of systematic review 
Focus The focus of the review is on factors and contexts influencing physician 
prescription behaviour. 
Source: knowledge must be produced by organizations adhering to accepted 
academic methods of inquiry and be research based.  
Content:  knowledge must be generated following academically accepted 
methodologies and aligned with appropriate epistemologies.  
Time Frame Searches will be conducted from 1980 onwards, as this denotes the time 
from which modern regulation of promotion of medicines was instituted.  
Literature earlier than this will be included if cross referenced within the 
original search frame. 
Language English only  
Discipline The review will examine the management, marketing, health economics, 
psychology and medical literature. List is not exhaustive, and flexibility will 
be key to extracting available information.  
3.2.2 Search Strategy 
The nature of research into physician prescribing behaviour makes it difficult to 
confine available literature into one specific domain (Mikkelsen, 2010). Therefore, 
the search strategy included databases and literature covering medicine, 
marketing, economics, health care, policy health technology assessment and 
decision-making. Consequently, the search for publications addressing the 
research question was conducted in citation databases, grey literature (SIGLE: 
International System for Grey Literature), references from other sources and 
manual searches of specific journals.   





 Web of Science 




 Cochrane Trials Database 
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 Index to Thesis 
In addition, references from the following sources were also included in the 
review: 
 References suggested by the review panel, knowledgeable researchers 
and practitioners  
 List of references from selected papers 
 Personal library (1050 books and articles) 
SIGLE was searched, but only contained unpublished work more than three years 
old. The protocol pre-specified that only unpublished work of 2 years or less 
would be included, thus SIGLE was not included in the review. 
Finally, manual searches based on findings from the scoping study were 
performed in the following sources: 
 International Journal of Research in Marketing 
 Journal of Marketing 
 Journal of Law and Economics 
 Social Science Medicine 
 The Academy of Management Review 
 Marketing Research 
 Medical Decision Making 
 Management Science 
 Journal of Advertising Research 
 Journal of the American Medical Association  
 British Medical Journal  
The search terms listed in Table A-3 Systematic review search terms were used 
to locate relevant studies and documents. These search terms were combined 
into search strings in the different databases to be combined as appropriate (see 
Table A-10 Systematic review search strings for details).  
3.2.3 Information and Data Handling 
The details (database collections, search strings, number of documents retrieved 
and number of documents initially selected) of the searches were captured and 
documented in Microsoft Excel using two by two tables including a unique 
identifier for further tracking. EndNote X5 was used for citation storage and 
management. Microsoft Excel 2010 and SPSS 19 were used for analysis and 
synthesis of data. 
3.2.4 Selection of Publications 
The selection of publications to be included in the systematic review was 
achieved through a predefined staged approach. 
3.2.4.1 Stage 1: Selection by Title and Abstract 
Papers were selected if they addressed the following aspects:  
 Frameworks and theoretical underpinnings of physician decision 
behaviour having a bearing on prescription behaviour 
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 Factors, interventions and contexts that influence physician decision 
behaviour 
3.2.4.2 Stage 2: Selection by Full Text  
Documents selected at stage 1 underwent a second selection stage with the 
following criteria: 
 Conceptual overview: papers included were those that addressed the key 
issues, framework and theoretical underpinnings of physician prescription 
behaviour. 
 Review of factors and contexts influencing physician prescription 
behaviour: Papers exploring factors and/or contexts influencing physician 
decision behaviour when prescribing were included at this step. 
3.2.5 Quality Appraisal & Review Panel 
Quality Appraisal criteria has been adapted from (Tranfield, Denyer, & Smart 
2003) and was applied to and documented for all literature selected for inclusion 
at stage 2. Only literature appraised as being of high and medium quality was 
included in the review. Furthermore, non-peer reviewed literature was appraised 
by a second reviewer (Dr. Javier Marcos), and judgement on reputability of 
source was made.  Only non-peer reviewed literature from a reputable source, 
such as academic and government institutions, having passed the quality 
appraisal criteria by the second reviewer, was included in the review. The review 
panel served as the final decision authority for all literature included in the review.  
The review panel consisted of the reviewer (Yngve Mikkelsen), lead supervisor 
(Dr. Javier Marcos), a senior academic supervisor (Professor Hugh Wilson) and 
senior academic supervisor (Professor Simon Knox).   
Table 3-4 Review panel members 
Person Role / Title and organization  
Yngve Mikkelsen MD Researcher, doctoral student, Cranfield School of 
Management 
Dr. Javier Marcos Lead supervisor, lecturer, Cranfield School of 
Management.  
Prof Simon Knox Senior supervisor, professor, Cranfield School of 
Management 
Prof Hugh Wilson  Senior supervisor, professor, Cranfield School of 
Management 
3.2.6 Descriptive Analysis and Data Extraction    
The data was extracted from the studies and input into EndNote X5, and 
subsequently into Microsoft Excel 2010 and SPSS 19 (please refer to Table A-6 
Data extraction form and Table A-12 Systematic review data extraction results 
for details). After extracting the data for the descriptive analysis, relevant 
information was imported and coded in SPSS 19. Furthermore, a factor analysis 
was performed to quantitatively interrogate the dataset for common themes and 
validate the selection of themes for further analysis and synthesis of the evidence.  
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3.2.7 Synthesis and Analysis 
A qualitative synthesis of the publications selected for review was conducted 
using the framework proposed by  Wallace and Wray (2006). Emerging themes 
were identified and grouped into dimensions following a retroductive analysis 
approach. 
Table 3-5 Principles of synthesis summarizes some principles of good synthesis 
methods (Tranfield et al., 2003) and how the synthesis strategy of this systematic 
review met these principles. 
Table 3-5 Principles of synthesis 
Principles Strategy: Approach and methods 
Synthesis method appropriate 
to research 
1. Explore and map the key issues, frameworks and 
theoretical underpinnings of physician decision 
behaviour having a bearing on prescription 
behaviour 
2. Investigate factors that influence physician decision 
behaviour, 
3. Investigate contexts under which these factors 
influence physician decision behaviour. 
Cope with diffuse and 
heterogeneous data 
Summaries of the studies following the Wallace and Wray 
framework will be import into SPSS 19 facilitating handing 
of diffuse and heterogeneous data.  
Transparency and detail of 
content allowing reader to 
adequately gauge quality of 
method, data and conclusion 
Transparent and exhaustive referencing of material 
included in the review will allow the reader to interpret and 
validate the conclusions of the review.  
Ensure audit trail Studies included and excluded from the review will be 
reported. Comprehensive descriptive analysis tables and 
coding in SPSS 19 will provide audit trials. 
3.3 Descriptive Analysis of the Literature 
In this section, the high-level results from the systematic review will be presented, 
with the aim to clearly map the structure of the literature addressing the research 
question. In order to structure the presentation of data from 160 articles, a subject 
matter approach was chosen, as suggested by (Leonard, 2001). This approach 
consists of grouping articles according to subject headings assigned by the 
researcher, following an inductive approach. However, due to the complexity and 
amount of data available, it became apparent that retroductive analysis alone 
would not suffice. Consequently, a factor analysis of the data was performed to 
aid in the determination and validation of appropriate subject matter headings.  
Based on the factor analysis, described in detail below, data is presented and 
structured in separate sections. Before presenting the data, the search results 
and selection flow are briefly described. Then, an overview of key literature 
dimensions related to the publications (type of intellectual project, study type, 
level of measurement, publication date, geography, level of influence and 
evidence) is provided. Next, data related to physician (specialty, age, gender, and 
time in practice) and practice characteristics are presented, followed by data on 
patient characteristics. After this, data on therapy area and medicine attributes 
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are presented, along with data on pharmaceutical promotion (detailing, samples, 
journal advertising), before presenting data on regulation and control. Then, 
economic factors and, finally, data on non-economic factors are addressed 
before a summary is offered. 
3.3.1 Search Results 
The initial search included publications from 1980 to 2011, and August 30th 2011 
was chosen as the cut-off point for inclusion.  The search yielded 3030 
publications, including 783 duplicates, leaving 2243 publications for title and 
abstract review. Title and abstract review identified 1794 publications as not 
relevant or of inferior quality, leaving 453 publications for full text review. The full 
text review identified 253 publications as not relevant and 33 of low quality. Thus, 




Figure 3-1 Search flow chart 
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3.3.2 Organizing the Literature Using Factor Analysis 
In this study, the author employs factor analysis to interrogate the data set to 
identify complex interrelationships among items and group items that are part of 
unified concepts, thus forming the basis of a data reduction strategy. Factor 
analysis allows using information about interdependencies between observed 
variables to reduce a set of variables in large datasets, thus it was considered 
appropriate. It complements and strengthen the summary of findings by the use 
of regression modelling techniques to identify groups of inter-related variables. 
Using the data variables captured during the review, a categorical coding 
structure was constructed, as can be seen in Table 3-6 Coding structure for factor 
analysis. The dataset was then evaluated by using Kaiser- Meyer-Olkin2 (KMO) 
measure of sampling adequacy and Bartlett’s test of sphericity3. The aim of these 
tests is to assess whether the dataset is adequately sampled and if correlations 
between the variables exist or not; in other words, to test whether a factor analysis 
of the data is appropriate.  
  
                                            
2 KMO measure of sampling adequacy is a test to assess the appropriateness of using factor 
analysis on the data set 
3 Bartlett’ test of sphericity is used to test the null hypothesis that the variables in the population 
correlation matrix are uncorrelated 
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As noted in Table 3-7 KMO and Bartlett's Test, the KMO value was 0.538 and 
Bartlett’s test of sphericity significant with a p value of < 0.0001. This indicates 
that the data set is adequately sampled and that a factor analysis of the data can 
be adequately performed.   
The results of the factor analysis before rotation can be seen in Table 3-8 
Structure matrix (factor analysis). It shows that component 1 may be composed 
of physician and practice characteristics; in addition, geography may be a 
constituent of the component. However, geography and clinical medicine is in 
itself a field of study (geographical medicine) looking at the interaction of health 
and factors such as location (spatial), social, financial and functional (Twigg, 
2002). Other fields of study that may have a bearing on the subject are 
epidemiology, climatology and demography.  For these reasons, geography is 
not considered as a part of component 1, but is instead addressed separately 
below. Component 2 is related to medicine attributes, component 3 to economic 
factors, component 4 to patient characteristics, component 5 to non-economic 
factors and, finally, component 6 to regulation and control.  
Table 3-7 KMO and Bartlett's Test 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .538
Bartlett's Test of Sphericity Approx. Chi-Square 134.713
Df 45
Sig. .000
Table 3-8 Structure matrix (factor analysis) 
 Component 1 2 3 4 5 6 
Physician characteristics .769 .139 .014 .095 .202 -.288
Practice characteristics .791 .084 -.082 -.011 .328 -.203
Patient characteristics .030 -.023 .072 .866 -.054 .026
Therapy area .246 .151 -.459 .435 .226 -.355
Medicine attributes .010 .806 .249 .155 .145 .121
Pharmaceutical promotion -.012 .676 -.229 -.361 -.331 -.260
Regulation & Control -.110 -.008 .028 -.031 -.045 .885
Economic factors .016 .149 .894 .079 -.029 -.052
Non-Economic factors .148 .022 -.099 -.017 .894 -.068
Geography .734 -.170 -.064 .133 -.217 .226
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
In order to confirm the component structure of the data set, a non-linear rotation 
(direct Oblimin with Kaizer normalization4) was performed with delta set at zero. 
The results can be seen in Table 3-9 Pattern matrix (factor analysis), depicting 
the pattern matrix where the rotation converged after 20 iterations. The pattern 
matrix overlaps the findings seen in the initial structure matrix, thus confirming 
the factor analysis. However, the component correlation matrix (see Table 3-10 
Component correlation matrix (factor analysis)) shows relatively little correlation 
                                            
4 The Kaiser's normalization tends to decrease the standard errors of the loadings for the variables 
with small communalities and to increase those of the correlations among oblique factors. 
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between components. This is to be expected, as authors have previously noted 
that physician behaviour is complex and that any successful strategy to influence 
it will have to be multifaceted (Segal and Wang, 1999). Furthermore, it has been 
widely stated that physician characteristics may only explain 20-30 per cent of 
the observed variation in prescribing (Hemminki, 1975, Denig and Haaijer-
Ruskamp, 1992, Segal and Wang, 1999). 
Table 3-9 Pattern matrix (factor analysis) 
 Component 1 2 3 4 5 6 
Physician characteristics .739 .092 .091 .012 .095 -.196
Practice characteristics .762 .044 -.011 -.106 .238 -.088
Patient characteristics -.040 .002 .044 .878 -.117 .009
Therapy area .126 .130 -.429 .423 .139 -.255
Medicine attributes -.003 .829 .204 .160 .132 .216
Pharmaceutical promotion .008 .661 -.219 -.314 -.351 -.185
Regulation & Control -.020 .109 -.087 -.023 .046 .912
Economic factors .061 .112 .912 .056 -.040 -.147
Non-Economic factors .053 -.003 -.079 -.091 .897 .038
Geography .790 -.142 -.047 .076 -.282 .273
Extraction Method: Principal Component Analysis.  
 Rotation Method: Oblimin with Kaiser Normalization. 
 
Table 3-10 Component correlation matrix (factor analysis) 
Component 1 2 3 4 5 6 
1 1.000 .024 -.071 .100 .115 -.111
2 .024 1.000 .021 -.023 .032 -.127
3 -.071 .021 1.000 .024 -.021 .124
4 .100 -.023 .024 1.000 .079 -.006
5 .115 .032 -.021 .079 1.000 -.101
6 -.111 -.127 .124 -.006 -.101 1.000
Extraction Method: Principal Component Analysis.   
 Rotation Method: Oblimin with Kaiser Normalization.  
3.3.3 Key Literature Dimensions 
In this section, key dimensions of the literature included in the systematic review 
are presented. First, an overview of the type- of intellectual projects undertaken 
by the authors is provided. Next, data on types of studies and level of 
measurements are presented. Following this, information about the time of 
publication before presenting information related to geography is provided. 
Finally, evidence related to level of influence and evidence is detailed. 
3.3.3.1 Wallace & Wray Framework 
Wallace and Wray’s framework categories (Wallace and Wray, 2006) are 
summarized in Table 3-11 Wallace and Wray Framework. For further details on 
the framework, please consult the Glossary of Terms on page xxiii. From the data, 
it is revealed that 52% of the articles are knowledge-for-critical review intellectual 
projects. This implies that there may be an inherent tendency for a critical view of 
the factors influencing physician prescribing behaviour in the available literature. 
It has been previously noted that this may represent an inherent critical bias of 
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interventions designed to influence physician prescribing behaviour, with special 
focus on pharmaceutical promotion (Gallan, 2005). 
Table 3-11 Wallace and Wray Framework 
 Frequency Percent 
Valid 
Percent Cumulative Percent
Valid Knowledge-for-understanding 47 29.4 29.4 29.4
Knowledge-for-action 30 18.8 18.8 48.1
Knowledge-for-critical review 83 51.9 51.9 100.0
Total 160 100.0 100.0  
3.3.3.2 Type of Study and Level of Measurement 
Of the 160 included articles, 138 (86.3%) were quantitative, 14 (8.8%) qualitative 
and 8 (5.0%) literature reviews; see Table 3-12 Study type for details. Only two 
(1.3%) meta-analyses were included (Pearson et al., 2009, Pippalla et al., 1995). 
In most cases (65%), the physician was the level of measurement, followed by 
patient (15%) prescription (9.4%) and practice (4.4%); see Table 3-13 Level of 
measurement. The level of measurement in the quantitative group spanned all 
levels of measurement; however, in the qualitative group, physician was the only 
level of measurement. From the above, it is therefore evident that the majority of 
the authors included in this systematic review have adopted a positivist 
epistemology. 
Table 3-12 Study type 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Quantitative 138 86.3 86.3 86.3
Qualitative 14 8.8 8.8 95.0
Literature review 8 5.0 5.0 100.0
Total 160 100.0 100.0  
Table 3-13 Level of measurement 
 Frequency Percent Valid Percent Cumulative Percent
Valid Physician 104 65.0 65.0 65.0
Patient 24 15.0 15.0 80.0
Prescription 15 9.4 9.4 89.4
Practice 7 4.4 4.4 93.8
Study 10 6.3 6.3 100.0
Total 160 100.0 100.0  
3.3.3.3 Publication Year 
In this systematic review, 160 articles from the period 1976 to 2011 were 
included. Figure 3-2 Frequency distribution by year of publication, depicts the 
frequency distribution by publication year. Approximately 80% of the publications 
have been published from 2000 onwards. The low number in 2011 is partly due 
to the cut-off date for the review (ultimo August 2011). The rise in number of 
publications post 2000 may be an indication of increased interest in the subject 
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matter, driven by continued focus on the accelerating growth in spends on 
prescription medicines. 
  
Figure 3-2 Frequency distribution by year of publication 
3.3.3.4 Geography 
There is good geographical representation in the sample included in this 
systematic review. However, Europe and North America account for more than 
90%, with 47.5% and 43.8%, respectively; please see Table 3-14 Geography for 
details. The rest of the world (ROW) representation is comprised of 10 (6.3%) 
articles. There are only a few articles, four in total (2.5%), addressing cross-
country effects.  
Table 3-14 Geography 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid North-America 70 43.8 43.8 43.8
Latin-America 1 .6 .6 44.4
Asia 2 1.3 1.3 45.6
Australia & NZ 5 3.1 3.1 48.8
Europe 76 47.5 47.5 96.3
Middle-East 1 .6 .6 96.9
Africa 1 .6 .6 97.5
Mix 4 2.5 2.5 100.0
Total 160 100.0 100.0  
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3.3.3.5 Literature Domains 
The publications included in the systematic review come from 108 different 
journals spanning five literature domains: medicine, marketing, economy, policy 
and health technology assessment (HTA); please see Table 3-15 Literature 
domains for details. The majority of articles (78.3%) have been published in 
journals covering one or more of the medical disciplines. Journals from the 
marketing domain account for 9.3% of the publications. Only a few publications 
come from policy and decision making domains of the literature, with 1.9% and 
1.2%, respectively. Finally, the HTA domain accounts for 4.3% of the 
publications.  
Table 3-15 Literature domains 
 
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Medicine 126 78.3 78.3 78.3
Marketing 15 9.3 9.3 87.6
Economy 8 5.0 5.0 92.5
Policy 3 1.9 1.9 94.4
Decision making 2 1.2 1.2 95.7
Health technology 
assessment 
7 4.3 4.3 100.0
Total 160 100.0 100.0  
The majority of journals (75.9%) represent one publication, and 24.1% of the 
journals represent more than one publication. The average number of 
publications per journal in the sample is 1.49 with a range of 1 – 7; please see 
Table A-11 Journals included in the review for details. 
3.3.3.6 Level of Influence and Evidence 
For the papers selected for this systematic review, the level of influence and the 
strength of the evidence of influence were assessed; see Table 3-16 Level of 
Influence and Table 3-17 Level of evidence for details. Please refer to the section 
on methodology (page 85) for details on the assessment of influence and 
evidence. As per protocol (see Appendix A.1 Protocol on page 317), only 
publications representing medium to high levels of evidence were included.    
Table 3-16 Level of influence 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Low 57 35.6 35.6 35.6
Medium 87 54.4 54.4 90.0
High 16 10.0 10.0 100.0




Table 3-17 Level of evidence 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Medium 130 81.3 81.3 81.3
High 30 18.8 18.8 100.0
Total 160 100.0 100.0  
At first glance, there appears to be a higher level of both influence and evidence 
in the quantitative study category; please see Table 3-18 Study type by level of 
evidence (cross tabulation) and Table 3-19 Study type by level of influence (cross 
tabulation). However, when accounting for the absolute numbers in each group, 
the percentage distribution is very similar. Furthermore, geography does not 
seem to influence level of influence or evidence; please see Table 3-20 
Geography by level of influence (cross tabulation).  
Table 3-18 Study type by level of evidence (cross tabulation) 
 Level of Evidence Total Medium High 
Study type Quantitative 113 25 138
Qualitative 14 0 14
Literature review 3 5 8
Total 130 30 160
Table 3-19 Study type by level of influence (cross tabulation) 
 Level of Influence Total Low Medium High 
Study type Quantitative 51 74 13 138
Qualitative 4 8 2 14
Literature review 2 5 1 8
Total 57 87 16 160
Table 3-20 Geography by level of influence (cross tabulation) 
 Level of Influence Total Low Medium High 
GEOGRAPHY North  America 19 40 11 70
Europe 34 43 3 80
ROW 4 4 2 10
Total 57 87 16 160
3.3.4 Physician- and Practice Characteristics 
Physician characteristics include specialty, age, gender and time in practice. 
Information on physician specialty was available in 72.5% of the articles included 
in the systematic review and is shown in detail in Table 3-21 Physician specialty. 
The data are presented in three categories: general practitioners, specialists and 
a mixture of both general practitioners and specialists.  
The category “Specialists” contains a variety of medical specialties. The literature 
is not consistent on medical specialty included in the studies. Furthermore, 
medical specialties are not geographically homogenous, as education and 
regulatory requirements differ between countries (UEMS, 1993).   
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Table 3-21 Physician specialty 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid General practitioner 71 44.4 61.2 61.2
Specialist 25 15.6 21.6 82.8
Mix 20 12.5 17.2 100.0
Total 116 72.5 100.0  
Missing Missing 44 27.5   
Total 160 100.0   
Information about physician age is available in 28 (17.5%) of the articles. The 
information is categorized and presented in Table 3-22 Physician age. Only a 
limited number of physicians in the included articles are under the age of 30 
years, as is expected due to the extended duration of medical education. The 
majority of information (71.4%) addressing physician prescribing behaviour and 
age comes from study populations between 30 and 50 years of age.  
Table 3-22 Physician age 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid < 30 years 1 .6 3.6 3.6
30 - 50 years 20 12.5 71.4 75.0
> 50 years 7 4.4 25.0 100.0
Total 28 17.5 100.0  
Missing Missing 132 82.5   
Total 160 100.0   
Information about physician gender is available in 29 (18.1%) of the articles 
included in the systematic review; please see Table 3-23 Physician gender for 
details. Of the 29 articles, 23 (79.3%) are based on a study population containing 
more than 50% males. More than 50% female representation can be seen in 6 
(20.7%) of the publications. In other words, approximately 80% of the information 
addressing physician prescribing behaviour is based on studies dominated by an 
overweighting of males in the study sample. 
Table 3-23 Physician gender 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid > 50% male 23 14.4 79.3 79.3
> 50% female 6 3.8 20.7 100.0
Total 29 18.1 100.0  
Missing Missing 131 81.9   
Total 160 100.0   
Information about time in practice is available from 18 (11.3%) of the articles 
included in the systematic review.  Please see Table 3-24 Time in practice for 
details. 17 (94.4%) of the articles include information on physicians with more 
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than 10 years in practice. Therefore, little information about those with less than 
10 years in practice is available for this review. 
Table 3-24 Time in practice 
 Frequency Percent Valid Percent Cumulative Percent
Valid < 10 years 1 .6 5.6 5.6
> 10 years 17 10.6 94.4 100.0
Total 18 11.3 100.0  
Missing Missing 142 88.8   
Total 160 100.0   
Information about practice characteristics is available from 94 (58.8%) of the 
articles included in the systematic review. The majority of publications containing 
practice characteristics (N=74, 78.7%) can be categorized as office based 
practices. Office based practice types include solo, double and group practices 
(three or more physicians). Hospital based practices (n=14, 14.9%) are those 
associated with a hospital, either academic or non-academic. In six publications 
(6.4%), there is a mixture of office and hospital based practice; please see Table 
3-25 Practice characteristics. As expected, there is a clear association between 
office characteristics and physician specialty; please see Table 3-26 Physician 
specialty by practice characteristics. Office based practices are mainly staffed by 
general practitioners, and conversely, hospital based practices are mainly staffed 
by specialists. 
Table 3-25 Practice characteristics 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Office based 74 46.3 78.7 78.7
Hospital based 14 8.8 14.9 93.6
Mix 6 3.8 6.4 100.0
Total 94 58.8 100.0  
Missing Missing 66 41.3   
Total 160 100.0   
Table 3-26 Physician specialty by practice characteristics 
 Practice Characteristics 
Total Office based Hospital based Mix 
Physician Speciality General practitioner 57 0 0 57
Specialist 4 10 3 17
Mix 7 1 3 11
Total 68 11 6 85
3.3.5 Patient Characteristics 
Information about patient characteristics can be found in 57 (35.6%) publications; 
please see Table 3-27 Patient characteristics. Patient characteristics described 
in the publications included in the systematic review contain information about 
gender, age, attitude/preference/expectations, and provision of information, 
biomedical and social factors. The most prevalent patient characteristics 
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mentioned in the publications included are gender (n=20, 35.1%) and 
attitude/preference/expectations (n=17, 29.8%). Biomedical factors can be found 
in 8 (14%) of the publications and are related to the diagnostic process or the 
diagnosis itself. Information about social factors and provision of information can 
be found in six (10.5%) publications.  
Table 3-27 Patient characteristics 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Gender 20 12.5 35.1 35.1
Age 6 3.8 10.5 45.6
Attitude/Preference 17 10.6 29.8 75.4
Information 3 1.9 5.3 80.7
Biomedical 8 5.0 14.0 94.7
Social 3 1.9 5.3 100.0
Total 57 35.6 100.0  
Missing Missing 103 64.4   
Total 160 100.0   
3.3.6 Therapy Area and Medicine Attributes 
Information on therapeutic area can be found in 130 (81.3%) of the publications 
included in the systematic review; please see The large proportion in the mix 
category is due to the fact that general practice is highly represented in this 
category; see Table 3-29 Therapeutic area category by physician specialty.  
Information about medicine attributes can be found in 17 (10.6%) of the 
publications included in this review; please refer to attributes for details. Medicine 
attributes is related to efficacy and safety or a combination of the two (benefit-
risk).  
Table 3-28 Therapy area category 
 Frequency Percent Valid Percent Cumulative Percent 
Valid CV/Metabolic 23 14.4 17.7 17.7
Gastroenterology 5 3.1 3.8 21.5
Infection/Immunology 12 7.5 9.2 30.8
Oncology 6 3.8 4.6 35.4
Pain/Inflammation 13 8.1 10.0 45.4
Psychiatry 14 8.8 10.8 56.2
Respiratory 10 6.3 7.7 63.8
Urology 3 1.9 2.3 66.2
Mix 44 27.5 33.8 100.0
Total 130 81.3 100.0  
Missing Missing 30 18.8   









practitioner Specialist Mix 
Therapeutic Area 
Category 
CV/Metabolic 11 3 5 19
Gastroenterology 1 2 1 4
Infection/Immunology 6 5 0 11
Oncology 1 3 0 4
Pain/Inflammation 2 4 1 7
Psychiatry 5 2 1 8
Respiratory 9 0 1 10
Urology 1 1 0 2
Mix 26 2 7 35
Total 62 22 16 100
Table 3-30 Medicine attributes 
 Frequency Percent Valid Percent Cumulative Percent
Valid Efficacy 6 3.8 35.3 35.3
Safety 6 3.8 35.3 70.6
Mix 5 3.1 29.4 100.0
Total 17 10.6 100.0  
Missing Missing 143 89.4   
Total 160 100.0   
3.3.7 Pharmaceutical Promotion 
Information about pharmaceutical promotion can be found in 26 (16.3%) of the 
publications included in the systematic review; please see Table 3-31 
Pharmaceutical promotion for details. Pharmaceutical promotion is related to 
detailing by sales force representatives, the provision of samples, journal 
advertising and a mixture of the above.  Detailing and mix categories account for 
22 (84.6 %) of the publications related to pharmaceutical promotion. Samples 
and journal advertising trail with two publications each. There are a high 
proportion of knowledge-for-critical review intellectual projects represented in the 
literature addressing pharmaceutical promotion. In total, 21 (80.1%) out of 26 
publications take critical perspective, with equal distribution across promotional 
tools. As mentioned previously, this may represent an inherent critical bias of 
pharmaceutical industry interventions designed to influence physician prescribing 
behaviour, as noted by (Gallan, 2005) among others. 
Detailing refers to sales face-to-face visits by industry representatives. This has 
been the preferred way of promotion by the pharmaceutical industry for more than 
a century (Leffler, 1981), and is addressed directly in 11 (6.9%) publications. The 
provision of free medicine samples is based on the assumption that it does more 
good than harm and is addressed in two publications. Journal advertising is 
addressed in two publications and represents advertising in academic journals 
directed at physicians of different specialities and subspecialties. Effective 
promotion often involves the use of several promotional instruments. The effect 
of a mix of promotional interventions is addressed in 11 (6.9%) publications.  
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Table 3-31 Pharmaceutical promotion 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Detailing 11 6.9 42.3 42.3
Samples 2 1.3 7.7 50.0
Journal advertising 2 1.3 7.7 57.7
Mix 11 6.9 42.3 100.0
Total 26 16.3 100.0  
Missing Missing 133 83.1   
System 1 .6   
Total 134 83.8   
Total 160 100.0   
3.3.8 Regulation and Control 
Information about regulation and control can be found in 16 (10.0%) of the 
publications included in the systematic review. The authors in this section 
address the effect of audits, formularies and preferred drug lists (PDLs). Audits 
in this context imply checks by regulatory agencies to ensure compliance with 
prescribing regulations. Formularies and preferred drug lists limit the spectrum of 
choice under which the physician is free to prescribe and are addressed in seven 
publications, see Table 3-32 Regulation and control.  
Table 3-32 Regulation and control 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Audits 9 5.6 56.3 56.3
Formularies/PDLs 7 4.4 43.8 100.0
Total 16 10.0 100.0  
Missing Missing 144 90.0   
Total 160 100.0   
3.3.9 Economic Factors 
Information about economic factors can be found in 38 (23.8%) of the publications 
included in the systematic review. Economic factors include price/cost (n=10), 
reimbursement (n=7), financial incentives (n=4), managed care (n=8) and a 
mixture of the above (n=9), see Table 3-33 Economic factors.  
Price and cost of medicines are thought to influence prescribing behaviour by 
physicians. Price sensitivity plays a special role due to the complexities of multiple 
agency relationships and strict price regulation (Kremer et al., 2008). The 
phenomenon has been investigated in 10 publications included in this review. 
Reimbursement transfers cost of prescribing from patient or end user to a central 
payer. The payer will often be a government agency, managed care organization 
or insurance company. Information about reimbursement is found in seven 
publications included in this review. Financial incentives are thought to influence 
prescribing behaviour, as financial theory postulates that behaviour is driven by 
the fulfilment of a person’s desire to increase his/her own benefit. This topic is 
addressed in four publications included in this review. Managed care represents 
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systems designed to finance and provide health care to patients enrolled in the 
programme. Central to managed care is the intention to reduce the cost of health 
care delivery. Information on managed care is found in eight publications. Mixed 
factor effects are addressed by several authors and can be found in nine 
publications included in this review.  
Table 3-33 Economic factors 
 Frequency Percent Valid Percent Cumulative Percent
Valid Price/Cost 10 6.3 26.3 26.3
Reimbursement 7 4.4 18.4 44.7
Financial Incentives 4 2.5 10.5 55.3
Managed Care 8 5.0 21.1 76.3
Mix 9 5.6 23.7 100.0
Total 38 23.8 100.0  
Missing Missing 122 76.3   
Total 160 100.0   
3.3.10 Non-Economic Factors 
Information about non-economic factors can be found in 115 (71,8%) of the 
articles included in the systematic review; please see Table 3-34 Non-economic 
factorsfor details. Non-economic factors are numerous and are categorized as 
follows: peer effects (n=5), academic detailing (n=15), guidelines (n=7), 
biomedical influence (n=13), academic literature (n = 8), clinical study 
participation (n=3), technology (n=14), legal concerns (n=3) and a mixture (n=13).  
Peer effects are concerned with the effect that physicians have on each other 
when it comes to prescribing. Most of the literature is concerned with the effect 
of key opinion leaders (KOLs) on prescribing behaviour. Academic detailing is 
concerned with the provision of information in an academic context. This form of 
detailing takes place in different formats, but face-to-face is the most frequent 
modality. Guidelines have a central place in evidence-based medicine and are 
prescriptive in nature when it comes to the prescribing of medicines. Biomedical 
influence is concerned with the diagnostic process or the diagnosis itself; the 
category addresses the influence in the spectrum of diagnostic tests to disease 
severity across therapeutic areas. Academic literature is concerned with the 
effect of medical journals as an information source on physician prescribing 
behaviour. Clinical study participation is concerned with the effect of a physician 
being an investigator in a clinical study on physician prescribing behaviour. 
Technology is concerned with the use of technological tools to influence physician 
prescribing behaviour. Legal concerns addresses the effect legal consequences 
of medical practice have on physician prescribing behaviour. Several authors 
also address the influence on physician prescribing across a spectrum of non-
economic factors.  
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Table 3-34 Non-economic factors 
 Frequency Percent Valid Percent Cumulative Percent 
Valid Peer effects 5 3.1 3.1 3.1
Academic detailing 15 9.4 9.4 12.5
Guidelines 7 4.4 4.4 16.9
Bio-medical influence 13 8.1 8.1 25.0
Academic literature 8 5.0 5.0 30.0
Clinical study participation 3 1.9 1.9 31.9
Technology 14 8.8 8.8 40.6
Legal factors 3 1.9 1.9 42.5
Mix 13 8.1 8.1 50.6
Missing 45 28.1 28.1 78.8
Other 34 21.3 21.3 100.0
Total 160 100.0 100.0  
3.4 Realist Synthesis 
The review identified two categories of influencers: contexts, a set of 
circumstances or facts surrounding prescription events; and interventions, in 
other words, proactive techniques, processes or actions introduced to create 
change.  In this section, a realist synthesis of the data captured in the systematic 
review is presented, following the convention and consequent structure made 
implicit by the separation of context and intervention.  
Therefore, contexts (physician characteristics, practice characteristics, patient 
characteristics, therapeutic area medicine attributes, and geography) are firstly 
addressed. Then, interventions (pharmaceutical promotion, regulation and 
control, economic factors and non-economic factors) are addressed separately, 
taking into account the contexts in which these interventions are applied. 
Theoretical considerations and a summary are provided for each category, and 
concluding remarks are made at the end of the section. 
3.4.1 Contexts 
In this section, the consistently present contextual factors are presented; these 
include physician characteristics, practice characteristics, patient characteristics, 
therapeutic area, medicine attributes, and geography. 
3.4.1.1 Physician Characteristics 
Physician characteristics have been suggested as a factor which may influence 
physician prescribing (Bradley, 1992). This review has identified specialty, age, 
time in practice, habit persistence and gender as physician characteristics. Since 
these characteristics are static at the time of prescription, it may reasonably be 
argued that physician characteristics constitute contextual components rather 
than interventions. In this section, the physician characteristics identified in the 
literature are addressed sequentially, before a summary is provided. However, it 
is worth noting that physician age, time in practice and habit persistence are all 




Pharmaceutical promotion and regulatory intervention are often directed to 
physicians (Gagnon and Lexchin, 2008, Gill et al., 1999), and this makes 
specialty a relevant context to investigate. The literature divides physicians into 
two main categories for comparison: specialists and general practitioners (GPs). 
Further division of the literature can be made into studies showing a relationship 
between specialty and physician prescribing behaviour and those that show little 
or no such association.  
Jones et al. (2001) explored specialists’ and general practitioners' perceptions of 
factors that influence their decisions to introduce new medicines into their clinical 
practice. The authors found that GPs generally prescribed more medicines that 
are new and for a wider range of conditions, but their approach varied 
considerably both between general practitioners and between medicines for the 
same general practitioner. Furthermore, the authors found that pharmaceutical 
sales representatives were an important source of information for GPs. However, 
specialists mainly used scientific literature and meetings to inform prescribing 
decisions and usually prescribed only a few new medicines relevant to their 
specialty. In another study, Biga et al. (2007) characterized profiles of physicians 
(GPs and rheumatologists) prescribing cyclo-oxygenase-2 inhibitors in France in 
2002. The authors found that there was a positive statistical link between a high 
level of cyclo-oxygenase-2 inhibitors prescriptions and the specialty of 
rheumatology.  Mamdani et al. (2002) examined the association between 
socioeconomic status, as indicated by neighbourhood median income levels, and 
physician medicine selection between older, less expensive generic medicines 
and newer, more expensive brand-name medicines for elderly patients initiating 
drug therapy in a universal health care system. Within each class of medicines, 
physician specialty consistently remained a significant independent predictor of 
newer brand-name medicine selection. The odds ratio of specialists initiating a 
patient on a newer brand-name medicine relative to non-specialists ranged from 
1.36 (95% CI 1.22 to 1.51) for ocular β-blockers to 7.17 (95% CI 6.43 to 7.99) for 
antipsychotics. Pressman et al. (2001) undertook a study aimed at describing 
initiation of osteoporosis drug therapy after bone mineral density (BMD) testing, 
physician factors, or both, adjusting for BMD status. The authors found that those 
whose BMD test was ordered by a gynaecologist or internist were more likely to 
receive osteoporosis therapy than women whose BMD test was ordered by 
practitioners in other medical specialties (OR = 1.4; CI = 1.1–1.7 for 
gynaecologists; OR = 1.2; CI = 1.0–1.5 for internists).    
Soumerai and Avorn (1987) analysed a university-based program to educate 
physicians about proper medication use. The authors investigated whether 
physician background characteristics and the quality or number of educational 
exposures influenced the rate of relinquishment of inappropriate prescribing. The 
results indicated that the rate of prescribing change was independent of most 
physician background characteristics studied, including age, board certification, 
specialty, rural versus urban practice, intensity of previous target medicine use, 
and size of Medicaid practice (Soumerai and Avorn, 1987). Pinto et al. (2010) 
investigated the main reasons physicians give for prescribing decisions. The 
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target population for the study consisted of physicians practicing in Portugal.  Of 
the 350 physicians randomly sampled, 102 were included (29% responder rate), 
of which 48.6% were GPs and 51.2% specialists from 15 various medical 
specialties.  The investigators used conjoint analysis as the principal statistical 
tool to rank the values most relevant for the analysis. Results of the analysis show 
that physicians place hierarchical importance on different factors when making 
prescribing decisions. The hierarchy, ranked from high to low, was as follows: 
effectiveness, tolerability, scientific sustainability, daily dosage, price, sales 
representative, institutional brand and generics. Specialty and geographical 
distribution were not found to influence the value placed on the determinants in 
relative or absolute terms (Pinto et al., 2010).  
The evidence supporting an association between specialty and physician 
prescribing behaviour is limited and conflicting. Thus, no consensus as to the 
effect of specialty on prescribing could be found in the literature identified in this 
review. 
3.4.1.1.2 Age, Time in Practice and Habit Persistence 
Physician age, time in practice and habit persistence are contextual components 
that may influence physician prescribing (Bradley, 1991). However, these 
components constitute a temporal dimension, raising the question about time as 
a factor. Time as an independent factor has not been addressed in the literature, 
and information on possible temporal effects can only be made by investigating 
age, time in practice and habit persistence. These three components are 
addressed separately before a summary is provided. 
In a study by Bauer et al. (2008), antidepressant prescribing patterns and factors 
influencing the choice of antidepressant for the treatment of depression were 
examined. The authors prospectively observed 3468 adults in 12 European 
countries who were about to start antidepressant medication for their first episode 
of depression or a new episode of recurrent depression. The authors found that 
older investigators were associated with a decreased likelihood of a serotonin-
reuptake-receptor-inhibitor (SSRI) being prescribed. In another study, Biga et al. 
(2007) characterized profiles of physicians (GPs and rheumatologists) 
prescribing cyclo-oxygenase-2 inhibitors in France in 2002. A negative statistical 
link was found between a high level of cyclo-oxygenase-2 inhibitors prescriptions 
and physician age below 44 years. Harries et al. (2007) investigated whether, 
and how, individual doctors are influenced by a patient's age in their investigation 
and treatment of angina pectoris (chest pain). Physicians who were influenced 
by age were on average five years older than those who were not; they were 
significantly positively influenced by old age on decisions to change prescriptions 
for ischemic heart disease - in particular, nitrates. It is also worth noting that 
female physicians were underrepresented in the study population, creating a 
male bias. In an Australian study aimed at investigating the effect of remuneration 
changes on physician prescribing behaviour, it was found that GPs aged over 55 
years old were less likely to counsel their patients and more likely to prescribe 
medication than GPs aged under 35 years old (Scott and Shiell, 1997). Hamann 
et al. (2004) interviewed 100 psychiatrists on drug choice for 200 patients 
suffering from schizophrenia and found that older physicians were up to five times 
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more likely to prescribe first-generation antipsychotics. Furthermore, the authors 
found that patient variables did not influence treatment decisions significantly.  
Time in practice has been mentioned as a possible factor influencing physician 
prescribing behaviour. However, few studies addressing this issue have been 
found in the literature. de Jong et al. (2009) investigated the influence of child, 
parent and physician factors on drug prescriptions for respiratory symptoms in 
primary care in infancy, as respiratory symptoms account for the majority of drug 
prescriptions in the first year of life.  The authors found that physicians with more 
than 15 years’ experience prescribed more. In another study, Mamdani et al. 
(2002) examined the association between socioeconomic status, as indicated by 
neighbourhood median income levels, and physician drug selection between 
older, less expensive generic drugs and newer, more expensive brand-name 
drugs for elderly patients initiating drug therapy in a universal health care system. 
The authors found that physician graduation year was inconsistently associated 
with newer brand-name drug prescribing across the three drug classes 
investigated in the study.  
Janakiraman et al. (2008) explored the effects of habit persistence on prescribing 
behaviour by examining 9672 prescriptions written for depression by 108 
physicians of non-specified specialities over a four-year period in the USA. A two-
state model was adopted based on the assumption that physicians can be either 
persistent or non-persistent. The authors investigated whether persistent 
physicians responded differently to detailing, out-of-office meetings, and 
symposium meetings. There is compelling evidence to show significant cross-
sectional levels of persistence in decisions concerning the prescription of 
medicines. Practice type may play a role, as it was found that physicians working 
in smaller practices are more likely to be persistent. Furthermore, age and 
detailing acceptance also play a role in defining persistence. Older physicians 
and those more accepting of detailing stand a higher chance of being persistent. 
Both persistent and non-persistent physicians appear be responsive to 
symposium meetings; however, only non-persistent physicians were found to be 
responsive to detailing. Out-of-office meetings had no effect on prescribing 
behaviour. In another study, Venkataraman and Stremersch (2007) also found 
that there is substantial habit persistence in physician decision making. Lilja 
(1976) performed an empirical study utilizing a mailed questionnaire examining 
how GPs (180) in Sweden chose medicines. The data were analysed using linear 
regression modelling, and the author found a positive effect on habitual choice 
with increasing age. Highest weight was given to curing effect of medicines 
prescribed. In addition to physician age, it was found that disease severity was a 
determining factor. Moreover, no significant relationships for background 
variables of physician were found. “The unique contribution of habit would lie in 
finding a residue of past experience that leads to habitual rather than reasoned 
responses” (Ajzen, 1991). Further support is provided by Coscelli (2000), who 
also notes that doctors' prescribing behaviour shows habit persistence. 
Furthermore, personal experience combined with social meaning of medicines 
drive prescribing behaviour during the end of life therapies (Zerzan et al., 2011); 
and early experience of using new medicines seems to strongly influence future 
prescribing (Jones et al., 2001). 
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Evidence supporting the effect of age and time in practice as individual 
components influencing physician prescribing behaviour is limited. However, both 
age and time are temporal, and it may therefore be argued that time is a factor 
influencing physician prescribing. This review has, however, not identified any 
evidence to link time to physician prescribing directly. The third component in this 
section is also temporally related, as habit represents residues of past behaviour 
and experiences (Ajzen, 1991). Age and time in practice may therefore merely 
represent the temporal axis on which past behaviours and experiences are 
placed. The key to understanding temporal effects can thus be found in the 
literature addressing habit persistence. From a theoretical perspective, temporal 
effects may simply reflect the sum of past behaviour and as such is best 
characterized as a reflection of all factors that determine the behaviour. The 
correlation between past and later behaviour is an indication of the behaviour’s 
stability or reliability (Ajzen, 1991). Furthermore, Ajzen (1991) notes that residual 
effects of past behaviour may constitute habit, but can also be the result of 
missing or unrecognized attributable factors. However, evidence presented in this 
review suggests a strong influence of habit persistence on physician prescribing 
behaviour. Thus, evidence of temporal components influencing physician 
prescribing is considered high. 
3.4.1.1.3 Gender 
In a prospective study, Bauer et al. (2008) examined antidepressant prescribing 
patterns and factors influencing the choice of antidepressant for the treatment of 
depression. The authors prospectively observed 3468 adults in 12 European 
countries who were about to start antidepressant medication for their first episode 
of depression or a new episode of recurrent depression. Female physicians were 
found to be more likely to prescribe a serotonin–norepinephrine reuptake inhibitor 
(SNRI) than male physicians (OR 1.77; 95% CI 1.27, 2.48).  In another study, 
Biga et al. (2007) characterized profiles of physicians (GPs and rheumatologists) 
prescribing cyclo-oxygenase-2 inhibitors in France in 2002. A negative statistical 
link was found between a high level of cyclo-oxygenase-2 inhibitors prescriptions 
and female physician gender. In a study undertaken by Pressman et al. (2001),  
aimed at describing initiation of osteoporosis drug therapy after bone mineral 
density (BMD) testing, it was found that if the BMD test was ordered by a female 
health care practitioner, prescription of osteoporosis drugs was more likely than 
if the BMD test was ordered by a male practitioner (OR = 1.3; CI = 1.1–1.5). In 
an Australian study aimed at investigating the effect of remuneration changes on 
physician prescribing behaviour, it was found that compared to male GPs, female 
GPs were less likely to provide prescription medicines as a form of treatment 
(Scott and Shiell, 1997).  
Evidence supporting a gender effect on physician prescribing behaviour is scant, 
and what evidence is available is scattered across different therapy areas, 
making a comparative analysis impossible.  Thus, no consensus as to the effect 





Evidence supporting physician characteristics as an influencer on physician 
prescribing is limited in quantity and quality, see Table 3-35 Summary of 
physician characteristics. There is no consensus in the literature supporting 
physician specialty, age, gender, or time in practice as independent influencing 
factors. However, habit persistence has been found by several authors to be a 
strong influencer on prescribing, and early exposure to new medicines may lay 
the ground for its development. Thus, in conclusion, the evidence of influence of 
physician specialty, age, and gender on physician prescribing is low; and the 
evidence supporting physician habit persistence as an influencer on physician 
prescribing is high.  
Table 3-35 Summary of physician characteristics 
Physician Characteristics 
Component Mechanism Theory Evidence of influence 
Specialty Modulate uncertainty TPB Low 
Age Temporal axis for habit persistence TPB Low 
Time in practice Temporal axis for habit persistence TPB Low 
Habit persistence Habit persistence TPB High 
Gender None identified TPB Low 
3.4.1.2 Practice Characteristics 
Practice characteristics may serve as an influencer on physician prescribing. 
Typical distinctions between practice types include location (rural versus urban), 
organization (solo versus group) and academic status. The literature addressing 
practice characteristics as an influencing factor on physician prescribing 
behaviour is limited and heterogeneous. 
Rice (2009) investigated whether health maintenance organizations (HMO) 
physicians are more price sensitive than non-HMO physicians are in their 
prescribing behaviour of brand-name medicine substitutes. The author found that 
the prescription of medicines was strongly influenced by the organization and 
structure of the physician’s practice. In another study by Stewart et al. (2003), two 
general practice variables, organization form and degree of urbanization were 
found to influence physician prescribing. Addressing the degree of urbanization, 
de Bakker et al. (2007) found that urban practice location was related to a broader 
range of prescribing by GPs.  Further evidence supporting the degree of 
urbanization as a factor influencing physician prescribing comes from a study 
undertaken by Canli et al. (2006). The authors found that antibiotics were most 
often prescribed in rural areas. Tett (2003) investigated whether geographical 
remoteness in Australia is a factor influencing physician prescribing behaviour. 
The author employed a self-reporting survey technique, and most respondents 
agreed that they prescribed differently in rural compared with city practices.  More 
specifically, the majority of respondents agreed that their prescribing was 
influenced by practice location, isolation of patient home location, limited 
diagnostic testing and increased medicine monitoring.  Furthermore, prescribing 
recently marketed medicines was more likely by doctors practicing in less remote 
rural areas. However, the evidence is not consistent. In a study investigating 
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determinants of prescribing for young children with respiratory symptoms, de 
Jong et al. (2009) found that urban or rural practice type does not affect 
prescribing by physicians.  
Investigating the organization of practices, Bro and Mabeck (1988) found that 
GPs in group practices used traditional penicillin more frequently and broad 
spectrum antibiotics less frequently than their colleagues in solo practices. It has 
also been noted by Muijreres et al. (2005) that there may be a correlation between 
quality of prescribing and solo versus group practice. The authors claim that the 
quality of prescribing, measured by guideline adherence, is higher in group 
practices when compared with solo practices. Furthermore, speculation around 
the reason behind these observations has surfaced and may in part be due to the 
internal audit effect, implicit or otherwise, existing in group practices (Bro and 
Mabeck, 1988).  
Cettomai et al. (2010) investigated the use of pneumocystis pneumonia (PCP) 
prophylaxis among immune-compromised patients. The authors found that there 
was a higher frequency of PCP prophylaxis being prescribed in academic-based 
practices when compared to non-academic based practices (OR 2.75, p < 0.001).  
The evidence supporting practice characteristics as an influencer of physician 
prescribing is limited; however, it has been suggested that degree of urbanization, 
practice organization and academic status may exert influence on physician 
prescribing. The evidence provided to support this view is not consistent, as some 
authors find no relation between practice characteristics and physician 
prescribing. Furthermore, degree of urbanization cannot be disengaged from the 
fact that there are several components of urbanization that have been shown to 
influence health status (Williams, 1990), and the consequent need for 
prescription medicines. It is therefore difficult to attribute influence on physician 
prescribing behaviour to the components of urbanization, and the authors 
contributing to the evidence shedding light on the subject have made no such 
attempts. Furthermore, it has also been noted that there may be a correlation 
between degree of urbanization and practice organization, in that there is a higher 
concentration of group practices in more urban areas (De Laat et al., 2002). Thus, 
practice organization befalls the same fate as degree of urbanization, in that the 
components influencing the need for prescription medicines are not accounted 
for. The same argument can be made for academic status, as it may be argued 
that disease severity is higher in academic practices as compared to non-
academic practice types. In conclusion, practice characteristics may influence 
physician prescribing, but health related components influencing prescribing 




Table 3-36 Summary of practice characteristics 
Practice Characteristics 
Component Mechanism Theory Evidence of influence
Degree of 
urbanization 
Differing prevalence and incidence of medical 
conditions requiring prescription medicines TPB Low 





Differing prevalence, incidence and severity  of 
medical conditions requiring prescription 
medicines  
TPB Low 
3.4.1.3 Patient Characteristics 
Much has been written about the effect of patient characteristics on physician 
prescribing behaviour. In a literature review by (Bradley, 1991), investigating 
factors which influence the decision whether or not to prescribe, it was found that 
important factors include age, ethnicity, social class and education, the doctor's 
prior knowledge of the patient, the doctor's feeling towards the patient, 
communication problems, and the doctor's desire to try to preserve the doctor-
patient relationship (see Table 3-37 Summary of patient characteristics). 
However, in another review by Chauhan and Mason (2008), little evidence on the 
influence of patients upon prescribing decisions was identified. Therefore, 
available literature may suggest that a clear consensus on the effect of patient 
characteristics on physician prescribing behaviour does not exist. Furthermore, it 
is worth noting that from a practitioner’s point of view, age, gender and race are 
all linked to health states that may require prescription medicines. The common 
link is differences in anatomy and physiology influencing both the prevalence and 
incidence of disease states that may require prescription medicines. Such 
information is common knowledge for physicians and provides part of the context 
under which prescribing decisions are made.  Thus, any literature addressing 
patient characteristics must consider these aspects in order to separate effects 
driven by common medical knowledge and consequent actions taken to remedy 
undesired health states directly or indirectly associated with the patient 
characteristic in question.  
3.4.1.3.1 Patient Age 
Age is the most prevalent patient characteristic potentially influencing prescribing 
behaviour by physicians mentioned in the literature included in this review. 
Harries et al. (2007) investigated whether, and how, individual doctors are 
influenced by a patient's age in their investigation and treatment of angina 
pectoris (chest pain). Age, independent of comorbidity, presentation and patients' 
wishes directly influenced decision-making about angina pectoris investigation 
and treatment by half of the doctors in the primary and secondary care samples. 
Furthermore, elderly patients were less likely to be prescribed a statin after 
cholesterol testing, suggesting inequity in health care related to patient age. In a 
study by Ohlsson et al. (2009) on factors related to early adoption of rosuvastatin 
(statin), it was found that rosuvastatin was prescribed more frequently to younger 
patients than to elderly patients. In another study aimed at determining the impact 
of differential Medicare medicine coverage on physicians' prescribing behaviour 
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in clinical practice, it was found that the dichotomous and continuous age terms 
and education level were significant independent predictors of biologic 
prescription choice (DeWitt et al., 2006). In a study by Kisely et al. (2000), 
addressing the growing interest in factors that might influence the prescription of 
psychotropic medicines in general practice, the authors found that older patients 
were significantly more likely to be prescribed psychotropic medication than their 
younger counterparts. Pressman et al (2001) focused on initiation of osteoporosis 
drug therapy after bone mineral density (BMD) testing. The authors found that 
compared with osteoporotic women aged 45-54 years, women aged 55-64 years 
who started drug therapy were 40% more likely (OR = 1.4; CI = 1.0-2.2) and 
women aged > or = 65 years were twice as likely (OR = 2.0; CI = 1.4-2.8) to start 
non-hormone replacement therapy medicines. In a study investigating the effect 
of GP and patient characteristics on physician prescribing, Stewart et al. (2003) 
found that age was a significant predictor for prescribing. The authors also found 
that patient characteristics have greater influence on physician prescribing 
behaviour than physician characteristics. However, not all authors have found a 
convincing association between age and physician prescribing behaviour. For 
example, Mamdani et al. (2002) investigated the association between 
socioeconomic status, as indicated by neighbourhood median income levels, and 
physician medicine selection between older, less expensive generic medicines 
and newer, more expensive brand-name medicines for elderly patients initiating 
drug therapy in a universal health care system. The authors found that patient 
age was inconsistently associated with newer brand-name medicine prescribing 
across the three investigated medicine classes (antipsychotic, 
hydroxymethylglutaryl-coenzyme A reductase inhibitor (statin), ocular beta-
blocker). 
Several authors have described the effect of patient age on physician prescribing 
behaviour, and it may therefore seem evident that convincing evidence to support 
the hypothesis that patient age can affect physician prescribing behaviour exists. 
However, none of the authors has addressed age as a temporal factor linked to 
the natural evolution of aging and associated health states. Age in itself, 
therefore, can be argued to be an axis on which the prevalence and incidence of 
pathology and pathophysiology vary accordingly. Not taking into account the 
natural evolution of medical conditions and the consequent need for prescription 
medicines severely weakens any argument claiming age to be an independent 
factor influencing physician prescribing. However, it may also be argued that age 
is an independent factor, as recently highlighted in a Norwegian newspaper 
article where a patient with terminal chronic obstructive lung disease was taken 
of the waiting list for lung-transplantation on the day he turned 67 (Aftenposten, 
5/12/2011).  The ensuing debate has made it clear that age, in itself, should not 
be a determining factor. On the other side, it is well known in the practice of 
medicine that age plays a role in the risk-benefit assessment of any medical 
intervention. For example, the decision to withhold medication for aged 
individuals may in part be due to the short duration of expected lifespan.  
However, in these cases, risk-benefit is associated with any likely benefit in the 
context of bio-medical factors present at any given evolutionary stage of aging.  
In conclusion, the available literature does not separate age and bio-medical 
influencers on physician prescribing behaviour; and any conclusion concerning 
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age as an independent factor influencing physician prescribing behaviour can 
therefore not reliably be drawn. Age in this context, can therefore be considered 
a temporal axis reflecting the evolution of aging and the associated pathology 
and pathophysiology, which influence physician prescribing. 
3.4.1.3.2 Patient Gender 
Patient gender is a factor that may influence prescribing behaviour by physicians, 
simply for the fact that men and women are different anatomically and 
physiologically. The difference in anatomy and physiology makes for differences 
in prevalence and incidence of different disease states. Further complicating the 
issue is the link between age and gender influencing health indirectly through 
prevailing bio-medical factors. Gender differences will therefore clearly influence 
prescribing; for example, therapies for prostate ailments are reserved for males, 
and hormone replacement therapy for menopause is reserved for women. 
However, there are also instances when gender difference does not play such an 
implicit role. It is under these circumstances that the influence of patient gender 
is less clear and that the literature may inform on evidence of influence.  
In an Australian study designed to investigate the effect of remuneration on 
prescribing behaviour, the authors found that the most important factors 
influencing decisions in consultations for upper respiratory tract infections and 
sprain/strain are the age and gender of patients, suggesting that patient 
characteristics are the most influential in the GP's utility function (Scott and Shiell, 
1997). Mamdani et al. (2002) investigated the association between 
socioeconomic status, as indicated by neighbourhood median income levels, and 
physician medicine selection between older, less expensive generic medicines 
and newer, more expensive brand-name medicines for elderly patients initiating 
medicine therapy in a universal health care system. It was found that patient 
gender was inconsistently associated with newer brand-name medicine 
prescribing across the three investigated classes of medicines (antipsychotic, 
hydroxymethylglutaryl-coenzyme A reductase inhibitor (statin), ocular beta-
blocker). In another study aimed at quantifying the relative contributions of patient 
versus physician factors to the decision to prescribe selective cyclooxygenase-2 
(COX-2) inhibitors during the first 2 years of their availability, it was found that 
first-time users of COX-2 inhibitors were more likely to be female than male, with 
88% versus 85 %, respectively (Schneeweiss et al., 2005). Stewart et al. (2003), 
in a cross-sectional study in the northern Netherlands, investigated a two-level 
multilevel model which was applied to patients (n = 269,067) in 190 practices with 
251 general practitioners. The authors found that gender was a significant factor 
influencing prescribing and adherence to pharmaco-therapeutic guidelines. In 
another study, Van der Ent et al. (2009) investigated the influence of child, parent 
and physician factors on medicine prescriptions for respiratory symptoms in 
primary care. The authors found that boys had a three times higher chance of 
receiving a prescription than girls.  
There are few studies specifically addressing patient gender as a factor that may 
influence physician prescribing behaviour. Furthermore, the available evidence 
is not consistent in quality or conclusion on the question related to whether patient 
gender influences prescribing behaviour. However, the topic is hotly debated in 
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some medical circles. For example, gender and coronary heart disease has been 
a hot topic for decades, and literature abounds with information on gender 
differences in presentation, prognosis and interventions (Fiebach, 1997). 
However, the context of gender differences in anatomy and physiology is not 
addressed in the studies uncovered in this review; thus, the available literature 
addressing patient gender as an influencer of physician prescribing behaviour 
does not separate gender and bio-medical influencers on physician prescribing 
behaviour, and any conclusion as to any effect cannot reliably be drawn. 
Evidence of influence is therefore felt to be low. 
3.4.1.3.3 Patient Race 
Patient race was suggested by Bradley (1991) to be a factor influencing physician 
prescribing behaviour. Only two studies addressing this topic have been 
uncovered in this review, and the consensus is that race does not affect physician 
prescribing behaviour (Schneeweiss et al., 2005, Tamayo-Sarver et al., 2003). 
However, race may imply differences in both anatomy and physiology. For 
example, Europeans (fair skin colour) will be at increased risk of skin cancer when 
compared to populations with darker skin (Boni et al., 2002), although none of 
the authors of publications included in this review have addressed race in the 
context of the potential differences in anatomy and physiology. Thus, the 
available literature does not separate race and bio-medical influencers on 
physician prescribing behaviour, and any conclusion as to any effect cannot 
reliably be drawn.  Evidence of influence is therefore felt to be low. 
3.4.1.3.4 Patient Expectation 
The physician’s desire to preserve the physician-patient relationship as a factor 
that may influence physician prescribing behaviour has been described in the 
literature (Bradley, 1992). In an agency context, patient expectancy may clearly 
influence physician prescribing behaviour. However, only a few authors included 
in this review address the question. Furthermore, the origin of patient expectancy 
is not clearly identified in the included literature, but it has been shown that 
patients exhibit strong state dependence (Coscelli, 2000).  
Lundin (2000) investigated the effect of moral hazard on physician prescribing 
and found that patient acquired taste (preference) is an important factor, giving 
further support to the findings of Coscelli (2000). In addition, Naik et al. (2009) 
note that patients requests for specific brands may influence physician 
prescribing behaviour. In a study by Tett (2003), it was found that 66.1% of GPs 
felt that patient expectation influences prescribing. Webb and Lloyd (1994), 
examined the effect of patient expectations of physician prescribing and hospital 
referrals; the investigators employed a self-administered survey, covering 1080 
consultations with 12 GPs. Results showed that physician prescribing behaviour 
was most strongly associated with patients’ expectations. The level of influence 
exerted by patient expectations on physician prescribing behaviour may be 
strong, as was found in a study assessing the influence of non-medical factors in 
the context of upper respiratory infections (Hummers-Pradier et al., 1999). The 
authors conclude that patient expectations are extremely important when 
prescribing medicines for cold and cough. This notion is further supported in a 
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similar study investigating the prevalence of patient expectations for upper 
respiratory infections (Faber et al., 2010). In another study, Macfarlane et al. 
(1997) investigated patient expectations in the context of antibiotic prescribing, 
and found that 85% of patients felt that symptoms were related to infections and 
that antibiotics would help (87%). The authors found that most (72%) patients 
wanted antibiotics and the same number of patients expected a prescription for 
antibiotics.  
The literature suggests that there may be a poor correlation between patient 
expectation and physician perception of this expectation. Whether it is the patient 
expectation or the physician’s perception of the patient expectation that is the 
influencer becomes a key question to address.  Mangione-Smith et al. (1999) 
investigated the expectation of parents among children diagnosed with a 
probable viral cause. The authors found that the actual parent expectation did not 
influence the decision to prescribe. The authors note that there was poor 
agreement between actual pre-visit expectations reported by parents and the 
perception of expectation by the physician. In a study exploring how GPs decide 
to prescribe, it was found that the decision is shaped by the perception of patient 
expectation (Hyde et al., 2005). Lado et al. (2008) conclude along the same lines 
and claim that there is no association between patient expectations and physician 
perception of such expectations. In an observational study, von Ferber et al. 
(2002) found that patients’ needs and expectations are lower than observed 
prescribing behaviour by physicians. More recently, further support to the 
perception of expectation is given by the work of Tusek-Bunc et al. (2010), where 
it was found that the physician perception of patient expectation was a significant 
factor influencing statin prescribing. 
From the evidence presented, patient expectation as an influencer is not well 
established. However, the evidence points in the direction of the physicians’ 
perceptions of patient expectation as an influencer of physician prescribing 
behaviour. Furthermore, it has been suggested that there may be differences in 
the level of reliance on these perceptions dependent on physician specialty 
(Lapeyre-Mestre et al., 1998).  Therefore, in conclusion, the evidence of influence 
is felt to be low. 
3.4.1.3.5 Biomedical Factors 
In general, it can reasonably be argued that the clinical practice of medicines is 
concerned with how bio-medical factors affect the physical and psychological 
wellbeing of patients. In this review, however, the quantity of literature addressing 
this very issue is limited. That said, a few publications included in this review do 
address the question (Cettomai et al., 2010, Choudhry et al., 2006, Schneeweiss 
et al., 2005, Blix et al., 2011, Crawford et al., 2011).  
Four publications present evidence of patient level bio-medical influence on 
physician prescribing behaviour, whereas one publication presents evidence 
contradicting such influence. Cettomai et al. (2010) investigated factors 
associated with the prescription of pneumocystis pneumonia (PCP) prophylaxis 
among 3150 members of the American College of Rheumatology. The authors 
found that patients currently on immunosuppressive therapy had a two-fold 
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chance of receiving prescriptions for PCP prophylaxis. In another study, Crawford 
et al. (2011) investigated the influence of patient and contextual factors on the 
prescribing for patients with personality disorders. The authors found that even 
though the evidence base for prescription medicines for patients with personality 
disorders is weak, it is still a widely employed treatment strategy. Furthermore, 
the authors note that the type of personality problem appears to have an impact 
on whether medicines are prescribed or not. Blix et al. (2011) investigated the 
effect of patient smoking status on antibiotic prescribing. The authors found that 
patient smoking habits influenced the prescribing of antimicrobials for several 
years in a dose-response relationship. In a study by Choudhry et al. (2006) 
investigating physicians’ experiences on prescribing behaviour, the authors found 
that the experience of an adverse event as a result of treatment can influence the 
prescribing of warfarin. However, the prescribing of warfarin was not affected 
after a physician had a patient with stroke, and physicians who had a patient with 
bleeding or stroke did not influence the prescribing of angiotensin-converting-
enzyme inhibitors.  
Schneeweiss et al. (2005) investigated patient versus physician factor influence 
on the prescribing of Cox-2 inhibitors during the first two years of their availability. 
The authors found that first time Cox-2 inhibitor prescribing is somewhat 
dependent on patient factors such as gastrointestinal toxicity. However, the 
proportional influence of physician preference increased substantially over the 
following two-year period, suggesting habit persistence as a temporal residue of 
experiences and past behaviours.  
The limited evidence found in support of bio-medical factors as an influencer on 
physician prescribing behaviour can be argued to be because such influence is 
presumed.  In fact, medical literature in general is focused on patient level bio-
medical factors as a cause of disease and focus for diagnosis and treatment, and 
ultimately lie at the core of decisions relevant to the practice of clinical medicine. 
Therefore, bio-medical factors can reasonably be argued to figure prominently 
among influencers of physician prescribing behaviour. Therefore, in conclusion, 
evidence of influence is felt to be high. 
3.4.1.3.6 Other Patient Factors 
Other factors mentioned in the literature included in this review are: social 
(Campo et al., 2006), price sensitivity and patient intervention (Arnold and Straus, 
2005, Ostini et al., 2011). However, only a few authors included in this review 
address these factors, making a comparative synthesis impossible. Furthermore, 
none of the factors was the primary focus of the studies and the contexts were 
heterogeneous; thus, no conclusions could be drawn as to possible influence on 
physician prescribing.  
3.4.1.3.7 Summary of Patient Factors 
Patient factors have been postulated to influence physician prescribing. However, 
the evidence presented in this review supporting this hypothesis is limited. 
Evidence addressing patient age, gender and race are detached from the 
biological links described in the medical literature as having impact on health 
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status and the consequent need for prescription medicines. On the question of 
patient expectations as an influencer, it has been suggested that it is not the 
expectation, but rather the physician’s perception of the patient expectation that 
constitutes the component directly influencing physician prescribing behaviour. 
Only a few authors addressed other factors identified included in the review, and 
as a consequence, no conclusion could be drawn as to their role in physician 
prescribing. Thus, the evidence of patient characteristics as an influencer on 
physician prescribing behaviour is in general low. However, based on included 
evidence and medical literature in general, patient-level bio-medical factors are 
felt to be significant influencers of physician prescribing. Considering the wealth 
of evidence provided in the medical literature on the connection between patient 
level bio-medical factors and clinical decision making, it is apparent that the 
evidence of influence is high.  
Table 3-37 Summary of patient characteristics 
Patient Characteristics 
Component Mechanism Theory Evidence of influence 
Age Temporal axis along which medical conditions requiring prescription medicines reside  TPB Low 
Gender 
Difference in anatomy, physiology and consequent 




Difference in anatomy, physiology and consequent 
medical conditions requiring prescription medicines. 
Modulate uncertainty.  
TPB Low 
Expectation Physician perception of patient expectation is the true driver. Modulate social norm.  TPB Low 
Bio-medical 
factors Modulate uncertainty TPB High 
Others None identified ? Low 
3.4.1.4 Therapy Area  
Therapy area is closely linked with bio-medical factors on a patient level; for 
example, diagnosis. Kremer et al. (2008) claim that the efficiency of 
pharmaceutical promotion differs across therapeutic areas; however, these 
findings are based on aggregated data and are not corrected for the influence of 
bio-medical factors. The literature included in this review does not clearly 
distinguish therapy area as an independent factor influencing physician 
prescribing behaviour. Thus, any further conclusion than simply assuming that 
any associated effect of physician prescribing is linked with patient level bio-
medical factors is not possible to make, given the available evidence uncovered. 
Therefore, in conclusion, evidence of therapy area as an independent factor 
influencing physician prescribing behaviour is low. 
3.4.1.5 Medicine Attributes 
Bradley (1991) found that a physician’s concern about medicines was a factor 
influencing physician prescribing behaviour. Several authors have since 
investigated the origin of these concerns and found that efficacy and safety are 
the main constituents, thus addressing the benefit-risk profile of medicines. 
Uncertainty is stated as the main driver of physician behaviour (Arrow, 1963), and 
 118 
it is therefore unreasonable to expect the benefit-risk profile of a medicine not to 
influence physician prescribing behaviour. Indeed, safety and effectiveness were 
considered highly influential by all participants in a study describing and 
comparing the opinion of physicians, clinical pharmacists and formulary 
committee members with respect to key factors that influence medication 
prescribing in community hospitals (Schumock et al., 2004). Physicians, 
however, may not be risk averse. Pinto et al. (2010) analysed the main reasons 
physicians give for their prescription choices. It was found that the effectiveness 
of the product; tolerability, which is directly related to the abandonment rate of a 
given course of treatment, was considered less important by doctors in this study. 
The authors argue that this proves that members of the medical profession are 
willing to take certain risks by using more effective medicines, even if they cause 
more reactions that are adverse. In another study, Choudhry et al. (2006) found 
that adverse events that are possibly associated with underuse of warfarin may 
not influence subsequent prescribing. When analysing trends in rosuvastatin 
prescribing, Ohlsson et al. (2009) realized that the medicine was the subject of 
safety concerns and subsequent regulatory warnings during the observation 
period of the study. The authors note that these warnings may have influenced 
the patterns of prescription. This conclusion was drawn on the basis of an overall 
reduction in the prevalence of rosuvastatin prescriptions in the latter third of the 
study. However, the clustering of rosuvastatin prescriptions was not substantially 
affected by the warnings.  
When Prosser and Walley (2006) investigated the range of factors influencing the 
prescription of new medicines, the key factors behind the first prescription of a 
new medicine were found to be an absence of current available treatment or 
expectation of better outcomes based on a medicine’s alleged relative advantage 
over current treatment. This was largely attributed to increased effectiveness and 
fewer side effects (Prosser and Walley, 2006). In another study, Schneeweiss et 
al. (2005) quantified the relative contributions of patient versus physician factors 
to the decision to prescribe selective COX-2 inhibitors during the first 2 years of 
their availability. The authors found that twice as much variability in COX-2 
prescribing could be explained by physician preferences than by the five 
gastrointestinal toxicity risk factors alone, indicating that safety may not be an 
overriding concern. One explanation may be that if a medicine has a novel 
mechanism of action, or belongs to a class of medicines with few alternatives, 
clinicians are more likely to consider it favourably as a prescribing option 
(Chauhan and Mason, 2008). In support of this notion, Tett (2003) found that a 
strong majority of participants in the study agreed that they would prescribe a 
new medicine based on its comparative efficacy to others (76.1%). However, 
even though physicians are not risk averse, safety concerns may influence 
prescribing. In a study aimed at investigating which factors influence physician 
prescribing behaviour regarding stress ulcer prophylaxis, concerns about side 
effects (OR = 0.24, 95% CI 0.09, 0.61) were associated with a decrease in 
prescribing (Hussain et al., 2010). Even though adverse drug reactions may not 
appear very often, they do have a profound effect on physician prescribing 
patterns (Banjo et al., 2010, Theodorou et al., 2009).  
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Calvo and Rubinstein (2002) evaluated the impact of the publication in a leading 
journal of different drug studies (metformin, alendronate, terazosin, and 
finasteride) on the prescription behaviour of generalists and specialists. In the 
evaluation, three studies showed efficacy and one study showed lack of efficacy. 
The proportions of new prescriptions changed between a 6-month period before 
publication and a 6-month period after publication. Others have also found that 
efficacy influences physician prescribing behaviour. For example, efficacy and 
utility of the drug was found to be a distinctive factor influencing prescribing of 
statins (Tusek-Bunc et al., 2010). Furthermore, Theodorou et al. (2009) found 
that clinical effectiveness is the most important factor, reaching 94.9% and 93.3% 
in Greece and Cyprus, respectively, and that there was no statistically significant 
difference between the two countries.  
In a seminal study addressing the issue of attributes of medicine as a factor 
influencing physician prescribing behaviour, Venkataraman and Stremersch 
(2007) investigated  the effect of promotional effect across brands. The database 
used for the study included, at the monthly level, all prescriptions within the 
examined medicine categories by a panel of 2774 physicians. This resulted in 
just under 40000 observations for the 12 brands included in the study. Detailing 
was found to have a more positive effect on prescriptions for more effective 
medicines as compared to less effective medicines, and for medicines with more 
side effects as compared to medicines with fewer side effects. In other words, it 
was found that that the effects of marketing efforts and patient requests on 
physician prescription behaviour do indeed vary by brand. Furthermore, medicine 
attributes such as effectiveness and safety moderate the response by physicians 
to promotional efforts on physician prescribing behaviour.  
Kurdyak et al. (2007) studied whether five regulatory agency advisories 
concerning the possible increased risk of suicidal behaviour during 
antidepressant therapy had an effect on antidepressant prescription trends in 
Ontario. The authors claim that safety advisories did not influence physician 
prescribing in North America, but similar advisories led to a decrease in 
prescribing in the UK in 2003. Thus, there may be geographical variations in the 
effect of safety advisories provided by regulatory agencies. In another study, 
Saad et al. (2010) investigated the warnings from the Food and Drug 
Administration (FDA) on the use of antipsychotics in the management of 
dementia. The authors found that information about medicine attributes may be 
effective and that the main barrier to change is the lack of treatment alternatives. 
However, medicine attributes may not be the only moderator. Weatherby et al. 
(2002) retrospectively investigated the effect of FDA warning letters in order to 
determine how such letters may be improved. The authors conclude that explicit 
wording can aid in changing physician prescribing behaviour.  
On the basis of biopharmaceuticals being one of the fasted growing segments of 
the pharmaceutical industry, Nonis and Hudson (2009) investigated the effect of 
physicians’ beliefs about genetic engineering on physician prescribing. There 
appears to be a lack of trust in the technology, driven by a fear of unknown 
consequences. On this basis, the authors claim that genetic modification as an 
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attribute influences physician prescribing behaviour by decreasing the likelihood 
in the decision making process leading to a prescription. 
From the evidence presented in this review, there appears to be a consensus on 
medicine attributes as a factor influencing physician prescribing behaviour, see 
Table 3-38 Summary of medicine attributes. Physicians appear to place great 
value on clinical efficacy and seem willing to take risks under certain conditions. 
Thus, the benefit-risk profile of a medicine is not a static factor, but a dynamic 
one moderating physician prescribing behaviour. Therefore, in conclusion, 
evidence of influence is felt to be high. 
Table 3-38 Summary of medicine attributes 
Medicine Attributes 
Component Mechanism Theory Evidence of influence 
Efficacy Modulate uncertainty TPB High 
Safety Modulate uncertainty TPB High 
Benefit-Risk Modulate uncertainty TPB High 
3.4.1.6 Geography 
Geographical variations in the delivery of health care have been described in the 
literature by several authors (Wennberg et al., 2002, Calleri et al., 2008, Sturm et 
al., 2007, Webster et al., 2009). Whether geography is an independent factor 
influencing physician prescribing behaviour, therefore, becomes an important 
question to address.  
Wennberg et al. (2004) note that Medicare spending varies across regions and 
that these variations persist after differences in health status are accounted for. 
This would suggest that increased spending does not necessarily lead to better 
health outcomes. Furthermore, the authors note that the main drivers for variable 
spending are increased use of supply-sensitive physicians’ services, specialist 
consultation, and hospitalization for patients with chronic disease. Calleri et al. 
(2008) claim that geographical variations in prescribing of malaria 
chemoprophylaxis in Europe can largely be accounted for by variability in 
evidence based on efficacy and tolerability. Sturm et al. (2007), on the other hand, 
conclude that it remains to be established which factors within a given health-
care system are responsible for the observed effects. Finally, Webster et al. 
(2009) find that early opioid prescribing for low back pain is almost fully explained 
by state-level contextual factors.   
In summary, geography remains a complex issue when it comes to discerning 
influencers on physician prescribing behaviour. However, based on the stated 
variability in health care spend and delivery without apparent health-outcome 
effects, it seems reasonable to argue that geography is not an independent 
influencer of physician prescribing behaviour, but represents a variable collection 
of factors and contexts. Based on the evidence presented in this review, evidence 
of influence is low. 
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3.4.1.7 Theoretical Considerations and Summary 
Evidence of influence by contextual factors on physician prescribing behaviour is 
in general low, with the notable exception of physician-level habit persistence, 
patient-level bio-medical factors and medicine attributes.  This conclusion is 
largely driven by the fact that the evidence addressing contextual factors is 
detached from the bio-medical circumstances known to influence health status 
and the consequent need for prescription medicines.  
The identification of habit persistence as a strong influencer on physician 
prescribing is not surprising when considering the complexities of medical 
decisions. Three main theoretical perspectives may be adopted to explain this 
observation. Firstly, physicians rely heavily on heuristics during the clinical 
decision process as a means for effort-reduction (Shah and Oppenheimer, 2008, 
Elstein, 1999). Second, from an economic theory perspective, it may be argued 
that the habit persistence is brand loyalty created by persuasive pharmaceutical 
promotion (Hurwitz and Caves, 1988). Finally, from an agency perspective, it may 
be argued that habit persistence embodies adverse selection.  
Medical literature abounds with effect measures of therapy, and the literature 
addressing medical decision-making focuses on the uncertainty associated with 
the benefit-risk of any medical intervention intended to address a bio-medical 
need in a clinical setting. It has indeed been stated that uncertainty is the main 
driver of physician behaviour (Arrow, 1963), and patient-level bio-medical factors 
may therefore be argued to influence physician prescribing behaviour by 
modulating uncertainty. Similarly, when Venkataraman and Stremersch (2007) 
compellingly argue the moderating effect medicine attributes have on the effect 
of detailing across brands, it is the uncertainty associated with prescribing that is 
the contextual component influencing physician prescribing. 
Contextual factors that have been suggested to have a bearing on physician 
prescribing behaviour have been inadequately investigated, and thus evidence 
of influence in general is low. However, three notable exceptions exist; physician-
level habit persistence, patient-level bio-medical factors and medicine attributes. 
Evidence of influence for these exceptions is high, as is the level of influence.  
3.4.2 Pharmaceutical Promotion Interventions 
The pharmaceutical industry is central in the delivery of modern health care. 
However, it also influences the way medicine is practiced, specifically how 
medicines are prescribed, through the use of promotional interventions (Sufrin 
and Ross, 2008). In this review, samples, detailing, academic journal advertising 
and sponsored medical education were identified as promotional interventions 
used by the industry. This broadly represents the categories identified by others 
(Gallan, 2005, Kremer et al., 2008). In each of the following sections, effect, 
mechanisms and context are addressed, and finally the evidence identified is 
linked with previously identified theoretical constructs relevant to this topic 




The provision of samples by the pharmaceutical industry has been the focus of 
investigation by several authors due to the effect it has on physician prescribing 
behaviour and potential impact on patient safety.  The European Federation of 
Pharmaceutical Industries and Associations’ (EFPIA) code of practice states that 
medical samples should be provided “...to health professionals so that they may 
familiarise themselves with the medicines and acquire experience in dealing with 
them” (EFPIA, 2011 p15). Furthermore, the code of practice dictates that “medical 
samples must not be given as an inducement to recommend, prescribe, 
purchase, supply, sell or administer specific medicinal products, and should not 
be given for the sole purpose of treating patients” (EFPIA, 2011 p15). However, 
samples are clearly part of the marketing mix employed by the pharmaceutical 
industry and, as such, an instrument critical in driving the adoption of new 
medicines (Groves et al., 2003). Both physicians and the pharmaceutical industry 
see value in samples which are provided, under the assumption that they do more 
good than harm (Groves et al., 2003). However, the literature addressing 
sampling is lacking in both quantity and quality, maintaining a heated debate on 
its use. Sales representatives may use samples to gain access and influence 
prescribing behaviour through detailing. On the other hand, samples can provide 
the physician with an opportunity to gain experience with new and innovative 
medicines early, and provide the opportunity to start treatment of financially 
stretched patients. Evidence also suggests that own experience with a medicine 
may reduce the uncertainty associated with future prescribing (Groves et al., 
2002), a topic which is further addressed below. The following sections start by 
comparing and contrasting the available evidence on the effect of sampling on 
physician prescribing behaviour. Then under which contexts sampling is 
conducted is addressed. Next, the possible mechanisms by which sampling may 
influence physician prescribing behaviour are contextually examined. Following 
this, effect, context and mechanism are linked by applying theoretical constructs 
identified during the scoping study. Finally, a summary is provided. 
Groves et al. (2003) critically evaluated existing research on the topic of samples 
for prescription medicines in the context of a classical marketing theory 
perspective. The review included 23 original research papers for critical review 
and 17 summary papers as background information. In all, 16 articles were found 
to be related to the influence on prescribing behaviour. The authors note that the 
studies conducted on the effect of samples on prescribing behaviour lack rigor, 
as all studies were observational, direct observation or questionnaires 
administered to nonrandomized samples. Even though rigor may be lacking, the 
authors claim that available literature is highly suggestive of samples influencing 
physician prescribing behaviour - and may in fact increase demand. Furthermore, 
the authors are critical of the finding that samples are almost exclusively provided 
for newer medicines during the two first years on the market. This notion is further 
supported by (Gallan, 2005) in another systematic review on factors influencing 
physician prescribing behaviour.  
In a later study, following the same observatory path as critiqued by Groves et al. 
(2003), Schumock et al. (2004) investigated and compared the opinions of 
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physicians, clinical pharmacists, and formulary committee members on the 
factors influencing prescribing of medicines and community hospitals. The 
authors found that physicians rated the availability of samples as more influential 
on prescribing behaviour than did clinical pharmacists and formulary committee 
members. Furthermore, physicians rated personal experience as an important 
factor influencing prescription behaviour; however, clinical pharmacists and 
formulary committee members did not. Both personal experience and the 
availability of samples may therefore be involved in reducing uncertainty 
surrounding this decision of whether to prescribe or not. Since clinical 
pharmacists and formulary committee members are not directly involved in the 
decision to prescribe and, as such, are insulated from the uncertainty associated 
with the prescribing act, it is hardly surprising to find that physicians rate the 
importance of personal experience and the availability of samples higher.  
Adair and Holmgren (2005) departed from the path critiqued by Groves et al. 
(2003), and employed a prospective randomized trial design when investigating 
whether access to drug samples influenced the prescribing behaviour of internal 
medicine residents. Highly advertised drugs were matched with generics or non-
advertised drugs. The authors found that residents who had access to samples 
were less likely to prescribe unadvertised medicines and recommend over the 
counter medicines. From a more theoretical perspective, Campo et al. (2006) 
performed an in depth analysis of physician prescribing decisions using a 
grounded theory approach, as described by Straus and Corbin (1990). Both GPs 
and specialists in the US were included. The authors found that sales 
representatives are valued as a source of information and may have a long lasting 
effect on prescription behaviour. There was also evidence suggesting a clear 
preference for oral information over written. Detailing was found to increase 
prescribing. However, samples were not found to directly increase prescribing 
except for in the early phases of a medicine’s commercial life cycle. Furthermore, 
it was found that free conference participation may in some situations also 
influence choice of medicines.  
Three further studies (Gönül et al., 2001, Rizzo, 1999, Venkataraman and 
Stremersch, 2007) provide academic rigor in that empirical techniques were 
employed. Gönül et al. (2001) investigated the effects of price, type of insurance, 
and direct selling efforts on prescription choice by employing a multinomial logit 
model, as suggested by (McFadden 1974). The authors found that physicians 
show limited price sensitivity and that detailing and sampling have mostly an 
informative effect on physicians. However, this notion is challenged by the 
findings of  (Rizzo, 1999), who found detailing to substantially lower price 
sensitivity through a strong advertising effect. In another study by (Mizik and 
Jacobson, 2004), the impact of detailing and use of samples on physician 
prescribing behaviour using a dynamic fixed-effects distributed lag regression 
mode was investigated. The authors made use of pooled time series cross-
sectional data involving 3 medicines, 24 monthly observations, and 74075 
individual physicians. Based on the results of the study, the authors claim that 
detailing and free medicine samples have positive and statistically significant 
effects on the number of new prescriptions issued by a physician; however, the 
magnitudes of the effects were found to be relatively small. In a seminal study 
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addressing the issue of attributes of medicine as a factor influencing physician 
prescribing and sampling behaviour, Venkataraman and Stremersch (2007) 
investigated the effect of promotional effect across brands. The database used 
for the study included, at the monthly level, all prescriptions within the examined 
medicine categories by a panel of 2774 physicians. The authors found that 
medicine characteristics such as effectiveness and side effects, moderate the 
response by physicians to marketing efforts and detailing of their sampling 
behaviour. 
More recently, Pinckney et al. (2011) investigated the effect of availability of 
samples in clinical practice on prescribing behaviour of physicians. Prescribers 
were presented with two clinical vignettes and asked to provide the name of the 
medicine they would prefer to prescribe considering the information provided. 
The results were compared with the responses to those of physicians without 
samples in their clinic. 631 physicians were included and 206 responded, giving 
a responder rate of 32.6%. The authors found that 70% of physicians with 
samples would prescribe a generic diuretic for hypertension compared with 91% 
for those without available samples. For the management of depression, the rates 
were 91% versus 100%, respectively. Both findings were statistically significant. 
Post-hoc analyses of the data confirm that none of the physician characteristics 
(age, gender and time in practice) or practice characteristics in the model had a 
statistical significant association with prescribing. The authors concluded that 
physicians with samples available in their clinics were less likely to prescribe 
preferred medications for hypertension and depression.   
The evidence presented is strongly suggestive of the fact that the provision of 
samples has the power to influence physician prescribing behaviour. However, 
little is known about the contexts in which these effects are exerted, but there are 
three explicitly stated contexts in which sampling takes place, which may inform 
the topic. Firstly, it takes place in the context of detailing, and therefore any effect 
may be tightly linked to detailing (Brundage, 1999). Secondly, it is almost 
exclusively provided for new medicines, driving the uptake of medicines early in 
their life cycle (Groves et al., 2003) when the level of personal experience by the 
physician is at its lowest. Lastly, physician characteristics do not seem to play a 
significant role (Pinckney et al., 2011). 
From a theoretical perspective, the provision of samples may play a role in 
influencing intent to prescribe by modulating the level of uncertainty. A prescribing 
decision will be taken under conditions of uncertainty, and it has been claimed 
that uncertainty is the strongest driver of physician behaviour (Arrow, 1963). The 
provision of samples gives the physician an opportunity to personally gain 
experience with new medicines in a clinical setting, and thus build the basis for 
adoption and further prescribing (Groves et al., 2002). The Theory of Planned 
Behaviour, at its simplest, predicts behaviour on the basis of intent (Ajzen, 1991). 
One of the components of intent is attitude, influenced by behavioural belief, 
being the belief in the consequence of the behaviour (Ajzen, 1991). Therefore, it 
may be argued that the mechanism by which the provision of samples may exert 
its effect is through the modulation of uncertainty in a clinical decision context. 
Furthermore, the contexts in which samples are provided may give further 
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credence to this claim, as according to Groves et al (2003), samples are almost 
exclusively only provided for new medicines. This is when the level of uncertainty 
would be greatest, as the experience base would be at its lowest (Groves et al., 
2002). In addition, sampling more often than not takes place in the context of 
detailing, providing the sales representative with the opportunity to underline the 
positive benefit-risk profile of the detailed medicine. This allows influence to be 
exerted, which may affect the level of uncertainty and lay the ground for the 
physician to give the sample to a patient and gain personal experience with its 
benefits and risks. 
The five main points made in this review on sampling will now be summarized. 
Firstly, there is agreement in the literature that the practice of providing samples 
to physicians by the pharmaceutical industry influences physician prescribing and 
increases demand, but these effects are small. However, there are opposing 
views on the effect of price sensitivity. Secondly, most of the available literature 
lacks rigor, and studies empirically testing the hypothesis are few, therefore 
weakening any argument made on its basis. Thirdly, samples are almost 
exclusively provided for new medicines, driving the uptake of new medicines. 
Fourthly, the use of samples more often than not take place in the context of 
detailing, and any effect is therefore linked (Brundage, 1999). Furthermore, 
medicine attributes, efficacy and safety, may modulate physician sampling 
behaviour. Lastly, the provision of samples may influence the intent to prescribe 
by modulating the level of uncertainty in a clinical decision setting. In conclusion, 
evidence of influence is high, but the level of influence is modest. 
3.4.2.2 Detailing 
Detailing is defined in this review as the visit to prescribing physicians by 
pharmaceutical sales representatives, and remains the most important 
promotional instrument available to the industry (Singh and Smith, 2005). The 
reality of detailing is in fact  sales promotion (Greene, 2004), and of all 
promotional interventions employed by the pharmaceutical industry directed at 
influencing prescribing behaviour, detailing is the most appreciated by physicians 
(Hemminki, 1975, Avorn et al., 1982, Vancelik et al., 2007). Furthermore, it is 
widely stated that detailing increases prescribing by physicians, but the effect has 
been found to be modest (Kremer et al., 2008, Manchanda and Chintagunta, 
2004, Mizik and Jacobson, 2004). Due to the emerging controversy surrounding 
detailing in recent years, largely fuelled by the high rate of spend per physician 
(8,000 – 13,000 USD in 2008), several authors have investigated its effect on 
physician prescribing behaviour (Sufrin and Ross, 2008).  
In the following section, the effects of detailing on physician prescribing behaviour 
are first addressed. Then, the contexts under which detailing takes place are 
examined. Next, the mechanism by which detailing may exert its effect on 
physician prescribing behaviour is addressed. Finally, a link to theory is presented 
before a summary is offered.  
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3.4.2.2.1 Effects of Detailing 
It is widely stated that detailing influences physician prescribing behaviour (Gönül 
et al., 2001, Kremer et al., 2008, Windmeijer et al., 2006, De Laat et al., 2002, 
Fullerton et al., 2010, Muijreres et al., 2005, Naik et al., 2009, Pinto et al., 2010, 
Rizzo, 1999, Roberts et al., 1997, Tett, 2003, Theodorou et al., 2009, Vancelik et 
al., 2007, Manchanda and Honka, 2005, Manchanda and Chintagunta, 2004, 
Parson and Abeele, 1981, Manchanda et al., 2005, Narayanan et al., 2003, Mizik 
and Jacobson, 2004, Narayanan et al., 2004, Chintagunta and Desiraju, 2005, 
Hurwitz and Caves, 1988, Leffler, 1981). At first glance, it may be evident that 
detailing increases prescribing at the physician level. Strong evidence to support 
this notion stems from the fact that the pharmaceutical industry invests heavily in 
the use of this promotional instrument. However, the picture painted in the 
literature is not as clear as it may appear at first glance. Effects of detailing on 
physician prescribing behaviour can loosely be categorised into two categories: 
increased prescribing and mixed effects.  
Several authors find that detailing increases prescribing on the physician level 
(Gönül et al., 2001, Manchanda and Chintagunta, 2004). However, the effect is 
not linear and shows diminishing returns (Manchanda and Chintagunta, 2004) 
and heterogeneity in physician responsiveness to detailing (Narayanan and 
Manchanda, 2005, Janakiraman et al., 2008). Furthermore, using aggregate 
sales or prescription data, several authors also find that detailing increases 
prescribing (Narayanan et al., 2005, Narayanan et al., 2004, Rizzo, 1999, 
Chintagunta and Desiraju, 2005).  In the mixed effects category, several authors 
also found that detailing increases prescribing, but that the effect is small (Mizik 
and Jacobson, 2004, Kremer et al., 2008). Also, some authors have found no 
significant effect of detailing on physician prescribing (Rosenthal et al., 2003), 
and others have even found a negative effect (Parson and Abeele, 1981). 
However, there exists a general consensus that detailing increases prescribing, 
but the effect is modest (Kremer et al., 2008). 
Evidence of effects other than increased prescribing can also be found in the 
literature; notably, quality related effect parameters and effect on price sensitivity 
at the physician level. Fullerton et al. (2010) evaluated whether pharmaceutical 
promotion influences off-label prescribing, especially in situations where options 
are limited. The study used an observational study design, utilising Medicaid 
administrative and Verispan marketing data focusing on gabapentin and 
psychiatrist prescribing. The authors found that pharmaceutical prescribing rates 
tracked promotional efforts from 1994 to 2002. In conclusion, pharmaceutical 
promotion increased prescribing rates of gabapentin and may lead to off-label 
prescribing in conditions of limited choice.  In another study, Muijreres et al. 
(2005) undertook a cross-sectional survey of 1434 GPs in The Netherlands in 
2001 in order to examine the influence of pharmacists and pharmaceutical sales 
force representatives on prescribing behaviour. The authors found a negative 
correlation between quality of prescribing by solo GPs and frequency of visits by 
pharmaceutical industry representatives. There was a higher number of detailing 
in the solo practice group versus the non-solo practices, at 5.7 versus 3.8 visits 
per month, respectively. Furthermore, 4.6% of solo practice physicians were 
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female compared with 26% for non-solo practices. In conclusion, more frequent 
visits from pharmaceutical industry representatives were associated with a lower 
quality of prescribing.  
Two academically rigorous studies addressing the effect of detailing on price 
sensitivity have been identified. Rizzo (1999) tested the hypothesis that 
advertising decreases the price elasticity of demand and found strong evidence 
to support the hypothesis. In other words, detailing was found to systematically 
lower price sensitivity at the physician level. In a similarly designed study, 
Windmeijer et al. (2006) found that general practitioners’ price sensitivity is small, 
but adversely affected by promotion. Furthermore, Rizzo’s findings are consistent 
with those of Hurwitz and Caves (1988), who also found that detailing inhibits 
entry into market by way of decreasing price sensitivity at the physician level. 
However, the findings of Hurwitz and Caves (1988) contrasts those of  Leffler 
(1981). This incongruence may in part be explained by the inclusion of generics 
in the model employed by Hurwitz and Caves (1988), a component excluded in 
the study by Leffler (1981). Even though no consensus exists in the literature on 
the effect of price sensitivity on pharmaceutical demand, there is solid evidence 
to suggest an effect on price sensitivity at the physician level. 
The source of information concerning medicines may influence prescribing in 
itself. Jones et al. (2001) found that GPs in general prescribe more new 
medicines when compared to specialists (internists and psychiatrists), and that 
pharmaceutical sales representatives were an important source of information for 
GPs. Others further support the finding that physicians may prefer commercial 
sources of prescribing information (Avorn et al., 1982, Theodorou et al., 2009).  
3.4.2.2.2 Contexts of Detailing 
Available literature acknowledges that detailing by the pharmaceutical industry 
affects prescribing; however, in which contexts influence is exerted is less well 
established. Pharmaceutical sales representatives have at their disposal several 
tools to increase the effect of a promotional message, which may be categorized 
as gifts (Wazana, 2000) and includes: token gifts, samples, meals, funding for 
attending educational symposia and continuous medical education (CME) 
sponsorship. Detailing must therefore be evaluated in the context of gifting. In 
addition, the attributes of medicines have recently been advocated to be a 
determining factor of physician prescribing behaviour (Venkataraman and 
Stremersch, 2007). Furthermore, characteristics of physicians, practices and 
patients may provide a moderating contextual influence on the effect of detailing. 
These topics are discussed in detail in Section 3.4 from page 104 and will 
therefore only be briefly mentioned in this section.  
Wazana (2000) conducted a systematic literature review, investigating the 
relationships between pharmaceutical sales representatives and physicians, with 
the focus on their impact on physician prescribing behaviour. The author 
identified a total of 538 studies by searching MEDLINE from 1994 to 2000, and 
found that 29 satisfied pre-specified inclusion criteria. In all, 16 studies were 
identified to address effects of interaction on physician prescribing behaviour. 
The studies employed cross-sectional, case control or pre- and post-interaction 
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methods to evaluate the impact. Detailing by sales representatives was 
associated with changes in prescribing behaviour and requests for adding 
medicines to hospital formularies. More specifically, these interactions were 
found to “…impact the prescribing practice in terms of prescribing cost, non-
rational prescribing, awareness, preference and rapid prescribing of new drugs, 
and decreased prescribing of generic drugs” (Wazana, 2000 p375). Furthermore, 
detailing was found to take place in the context of gifting. Gifting is related to the 
provision of token gifts, samples, meals, funding for attending educational 
symposia and continuous medical education (CME) sponsorship.  
Even small gifts can be powerful influencers of behaviour, and may therefore 
contribute to possible conflicts of interest for the physician (Dana and 
Loewenstein, 2003). In a 2001 study by Steinman et al. (2001), it was found that 
61% of physicians believe that they are not influenced by gifts provided by sales 
representatives. However, this was only 16% for their colleagues. Gifting in the 
context of samples has been addressed in this paper and will not be further 
discussed here. Literature on token gifts and meals is scant and not of adequate 
rigor to be included in this review. However, several authors have addressed 
education in broader terms, and this issue is addressed briefly.   
Hemminki (1975) summarizes the few studies on the effect of education that were 
available prior to 1975 (Becker et al., 1972, Joyce, 1970, Lee et al., 1965). There 
appears not to be any difference in prescribing patterns for graduates from 
different medical schools; however, it has been shown that higher postgraduate 
qualifications result in lower rate of prescription of any kind. Hemminki (1975) 
concludes that there is evidence to suggest that there is a link between education 
and quality of prescribing. More recently, Carroll et al. (2007) investigated 
educational interventions and regulatory policies on trainee perceptions of the 
pharmaceutical industry. The authors performed a literature search using Medline 
and bibliographies or review articles of relevant studies. Articles published before 
1991 were excluded. The review suggests that well-designed seminars, role 
playing and focused curricula can affect trainee attitudes and behaviour, but 
whether the effect is sustainable over time is still unknown. Ellison et al. (2009) 
investigated post-activity Continuing Medical Education (CME) evaluation 
surveys. The background for the survey was the concerns raised around possible 
bias in commercially supported CME activities. The authors conclude that 93% 
of physicians participating claim to perceive no bias. Ross and Loke (2009) 
performed a systematic review of literature, investigating whether educational 
interventions improve prescribing by medical students and junior doctors. The 
authors searched MEDLINE, EMBASE, Educational Resource Information 
Centre, British Education Index, PsycINFO, CINAHL, TIMELIT, Cochrane Trials 
Database and grey literature. Of the 3189 studies identified for initial screening, 
only 22 studies were included in the review. The World Health Organization 
(WHO) Good Prescribing Guide is the most widely tested and has demonstrated 
efficacy. However, the authors conclude that further work is needed to produce 
high-quality interventions. Further support can be found in the work by Tett 
(2003), where factors such as access to continued medical education were 
confirmed as having an influence on prescribing.   
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Other contextual factors identified as possibly having a bearing on the influence 
of detailing on physician prescribing behaviour are physician characteristics, 
practice characteristics, patient characteristics and medicine attributes.  
Physician characteristics include specialty, age, gender and time in practice. The 
available literature addressing physician characteristics as an influencing factor 
on physician prescribing behaviour is limited and inconclusive. However, 
evidence supporting physician-level habit persistence as a factor influencing 
physician prescribing behaviour is strong, as noted in Section 3.4.1.1. It can 
therefore reasonably be argued that physician-level habit persistence must be 
overcome for detailing to impart meaningful influence on physician prescribing 
behaviour. Conversely, it can therefore also be argued that physician-level habit 
persistence modulates any influence imparted by detailing on physician 
prescribing behaviour. 
Practice characteristics include location, organisation and academic status. In 
addition, on this topic, the evidence is limited and inconclusive, as noted in 
Section 3.4.1.2. Therefore, no conclusion can be drawn with respect to any 
modulating effect on the influence that detailing may have on physician 
prescribing behaviour. 
Patient characteristics include age, gender, race and social factors. However, 
none of the factors distinguished from biomedical contexts known to influence 
health and the consequent need for prescription medicines, although bio-medical 
factors as an influence of physician prescribing is presumed to be high on the 
basis of general medical literature, as noted in Section 3.4.1.3. The direct link to 
effects on detailing is lacking, but it can reasonably be argued that patient level 
bio-medical factors may impart an indirect modulating effect on the influence of 
detailing on physician prescribing behaviour.  
Medicine attributes is one of the key topics covered in any detailing event. Thus, 
it is reasonable to expect an effect on the influence which detailing may have on 
physician prescribing behaviour. In a seminal study, Venkataraman and 
Stremersch (2007) investigated the effect of promotions across brands and found 
that medicine attributes modulate the influence of detailing on physician 
prescribing behaviour.  
In summary, evidence of influence of continued medical education, physician 
characteristics, practice characteristics and patient characteristics is low. 
However, notable exceptions of physician-level habit persistence and patient-
level bio-medical factors may clearly moderate the influence detailing may have 
on physician prescribing behaviour. The same can also be said for medicine 
attributes, and the evidence for this is stronger and more directly linked.   
3.4.2.2.3 Mechanisms of Detailing Effects 
Detailing serves two roles: information and persuasion (Hurwitz and Caves, 
1988). Narayanan et al. (2005) argue that information may serve to reduce 
cognitive uncertainty, whereas persuasion serves to induce positive affect. 
Interestingly, habit persistence is noted in the literature as a possible residue of 
early experience with the use of new medicines (Jones et al., 2001), and has 
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been acknowledged by several authors (Jones et al., 2001, Lilja, 1976, 
Janakiraman et al., 2008, Venkataraman and Stremersch, 2007). “The unique 
contribution of habit would lie in finding a residue of past experience that leads to 
habitual rather than reasoned responses” (Ajzen, 1991 p. 203). Habit 
persistence, in the context of detailing, may be considered brand loyalty 
(Grabowski and Vernon, 1992). Several authors find that detailing mostly serves 
a persuasive role (Hurwitz and Caves, 1988, De Laat et al., 2002). Habit 
persistence is not associated with a reasoned response (Ajzen, 1991), and it may 
therefore be argued that detailing can influence physician prescribing behaviour 
through habit formation. On the other hand, detailing may involve reasoned 
responses to clinical challenges, and detailing may be argued to influence 
physician prescribing by modulating the cognitive uncertainty associated with 
prescribing medicines through an informative role.   
Jones et al. (2001) found that GPs in general prescribe more new medicines 
when compared to specialists (internists and psychiatrists), and that 
pharmaceutical sales representatives were an important source of information for 
GPs. Others further support the finding that physicians may prefer commercial 
sources of prescribing information (Avorn et al., 1982, Theodorou et al., 2009). 
Janakiraman et al. (2008) explored the effects of habit persistence on prescribing 
behaviour by examining 9672 prescriptions written for depression by 108 
physicians of non-specified specialities over a four-year period in the US. A two-
state model was adopted, based on the assumption that physicians can be either 
persistent or non-persistent. The authors investigated whether persistent 
physicians responded differently to detailing, out-of-office meetings and 
symposium meetings. There is compelling evidence to show significant cross-
sectional levels of persistence in decisions concerning the prescription of 
medicines. Practice type may play a role, as it was found that physicians working 
in smaller practices are more likely to be persistent. Furthermore, age and 
detailing acceptance also play a role in defining persistence. Older physicians 
and those more accepting of detailing stand a higher chance of being persistent. 
Both persistent and non-persistent physicians appear to be responsive to 
symposium meetings; however, only non-persistent physicians were found to be 
responsive to detailing. Out-of-office meetings had no effect on prescribing 
behaviour. Venkataraman and Stremersch (2007) also found that there is 
substantial habit persistence in physician decision making. Lilja (1976) performed 
an empirical study utilizing a mailed questionnaire examining how GPs (180) in 
Sweden chose medicines. The data was analysed using linear regression 
modelling. The author found a positive effect on habitual choice with increasing 
age. Highest weight was given to curing effect of medicines prescribed. In 
addition to physician age, it was found that disease severity was a determining 
factor. Moreover, no significant relationships for background variables of 
physician were found. “The unique contribution of habit would lie in finding a 
residue of past experience that leads to habitual rather than reasoned responses” 
(Ajzen, 1991 p. 203). Furthermore, this finding was corroborated by Coscelli 
(2000), who found that doctors' prescribing behaviour shows habit persistence. 
In addition, early experience of using a new drug seems to strongly influence 
future use (Jones et al., 2001). 
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In summary, it may appear that detailing serves an informative and persuasive 
role. Both roles play a part in the modulation of uncertainty and lay the 
foundations for behaviour and experience, leading to the formation of habit. The 
evidence presented provides a solid foundation for such arguments, but the lack 
of theoretically based evidence may only serve to weaken the arguments.  
3.4.2.3 Academic Journal Advertising 
Advertising by the pharmaceutical industry in academic journals is a time 
honoured practice dating back to the 1860’s when Park Davis first advertised in 
a journal directed at physicians (Leffler, 1981). Advertising serves two purposes: 
information and persuasion (Hurwitz and Caves, 1988). Most of the evidence 
pointing to its effect on physician prescribing stems from panel data on 
pharmaceutical advertising spend and consequent sales. However, a few studies 
addressing the effect of academic journal advertising on the physician level have 
been found in the literature and are included in this review.  Walton (1980) 
investigated the effect of 354 ads on 1000 physicians and claim that there is a 
link between journal adverting and increased prescribing. More specifically, the 
authors note that within 60 days of a quarterly period of advertising, the 
physicians who recalled ads became prescribers more often than those that did 
not recall. Avorn et al. (1982) investigated the impact of commercial versus non-
commercial sources of information on physician prescribing behaviour and found 
that academic journal advertising for medicines was believed to have little 
influence on physician prescribing by 68% of the participants; 28% of the 
participants believed that there was a moderate influence and only 3% a strong 
influence. Physicians who held advertising-oriented beliefs about the index 
medicines were generally unaware that they were strongly influenced by non-
scientific sources (Avorn et al., 1982). In another study investigating advertising, 
Azoulay (2002) found that the journal advertising increased prescribing and that 
the finding was marginally significant. Furthermore, journal-advertising 
expenditures increase with the number of indications recently approved by the 
Federal Drug Administration (FDA), USA (Azoulay, 2002). It may therefore be 
argued that the effect of journal advertising in part is due to the medicine 
attributes advertised. In addition, Campo et al. (2006) claim that physicians' views 
of the effectiveness of lipid lowering drugs and the decision to prescribe such 
drugs is affected by the predominant use of reduction of relative risk in trial reports 
and journal adverting. 
There is limited evidence to support that academic journal advertising increases 
physician prescribing. The dual function of advertising may provide a possible 
explanation of the mechanism by which the effect is exerted. Advertisements 
directed at physicians may inform or indeed persuade the physician about the 
attributes of a specific medicine. According to Gönül et al. (2001), advertisements 
may have a positive effect in that information about efficacy and safety is 
provided, thereby reducing cognitive uncertainty. It has been widely stated that 
physicians prefer and often rely on commercial sources for information when 
prescribing (Azoulay, 2002, Avorn et al., 1982); this may be problematic in that 
the accuracy of journal advertisements has been questioned (Wilkes et al., 1992). 
There is also evidence to suggest that verbal information is preferred over written 
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(Robertson et al., 2003, Wensing et al., 2009, Straus and Corbin, 1990). Thus, it 
may be inferred that evidence of influence in support of academic journal 
advertising as a factor influencing physician prescribing behaviour is low. In 
addition, the evidence presented points to the fact that any primary effect on 
physician prescribing behaviour is very limited.  
3.4.2.4 Theoretical Considerations and Summary  
It is widely stated that detailing influences physician prescribing. However, the 
components of contextual circumstances under which this influence is exerted 
lack credible evidence, with three notable exceptions: physician-level habit 
persistence, patient-level bio-medical factors and medicine attributes.  
Physician-level habit persistence has been widely stated (Janakiraman et al., 
2008, Venkataraman and Stremersch, 2007, Jones et al., 2001, Lilja, 1976, 
Coscelli, 2000) and is a context invariably present before, during and after 
detailing. The Theory of Planned Behaviour predicts behaviour by proxy of 
behavioural intent, which is modulated by cognitive processes focused on the 
balance between attitude, social norm and control beliefs (Ajzen, 1991). Habit 
persistence, on the other hand, is the residue of past behaviours and 
experiences, and by definition, does not involve conscious processing. From a 
decision theoretical perspective, it can be argued that habit reduces the effort 
associated with decision making in complex clinical settings (Payne et al., 1993). 
Furthermore, it is widely stated that physicians make extensive use of heuristics 
when making clinical decisions, including those pertaining to the prescription of 
medicines (Bornstein and Emler, 2001). Thus, habit persistence may simply be 
driven by the economy of decision-making; in other words, it is necessary for the 
physician to form habits to reduce the burden of decision making related to the 
act of prescribing. When combining the two theoretical perspectives, Theory of 
Planned Behaviour and decision under uncertainty, it can be further argued that 
the mechanism by which habit persistence modulates the influence of detailing 
on physician prescribing behaviour is related to attitude formation. This can be 
explained by the fact that that the physicians’ beliefs about consequence play a 
central role when evaluating benefit-risk of any treatment prescribed in a clinical 
setting. Janakiraman et al. (2008) claim that only non-persistent physicians are 
sensitive to detailing.  
Patient-level bio-medical factors lie at the core of modern medical practice and, 
as such, influence physician prescribing behaviour. Detailing designed to 
influence physician prescribing does so by way of information and persuasion 
(Hurwitz and Caves, 1988). Information may reduce the cognitive uncertainty and 
persuasion positive affect associated with the act of prescribing the medicine 
being detailed. From a cognitive behaviour theoretical perspective, detailing thus 
modulates behavioural intent by influencing both attitude and social norm. It can 
therefore reasonably be argued that patient-level bio-medical factors play a 
central role in modulating the level of uncertainty, as they are directly involved in 
the benefit-risk evaluation of any prescribed treatment. Therefore, patient-level 
bio-medical factors may modulate the influence of detailing on physician 
prescribing behaviour through attitude formation. 
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Medical literature abounds with effect measures of therapy, and the literature 
addressing medical decision-making focuses on the uncertainty associated with 
the benefit-risk of any medical intervention intended to address a bio-medical 
need in a clinical setting. Benefit-risk assessments are also a central part of any 
marketing authorization for medicines, and continued safety surveillance and 
updates to the labelling ensures up to date information on benefit-risk for 
medicines (Permanand, 2006). Venkataraman and Stremersch (2007) argue 
compellingly for the moderating effect medicine attributes have on the effect of 
detailing across brands. Furthermore, it has been argued that detailing may have 
both an informative and persuasive role.  Narayanan et al. (2005) argue that 
information may serve to reduce cognitive uncertainty, whereas persuasion 
serves to induce positive affect. Both may impact on the intent to prescribe by 
altering the balance of normative and subjective beliefs, as described in the 
Theory of Planned Behaviour by Ajzen (1991). Thus, detailing influences 
physician prescribing behaviour, and the effect is moderated by medicine 
attributes through modulation of intent.  
It is widely stated that pharmaceutical promotion increases demand and may 
decrease price sensitivity. However, the observed effects are limited and 
modulated by three contextual factors (physician-level habit persistence, patient-
level bio-medical factors and medicine attributes). Thus, evidence of influence is 
high and level of influence is low (see Table 3-39 Summary of pharmaceutical 
promotion).  
Table 3-39 Summary of pharmaceutical promotion 
Pharmaceutical promotion 
























uncertainty TPB Low Low 
3.4.3 Regulation and Control Interventions 
In all aspects concerning prescription medicines, regulation and control is 
prevalent. It is therefore worthwhile considering the potential influence that 
regulation and control may exert on physicians when prescribing. In this review, 
audits, formularies and preferred medicines lists have been identified as 
influencing factors; these factors are discussed sequentially in this section.  
3.4.3.1 Audits 
Audits have been suggested to influence physician prescribing and are actively 
used as an intervention to achieve this effect. Several authors have addressed 
the topic, and the ensuing prolific literature follows two separate streams: effect 
and none-to-little effect. 
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Evidence supporting the hypothesis that audits influence physician prescribing 
behaviour is provided by only a handful of authors identified in this review.  
Melander et al. (1999) evaluated the effect of using the Audit Project Odense 
(APO) model for registration and quality development to reduce the prescribing 
of antibiotics in respiratory tract infections. “The Audit Project Odense (APO) 
method is an increasingly popular quality improvement concept including GPs' 
repeated registrations of their own activities, feedback, additional interventions 
and a final evaluation” (Sondergaard et al., 2006 p.198). The proportion of 
patients not receiving an antibiotic increased from the first to the second 
registration in both groups, in the intervention group from 45 to 55% (p < 0.001) 
and in the control group from 36 to 40% (p = 0.0298). The authors conclude that 
it is possible to achieve a change in the prescribing of antibiotics in the treatment 
of respiratory tract infections using audits. In a literature review, Gill et al. (1999) 
addressed interventions influencing physician prescribing, and identified 79 
studies and 96 separate interventions. The authors found that “Studies that have 
used patient mediated interventions only yield the highest proportion of positive 
results. Next come interventions, which provide outreach (‘academic detailing’), 
and audit and feedback (including reminders). The least effective were 
distribution of educational materials (43%, 13%-78%)” (Gill et al., 1999) p.163. 
Overall, the authors found that 51% of interventions demonstrate a significant 
influence on physician prescribing. More recently, Baehren et al. (2010) studied 
the influence of the Ohio automated prescription reporting system data on clinical 
management of emergency department patients with painful conditions. The 
authors found that the 18 clinicians in this study changed their opioid prescription 
plan for 41% (74/179) of patients after reviewing the patients’ prescription 
histories. In two systematic reviews addressing interventions to improve 
prescribing and how medication prescribing is ceased, it was found that 
regulatory intervention was an effective influencer on physician prescribing 
(Ostini et al., 2009, Ostini et al., 2011). However, the two audits differ in the 
findings on audits and feedback. Ostini et al. (2009) found that audits and 
feedback were partially effective, whereas (Ostini et al., 2011) found that  audits 
and feedback consistently showed positive results.  
On the other hand, evidence pointing in the direction of a none-to-little effect of 
audits on physician prescribing has also been identified. O'Connell et al. (1999) 
evaluated the effect on general practitioners' prescribing of feedback on their 
levels of prescribing and found no evidence of influence. Furthermore, the 
authors note that the form of feedback (mailed, unsolicited, centralized, 
government sponsored), based on aggregate data, had no impact on the 
prescribing levels of general practitioners. Further support is provided in a 
Cochrane review by Arnold and Straus (2005), where the authors estimated the 
effectiveness of professional interventions, alone or in combination, in improving 
the selection, dose and treatment duration of antibiotics prescribed by health care 
providers in the outpatient setting. The authors claim that audit and feedback 
alone resulted in no or only small changes in prescribing. 
Evidence supporting audit influence on physician prescribing is not consistent. 
On one hand, there is credible evidence that an influence is present. However, 
there is also credible evidence rejecting the hypothesis. In other words, the 
 135 
evidence is strong but no consensus exists. Thus, it must be concluded that 
influence is low and the evidence of influence is inconclusive.  
3.4.3.2 Formularies and Preferred Drug Lists (PDLs) 
Even though physician autonomy is under pressure, managed-care 
notwithstanding, the physician acts as a decision maker on behalf of payers and 
patients when administering prescription medicines. Physician authority and 
control concerning decision outcome remains intact, but the spectrum of 
outcomes are typically preselected (Miller, 1989), by measures such as 
formularies and preferred drug lists (PDLs). This review has only identified seven 
studies addressing the question of formularies and PDLs. 
Deviating from the trusted path of qualitative analysis employed by previous 
researchers in the field, Pippalla et al. (1995) quantitatively analysed the 
evaluations of formularies on physician prescribing behaviour. The results from 
26 published studies were pooled before analysis. Based on the analysis, the 
authors claim that prescribing restriction through formularies may be an effective 
intervention influencing prescribing behaviour of physicians. Nutescu et al. (2005) 
found efficacy, formulary status, and policies restricting drug use to be highly 
influential in the decision to prescribe low molecular weight heparin instead of 
another anti-coagulant. In another study exploring the differences among GPs in 
their decisions to prescribe new medicines, it was found that physicians 
prescribing new medicines infrequently adopt a more cost-conscious approach 
to prescribing than frequent prescribers (Jacoby et al., 2003). Furthermore, the 
authors found that physicians prescribing new medicines less frequently were 
more likely to conform to a practice norm that encourages use and compliance 
with prescribing formularies. Schumock et al. (2004) investigated the opinion of 
physicians, clinical pharmacists, and formulary committee members with respect 
to key factors that influence medication prescribing in community hospitals; it was 
found that formulary status and restrictions on prescribing were considered highly 
influential by all participants. The effect of restrictive formularies has been 
claimed to also influence physician prescribing behaviour for other patients with 
more generous drug benefit; so-called “spill over effects” (Wang and Pauly, 
2005). In a study on off-label prescribing of gabapentin, the authors of another 
study conclude that “restrictive formulary policy can alter prescriber behaviour 
away from targeted pharmacologic treatments” (Fullerton et al., 2010 p.372). In 
a study employing a quasi-experimental study design, Virabhak and Shinogle 
(2005) investigated the extent to which the strictness of the criteria used to control 
utilization of medicines not on a Medicaid PDL changes physician prescribing for 
non-Medicaid patients. The authors found strong evidence of relatively large 
direct and spill over effects of Medicaid PDLs across Medicaid, third-party payer, 
and cash markets. Furthermore, the authors also note that even under conditions 
that are more lenient, the influence on physician prescribing behaviour was 
significant.  
There is apparent consensus on the restrictive effect of formularies and PDLs on 
physician prescribing behaviour, which is in line with the general findings of Miller 
(1989). There is a limited quantity of studies addressing this issue; however, in 
general, restrictions influence choice in almost every decision (Botti et al., 2008). 
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Even though the quantity of evidence identified in this paper is limited, it is felt 
that when considering the evidence in the context of choice under restrictions, 
evidence of influence is medium.   
3.4.3.3 Theoretical Considerations and Summary 
Audits and feedback provide the physician with summary information on their 
prescribing practice over time. Even though the evidence of influence is 
inconclusive and level of influence low, audits and feedback information serve a 
quality assurance role for the physician. It may be argued that such information 
may influence the physician’s perception or subjective belief of what is 
acceptable, both from a medical and regulatory perspective, thus influencing and 
forming the physician’s attitude toward the prescribing behaviour. Ajzen (1991) 
argues that the attitude is a component of intent, which in combination with 
perceived behaviour control, accounts for a considerable variation in behaviour. 
On the other hand, following traditional economic theory, it may be argued that 
the physician acts in self-interest when prescribing. Audit and feedback may 
therefore influence the physician-patient agency by providing a focus on the 
patient, whereby physician prescribing behaviour is governed by the concern for 
the patient and not self-interest. However, this leads back to the question 
concerned with acceptable prescribing behaviour, in terms of the Theory of 
Planned Behaviour.  
Botti et al. (2008) p. 183, note that “nearly every decision a person makes is 
restricted in some way”; and formularies and PDLs are intended to restrict a 
physician’s spectrum of choice when prescribing. A central component of the 
Theory of Planned Behaviour is perception of behavioural control (Ajzen, 1991). 
In the case of restrictive interventions such as formularies and PDLs, it may 
therefore be argued that the restrictions on choice imposed by the interventions 
modulate prescribing behaviour through their effect on the physicians’ 
perceptions of behavioural control, see Table 3-40 Summary of regulation and 
control.  
Table 3-40 Summary of regulation and control 
Regulation & Control 
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control Agency High Medium 
3.4.4 Economic Factors 
In this section, evidence on economic factors and their influence on physician 
prescribing behaviour are presented. In this review, price/cost, reimbursement, 
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financial incentives and managed care have been identified as economic factors 
having a bearing on physician prescribing. 
3.4.4.1 Price/Cost 
At first glance, it appears that there is wide consensus in the literature on the fact 
that promotion lowers price sensitivity at the physician level (Kremer et al., 2008, 
Manchanda and Honka, 2005, Rizzo, 1999). However, others have found that 
physicians demonstrate a basic lack of price sensitivity (Gönül et al., 2001). This 
finding may be due to low physician awareness of price (Ryan et al., 1990, Ryan 
et al., 1996, Ryan et al., 1992). The rise in overall health care expenditure has 
been out-paced by the increase in cost of medicines (Theodorou et al., 2009), 
and this has sparked an interest in the influence of price and cost of medicines 
on physician prescribing. The literature shedding light on the issue follows two 
main streams: effect or no effect. 
From the literature, there is more evidence supporting an influence of price/cost 
on physician prescribing than not. Ryan et al. (1996) convincingly argue that 
physicians in general exhibit low price awareness. Furthermore, with the 
exception of Gönül et al. (2001), there is credible evidence supporting that 
physicians’ price sensitivity may be modulated by detailing  (Kremer et al., 2008, 
Manchanda and Honka, 2005, Rizzo, 1999) and samples (Campo et al., 2006). 
Campo et al. (2006) and Kahan et al. (2006) claim that the effect on price 
sensitivity is due to increased price knowledge and that pharmaco-economic 
information as such may influence prescribing. In a study exploring the 
determinants of uptake and geographical variations of new medicines, Mason 
(2008) p. 7, claims “that self-reported evidence indicates that cost may inform 
prescribing decisions, but is not a barrier to uptake of new medicines”. 
Furthermore, it has been found that cost may influence hospital prescribing of 
new medicines, but is rated as less influential on prescribing than medicine 
attributes (Chauhan and Mason, 2008, Jernigan et al., 1996, Rodriguez-Calvillo 
et al., 2011).  
In general, it is widely stated that physicians rate cost to be an important 
influencer of prescribing behaviour (Theodorou et al., 2009, Tusek-Bunc et al., 
2010, Hyde et al., 2005). However, when compared to clinical pharmacists, 
physicians rate the cost of medicines lower when considering influence on 
prescribing behaviour (Nutescu et al., 2005). Furthermore, it is claimed that the 
opinion held by physicians that price comparison is important strongly influences 
prescribing of cheaper alternatives (Wensing et al., 2009). Investigating factors 
influencing prescribing in Italy and the UK, Hassell et al. (2003) found that UK 
GPs employ cost reduction strategies when prescribing on the basis of high rate 
of patient co-payment and that reimbursement in Italy pre-empts the Italian 
physician from adopting the same strategies as their UK counterparts. However, 
the co-payment influence on physician prescribing is not supported by (Pham et 
al., 2007 p. 663), who found that “physicians do not routinely consider patients’ 
out-of-pocket costs when making decisions regarding more expensive medical 
services”.  
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Available evidence also suggests that price/cost may not influence physician 
prescribing. Exploring the differences among GPs in their decisions to prescribe 
new medicines drugs, Jacoby et al. (2003) p. 121, found that “high prescribers 
more often expressed themselves to be indifferent to medicine costs and a 
shared practice ethos”. In another study, Rice (2009) estimated whether health 
maintenance organizations (HMO) physicians are more price sensitive than non-
HMO physicians in their prescribing behaviour of brand-name substitutes. The 
results indicate that the price of medicines does not influence physician 
prescribing concerning whether a physician will choose to prescribe a common 
medicine, or alternate prescriptions among therapeutic substitutes. Patients 
increasingly face co-payment schemes, influencing out-of-pocket expenses 
(Pham et al., 2007). Addressing this issue, it is claimed that “physicians do not 
routinely consider patients’ out-of-pocket costs when making decisions regarding 
more expensive medical services” (Pham et al., 2007 p. 663).  
3.4.4.2 Reimbursement 
Literature addressing the effect of reimbursement on physician prescribing 
directly is limited, but influence of reimbursement on prescribing behaviour is 
widely stated (Tett, 2003, Dybdahl et al., 2005, Fretheim et al., 2006, Oxman et 
al., 2007, Hyde et al., 2005, Kahan et al., 2006, Steffensen et al., 1997, 
Theodorou et al., 2009).  
Reimbursement has an effect on patient co-payments for prescription medicines, 
and hence, price perceptions by both patients and physicians are influenced 
(Dybdahl et al., 2005); in other words, reimbursement affects price (OECD, 2008). 
Whether the physician is sensitive to price at the patient or payer level thus 
becomes an important aspect to bear in mind when considering reimbursement 
as a factor influencing prescribing. Literature addressing patient price sensitivity 
in the context of prescription medicines has not been found, but in general, it 
seems reasonable to assume that to a greater or lesser extent, price sensitivity 
at the patient level exists.  
There is conflicting evidence supporting physician sensitivity to patient 
price/costs perceptions. However, from an industry perspective, the fight for 
reimbursement is critical to pharmaceutical sales; for example, the loss of 
reimbursement of Lipitor in Spain caused a loss in revenue for Pfizer Spain of 
396 million USD over a three year period (Alvarez, 2011). The effect on 
pharmaceutical sales supports the notion of an influence of price on prescribing, 
but the evidence suggesting a possible mechanism of influence is not clear. On 
one hand, physicians’ demonstrated price sensitivity could be modulated by 
interventions such as detailing and samples. Furthermore, physicians do no 
exhibit strong price awareness. Observations of reimbursement effects on 
pharmaceutical sales indicate a strong relationship and an implicit although 
indirect impact on physician prescribing.  At the same time, evidence supporting 
price/cost concern on behalf of the patient is lacking. What remains is the price 
sensitivity at the patient level. At this point, it seems reasonable to argue that a 
plausible mechanism by which reimbursement influences physician prescribing 
is by way of patient level price sensitivity and an expectation of the cheaper 
alternative, given equal health benefits. Thus, the spectrum of choice available to 
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the physician when prescribing is limited by the patient expectation driven by 
price sensitivity at the patient level. However, as noted previously, it may be the 
physician’s perception of the patient expectation that is the real driver. Evidence 
of influence is high, but the mechanism by which influence is exerted remains 
elusive.  
3.4.4.3 Financial Incentives 
Economic theory predicts that self-interest is a strong motivator for behaviour 
(Arrow, 1963), and it may therefore be argued that physicians are not much 
different from the population in general. However, it is argued that the physician’s 
behaviour is governed by the concern for the patient and not by self-interest 
(Arrow, 1963). In an intellectual project for understanding, (McGuire 2001) has 
provided a comprehensive review of the topic of agency from a health economic 
perspective. Interestingly, the author concludes that economic models often 
ignore uncertainty and informational asymmetry inherent in modern health care 
(McGuire 2001, p. 496). The authority of the physician is strong and plays a 
central role in any decisions related to medical care (McGuire 2001, p.463). In 
light of the central role played by physicians in medical decisions, it is important 
to address aspects of moral hazard and adverse selection in the context of this 
review. 
Moral hazard is said to take place when an individual not fully exposed to a risk 
would behave differently than if fully exposed to the risk (Gaynor and Gertler 
1995). Both physician and patients are insulated from the financial realities of 
medical decisions (Illert and Emmerich, 2008), and thus subject to forces of moral 
hazard. Both the physician and the patient may therefore engage in behaviour 
motivated by self-interest. The physician may drive demand beyond what would 
be the case if exposed to the financial risk implicit in making the decision 
(McGuire 2001, p.503). A physician may also influence quantity of care, and this 
is achieved by: setting the level of non-contactable input (quality), influencing 
patient preference and physician induced demand (McGuire 2001, pp.503-519). 
Increasing quality may increase cost, changing patient preference in accordance 
with physicians, and self-interest may have the same effect. Physician induced 
demand will occur if the physician uses his “superior” knowledge to his benefit, 
driving use of health care resources to a higher level than would be the case if 
information was symmetric between agent and principal (McGuire 2001, p.503). 
On the other hand, the patient may seek to engage in behaviour driving the 
consumption of health care. A patient may, for example, simply opt for taking a 
pill for high cholesterol rather than engaging in lifestyle changing behaviour such 
as exercise and eating healthy. Thus, patient preference may therefore influence 
demand for health care services from physicians. 
The literature addressing the influence of financial incentives on physician 
prescribing behaviour is both limited and inconclusive. Chauhan and Mason 
(2008) found that the impact of financial prescribing incentives on secondary care 
prescribing is unclear. In the context of clinical studies, Glass (2003) found that 
investigators receiving higher grant payments were more likely to prescribe the 
study drug at any of the time points covered in the study. In a later study under 
the same context, the same author found no effect (Glass, 2004). On a more 
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positive note, (Sturm et al., 2007) financial incentives may aid in limiting the 
volume of prescribed medicines. (Chauhan and Mason, 2008, Mason, 2008) 
claims that financial incentives positively influence prescribing quality, as 
measured by guideline adherence. Furthermore, behaviour independent financial 
incentives have been claimed to aid in changing prescription behaviour of GPs, 
but effects are small-scale and temporary (Martens et al., 2007). Finally, 
fundholding may influence prescribing when measured at the total prescription 
cost level (Wilson et al., 1996). 
In conclusion, evidence of influence is low and the level of influence is unclear. 
The underlying basis for financial incentives in health care may be questioned, 
as the intent is to drive behaviour in a given direction driven by self-interest. Self-
interest driven behaviour at the physician level is not deemed appropriate and 
would potentially put the patient at risk due to conflict of interest created by the 
intervention. It may therefore be argued that financial incentives without adequate 
regulation are inappropriate in this context.  
3.4.4.4 Managed Care 
Physicians have autonomy in decision making on the basis of an understanding 
that they will act in the best interests of their patients (Arrow, 1963). However, it 
has been argued that managed care may threaten the physician’s loyalty to the 
patient (McGuire, 2001 p. 520). The physician is an agent for both the patient and 
the payer, potentially resulting in a loyalty conflict and cognitive dissonance. A 
payer can take advantage of the ethical constraints imposing payment systems 
that force the physician to personally take on more of the effort to attain an 
acceptable outcome for the patient (Fugh-Berman and Ahari, 1997).  
Managed care in its nature is prescriptive and thus choice limiting. Literature 
addressing the topic is limited, but consensual as to the influence on physician 
prescribing. It is widely stated that the administrative interventions represented 
by managed care have a significant impact on physicians’ prescribing behaviour, 
resulting in cost savings (Ahluwalia et al., 1996, Avorn and Soumerai, 1982, 
DeWitt et al., 2006, Ohlsson and Merlo, 2009, Rice, 2009, Fullerton et al., 2010).  
Managed care also influences the share of cost for medical services, including 
prescription medicines, carried by member patients. The patient cost share has 
been found to influence physician prescribing by way of inequities in 
reimbursement between treatment options (Campo et al., 2006, DeWitt et al., 
2006). This does not seem to be influenced by physician characteristics (Biga et 
al., 2007). However, Ohlsson et al. (2009) found that private and public 
physicians show a difference in the early adoption of medicines. Furthermore, 
Rice (2009) claims that managed care physicians are more price sensitive and 
prescribe a wider range of medicines than non-managed care physicians. 
Granlund et al. (2006) evaluated the effect of fixed versus open-ended budget on 
prescription behaviour, and found that the introduction of fixed pharmaceutical 
budgets did not affect physicians' prescription behaviour. 
Managed care is primarily designed to reduce the cost of health care and 
achieves this effect through two separate mechanisms affecting physician 
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prescribing behaviour: first, the spectrum of choice available to the physician 
when prescribing is limited; and second, the physicians’ price sensitivity at the 
patient level is influenced.  
3.4.4.5 Theoretical Considerations and Summary 
Economic interventions focusing on limiting choice are in general more effective 
than those that do not, see Table 3-41 Summary of economic factors. Price/cost 
is widely studied, but physicians generally exhibit a low degree of price sensitivity. 
However, reimbursement is an important and strong influencer of physician 
prescribing, indicating that the physician price sensitivity may not be at the system 
level, but rather at the patient level. Furthermore, this implies that the principal-
agent relationship between physician and patient may be stronger than that 
between physician and payer.  
From an economic theory perspective, it is claimed that self-interest is a key 
driver of behaviour (Arrow, 1963). Thus, economic interventions focused on self-
interest as a motivator for behaviour lie within the remit of Agency Theory. It may 
therefore be argued that the central theme is conflict of interest and that economic 
interventions are used to modulate both level and direction of interest.  
Considering the patient needs, it is evident that balancing the triad of interests 
defined by the key stakeholders (payer, provider and patient triad) is a complex 
and arduous task. Further complicating the picture is the question addressing 
what constitutes optimal consumption of health care services. Given that the 
conflict of interest is defined by the triad of stakeholders, loyalty to the principal 
may come under attack in the context of a principal-agent relationship.  
Table 3-41 Summary of economic factors 
Economic factors 
Component Effect Mechanism Theory Influence Evidence of influence 
Price/Cost Influence demand 
Modulate 
perceived control 
and moral hazard 
TPB 
Agency Low High 
Reimbursement 







and moral hazard 
Agency High Medium 
Financial 
incentives 
Shift prescribing in 
line with incentives 
Modulate self 
interest Agency Medium Low 
Managed care 








Agency High High 
Payers must balance the needs of the individual against those of society, 
prioritizing the distribution of health care in a welfare context. The physician-
patient relationship is focused on the individual, and may therefore be at odds 
with the priorities defined by payers. Furthermore, patients and physicians are 
often insulated from the economic consequences of medical decisions. 
Therefore, in the context of physician prescribing behaviour, economic 
interventions focus on two mechanisms. First, economic interventions focus on 
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reducing the spectrum of choice available for the physician when prescribing. 
Second, the focus is on affecting the price sensitivity at the patient-level. The 
consequence is a reduction of moral hazard and adverse selection by influencing 
the spectrum of choice and patient-level price sensitivity, respectively. 
3.4.5 Non-Economic Factors 
Non-economic factors influencing physician prescribing behaviour have been 
widely investigated, but the number of factors is many and evidence of influence 
varies across the identified factors.This section begins by presenting evidence of 
influence on physician prescribing behaviour on the following identified non-
economic factors: peer effects, academic detailing, guidelines, academic 
literature, bio-medical, clinical research participation, legal concerns and 
technology. Finally, the evidence is considered from a theoretical perspective, 
before a summary is provided. 
3.4.5.1 Peer Effects 
It is widely stated that peer effects can have a strong influence on physician 
prescribing. This is claimed to be especially true for GPs and for specialists when 
prescribing outside their specialist domain (Gallan, 2005, Jones et al., 2001, 
Jones et al., 2001, Lapeyre-Mestre et al., 1998, Tusek-Bunc et al., 2010). For 
specialists, the support structures within the facilities where they provide health 
care services may shape specialist prescribing (Chauhan and Mason, 2008). 
Further investigating this context, Prosser and Walley (2006) p. 1565, found that 
“prescribing was often influenced by ‘tacit’ knowledge derived from social 
influence, interpersonal relations and professional networks”, and that “this 
information was an authoritative influence, representing a legitimate and decisive 
interchange through which doctors acquire knowledge and experience of new 
drugs”. Lewis and Tully (2009) employed the critical incident technique and in-
depth interviews in investigating the influence of team interactions on prescribing 
behaviour. The authors found that physicians’ prescribing decisions were strongly 
influenced by relationships with other team members. Furthermore, physicians 
admitted to prescribing to preserve relationships, often at the cost of non-
compliance with hospital regulations and guidelines. Glass and Rosenthal (2005) 
investigated the influence of clinical investigators on physician prescribing 
behaviour, and found that clinical investigators play an important role in 
influencing the prescribing behaviour of their specialist peers.  
Peers also influence GP prescribing behaviour. Naik et al. (2009) found that local 
physician experts interpret and provide context for new clinical evidence, practice 
guidelines, and pharmaceutical marketing. However, the effect of marketing 
efforts on key opinion leaders is not symmetric (Nair et al., 2010). Advice from 
colleagues had similar, but less important status than academic literature (Arnold 
and Straus, 2005). In another study,  Altiner et al. (2007) found that peer visits 
that focused on doctor–patient communication and patient empowerment is an 
effective concept to reduce antibiotic prescriptions in primary care. Furthermore, 
GPs are influenced not only by their immediate peers, but also by specialists 
(Tett, 2003, Taketomo et al., 1989) and pharmacists (Thornton et al., 1991). In 
another study investigating factors influencing physician prescribing behaviour, 
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Schroder-Bernhardi and Dietlein (2002) found that hospitals significantly 
influence the prescribing behaviour of general practitioners. 
There is sufficient evidence to claim that peers influence physician prescribing 
behaviour. However, it is important to bear in mind that the majority of evidence 
is within the context of adoption of new medicines. Specialists rely on peers, 
especially when prescribing outside of their specialist domain, and the context 
created within a secondary care facility provides social reinforcement through 
which specialists acquire knowledge and experience of new drugs. In addition to 
the context provided by the local expert, specialists and hospital practices also 
influence GPs. It may therefore be argued that observed practice and 
communicated experience of peers serve to reduce uncertainty when prescribing 
new medicines.  
3.4.5.2 Academic Detailing 
Academic detailing in this context involves non-commercial-based educational 
outreach, and is widely stated to influence physician prescribing behaviour by 
affecting the level of guideline compliance (Avorn and Soumerai, 1983, Ostini et 
al., 2011, Ostini et al., 2009, Lundborg et al., 1999, Klein et al., 1981, Herbert et 
al., 2004, Greving et al., 2006, Melander et al., 1999, Seneviratne et al., 1998, 
Newton-Syms et al., 1992, Fretheim et al., 2006, Welschen et al., 2004, Watson 
et al., 2001, Lagerlov, 2000, Bingle et al., 1991, Cochella and Bateman, 2011, 
Nilsson et al., 2001, Schuit et al., 2000). In addition, academic detailing is found 
to be most effective when conducted face-to-face (Pippalla et al., 1995). In a 
study by Arnold and Straus (2005), it was found that interactive educational 
meetings appeared to be more effective than didactic lectures. However, 
academic detailing conducted in groups may not be effective (Simon et al., 2006). 
Further support is provided by Goldstein et al. (2005) p. 677, who found that  
“individualized advice regarding drug therapy for hypertension given to the 
clinician at each patient visit was more effective in changing clinician prescribing 
behaviour than implementation of a general guideline”. Addressing the level of 
influence, Avorn and Soumerai (1983) found mixed results. In another study, 
Herbert et al (2004) found the level of influence to be modest, but meaningful. 
However, several authors have found the level of influence to be high (Klein et 
al., 1981, Kralj et al., 2003, Soumerai and Avorn, 1987, Welschen et al., 2004, 
Watson et al., 2001, Seneviratne et al., 1998, Pippalla et al., 1995), but repetition 
may be necessary for full effect (Schuit et al., 2000).  
The influence of academic detailing on physician prescribing behaviour 
measured by guideline compliance is widely stated. Furthermore, it is also widely 
stated that the level of influence is high, but no absolute consensus exist. The 
level of influence is found to be positively associated with individualized and face-
to-face communication. Thus, it may be argued that academic detailing is 
effective in driving physician guideline adoption.  
3.4.5.3 Guidelines 
Guidelines in the context of this review aim to influence decisions regarding 
prescription of medicines. The guideline content is based on examination of 
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available evidence in the context of evidence-based medicine, resulting in 
consensus statements on best practice within a therapeutic area. As guidelines 
are not mandatory, the level of prescriptive influence may therefore be variable. 
Guideline adherence is thus dependent on whether the physician decides to 
follow the guidance when prescribing. It is widely stated that the level of guideline 
adherence is variable (Smolders et al., 2007, Lagerlov, 2000, Chauhan and 
Mason, 2008, Nast et al., 2009, Rashidian and Russell, 2011);  in fact, it has been 
found that in some cases, more than 50% of decisions resulting in a prescription 
contradict clinical practice guidelines (Ventelou, 2010). The literature addressing 
the topic is in general focused on interventions to influence guideline adherence 
and follows two main streams: effective and non-effective interventions.   
Digital decision support systems have been shown to increase guideline 
adherence across therapy areas (Bertoni et al., 2009, Bouaud et al., 2001, Filippi 
et al., 2003). However, patient level bio-medical factors such as disease severity, 
have been shown to modulate guideline adherence (Filippi et al., 2003). Doyon 
et al. (2009) evaluated physicians’ compliance with guidelines before and after 
dissemination. The intervention period was divided into two temporal phases 
without overlap. In the first phase, consultation by peer leaders and networking 
was employed, whereas in the second phase, dissemination of official guidelines 
and of a pre-printed prescription sheet, an educational session led by a peer 
leader for residents and further networking was used. “An improvement in 
compliance over the intervention phase 1 (47.0%) and the intervention phase 2 
(64.3%) periods was observed: a difference of 17.4 (95% CI 8.2, 26.0)”  (Doyon 
et al., 2009 p. 1111). Nast et al. (2009) found that the proportion of prescribed 
systemic treatments for patients with moderate to severe psoriasis increased as 
a result of guideline publication. In another study, educational intervention based 
on management guidelines was found to influence prescribing behaviour of 
physicians (Zwar et al., 2002). Furthermore, the majority of physicians (80%) felt 
that the guidelines had led to changes in their prescribing, whereas 20% stated 
that the guidelines had had no impact on prescribing (Nast et al., 2009). More 
recently, Leslie et al. (2010) investigated the effect of introducing absolute 10-
year fracture risk reporting on physician prescribing. The authors found that a 
system based on absolute 10-year fracture risk was associated with increased 
guideline adherence.  
However, simple publication of guidelines may not be enough to influence 
prescribing behaviour of physicians. (Lagerlov, 2000) investigated the effect of 
guideline publication on physician prescribing behaviour and found that 
publication of guidelines did not influence physician prescribing patterns for 
urinary tract infections. In another study, it was found that conducting a trial 
sponsored by a pharmaceutical company had no significant impact on physicians' 
adherence to international treatment recommendations, but increased their use 
of the trial sponsor's drugs (Andersen et al., 2006). Furthermore, it is claimed that 
mailed dissemination of guidelines has little or no effect on GP prescribing 
(Watson et al., 2001, Sondergaard et al., 2002, Filippi et al., 2003, Hunskaar et 
al., 1996). However, when guidelines are included in an on-going educational 
series of letters, they have been found to be effective (Dormuth et al., 2004).   
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In a study looking at the guideline adherence in asthma patients in five European 
countries, it was found that “although many doctors in different health care 
contexts have accepted the recommendations given in guidelines, the proportion 
of their patients treated accordingly differed” (Lagerlov et al., 2000 p. 25), 
indicating geographical difference in guideline adherence. Furthermore, 
individualized advisory regarding drug therapy for hypertension given to the 
clinician at each patient visit is claimed to be more effective in changing clinician 
prescribing behaviour than implementation of a general guideline (Goldstein et 
al., 2005). 
In summary, it is recognized that guidelines have the power to influence physician 
prescribing behaviour.  However, guideline adherence is widely stated to be 
variable, and much of the research on guidelines is focused on finding effective 
interventions to influence guideline adherence, thereby influencing physician 
prescribing. Evidence of influence is medium and due to the high degree of 
variability in guideline adherence, the level of influence is low.  
3.4.5.4 Bio-Medical Factors 
Medicine in general is concerned with the pathological states of anatomy or 
physiology having a meaningful impact on health and its diagnosis, treatment 
and/or prevention (bio-medical). Medicines are important when treating ailments 
within the context of modern medical practice (Lilja, 1976, Hemminki, 1975). It is 
widely stated that diagnosis, signs, symptoms and disease severity across 
therapy areas are all positive predictors of prescriptions (de Jong et al., 2009, 
Hussain et al., 2010, DeWitt et al., 2006, Hummers-Pradier et al., 1999, Hyde et 
al., 2005, Mesker et al., 2009, Pressman et al., 2001, Solomon et al., 2003, Tan 
et al., 2009, Biga et al., 2007, Van der Ent et al., 2009, Macfarlane et al., 1997). 
In addition, it has been claimed that psychiatric co-morbidities in patients with 
anxiety may influence prescribing by physicians (Smolders et al., 2007). Wanting 
to limit treatment failures have been found to influence prescribing (McGregor et 
al., 2007). Bio-medical effects caused by medicines may also influence 
prescribing. Choudhry et al. (2006) found that a physician’s experience with 
bleeding events associated with warfarin can influence prescribing warfarin, but 
adverse events that are possibly associated with underuse of warfarin were not 
found to affect subsequent prescribing. Furthermore, pharmaceutical knowledge 
(efficacy and safety) does not significantly influence prescribing range (de Bakker 
et al., 2007). In the context of preventive medicine, Izuora et al. (2011) 
investigated the influence of the World Health Organization Fracture Assessment 
Tool on physician prescribing behaviour for the prevention of osteoporosis. The 
authors found no influence of the tool on physician prescribing. 
In conclusion, there is credible evidence for bio-medical factors influencing 
physician prescribing behaviour across therapeutic areas. This may seem like 
stating the obvious, as medicines are designed to address bio-medical needs at 
the patient level, but it is worth noting that the influence is universally applied 
across therapy areas.  
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3.4.5.5 Academic Literature 
Academic literature is widely stated to be a valuable and preferred source of 
information among physicians (Gallan, 2005, Naik et al., 2009, Theodorou et al., 
2009, Avorn et al., 1982, Prosser et al., 2003, Adair et al., 2005, Azoulay, 2002). 
In the context of this review, academic literature refers to peer-reviewed literature 
(paper or digital) used as sources of new evidence and practice guidelines 
relating to prescription medicines. 
Academic literature plays an important role, but figures more strongly in 
determining prescribing behaviour in specialists than GPs (Gallan, 2005). 
Specialists have been found to prescribe based mainly on scientific literature and 
meetings (Jones et al., 2001), but this is not universally true, as GPs are claimed 
to place more importance on official data than psychiatrists (Lapeyre-Mestre et 
al., 1998). 
Not only is academic literature an important source of information, but also the 
type of information that may play a role in influencing physician prescribing 
behaviour. Fullerton et al. (2010) p. 372, found that “publication of scientific 
evidence had the combined effect of decreasing the predicted probability of 
receiving gabapentin by 5.4% at one year from 17.1% to 11.7%”. In another 
study, Calvo and Rubinstein (2002) investigated the proportions of new 
prescriptions changed between a 6-month period before publication and a 6-
month period after publication of alendronate, metformin and finasteride. The 
authors found a heterogeneous response and that the prescription patterns of all 
physicians showed a clear temporal association with the publication of new 
evidence. More importantly, the authors note that “the greater change observed 
for generalists could be explained by their lower baseline use of the drugs and a 
more conservative behaviour that might defer the adoption of new treatments 
until they are supported by strong evidence published in major journals” (Calvo 
and Rubinstein (2002) p.457). Furthermore, Menon et al. (2010) found that a 
rapid and sustained reduction in the frequency of aspirin clopidogrel use in 
ischemic stroke and transient ischemic attack was observed after publication of 
the MATCH5 trial in the absence of MATCH-specific GWTG6-Stroke initiatives 
and preceding an American Heart Association guideline update.  
The manner in which information is provided may also play a role in modulating 
the influence of academic literature on physician prescribing. For example, 
physicians' views of the effectiveness of lipid lowering drugs and the decision to 
prescribe such drugs is affected by the predominant use of reduction of relative 
risk in trial reports and advertisements (Bucher et al., 1994). 
Ideally, the doctors preferred to prescribe drugs for which they had scientific 
knowledge; “They all rated independent research evidence as the key source of 
empirical validation for a new drug, more than drug company funded studies”  
(Prosser et al., 2003 p. 61). 
                                            
5 Management of Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) 
6 Get With The Guidelines (GWTG) 
 147 
From the evidence presented, it is reasonable to argue that that academic 
literature serves as a valued and preferred source of information in influencing 
physician prescribing. However, to what extent influence is exerted is not fully 
understood. 
3.4.5.6 Clinical Study Participation 
Clinical study participation exposes the physician to new medicines in a well-
defined and monitored setting, providing useful experience with efficacy and 
safety. Literature addressing the issue is limited and reported results 
heterogeneous, indicating that no consensus exists as to its influence on 
physician prescribing behaviour.  
Using a matched case–control design, Corrigan and Glass (2005) investigated 
whether participation in Phase III trials influenced the prescription of study 
medicines 18 months after trial closure. The authors found that for all indications, 
investigators prescribed the study drug more often than control physicians did. 
Three months after the product launch of the new drug, the number of 
prescriptions for the clinical trial drug written by the investigators accounted for a 
statistically significant higher share than did the number of prescriptions written 
by controls (26% vs. 16%; P ≤ .001), even with controlling for the additional 
variables used in the multiple analysis-of-covariance model. In another study, 
(Glass, 2003, Glass and Rosenthal, 2005) investigated the participation in Phase 
III and IV studies and the subsequent influence on prescribing behaviour by 
physicians. The authors found that there was a stronger relationship in Phase III 
studies than in Phase IV studies between participation in clinical trials and 
increased study drug prescribing, and no causal relationship between trial 
participation and additional sponsor company prescribing for other, non-study 
drugs was found.  
However, it has also been claimed that conducting a trial sponsored by a 
pharmaceutical company had no significant impact on physicians' adherence to 
international treatment recommendations, but increased their use of the trial 
sponsor's drugs (Andersen et al., 2006). Importantly, Chauhan and Mason (2008) 
p. 339, note that “clinical trial investigators and physicians who sit on decision-
making bodies such as formularies and appear to have a special influence due 
to their proximity to their research and understanding of evidence base”.  
Evidence of influence of clinical study participation is limited and non-consensual. 
However, clinical investigators in central positions on formularies may influence 
decision-making through their proximity and understanding of the evidence.  
3.4.5.7 Legal Concerns 
Physicians are liable under a negligence rule of liability, and as many as 1% of 
all hospital admissions in the US may involve legal action due to negligence 
(Danzon, 2000). Therefore, it may be assumed that there are legal constraints on 
physicians’ choices in the practice of medicine. However, the same rate of 
litigations is not seen in Europe (Anderson et al., 2005). None the less, legal 
constraints limit choices, but may also drive behaviour leading to the practice of 
defensive medicine, which occurs when a physician practices medicine to protect 
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him/herself against litigation (Danzon, 2000). The resulting practice of defensive 
medicine may drive demand for care higher than would otherwise be the case.   
Only two studies with reference to legal concerns having a bearing on physician 
prescribing behaviour were identified. Hussain et al. (2010) studied which factors 
influence physician prescribing behaviour regarding stress ulcer prophylaxis. The 
authors employed multivariate analysis and found that legal repercussions of not 
prescribing stress ulcer prophylaxis led to increased prescribing. In a systematic 
review of factors that influence physician prescribing of medicines, Gallan (2005) 
did not identify credible evidence to support an influence and merely stated that 
further research is needed. 
Evidence of influence uncovered in this paper is very limited, and any conclusions 
on this basis may not be drawn. However, legal constraints limit choice and as 
such have been addressed by background literature, providing some clues to the 
possible mechanisms. In conclusion, further research on the topic is needed. 
3.4.5.8 Technology 
Technology touches the practice of medicine in ever increasing and novel ways 
and is widely stated to influence physician prescribing behaviour (Greving et al., 
2006, Fischer et al., 2008, Martens et al., 2007, Ostini et al., 2011). In this review, 
the technology identified to influence physician prescribing is computerised 
decision support systems (Pearson et al., 2009), electronic reminders (Filippi et 
al., 2003), electronic prescribing (Fischer et al., 2008) and computerised order 
entry forms (Teich et al., 2000).  
In a systematic review of the literature (1990-2007), Pearson et al. (2009) 
investigated computerised clinical decision support systems (CDSS) for 
prescribing change practice. The authors note that “the most consistently 
effective approaches used system-initiated advice to fine-tune existing therapy 
by making recommendations to improve patient safety, adjust the dose, duration 
or form of prescribed drugs, or increase the laboratory testing rates for patients 
on long-term therapy” (Pearson et al., 2009 p. 1). At the time of initiating therapy, 
CDSS is claimed to be more effective after rather than before the selection of 
medicines has taken place, and may be effective in monitoring therapy. However, 
CDSS was not found to be effective in stopping prescribing. Furthermore, CDSSs 
may perform better in institutional compared to ambulatory settings, and when 
decision support was initiated automatically by the system as opposed to user 
initiation. CDSSs implemented with other strategies such as education were no 
more successful in improving prescribing than standalone interventions. In a 
study by Berner et al. (2006), it was found that physicians provided with a PDA-
based CDSS for NSAID prescribing made fewer unsafe treatment decisions than 
participants without the CDSS. In a well-designed study not identified or included 
in the work by Pearson et al (2009), McMullin et al. (2005) found that electronic 
prescribing system with integrated decision support shifted prescribing behaviour 
away from high-cost therapies and significantly lowered prescription drug costs. 
The savings associated with altered prescribing behaviour offset the monthly 
subscription cost of the system. Use of the CDSS was also associated with 
significant shifts in prescribing behaviour. Within the eight targeted therapeutic 
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categories, prescriptions for high-cost target medications overall decreased by a 
relative 9.1% in the intervention group (from 39.4% to 35.8%) and increased by 
a relative 8.2% in the control group (from 40.1% to 43.4%). Compared with the 
control group, the prescription ratio for high-cost medicine classes was a relative 
17.5% lower in the group using the CDSS (35.8% versus 43.4%, P=0.03). 
Clinicians using electronic prescribing with formulary decision support were 
significantly more likely to prescribe tier one-medications (Fischer et al., 2008). 
On the topic of cost, computerised feedback on drug costs increased generic 
prescribing (Beilby and Silagy, 1997). Zuker et al. (2011) found that physicians 
selectively complied with electronic recommendations to substitute less costly for 
more costly drugs. Compliance was neither automatic nor thoughtless and 
entailed cost containment with possibly marginal compromise on quality of care 
or none at all, as compliance mostly involved substituting generic for patent 
drugs.  
Filippi et al. (2003) argue convincingly that electronic reminders influence 
prescribing behaviour of GPs. However, the adherence to the advice provided by 
the DSS is not 100 % for the physicians using such system. Physicians not using 
the DSS will be less adherent to the guideline advice provided by the DSS (de 
Jong et al., 2009). In another study, no favourable effects were found for 
computerised reminders with the message to prescribe certain medicines. On the 
other hand, computerised reminders with the message not to prescribe certain 
medicines sometimes positively influence the prescribing behaviour of GPs 
(Martens et al., 2007, Henderson et al., 2008).  Simon et al. (2006) found that 
age-specific alerts resulted in a continuation of the effects of the medicine-specific 
alerts without measurable additional effect, but the age specific alerts led to fewer 
false-positive alerts for clinicians. GPs who reported use of a prescribing decision 
support system were less likely to prescribe angiotensin II receptor blockers 
(Greving et al., 2006). Furthermore, computerized physician order entry was 
found to be a powerful and effective tool for improving physician prescribing 
practices (Teich et al., 2000, Christakis et al., 2001).  
Two authors have addressed quality of prescribing as measured by guideline 
adherence. The first study indicated that a multifactor intervention including 
personal digital assistant–based decision support may improve primary care 
physician adherence to the ATP III guidelines (Bertoni et al., 2009). The second 
study found that physicians’ compliance with OncoDoc was significantly improved 
(p < 0.001) to reach 85.03% after using the CDSS (Bouaud et al., 2001). 
Strom et al. (2010) investigated the effect of CDSS on preventing medicine 
interactions, specifically between non-steroidal anti-inflammatory analgesics 
(NSAIDs) and warfarin. The authors found that customized warnings that 
required a physician’s response did not meaningfully influence concomitant 
prescribing of NSAIDs and warfarin when compared to commercially passive 
alerts.  
Evidence of influence of technology on physician prescribing behaviour is widely 
stated. The aim of technological interventions is firstly to improve prescribing by 
increasing adherence to guidelines, and secondly, as a cost control measure. 
However, the technology identified in this review is closely associated with the 
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decision process, and no information as to the effect of technologies not directly 
involved with the decision process was identified. 
3.4.5.9 Theoretical Considerations and Summary 
The plethora of non-economic factors influencing physician prescribing behaviour 
speaks to the complexities surrounding the issue being addressed. Non-
economic factors influencing physician prescribing behaviour have been widely 
investigated, but the number of factors is many and evidence of influence varies 
across the identified factors.   
Peers are widely stated to be a powerful influencer on physician prescribing. In 
this context, peer interaction provides authoritative influence, representing a 
legitimate and decisive interchange through which doctors acquire knowledge 
and experience of new drugs. The mechanism by which peers influence 
prescribing can therefore be argued to be related to the level of uncertainty 
associated with prescribing medicines. Uncertainty is stated to be the main driver 
for physician behaviour (Ajzen, 1991), and factors modulating uncertainty in the 
context of prescribing will potentially have an effect.  
Academic detailing is widely stated to influence physician prescribing and is 
possibly the most potent influencer identified in this review. Mechanisms by which 
academic detailing exerts influence on physician prescribing is not explicitly 
stated in the literature. However, breaking the factor into separate components 
may help in shedding light on the subject. What are the components of academic 
detailing? First, it is an information channel. Second, it is often a peer interaction. 
Finally, academic detailing embodies guidelines - the essence of evidence-based 
practice.  
Considering academic detailing as an information channel provides the implied 
context of unbiased and legitimate information concerning prescribing behaviour. 
It is also a two-way communication channel, providing the opportunity for 
individualized guidance based on the physician’s need. Furthermore, it provides 
a social network context. The provision of balanced information from legitimate 
sources provides the base of strong influence to be exerted (Hunt, 2002). 
Individualized information is claimed to provide stronger influence than general 
information (Goldstein et al., 2005). On the topic of guidelines, it is widely stated 
that the effect on prescribing behaviour is variable. However, individualised 
information in a trusted and legitimate social context positively modulates 
guideline adherence. Thus, it can be argued that academic detailing increases 
guideline adherence and so approximates the practice to that of evidence-based 
medicine. The effect is therefore, in essence, one of perceived social norm. It can 
therefore be argued that academic detailing influences physician prescribing 
behaviour by modulating the perceived social norm related to intent, as proposed 
by Ajzen (1991) in the Theory of Planned Behaviour.  
The influence of guidelines on physician prescribing behaviour is widely stated to 
be variable. The nature of guidelines provides the option for a physician to adopt 
them or not, and therefore the literature addressing the topic is mainly concerned 
with interventions designed to influence guideline adherence. In a theoretical 
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perspective, guidelines provide a best practice suggestion and thereby may 
constitute an acceptable social norm. It may therefore be argued that guidelines 
exert influence on physician prescribing behaviour in two ways: firstly, being the 
socially accepted norm linked to the Theory of Planned Behaviour; and secondly, 
by being the measure of success of interventions designed to influence physician 
prescribing.  
Academic literature is a source of peer-reviewed information. Information in this 
context can influence physician prescribing by simply creating awareness of more 
complex modulation of uncertainty. Furthermore, information presented as 
evidence may also influence normative beliefs. From a theoretical perspective, 
academic literature therefore influences physician prescribing through the 
balance of value beliefs and strength of beliefs, in addition to effects on normative 
beliefs. Thus, behavioural intent, an immediate precursor to behaviour, may be 
influenced.  
Bio-medical factors are natural influencers of physician decision making, but 
uncertainty related to the outcome of any therapeutic intervention is consistently 
present and considered the main driver for physician prescribing in general 
(Ajzen, 1991). From a theoretical perspective, bio-medical factors can be argued 
to influence both the evaluation and strength of beliefs associated with 
uncertainties of prescribing medicines. Thus, bio-medical factors may influence 
prescribing by modulating the intent to prescribe. In this review, however, bio-
medical factors were not explicitly addressed, but it follows from general medical 
literature that bio-medical factors are at the core of any medical decision. 
Therefore, on the basis of general medical literature, evidence of influence is 
assumed to be high.  
Clinical study participation gives the participating physician experience with new 
medicines in a controlled environment. It has been stated that early experience 
with new medicines is an important influencer of physician prescribing (Jones et 
al., 2001). Thus, it may be argued that clinical study participation can influence 
physician prescribing by building habit persistence. However, no consensus has 
been reached by scholars, and as such, it remains a hypothesis to be tested. 
Technology identified in this review is directly linked with the decision process 
involved in prescription decisions. In this context, technology has three central 
roles: distribution of information, control and feedback. Based on guidelines, 
technology may aid the physician in choosing the correct medicine supported by 
available evidence. From a theoretical perspective, this makes for economic 
decision-making and removes some of the effort associated with prescribing. 
Technology can apply control in real time, and thus effectively limit available 
choice. Furthermore, feedback may be provided and function as a base for 
learning through experience.  
Legal concerns may influence physician prescribing by modulation perception of 
control and normative beliefs, thus influencing intent to prescribe and finally 
prescribing behaviour. Furthermore, in an agency context, legal concerns may 
induce prescribing behaviour that may be defensive in nature, and so serve the 
physician’s self-interest rather than the principal.  
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Table 3-42 Summary of non-economic factors 
Non-economic factors 
Component Effect Mechanism Theory Influence Evidence of influence 
Peer effects 
Influence prescribing in 
line with peer practice and 
guidance 






Modulate uncertainty TPB High High 
Guidelines 
Improve quality of 
prescribing in line with 
available evidence 
 






and perceived control TPB Medium Low 
Bio-medical 
Central to all medical 
decisions and is the basis 
for uncertainty 
 
Modulate value of 
belief and control 
belief 
TPB High Low 
Clinical study 
participation 
Increase prescription of 
study medicine and other 
medicines in sponsor 
portfolio 
 





Limit choice and 
modulate normative 
beliefs 
TPB Low Low 
Legal 
concerns 




subjective norm and 
perception of control 
Agency Low Low 
3.4.5.10 Summary 
There is credible evidence to support the influence on physician prescribing 
behaviour by interventions across different contexts. Bio-medical factors lie at the 
core of any medical decision and are central to physicians prescribing.  
From a theoretical perspective, the most effective interventions are those that 
influence through control beliefs. Uncertainty is a strong driver of physician 
behaviour, and interventions designed to modulate uncertainty may therefore 
have the potential to be effective influencers. However, uncertainty is complex, 
and from a theoretical perspective, the belief strength is counterbalanced by 
value beliefs. Thus, interventions focused on influencing physician prescribing 
through attitude have been shown to be less effective than choice limiting 
measures.  
In economic theory, self-interest is a strong influencer of behaviour. The 
information asymmetry inherent in medical practice, combined with multiple 
principal-agency relationships, provides a fertile ground for behaviour driven by 
self-interest. Interventions based on financial incentives are designed to take 
advantage of this very fact. However, evidence of influence is low, which may in 
part be because literature addressing the issue is limited. From an agency 
perspective, however, it is clear that moral hazard is prevalent and may be driven 
by the fact that both physician and patient are insulated from the economic 
realities of any decisions made regarding prescription medicines. 
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3.4.6 Key Gaps in the Literature 
This section begins with a brief summary of the evidence that the systematic 
review has uncovered concerning factors and contexts influencing physician 
prescribing behaviour, before addressing the key gaps in the literature.  
Interventions designed to influence prescribing behaviour modulate perception of 
control, attitude toward the behaviour and/or the perception of what is expected 
from health care stakeholders and society at large (social norm). The most 
effective interventions are those that influence the physician’s perception of 
control, followed by social norm and attitude formation, respectively. Perception 
of control was found to be most affected by implementing choice limiting 
measures, such as formularies, preferred medicine lists, managed care and 
reimbursement, thus affecting the spectrum of choice available for the physician 
when prescribing. Social norm was found to be most affected by interventions 
making use of bio-medical factors, academic detailing and peer effects, 
respectively. Physicians’ attitudes toward prescribing were found to be relatively 
resistant to interventions, and consequently, the effect of pharmaceutical 
promotion was found to be modest. However, face-to-face interventions such as 
detailing were found to be more effective than less direct measures, signalling a 
relationship effect often exploited by the pharmaceutical industry. 
Based on the findings of this systematic review, key gaps in the literature 
addressing factors and contexts influencing physician prescribing behaviour can 
be divided into five categories: outcomes data, theoretical framework, agency 
(moral hazard and adverse selection), and feedback and learning. These 
categories will be addressed below.  
It has been widely stated that any intervention influencing physician prescribing 
behaviour may affect patient outcomes (Klein, 2005). There is no consensus on 
what constitutes optimum pharmaceutical consumption (Rizzo, 1999), and none 
of the authors of publications included in this review have attempted to address 
the outcome of interventions or contexts influencing physician prescribing 
behaviour. However, several authors have studied the effect of interventions 
against guideline adherence as a proxy for prescribing quality (Smolders et 
al.,2007, Lagerlov et al., 2000, Chauan and Mason, 2008, Nast et al., 2009, 
Rashidian and Russel, 2011). The same authors have described the variability in 
guideline adoption, and in addition, it has been found that more than 50% of 
prescriptions may contradict clinical guidelines.  In conclusion, the consistent lack 
of patient outcomes data is the most notable gap in the literature.  
There is apparent consensus on the fact that medical decisions are made under 
conditions of uncertainty (Reyna, 2008), but no grand theory of medical decision 
exists (Reyna and Rivers, 2008). Medical decision-making employs adaptive 
decision strategies (Payne, 1993), but the cognitive behaviour theory, Theory of 
Planned Behaviour, most used to predict actual behaviour (Godin et al., 2008), 
lacks feedback mechanisms. Furthermore, there is consensus about conflict of 
interest being at the centre of the agency problem related to the presence of 
multiple principal.-agent relationships at the time of prescribing (Eisenhardt, 
 154 
1989). Literature addressing moral hazard and adverse selection in the context 
of multiple principal-agent relationships influencing physician prescribing has not 
been found. Thus, there are basic deficiencies within the theoretical constructs 
used to explain physician prescribing behaviour, and attempts to link the 
constructs have not been made.  
3.5 Conclusion 
In this section, a brief summary of the findings and insights that emerged from 
the review are presented. In so doing, the key theoretical lenses that explain 
physician prescription behaviour are summarised in order to build up a framework 
that both synthesises the systematic review and provides a first step towards 
empirical research.  
3.5.1 Theoretical Perspectives 
In this section, the theoretical perspectives that best explain physician 
prescription behaviour are presented, starting with the Agency Theory, before 
specific aspects of cognitive behavioural theory are addressed. Following this, a 
model linking the theoretical perspectives is presented. 
3.5.1.1 Agency Theory 
In an intellectual project for understanding, Eisenhardt (1989) undertook a 
thorough review of agency and Agency Theory. The basis for agency is that one 
party (principal) delegates work to another (agent), and Agency Theory is 
concerned with two problems occurring in agency relationships (Eisenhardt, 
1989). The first problem relates to conflict of interest (moral hazard) and the 
second to risk sharing (adverse selection).  Studies of agency relations date back 
to the early sixties, and the seminal work done by Arrow (1963) is central in 
defining the difference in attitudes toward risk from an economic perspective 
(Arrow 1963). From the same perspective, Jensen and Meckling (1976) and Ross 
(1973) introduce the concept of different goals and division of labour (Ross, 
1973).  (Mitnick (1986), 1994) takes on a political science perspective and 
challenges the positivist views presented by Arrow (1963) and Ross (1973), 
arguing that the central problem with Agency Theory is the lack of consensus as 
to what the agency problem really is all about. Moral hazard and adverse 
selection lie at the core of Agency Theory, and both presume a conflict of interest 
between agent and principal (Mitnick 1994). Moral hazard occurs when a person 
is insulated from risk and behaves differently than he/she would if exposed to the 
risk (Arrow 1963). Adverse selection refers to a situation when undesired results 
occur on the bases of the principal and agent having different information 
(asymmetry of information) (Arrow 1963). From the health care value chain 
perspective, physician agency is of importance as it may have a bearing on 
prescription behaviour, as detailed in the health economic domain of literature, 




3.5.1.1.1 Physician Agency 
Uncertainty is the most important factor influencing physician behaviour (Arrow, 
1963) and has been addressed in the context of physician agency. In an 
intellectual project for understanding, McGuire (2001) provided a comprehensive 
review of the topic from a health economic perspective. The author concludes 
that economic models often ignore uncertainty and informational asymmetry 
inherent in modern health care (McGuire, 2001 p. 496). Perfect physician agency 
may exist if agent and principal have the same information, but no demand on 
the quality of information is made. Thus, perfect agency can be based on 
imperfect information (Mitnick, 1994). According to Eisenhardt (1989), moral 
hazard refers to the lack of effort by the agent, and adverse selection refers to 
the misinterpretation of ability by the agent. Asymmetry of information concerning 
these two aspects may be considered an advantage when the agent acts in the 
best interests of the principal, and if used inappropriately, be against the interests 
of the principal.  
The physician plays the role of agent for several principals in the health care value 
chain. First and foremost, the physician is an agent on behalf of the patient. 
Asymmetry of information regarding diagnosis and treatment options is a natural 
consequence of the physician’s extensive training and resultant expertise. This 
training is complex, time consuming and costly, creating a situation where it is not 
possible for a patient to correctly verify quality or utility of health care provided. It 
has been argued that only about 25 % of patients are reasonably well informed 
about the care they receive (McGuire 2001, p.465). Physician agency may also 
exist, with payers and/or employers as principals. Given the potential complexity 
of physician agency with several simultaneous principals, physician loyalty will be 
under pressure and may be influenced by shifting power between principals, thus 
having a bearing on patient health. However, the authority of the physician is still 
strong and plays a central role in any decisions related to medical care (McGuire 
2001, p.463). In light of the central role played by physicians in medical decisions, 
it is important to further address aspects of moral hazard and adverse selection 
in this context. 
Moral hazard is said to take place when an individual not fully exposed to a risk 
would behave differently than if fully exposed to the risk (Gaynor and Gertler, 
1995). Both physician and patients are insulated from the financial realities of 
medical decisions (Illert and Emmerich, 2008), and thus subject to forces of moral 
hazard. Both the physician and the patient may therefore engage in behaviour 
motivated by self-interest. The physician may drive demand beyond what would 
be the case if exposed to the financial risk implicit in making the decision 
(McGuire 2001, p.503). A physician may also influence quantity of care, and this 
is achieved by: setting the level of non-contactable input (quality), influencing 
patient preference and physician induced demand (McGuire 2001, pp.503-519). 
Increasing quality may increase cost, and changing patient preference in 
accordance with physicians’ self-interests may have the same effect. Physician 
induced demand will occur if physicians use their “superior” knowledge to their 
benefit, driving use of health care resources to a higher level than would be the 
case if information was symmetric between agent and principal (McGuire 2001, 
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p.503). On the other hand, the patient may seek to engage in behaviour driving 
the consumption of health care. A patient may, for example, simply opt for taking 
a pill for high cholesterol rather than engaging in lifestyle changing behaviour 
such as exercise and eating healthy. Thus, patient preference may impact 
demand for health care services from physicians. 
Moral hazard, as illustrated above, is but one outcome of the agency problem. 
Physician agency may also have an impact on public policy through mechanisms 
of adverse selection.  In certain circumstances, it will be impossible to know what 
the physician did or knew (Pauley, 1978) at  the time of prescribing. This extreme 
form of informational asymmetry may lead to uninformed decisions by the 
principal, and consequently, adverse selection (McGuire 2001, p. 498).  
It is widely stated that behaviour which is motivated by self-interest of the agent 
lies at the heart of the principal-agent problem (Eisenhardt, 1989). The physician 
is an “experience good”, as the patient cannot reliably measure quality of health 
care provided before it is experienced (Gaynor, 1994). Consequently, a patient 
will not know the quality of care before having experienced the care provided by 
the physician. McGuire (2001, p. 502) argues that learning is slow, and therefore 
the reward for quality is likely to be inadequate. Thus, the physician may be given 
room to adjust quality as an input factor (effort) according to prevailing 
motivations, including self-interest. Furthermore, credible evidence suggest that 
compensation arrangements with high degree of revenue sharing reduces 
physician effort (Gaynor and Gertler, 1995). 
Since the introduction of the Hippocratic Oath in 4th century BC, ethics have 
played a central role in the practice of medicine. Physicians have autonomy in 
decision making on the basis of an understanding that they will act in the best 
interests of their patients (Arrow 1963). However, it has been argued that 
managed care may threaten the physician’s loyalty to the patient (McGuire, 2001) 
(McGuire 2001, p.520). The physician is an agent for both the patient and the 
payer, potentially resulting in a loyalty conflict and cognitive dissonance. A payer 
can take advantage of the ethical constraints, imposing payment systems that 
force the physician to personally take on more of the effort to attain an acceptable 
outcome for the patient (Fugh-Berman and Ahari, 1997).  
In addition to ethics, legislation also plays a central role in the practice of 
medicine. Legal constraints limit choices, but may also drive behaviour leading to 
the practice of defensive medicine, which occurs when a physician practices 
medicine to protect him/herself against litigation (Danzon, 2000). The practice of 
defensive medicine may drive demand for care higher than would otherwise be 
the case.   
3.5.1.1.2 Summary 
At the heart of Agency Theory lays the conflict of interest concept between agent 
and principal. However, conflict of interest may also be present between 
simultaneous principals, further complicating physicians’ agency by influencing 
physician loyalty and possibly affecting patients’ health outcomes. Uncertainty 
and asymmetry of information play a central role in influencing physician 
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behaviour and can negatively influence public policy decisions and outcomes 
through adverse selection. Furthermore, physicians may drive health care 
demand by changing quality of service, influencing patient preference and using 
asymmetry of information to drive demand for care. Ethical and legal constraints 
of decision choices exist, and may be exploited by both agent and principal in 
addition to motivating the practice of defensive medicine. Thus, Agency Theory 
and, more specifically, physician agency illuminates the contextual framework of 
the payer-physician-patient interaction and is suggestive of factors of practice 
and organization having a bearing on physician prescribing behaviour. 
Furthermore, academics investigating physician agency have largely ignored 
uncertainty and informational asymmetry when modelling and investigating 
physician agency, thus weakening any arguments made. 
3.5.1.2 Theory of Reasoned Action and Theory of Planed Behaviour 
Theory of reasoned action (TRA) is concerned with what determines intention. 
Intention to perform a certain action is a function of two factors: attitude and 
subjective norm (perception of importance). Determinants of attitude have been 
identified as: evaluation of belief and strength of belief (O'Keefe, 2002 pp. 103-
109). Perceived lack of ability may have an impact on intention to perform an 
action. In 1991, Ajzen revised the theory, and in so doing, added a third factor, 
perceived behavioural control, leading to the Theory of Planned Behaviour (TPB) 
(Ajzen, 1991). Persuasive efforts from a TRA perspective may take three forms: 
changing the attitudinal component, changing the normative component or the 
relative difference between the two (O'Keefe 2002, p.109).  
In a systematic review of health care professionals’ intentions and behaviours, 
Godin et al. (2008)  included studies that aimed to predict health care 
professionals' intentions and behaviours, with a clear specification of relying on a 
social cognitive theory. This study shows that the theory most often used as 
reference was the Theory of Reasoned Action (TRA) or its extension, the Theory 
of Planned Behaviour (TPB); and the authors suggest that the TPB appears to 
be an appropriate theory for predicting actual behaviour, whereas other theories 
better capture the dynamic underlying intention (Godin et al., 2008). Finally, the 
authors provide a hypothetical framework for studying health care professionals’ 
intentions and behaviours, as shown in Figure 3-4 Hypothesized theoretical 
framework. The framework has explanatory power, as it provides a simple and 
credible explanation. However, it is not fully supported by the findings of this 
systematic review, as physician characteristics in general, with the notable 
exception of physician-level habit persistence, have not been shown to influence 
physician prescribing behaviour. Furthermore, the framework lacks the provision 
for feedback, a central element of dynamic decision making central to medical 
decision making in general (Kleinmuntz, 1993). Furthermore, it lacks testability 
and may therefore not be regarded or used as a well-established method.  
In a study designed to look at factors affecting antibiotic prescribing in a managed 
care setting, the authors found that behavioural intention was significantly 
correlated with both attitude and subjective norms, but was not predictive of 
actual prescribing behaviour (Lambert et al., 1997). The authors thus posit that it 
is possible that prescribing behaviour is influenced by non-psychological factors. 
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Furthermore, physician autonomy is challenged, and it can be argued that a 
system-level approach may be needed to yield a descriptive model of physician 
prescription decisions. In concordance with this notion, it is found in this review 
that physician prescribing behaviour is best described using three theoretical 
lenses: Decision Theory, cognitive behaviour theory and Agency Theory. 
However, the resulting proposed framework has yet to be tested. 
3.5.2 Proposed Framework 
Prior to undertaking this systematic review, a scoping study was conducted 
(Mikkelsen, 2010), which identified three theoretical domains that help explain the 
physician’s prescription behaviour: cognitive decision theories, economic 
theories and behaviour theories.  
Decision making is important in medical practice, and because health outcomes 
are probabilistic, most decisions are made under conditions of uncertainty 
(Kaplan and Frosch, 2005, Elstein and Schwarz, 2002). Medical science has not 
yet solved the uncertainty surrounding many medical decisions (Gillett, 2004), 
and as a consequence, medical decision making is the least developed aspect of 
evidence-based practice (Spring, 2008). Furthermore, uncertainty has been 
characterized as the most important factor influencing physician behaviour 
(Arrow, 1963). Thus, uncertainty is central to Decision Theory concerned with 
medical decision-making.  
In an intellectual project for understanding, (McGuire, 2001) has provided a 
comprehensive review of the topic from a health economic perspective. 
Interestingly, the author concludes that economic models often ignore uncertainty 
and informational asymmetry inherent in modern health care (McGuire, 2001 p. 
496). Perfect physician agency may exist if agent and principal have the same 
information; however, no demand on the quality of information is made. Thus, 
perfect agency can be based on imperfect information (Mitnick, 1994). According 
to Eisenhardt (1989), moral hazard refers to the lack of effort by the agent, and 
adverse selection refers to the misinterpretation of ability by the agent. 
Asymmetry of information regarding these two aspects may be considered an 
advantage, and if used inappropriately, may be unbeneficial to the principal.  
From an agency perspective, the physician may play the role of agent for several 
principals. First and foremost, the physician is an agent on behalf of the patient. 
Asymmetry of information regarding diagnosis and treatment options is a natural 
consequence of the physician’s extensive training and resulting expertise. This 
training is complex, time consuming and costly, creating a situation where it is not 
possible for a patient to correctly verify quality or utility of health care provided. In 
other words, the provision of health care is experience goods.  It has been argued 
that only about 25 % of patients are reasonably well informed about the care they 
receive (McGuire, 2001 p. 465). Physician agency may also exist with payers 
and/or employers as principals. Given the potential complexity of physician 
agency with several simultaneous principals, physician loyalty will be under 
pressure and may be influenced by shifting power between principals, thus 
having a bearing on patient health. However, the authority of the physician is still 
strong and plays a central role in any decisions related to medical care (McGuire, 
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2001 p. 463). In light of the central role played by physicians in medical decisions, 
it is important to consider aspects of moral hazard and adverse selection from an 
agency perspective. 
The theory of reasoned action and its extension, the Theory of Planned 
Behaviour, is the most studied theoretical framework informing on the topic of 
physicians’ cognition leading to decision behaviour. In addition, Agency Theory 
plays a central role in defining contextual contributors to the decision making 
process. Despite being highly trained, doctors are prone to making mistakes, and 
cognitive biases may detract from the use of logical and statistical decision 
heuristics. Given the multidimensional theoretical framework having a bearing on 
medical decision-making, deciding how to decide is central. 
The theoretical construct having a bearing on physician prescribing behaviour, 
therefore, should include Decision Theory (under uncertainty), Agency Theory 
and Theory of Planned Behaviour; please see Figure 3-3 Theoretical domains. 
However, the Theory of Planned Behaviour speaks to attitude in the context of 
belief strength. It can therefore reasonably be argued that uncertainty from a 
Theory of Planned Behaviour perspective is a component of attitude.  
 
Figure 3-3 Theoretical domains 
Godin et al. (2008) argue convincingly that among cognitive behaviour theories, 
the Theory of Planned Behaviour has the highest predictive power for physician 
behaviour. However, the authors conclude that the theory has insufficiencies and 
propose a new framework; please see Figure 3-4 Hypothesized theoretical 
framework. The framework has explanatory power, as it provides a simple and 
credible explanation. It purports that physician characteristics, role, and identity 
are factors influencing behavioural intent. Furthermore, physician-level habit 










Figure 3-4 Hypothesized theoretical framework 
The framework proposed by Godin et al. (2008), as an extension to the Theory 
of Planned Behaviour, is not fully supported by the results of this review. The 
deficiency is highlighted by the fact that physician characteristics is not found to 
be a key factor influencing physician prescribing behaviour. Godin et al. (2008) 
argue that role and identity, beliefs about capabilities and past behaviour/habit 
are distinct from physician characteristics. From the findings in this review, two 
counter points are presented.  First, role and identity is tightly linked with 
specialty, which has been found to be integral to the definition of physician 
characteristics. Second, beliefs about capabilities are related to attitude. Thus, 
only past behaviour/habit remains, which has been found to be a component of 
physician characteristics. In fact, habit persistence is found to be a strong 
influencer of physician prescribing behaviour, whereas other components of 
physician characteristics have not been found to influence physician prescribing 
behaviour. In addition, the framework proposal does not agree with the premise 
of dynamic decision making, as feedback is lacking from the framework. 
Feedback from previous action is precisely what makes dynamic decision 
strategies effective (Kleinmuntz, 1993), and not including feedback limits the 
validity of the proposed framework. 
The question that remains to be answered is whether the Theory of Planned 
Behaviour is a “good” fit for physician prescribing behaviour. In essence, the 
Theory of Planned Behaviour can account for the majority of the factors, but it 
does not account for habit persistence and information asymmetry; please see 
Table 3-5 Strength of Influence for  further details. Habit persistence can be 
considered as residues of experiences and past behaviours. Information 
asymmetry is inherent to the practice of medicine, and when coupled with 
uncertainty, it is the driver of moral hazard and adverse selection. Furthermore, 
the theory lacks feedback or learning, and so discounts the temporal aspects of 
medical practice.  
Thus, it may be argued that the Theory of Planned Behaviour does not fully 
explain the observed behaviours uncovered in this review. As proposed by Godin 
et al. (2008), further development of the Theory of Planned Behaviour is needed 
to fully explain physician prescribing behaviour. Based on the evidence 
uncovered in this review, the framework depicted in Figure 3-6 Proposed 
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conceptual framework is therefore proposed in order to explain physician 
prescribing behaviour.   
The proposed framework is based on the evidence of influence uncovered in this 
systematic review. Furthermore, the model should be subject to 
operationalization employing qualitative methodology, and finally, quantitatively 
tested in a clinical setting. For instance, further research could focus on the model 
fit concerning prescribing pain medication for cancer patients. Further work would 
also be needed to ascertain the internally consistency of the model, and this may 
be the focus of future doctoral research. In addition, based on the fact that most 
(70%) of all physician-patient consultations result in the prescription of a medicine 
as part of the treatment, physician prescribing may be considered a proxy for 
medical decision making by physicians in general. Thus, it is also proposed to 
test whether the framework is a good fit for medical decision making by 
physicians in general. 
In summary, the framework outlines how components from cognitive behaviour 
theory, Agency Theory and Decision Theory are interlinked to explain physician 
prescribing behaviour.  
 
 





Figure 3-6 Proposed conceptual framework 
The proposed framework illustrated in Figure 3-6 Proposed conceptual 
framework is derived from the three theoretical domains (agency, decision under 
uncertainty and TPP) that help explain physician prescription behaviour and that 
were identified in the scoping study (Mikkelsen, 2010) and further substantiated 
by the evidence presented in this systematic review. Following an explanation of 
the conceptual framework, origin and flow of influence on behaviour in the context 
of physician prescribing is addressed. 
TPP assumes that subjective norm, attitude and perceived control influence 
behavioural intent, the immediate antecedent to behaviour (Ajzen, 1991). 
Subjective norm consists of normative beliefs that are influenced by the 
stakeholders, with a bearing on physician prescribing behaviour. The physicians’ 
perception of social normative pressures of whether to perform the behaviour or 
not is argued to be influenced by agency. Both the physician and patient are 
largely insulated from the economic realities of any decision made in the context 
of prescribing medicines. This creates a situation where conflict of interest exists 
between the physician and payer, and moral hazard may be present.  
Furthermore, the inherent information asymmetry of agency may also lead to 
adverse selection (Eisenhardt, 1989). In this context, it could be argued that 
agency effects may in part be caused by an influence on social normative 
pressures, thus influencing physician prescribing. For example, patient 
expectations and the physician’s perception of patient expectations may lead to 
overprescribing of antibiotics.  
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From the TPP, it can be assumed that attitude consists of behavioural beliefs 
influenced by the probability of the behaviour producing the desired outcome, and 
the physician’s positive or negative self-evaluation of the behaviour, thus forming 
the attitude component of the theory (Ajzen, 1991). From a physician prescribing 
behaviour perspective, there is an overlap between the attitude component of the 
Theory of Planned Behaviour and the uncertainty inherent in any medical 
decision. Therefore, it may be argued that uncertainty modulates the perceived 
probability of desired outcomes as a result of behaviour.  
Perceived control is a central element of TPB and represents the difference 
between TPP and the preceding theory of reasoned action. The concept is based 
on the assumption that an individual's perceived ease or difficulty of performing 
the particular behaviour is that perceived behavioural control is determined by the 
total set of accessible control beliefs; presence of factors that may facilitate or 
impede performance of the behaviour (Ajzen, 1991). 
Intention is an indication of a physician’s readiness to prescribe, and it is assumed 
to be an immediate antecedent of prescribing behaviour. Behaviour is an 
individual physician’s observable response in a given situation with respect to 
prescribing. Ajzen (1991) claims that behaviour is a function of behavioural intent 
and perception of control. Perceived behavioural control is therefore assumed to 
moderate the effect of intention on physician prescribing behaviour.  Thus, 
favourable intention produces a prescription only when perceived behavioural 
control is strong. For example, a physician will only prescribe medicines in the 
geographic area where he/she has a licence to practice.   
Experience from own behaviour is expected to form the basis of a learning 
process which may influence future behaviour. “Learning is the process whereby 
knowledge is created through the transformation of experience”  (Kolb, 1984, p. 
38). Prior experience is expected to moderate future physician prescribing 
behaviour (Webb and Lloyd, 1994). In fact, physicians may exhibit overreliance 
on personal experience as compared to scientific data when prescribing 
(Soumerai et al., 2000). Thus, experience may feedback and moderate subjective 
norm, attitude and control beliefs. For instance, in cases where a physician has 
a positive experience with a medicine, with regards to efficacy and safety, this is 
likely to reinforce future prescriptions, and negative experiences will have the 
opposite effect.   
3.5.3 Implications for Practice 
Before addressing what the implications for practice of the findings of the review 
may be, it is important to identify for whom the review may be relevant; in other 
words, who are the stakeholders? Burns et al. (2002) and Stremersch (2008) 
have identified  health care stakeholders from a value chain perspective, as 
illustrated in Figure 3-7 Health care value chain (Stremersch, 2008). Burns et al. 
(2002) p. 18, claim that the stakeholders in health care contest access to and 
control over three critical flows: products, money and information. From a payer 
and public policy perspective, there are three different policy inputs regulating 
medicines: public health (quality, safety and efficacy), health care (financing and 
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reimbursement of medicines), and industrial policy (Permanand (2006) p. 4). 
From a delivery perspective, competitive forces prevail as individual companies 
pursue profits in order to fulfil the primary goal of survival  (Hunt, 2002 p. 262). 
Therefore, it can be argued that the stakeholders for whom this review may be 
relevant are payers, providers and producers.  
 
 
Figure 3-7 Health care value chain (Stremersch, 2008) 
3.5.4 Implications for Payers 
From a payer perspective, the physician-payer agency should be the prevailing 
force driving the delivery of health care. However, this review has shown that this 
is not necessarily the case, as physician prescribing is driven by bio-medical 
factors governing the physician-patient agency relationship. The autonomy of the 
physician remains strong, and asymmetry of information is present. Effective 
regulatory and cost containment interventions regulate the spectrum of choice 
available for the physician when prescribing. The payer may also take advantage 
of the ethical constraints, imposing payment systems that force the physician to 
personally take on more of the effort to attain an acceptable outcome for the 
patient.  
3.5.4.1 Implications for Providers 
In this case, the central provider is the physician, but in the context of practice 
characteristics, it may also be larger organizational units such as hospitals. For 
simplicity, the physician will suffice, as the review has not revealed practice 
characteristics as a potent influencer on physician prescribing behaviour.  
Uncertainty remains a strong contributor of behaviours associated with physician 
prescribing. Factors influencing or modulating the level of uncertainty will be 
potentially valuable for the physician. However, uncertainty remains in an agency 
context, simply due to the inherent information asymmetry associated with the 
practice of medicine. This asymmetry of information leads to heated debates 
driven by self-interest as a potent preserver of status quo when challenged by 
interventions designed to drive cost effectiveness to higher levels.  
The problem lies not only in the information asymmetry, but the fact that no 
consensus exists on what constitutes optimum pharmaceutical consumption. 
This stems from the inability to define and agree on standard quality measures 
on which innovation can be based within a constrained fiscal budget. Innovation 
is the key to future health care, as it is deemed necessary to drive efficiencies to 
meet future demand without crippling health care providers.  
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Providers, therefore, must realise their role in innovation and the use of 
technology to achieve these goals in order to ensure the future delivery of health 
care within a welfare context. 
3.5.4.2 Implications for Producers of Medicines 
It can be argued that the two sides of the health care value chain are driven by 
different logics in the contest for flow of products, money and information.  
Payers are focused on welfare and producers on profit maximisation. In the 
middle sits the provider, acting out of self-interest. Mechanisms to regulate the 
flow of information, money and products are therefore central to the future of 
health care where prescription medicines will continue to play an important role. 
The model successfully utilized by the pharmaceutical industry for more than a 
century is at odds with the future needs of patients, payers and providers. This is 
highlighted by the recent McKinsey report (Q4 2011), addressing the 
pharmaceutical industry, where it is evident that change must come swiftly if 
competitive advantage is to be maintained. Loss of exclusivity of block buster 
medicines and generic competition, combined with a lean pipeline of new and 
promising products, has led the industry down the path of extensive cost cutting 
(Hunt et al., 2011). However, cost cutting alone will not sustain investor relations 
in the long term. Thus, a new model must be successfully implemented. The main 
ingredients are innovative partnerships and technology.   
3.5.5 Limitations of the Systematic Review 
In this review, every effort has been made to follow the steps designed to reduce 
bias and increase rigor and transparency by systematically searching all available 
literature and extracting relevant evidence. However, as with any academic work, 
this review is associated with limitations. The aim of this section is therefore to 
clarify the three main limitations of this systematic review.   
First, only one reviewer was employed in this review, and the possibility for 
researcher bias is therefore present. By following a strict and predefined protocol 
and carefully documenting each step, attempts have been made to reduce any 
untoward bias during the search, extraction and synthesis of the evidence 
presented in this paper.   
Second, interventions reviewed were often based on previous research and 
therefore lacking a strong theoretical basis. The research on interventions 
identified in this review typically focus on the clinical or administrative needs for 
interventions. As no consensus on what constitutes optimal pharmaceutical 
consumption, and outcomes data on administrative interventions are lacking, it 
appears that the choice of intervention is not well grounded in theory and at the 
same time may be inadequately described in the literature (Theory of Planned 
Behaviour, Agency Theory and decision under uncertainty). However, each study 
has been evaluated from the theoretical perspectives identified in the scoping 
study, and mechanisms of influence have been identified within the same 
theoretical domains.   
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Finally, no restriction on study type for inclusion was made. The tendency for 
reviews published within the medical domain of the literature (approximately 
80%) is focused on randomized controlled trials as the gold standard. This 
positivist approach may not be the best when dealing with complex issues such 
as physician prescribing behaviour, and elements of realist synthesis have 
therefore been employed.  
3.5.6 Next Steps 
3.5.6.1 Dissemination of the Review  
The aim of this review is to fulfil the DBA requirements of the Cranfield School of 
Management. The review will be updated on an on-going basis, using an 
automatic alert from the British Library. Identified literature titles will be collected 
and stored and added as part of an update prior to publication of the study. 
After successful completion of the requirements for the Cranfield DBA, the review 
will be adapted for publication as one practitioner paper and one academic paper. 
Adaptation for publication will be conducted in close collaboration with the review 
panel during the first half of 2014. 
3.5.6.2 Further Research 
The review has uncovered key gaps in the literature related to quality in health 
care.. Since physicians make decsions on behalf of patients and stakeholders in 
health care alike, Project Two of the DBA will be concerned with the 
understanding of physicians’ perception of quality in healthcare. Thus, the 
following research question has been formulated for Project Two: 
How do physicians construct quality of health care in a hospital setting? 
Physicians make decisions on behalf of patients and stakeholders when 
delivering health care (Vogel et al. 2003). In other words, physicians are relied 
upon to decide the clinical content of health care delivery. Thus, physicians 
invariably supply decision effort into the delivery of health care.  Physicians’ effort 
supplied into the delivery of health care is comparable to quality (Ma & McGuire, 
1997) and therefore a key component of quality in health care). Hence, physician 








 CHAPTER FOUR: PROJECT TWO 
Chapter Three set out the research question for this study. The research strategy 
and method is detailed in Appendix B, and this chapter uses the research strategy 
and method to explore the gap identified in the first project of the Executive 
Doctorate Programme. The academic and business context of the project forms 
the introduction of the chapter. Following this introduction, the detail of the 
research question for Project Two, the research strategy and methods used 
during Project Two are discussed. The chapter further describes the pilot study 
that was conducted, which is followed by the description of how the main study 
is carried out. The findings and the results of Project One are then discussed in 
detail. 
4.1 Introduction & Background 
This project, the second of the DBA, is concerned with quality of health care 
delivery from a physician perspective. The reason for this focus of the project and 
its link to the first project of the DBA is now explained. 
The health care system may be conceptualised as a value chain of which key 
constituencies are the payer (public bodies and insurers), the pharmaceutical 
companies and the physicians (Burns et al., 2002). It also includes heath care 
providers, regulators and patient groups. Even though physician autonomy is 
under pressure, managed-care notwithstanding, the physician acts as a decision 
maker on behalf of payers and patients when diagnosing and treating patients 
(Vogel et al., 2003). Stakeholders in the value chain therefore have a vested 
interest in influencing physicians and their decisions when providing health care 
services. Physician authority and control with regards to clinical decisions is 
generally granted, but the spectrum of choices available to physicians is typically 
preselected  (Miller, 1989). Factors influencing physician decisions have been 
widely stated, but the linkages amongst these factors and how these influencers 
impact patient outcomes is lacking (Gill et al., 1999).  
Stakeholders in the supply chain fight for access to and control over three critical 
flows: products, money and information (Burns et al., 2002). Interactions between 
stakeholders are addressed using agency as a theoretical framework. The profit 
maximizing hypothesis posits that physicians will act in a context of imperfect 
information and in a manner motivated by financial self-interest (Hunt et al., 
2002). Asymmetry of information may perpetuate self-interest behaviour in a 
manner not beneficial to either side of the value chain, and thus lead to poor 
decisions being made on behalf of the principal (Eisenhardt, 1989, McGuire, 
2001). Loyalty issues having a bearing on patient health may arise as a 
consequence. The practice of medicine is further complicated by the context of 
ethical and legal constraints on decision choices (Ma and McGuire, 1997, 
McGuire, 2001).  
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, it is widely 
recognized that because medical decisions have an impact on patients’ health, 
they should be of high quality (Klein, 2005). There appears to be consensus that 
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decision making in medicine is made under uncertainty (Bornstein and Emler, 
2001, Elstein, 1999, Elstein and Schwarz, 2002, Payne et al., 1993, Reyna and 
Rivers, 2008, Spring, 2008). However, no general theory of medical decision has 
been formulated, but the Theory of Planned Behaviour is the most studied 
theoretical framework informing on the topic of physicians’ decision behaviour 
(Reyna, 2008). Given the complexities of medical decision making and that no 
grand theoretical framework exists, deciding how to decide is central (Payne et 
al., 1993). Despite being highly trained, doctors are prone to making mistakes, 
and cognitive biases may detract from the use of logical and statistical decision 
heuristics (Hershberger et al., 1994). Mistakes in medicine are well documented, 
and the Institute of Medicine has reported that close to one million people per 
year are injured and close to one hundred thousand people a year die as a result 
of preventable medical errors (Kohn et al., 1999). As a consequence, 
standardization of the provision of care in hospitals has come into greater focus. 
Implementing a systematic approach to the implementation and compliance with 
guidelines can help reduce variation in core processes of organizations (Flynn et 
al., 1994) and, at the same time, increase the quality of health care provided 
(Leape, 1994).  
Thus, a systematic literature review was conducted (Project One) to investigate 
influencers on physician prescribing behaviour. The review identified two sets of 
categories of key influencers of physician decisions; interventions and contexts. 
Interventions refer to proactive techniques, processes or actions introduced to 
create change in physician decisions. Contexts are the set of circumstances or 
facts surrounding decision events; see Section 1.8.1.1 on page 20, for further 
details.  
In performing their duties, physicians must decide how to decide.  Information is 
not equally shared between physicians, patients and stakeholders. The physician 
has far more information than the patient and stakeholders, so physician 
decisions are made in the context of information asymmetry. However, physicians 
rarely have perfect information about clinical work (diagnostic, interactions, 
response to treatments), thus decisions are also made under uncertainty. 
Physicians rely heavily on past experience, forming constructs guiding future 
choice and action (Ajzen, 1991 p. 203). Therefore, influence of physicians’ 
decisions can be investigated by adopting experiential constructivism and 
personal construct theory.   
Improving quality of health care has two main approaches: clinical and 
experiential quality. Clinical quality is aimed fundamentally at reducing variation, 
in recognition of large numbers of preventable medical errors leading to injury or 
even death. On the other hand, experiential quality relates to “responsiveness to 
the needs and preferences of the patient” (Chandrasekaran et al., 2012) p.1. 
Increasing academic attention is being paid to the balance between clinical and 
experiential quality; however, no “magic bullet” exists to improve professional 
practice (Oxman et al., 1995).  
In order to gain insight into how key influencers of physician decisions may 
ultimately impact quality of health care, it is important to first understand how 
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quality of health care is perceived by physicians. Therefore, the following 
research question (RQ) is posed:  
RQ: How do physicians construct quality of health care delivery in a 
hospital setting? 
The patient-physician encounter takes place in the context of information 
asymmetry, and decisions are made under uncertainty. Uncertainty is the main 
driver of physician behaviour (Arrow, 1963) and has received less attention than 
information asymmetry (Rizzo, 1993). Perceived behavioural control is assumed 
to reflect past experience (Ajzen, 1991), and may therefore influence uncertainty. 
Each patient-physician encounter is different and forges a set of temporal 
experiences unique to each physician. To gain insight into how factors influencing 
physician decisions impact quality of health care, it is important to better 
understand how those in charge of providing health care (the physicians) 
construct the perception of quality of health care delivery. Thus, physicians’ 
perceptions about quality of health care delivery can be investigated by adopting 
experiential constructivism and personal construct theory. George Kelly 
developed the repertory grid interview technique (RGT) in the 1950’s, which was 
designed in order to surface subconscious insights about a phenomenon of 
interest.  Therefore, RGT is adopted as the research methodology for answering 
the research question.  
4.2 Theoretical Positioning 
In the preceding systematic literature review, three theoretical domains of 
physician decision behaviour were identified; see Figure 4-1 Theoretical 
domains. The focus of this study is the physicians’ perceptions of quality of health 
care delivery. The practice of clinical medicine requires knowledge about the 
science of medicine and applied practice. Personal experience plays a central 
role in physician decisions and consequently influences the practice of medicine, 
and it is therefore legitimate to adopt experiential constructivism and personal 
construct theory as a framework for investigating how physicians perceive and 
construct quality of health care delivery. The following theoretical domains are 
described briefly: Agency Theory, Theory of Planned Behaviour, Decision Theory 
and personal construct theory. A definition of quality is also provided in this 
section. 
 









4.2.1 Agency Theory 
In an intellectual project for understanding, Eisenhardt (1989) undertook a 
thorough review of agency and Agency Theory. The basis for agency is that one 
party (principal) delegates work to another (agent), and Agency Theory is 
concerned with two problems occurring in agency relationships (Eisenhardt, 
1989). The first problem relates to conflict of interest (moral hazard) and the 
second to risk sharing (adverse selection). Studies of agency relations date back 
to the early sixties, and the seminal work by Arrow (1963) is central in defining 
the difference in attitudes toward risk from an economic perspective (Arrow 
1963). From the same perspective, Jensen and Meckling (1976) and Ross (1973) 
introduce the concept of different goals and division of labour (Ross, 1973). 
(Mitnick (1986), 1994) takes on a political science perspective and challenges the 
positivist views presented by Arrow (1963) and Ross (1973), arguing that the 
central problem with Agency Theory is the lack of consensus as to what the 
agency problem really is all about. Moral hazard and adverse selection lie at the 
core of Agency Theory, and both presume a conflict of interest between agent 
and principal (Mitnick 1994). Moral hazard occurs when a person is insulated 
from risk and behaves differently than he/she would if exposed to the risk (Arrow 
1963). Adverse selection refers to a situation when undesired results occur on 
the bases of the principal and agent having different information (asymmetry of 
information) (Arrow 1963). From the health care value chain perspective, 
physician agency is of importance because it may have a bearing on decision 
behaviour, as detailed in the health economic domain of literature, and this is 
addressed in detail below. 
4.2.1.1 Physician Agency 
Uncertainty is the most important factor influencing physician behaviour (Arrow, 
1963) and has been addressed in the context of physician agency. In an 
intellectual project for understanding, McGuire (2001) provided a comprehensive 
review of the topic from a health economic perspective. The author concludes 
that economic models often ignore the uncertainty and informational asymmetry 
inherent in modern health care (McGuire, 2001 p. 496). Perfect physician agency 
may exist if agent and principal have the same information, but no demand on 
the quality of information is made; thus, perfect agency can be based on imperfect 
information (Mitnick, 1994). According to Eisenhardt (1989), moral hazard refers 
to the lack of effort by the agent, and adverse selection refers to the 
misinterpretation of ability by the agent. Asymmetry of information concerning 
these two aspects may be considered an advantage when the agent acts in the 
best interests of the principal, and if used inappropriately, may be against the 
interests of the principal.  
The physician plays the role of agent for several principals in the health care value 
chain. First and foremost, the physician is an agent on behalf of the patient. 
Asymmetry of information regarding diagnosis and treatment options is a natural 
consequence of physicians’ extensive training and resultant expertise. This 
training is complex, time consuming and costly, creating a situation where it is not 
possible for a patient to correctly verify quality or utility of health care provided. It 
has been argued that only about 25 % of patients are reasonably well informed 
about the care they receive (McGuire 2001, p.465). Physician agency may also 
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exist, with payers and/or employers as principals. Given the potential complexity 
of physician agency with several simultaneous principals, physician loyalty will be 
under pressure and may be influenced by shifting power between principals, thus 
having a bearing on patient health. However, the authority of the physician is still 
strong and plays a central role in any decisions related to medical care (McGuire 
2001, p.463). In light of the central role played by physicians in medical decisions, 
it is important to further address aspects of moral hazard and adverse selection 
in this context. 
Moral hazard is said to take place when an individual not fully exposed to a risk 
would behave differently than if fully exposed to the risk (Gaynor and Gertler, 
1995). Both physician and patients are insulated from the financial realities of 
medical decisions (Illert and Emmerich, 2008), and thus subject to forces of moral 
hazard. Both the physician and the patient may therefore engage in behaviour 
motivated by self-interest. The physician may drive demand beyond what would 
be the case if exposed to the financial risk implicit in making the decision 
(McGuire 2001, p.503). A physician may also influence quantity of care, and this 
is achieved by: setting the level of non-contactable input (quality), influencing 
patient preference and physician induced demand (McGuire 2001, pp.503-519). 
Increasing quality may increase cost, and changing patient preference in 
accordance with physicians’ self-interest may have the same effect. Physician 
induced demand will occur if the physician uses his/her “superior” knowledge to 
his/her benefit, driving use of health care resources to a higher level than would 
be the case if information was symmetric between agent and principal (McGuire 
2001, p.503). On the other hand, the patient may seek to engage in behaviour 
driving the consumption of health care.  A patient may, for example, simply opt 
for taking a pill for high cholesterol rather than engaging in lifestyle changing 
behaviour such as exercise and eating healthy. Thus, patient preference may 
impact demand for health care services from physicians. 
Moral hazard, as illustrated above, is but one outcome of the agency problem. 
Physician agency may also have an impact on public policy through mechanisms 
of adverse selection. In certain circumstances, it will be impossible to know what 
the physician did or knew (Pauley, 1978) at  the time of clinical decision making. 
This extreme form of informational asymmetry may lead to uninformed decisions 
by the principal, and adverse selection as a consequence (McGuire 2001, p. 498).  
It is widely stated that behaviour which is motivated by self-interest of the agent 
lies at the heart of the principal-agent problem (Eisenhardt, 1989). The physician 
is an “experience good”, as the patient cannot reliably measure quality of health 
care provided before it is experienced (Gaynor, 1994). Consequently, a patient 
will not know the quality of care before having experienced the care provided by 
the physician. McGuire (2001, p. 502) argues that learning is slow, and therefore 
the reward for quality is likely to be inadequate. Thus, the physician may be given 
room to adjust quality as an input factor (effort) according to prevailing 
motivations, including self-interest. Furthermore, credible evidence suggests that 
compensation arrangements with high degree of revenue sharing reduces 
physician effort (Gaynor and Gertler, 1995). 
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Since the introduction of the Hippocratic Oath in 4th century BC, ethics have 
played a central role in the practice of medicine. Physicians have autonomy in 
decision making on the basis of an understanding that they will act in the best 
interests of their patients (Arrow 1963). However, it has been argued that 
managed care may threaten the physician’s loyalty to the patient (McGuire, 2001 
p. 520). The physician is an agent for both the patient and the payer, potentially 
resulting in a loyalty conflict and cognitive dissonance. A payer can take 
advantage of the ethical constraints, imposing payment systems that force the 
physician to personally take on more of the effort to attain an acceptable outcome 
for the patient (Fugh-Berman and Ahari, 1997).  
In addition to ethics, legislation also plays a central role in the practice of 
medicine. Legal constraints limit choices, but may also drive behaviour leading to 
the practice of defensive medicine, which occurs when physicians practice 
medicine to protect themselves against litigation (Danzon, 2000). The practice of 
defensive medicine may drive demand for care higher than would otherwise be 
the case.   
4.2.2 Theory of Reasoned Action and Theory of Planed Behaviour 
Theory of reasoned action (TRA) is concerned with what determines intention. 
Intention to perform a certain action is a function of two factors: attitude and 
subjective norm (perception of importance). Determinants of attitude have been 
identified as: evaluation of belief and strength of belief (O'Keefe, 2002 pp. 103-
109). Perceived lack of ability may have an impact on intention to perform an 
action. In 1991, Ajzen revised the theory, and in so doing, added a third factor, 
perceived behavioural control, leading to the Theory of Planned Behaviour (TPB) 
(Ajzen, 1991). Persuasive efforts from a TRA perspective may take three forms: 
changing the attitudinal component, changing the normative component or the 
relative difference between the two (O'Keefe 2002, p.109).  
In a systematic review of health care professionals’ intentions and behaviours, 
Godin et al. (2008) included studies that aimed to predict health care 
professionals' intentions and behaviours, with a clear specification of relying on a 
social cognitive theory. This study shows that the theory most often used as 
reference was the Theory of Reasoned Action (TRA) or its extension, the Theory 
of Planned Behaviour (TPB); and the authors suggest that the TPB appears to 
be an appropriate theory to predict actual behaviour, whereas other theories 
better capture the dynamic underlying intention (Godin et al., 2008). The authors 
provide a hypothetical framework for studying health care professionals’ 
intentions and behaviours, as in Figure 4-2 Theoretical framework proposed by 
Godin (2008). The framework has explanatory power, as it provides a simple and 
credible explanation. However, it is not fully supported by the findings of DBA 
project 1, as physician characteristics in general, with the notable exception of 
physician-level habit persistence, have not been shown to influence physician 
prescribing behaviour. Furthermore, the framework lacks the provision for 
feedback, a central element of dynamic decision making central to medical 
decision making in general (Kleinmuntz, 1993). Finally, the proposed framework 




Figure 4-2 Theoretical framework proposed by Godin (2008) 
In a study designed to look at factors affecting antibiotic prescribing in a managed 
care setting, the authors found that behavioural intention was significantly 
correlated with both attitude and subjective norms, but was not predictive of 
actual choice  behaviour (Lambert et al., 1997). The authors thus posit that it is 
possible that choice behaviour is influenced by non-psychological factors. 
Furthermore, physician autonomy is challenged, and it can be argued that a 
system-level approach may be needed to yield a descriptive model of physician 
decisions. In concordance with this notion, it is found in this review that physician 
choice behaviour is best described using three theoretical lenses: Decision 
Theory, cognitive behaviour theory and Agency Theory.  
4.2.3 Decision Theory 
Several factors influence decision making, and understanding these factors helps 
understand the decision making process and potential outcomes. Because 
medical decisions have an impact on patient health, they should be of high quality 
(Klein 2005). However, medical practice is complex and time is often limited, 
leading to use of shortcuts to decisions, or heuristics. Unfortunately, the use of 
heuristics also brings with it some pitfalls (Klein 2005). Despite being highly 
trained, doctors are prone to making mistakes (Bornstein and Emler 2001). 
Cognitive biases may detract from the use of logical and statistical decision 
heuristics (Hershberger et al. 1994).  
Decision making is important in medical practice, and because health outcomes 
are probabilistic, most decisions are made under conditions of uncertainty 
(Kaplan and Frosch 2005). Medical science has not yet solved the uncertainty 
surrounding many medical decisions (Gillett 2004) and is the least developed 
aspect of evidence-based practice (Spring 2008). Furthermore, uncertainty has 
been characterized as the most important factor influencing physician behaviour 
(Arrow 1963). Thus, understanding the role of uncertainty is central to 
comprehending decision processes in medical decision making.  
Decision theories are developed to explain decisions under three main conditions 
of consequence of choice: certainty, risk and uncertainty. Decision under 
certainty applies when all decisions will lead to only one consequence. Decision 
under risk applies when a choice will have one of several possible consequences 
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and the probabilities of the consequences are known (Heylighen 2010). Contrary 
to decision under risk, decision under uncertainty applies when a choice will have 
one of several possible consequences, but the probabilities of the consequences 
are not known.  
Decision theories fall into two main categories - normative and descriptive. 
Normative or prescriptive theories are based on idealized situations where a 
decision can be fully rational and all probabilities calculated. Descriptive theories 
work on the principle that people do not necessarily follow axioms, and thus 
describe what people do rather than focus on optimality. Evidence-based 
medicine is concerned with integrating individual clinical expertise and the best 
available external evidence (Sackett et al. 1996); and works on the basis of 
known probabilities (Kaplan & Frosch 2005). However, in a knowledge-for-critical 
evaluation project, Greenfeld et al (2007) address the usefulness of the results of 
randomized controlled trials for clinical and policy application. The authors 
conclude that the evidence includes patients who may have minimal benefit and 
that generalization to patients excluded from the study may result in 
overtreatment.  
Thus, it could be argued that the axioms of evidence-based medicine may be 
invalid in individual treatment decisions, and consequently, normative decision 
theories explaining decisions under risk may be not be applicable in medical 
decision making. Further support is provided by (Eddy 1994) in that clinicians 
often disagree about appropriate action in similar clinical situations. In addition, 
there is evidence to support large geographical variations in the use health care 
(Wennberg et al. 2002;Wenneberg et al. 2004), and that this variation does not 
result in the same variation in patient outcomes (Fisher et al. 2003). This leaves 
descriptive theories as a possible framework for medical decision making. 
However, evidence based theories are not abundant, and the lack thereof to 
support medical decision making has led to clinical approaches and decisions 
tools being based on assumptions - and these assumptions have been 
challenged by behavioural research (Reyna 2008b). Modern theories supported 
by empirical evidence differ in their views of risky decision making, behavioural 
change, health promotion and medical decision making (Reyna 2008b). Three 
such theories have recently been gaining recognition:  theory of reasoned action 
and its extension the Theory of Planned Behaviour, the trans-theoretical model 
and fuzzy trace theory.  
4.2.4 Personal Construct Theory  
The overall aim of this research project is to improve our understanding of the 
physicians’ perception of quality in healthcare. In this research project the author; 
therefore turn to physicians as the experts. Physicians are actively engaged in a 
profession that involves diagnosing and treating patients. Thus, the aim of the 
project is to comprehend how physicians construct the notion of quality in health 
care in order to extend our understanding of quality of health care delivery from 
the perspective of a key stakeholder group search and compare their experience. 
Exploring perceptions has involved the use of qualitative interview methods with 
researcher-generated statements, which are prone to issues in interpretation. 
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The interviewers’ intended meaning of a question may not reflect the 
interviewees’ understanding and interpretation of their world experience. 
Overcoming these issues in a clinical setting is a challenge; however, a method 
that may address these issues is the repertory grid technique. The repertory grid 
technique is of interest because it provides an opportunity of obtaining an 
understanding of how the physicians see and judge their own reality while 
minimizing the risk of influence by the interviewer. It also provides the ability to 
use real patient cases provided by the respondents in the study, which is 
appropriate considering the special knowledge of patient care that physicians 
have. 
In the context of uncertainty, information asymmetry and lack of a grand theory 
of medical decision, the repertory grid technique has been adopted to elicit 
embedded constructs related to how physicians perceive quality of health care 
delivery. However, in order to explain the repertory grid technique and why it is 
legitimate to use for the purpose of this study, it is important to address the 
underlying philosophical and theoretical assumptions inherent in the personal 
construct theory underpinning the development of the repertory grid interview 
technique (RGT). 
Personal construct theory (PCT) is a psychological theory of personality, 
developed by George Kelly in the 1950’s. PCT is based on the philosophical 
assumption that “…whatever nature may be, or howsoever the quest for truth will 
turn out in the end, the events we face today are subject to as great a variety of 
construction as our wits will enable us to contrive” (Kelly, 2003 p. 3). Based on its 
philosophical assumption, PCT falls in the category of experiential epistemology. 
This is in contrast to its use in psychology, where a positivist preference exists 
(Jankowicz, 2004 p. XVII). This has led to a heated debate addressing the utility 
of PCT, where proponents of qualitative methods have been pitched against 
those favouring quantitative methods. However, RGT as a tool for understanding 
all epistemologies has largely been neglected (Jankowicz, 2004 p. XVIII). 
The basic postulate of PCT is: “A person’s processes are psychologically 
channelized by the ways in which he anticipates events” (Kelly, 2003 p. 7). In his 
writing, Kelly puts great emphasis on anticipation and prediction as drivers of the 
human mind (Kelly, 1955, Kelly, 1963, Kelly, 2003). “Each person 
characteristically evolves, for his convenience in anticipating events, a 
construction system embracing ordinal relationships between constructs” (Kelly, 
2003 p. 9). In other words, constructs have two extremes such as good-bad. 
These constructs can be said to exist at a low level of awareness. Persons, 
events and circumstances are characterized by the construct and the position it 
is given within the limits of a particular construct. According to Kelly (2003), 
people construe reality by ‘constructing constructs’. Thus, eliciting personal 
constructs related to persons, events or circumstances would help understand 
how a person perceives reality. This led Kelly to develop the repertory grid 
technique in order to uncover the personal constructs. 
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4.2.4.1 Repertory Grid Technique 
The repertory grid technique is a semi structured interview technique devised by 
George Kelly in the 1950’s to elicit personal constructs. The grid consists of four 
components: a topic, elements, constructs and rating of constructs and elements 
(Jankowicz, 2004 p. 10). The topic is about some parts of a person’s experience. 
“As with other topics with which it deals, personal construct theory attempts to 
define psychological constructs in terms of the personal experience of the 
individual to which they are to be applied” (Kelly, 2003 p. 19). Elements are 
examples or instances of the topic. Constructs can be understood as basic terms 
used to make sense of the elements. Rating is done using a five or seven point 
Likert like scale, capturing the position within constructs.  
Elements are defined as: “the things or events which are abstracted by a 
construct” (Kelly, 1955 p. 95) and are formal aspects of constructs (Fransella et 
al., 2003 p. 15). Thus, it follows that constructs have formal aspects and are 
therefore more difficult to define. However, the most important aspect of a 
construct is that it is bipolar (Fransella et al., 2003 p. 15). Kelly states six 
assumptions for valid constructs (Fransella et al., 2003 p. 23): 
1. The constructs elicited should be permeable 
2. Pre-existing constructs should be elicited 
3. The verbal label attached to the construct should be communicable 
4. It should represent the subject’s understanding of right and wrong 
5. Respondents should not dissociate themselves from constructs or 
elements 
6. Elicited constructs should be bi-polar 
 
The repertory grid technique elicits personal constructs with minimal intervention 
or interpretation by the researcher, thus surfacing embedded assumptions about 
a topic. It is a technique that is useful to understand how a person thinks about a 
topic based on his/her personal experience. Repertory grid technique has been 
adapted since Kelly’s work, and used to study different aspects in many areas of 
society too numerous and outside the context of this paper. For a detailed review, 
see Fransella et al. (2003) pp. 168-229. However, the repertory grid technique 
has been widely used to study a large variety of fields of management and 
medicine: organizational issues (Stewart and Stewart, 1981), human resource 
development (Easterby-Smith, 1980), operations (Goffin et al., 2006), 
manufacturer- supplier relationships (Szwejczewski et al., 2005), marketing 
(Mardsen and Littler, 1998), adolescent smoking (Lynch, 1995), low back pain 
(O'Farrel et al., 1993), quality of life (Kendrick et al., 1994), angina pectoris (Rowe 
et al., 1982), varicose veins (Baker, 1996), risk behaviour (Okoroh et al., 2006), 
prescription behaviour (Taylor and Bond, 1991) and effectiveness of medical 
interventions (Vogt et al., 2010). Thus, applying the repertory grid technique to 
questions related to medicine is widely accepted.    
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4.2.5 Definition of Quality of Health Care Delivery 
Before discussing the findings of the study, it is important to define quality of 
health care delivery. Several authors and institutions have made attempts at 
defining quality in health care. Below are listed seven examples of definitions.  
“That which consistently contributes to improvement or maintenance of the 
quality and/or duration of life.” American Medical Association (1986) 
“That kind of care which is expected to maximize an inclusive measure of 
patients’ welfare, after one has taken account of the balance of expected 
gains and losses that attend the process of care in all ill parts.” 
(Donabedian, 1966, Donabedian, 1979, Donabedian, 1988, Donabedian, 
2005) 
“Clinically effective, personal and safe.” High Quality Care for All: NHS 
Next Stage Review, Final Report (2011). 
“Quality of care is the level of attainment of health systems’ intrinsic goals 
for health improvement and responsiveness to legitimate expectations of 
the population.” World Health Organisation (2000) 
“The degree to which health services increase the likelihood of desired 
health outcomes and are considered consistent with current professional 
knowledge.” Institute of Medicine (2000) 
“Health care should be safe, effective, patient-centred, timely, efficient and 
equitable.” Quality Chasm Report, Institute of Medicine (2011) 
“Medical quality is the degree to which health care systems, services and 
supplies for individuals and populations increase the likelihood for positive 
health outcomes and are consistent with current professional knowledge.” 
American College of Medical Quality (2011) 
It is clear that a global or unified definition of quality of health care does not exist. 
Human health is dynamic and represented by individuals carrying unique 
expectations. Thus, global objective measures of health quality may be 
impossible. However,  according to Glickman et al. (2007) p. 342, and Peabody 
et al. (2006) p. 1294, Donabedian (1978) has defined three elements of quality: 
“Structure refers to stable, material characteristics (infrastructure, tools, 
technology) and the resources of the organizations that provide care and 
the financing of care (levels of funding, staffing, payment schemes, and 
incentives). 
Process is the interaction between caregivers and patients during which 
structural inputs from the health care system are transformed into health 
outcomes. 
Outcomes can be measured in terms of health status, deaths, or disability-
adjusted life years—a measure that encompasses the morbidity and 
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mortality of patients or groups of patients. Outcomes also include patient 
satisfaction or patient response.” 
At the core of clinical medicine is the decision making process leading to 
diagnosis and treatment for individual patients and populations. The American 
College of Medical Quality has defined the medical decision process:  
“The medical decision-making process used in medical quality 
management reflects a consensus of opinion of clinical judgment that is 
supported by published peer reviewed scientific literature.” American 
College of Medical Quality (2011) 
The definition of the decision-making process makes it reasonable to assume 
that the process is as dynamic as is medical quality. Each physician-patient 
encounter is a unique experience for both the patient and the physician. 
Aggregation of experiences over time may therefore form constructs defining 
future outcome expectations. The variation created by different encounters may 
thus create a unique set of perceptions of quality for both the patient and the 
physician. However, since concordance in general is low (Stevenson et al., 2004), 
the physician is the main decision maker. As such, the physician’s perception 
represents a window into the “moment of truth” (Sokol, 2010) in health care 
delivery, and is therefore the chosen level of measurement in this study.  
4.3 Methodology 
From the literature reviewed, it is clear that an empirical study is warranted to 
investigate how physicians construct quality of health care delivery. Thus, the 
research question formulated for this study was: 
How do physicians construct quality of health care delivery in a hospital 
setting? 
4.3.1 Description of the Method 
Repertory grid technique is based on Kelly (1955) personal construct theory, and 
is used to elicit a personal description about an aspect of a person’s reality. Kelly 
was a psychologist, so the methodology was primarily designed for use in 
psychology (Fransella et al., 2003 p. 170). For an overview of its use in 
psychology, see (Winter, 2003). Repertory grid has also been used in other fields; 
for a detailed review, see Fransella et al. (2003) pp. 168-229.  
In this study, repertory grid is used to gain a deeper understanding of physicians’ 
perceptions of quality of health care delivery. In particular, repertory grid is used 
to identify the constructs physicians employ in characterizing quality in health 
care delivery. 
The grid consists of four components: a topic, elements, constructs, and rating of 
constructs and elements (Jankowicz, 2004 p. 10). The topic concerns some parts 
of a person’s experience. “As with other topics with which it deals, personal 
construct theory attempts to define psychological constructs in terms of the 
personal experience of the individual to which they are to be applied” (Kelly, 2003 
p. 19). Elements are examples or instances of the topic. Constructs can be 
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understood as basic terms used to make sense of the elements. Rating is done 
using a five or seven point Likert like scale, capturing the position within 
constructs.  
4.3.2 Conducting of the Repertory Interview 
The interviews are conducted using the repertory grid technique based on Kelly’s 
Personal Construct Theory (Kelly, 1955). This technique involves a form of 
structured interviews and has been found to be a powerful tool in management 
research (Goffin, 2002). Furthermore, the technique is useful for limiting jargon 
and social desirability (Goffin, 2002, Szwejczewski et al., 2005, Lemke et al., 
2011). Repertory interview technique requires familiarity and skills similar to those 
needed to conduct interviews. 
The operationalization follows Goffin (2002) by using six elicited “elements“. Two 
basic methods for selecting elements exist: supplied and elicited. Supplied 
elements are provided by the researcher, whereas elicited elements are provided 
by the respondent. In addition, there are several rules for selecting supplied or 
elicited elements: 
 Elements must be discrete (Stewart and Stewart, 1981)  
 Elements must be homogeneous (Easterby-Smith, 1980) 
 Elements must not be evaluative (Stewart and Stewart, 1981) 
 Elements should be representative of the area to be investigated (Beail, 
1985, Easterby-Smith, 1980) 
 
Reger (1990) proposes three main reasons for why a researcher may want to 
supply elements. Firstly, the researcher may wish to learn more about a given set 
of elements from various respondents. Secondly, theory may guide the choice of 
elements. Finally, the researcher may wish to compare responses within a group 
or across groups. The latter instance will require a uniform set of elements to 
make cross group comparisons possible. 
In this study, elicited elements are employed as the basis for understanding how 
physicians think about quality of health care delivery. Each respondent is asked 
to provide two examples of patient encounters where the respondent was 
involved and where he/she was very satisfied with the quality of health care 
delivery, two examples of patients encounters where the respondent was 
involved and where he/she was medium satisfied with the quality of health care 
delivery, and two examples of patients encounters where the respondent was 
involved and where he/she was unsatisfied with the quality of health care delivery. 
Each of the six elements are written down on randomly numbered cards by the 
respondents and presented to the respondents by the researcher during the 
interview.  
Using the triad method from (Kelly (1955), Kelly (1963)), as described by 
Fransella et al. (2003), the interviewer presents the respondent with three cards 
asking: “How are two of these similar and different from the third in terms of quality 
of health care delivery?” The results are captured on a data capture sheet 
(repertory grid) by the researcher; please see Table B-5 Repertory Grid. Each 
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captured response results in a bi-polar construct; for example, construct “patient 
adapted communication” and construct pole “patient un-adapted 
communication”. The construct pole is elicited by asking what the respondent 
feels is the opposite of the construct. 
After the meaning of the constructs has been discussed, the respondent is asked 
to rate all six elements on a 5-point Likert scale (Fransella et al., 2003), where 1 
represents the construct and 5 represents the construct pole. The process is 
repeated by the researcher by presenting the respondent with another set of three 
cards restating the original question. The respondents are encouraged not to 
repeat constructs which have already been elicited. This process continues until 
further constructs can no longer be elicited or the time limit of 60 minutes has 
expired. The use of fresh triads ensure variation and has been shown to facilitate 
the uncovering of unconscious constructs (Bender, 1975).  
A given construct is also used to gain information about the overall quality of each 
of the elements. The respondents are asked to rate the elements on the same 
Likert scale, where 1 represents “Overall quality of care delivered was high” and 
5 represents “Overall quality of care delivered was low”.  
4.3.3 Analysis of Repertory Grid  
Repertory grids analysis may adopt a qualitative and/or quantitative approach. 
The fundamental task is to identify the respondents’ meanings and implications 
for the research being conducted. The focus of the data in this study is to 
characterize how physicians perceive quality of health care delivery. Therefore, 
the relevant analysis of the repertory grids in this study is primarily quantitative in 
nature, focusing on standardization of construct, categorization of constructs and 
identification of key constructs.  
Some constructs will be provided by more than one respondent, and therefore 
appear in more than one grid. The grids are examined by the researcher to 
identify repetition of constructs, resulting in standardization of constructs. 
Standardized constructs are categorized by the researcher and used for 
characterization of constructs. Construct characterization involves identification 
of key constructs and their importance with respect to the aim of the study 
(Jankowicz, 2004 pp. 77-88).  Construct characterization and identification of key 
constructs is accomplished by employing frequency counts and average 
normalized variability, as described by (Goffin, 2002, Goffin et al., 2006). 
Frequency is considered an indication of importance; however, frequency alone 
may simply indicate that it is obvious. The threshold for key construct was set at 
25 % responder mention (Lemke et al., 2003). Variability is another indication of 
importance, as constructs with wide spread of ratings strongly differentiate 
among the elements. Variability is dependent on the number of constructs in an 
individual grid, so variability figures from grids with different numbers need to be 
normalized (Goffin et al., 2006 p. 19). Normalization is achieved by multiplying 
the variability of each construct by the number of constructs in an individual grid 
and dividing by the average number of constructs across all respondents, yielding 
a normalized variance (NV). Average normalized variability (ANV) is calculated 
using SPSS 19.1, employing the following formula (Goffin et al., 2006 p. 19): 
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ሺ1ሻ	ܸܰ ൌ ܸܽݎ	ܥ	ݔ	ܰܯ݁ܽ݊	ܥ/ܴ 
Equation 4-1 Normalized variance 
In this sample, the average number of constructs per respondent was 8.4, so the 
formula for NV in this sample can be reduced to: 
 
ሺ2ሻܸܰ ൌ ൬ ܸܽݎ	ܥܶ݋ݐ	ܸܽݎ	൰ ݔ
ܰ
8.4 
Equation 4-2 Normalized variance for this sample 
Converting to NV (%) yields: 
 
ሺ3ሻܸܰ	ሺ%ሻ ൌ ൬ ܸܽݎ	ܥܶ݋ݐ	ܸܽݎ	൰ ݔ
ܰ
8.4 ݔ	100 
Equation 4-3 Normalized variance (%) 
Average normalized variance (ANV) % is derived by calculating the sum of all NV 
(%) across all respondents and dividing by the total number of mentions. For 
clarity of NV (%) calculations used in this study, a worked example of the first grid 
is provided below. 
4.3.3.1 Worked Example Based on Individual Grid (Grid Number 1) 
In this example, construct # 1 (Construct label: Time) is used from the Table 4-1 
Grid number 1. The variance across all elements (E1-E6) is 2.57 and the sum 
variance in the grid is 13.47, the number of constructs in the grid is 8 and average 
number of constructs in the sample is 8.4. Thus, the NV (%) using formula (3): 
	




ܸܰ	ሺ%ሻ ൌ 18.17	% 
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Table 4-1 Grid number 1 
# Construct 
Label 
Construct  E 1 E 2 E 3 E 4 E 5 E 6 Construct 
Pole 
VAR NV % 
1 Time Long 
treatment 
period 




2 Continuity Disrupted 
treatment 










































of past  
2 4 2 5 1 3 Focus on 
present 
2.17 15.32 
7 Context Family 
context 
important 
2 2 2 4 2 2 Family 
context not 
important 
0.67 4.71  











The overall advantage of the repertory grid is its flexibility, as it can be used for 
many different purposes (Jankowicz, 2004 p. 27). It constitutes a method for 
surfacing low awareness verbalization of how a respondent makes sense of a 
topic of interest without imposing the researcher’s perspective. However, as with 
most research, repertory grid technique is also prone to researcher bias (Goffin, 
2002). Furthermore, the technique may prove to be complicated and difficult to 
understand for the respondent. Several methods for analysis of repertory grid 
exist, but the problem related to data loss when aggregating across grids remains 
(Jankowicz, 2004).  
Analysis of a repertory grid using the approach outlined above gives information 
about “how to say something about the different meanings being expressed in a 
set of grids, making general statements about the sample as a whole, while 
reflecting the particular meanings being offered by individual interviewees as they 
express their personal and, at times, idiosyncratic knowledge” (Jankowicz, 2004 
p. 169). However, by employing this approach, information about what the 
individual respondent was saying about the topic is lost. By using Honey’s (1979) 
content analysis, it is possible to aggregate different constructs across a sample, 
and this approach provides a way in which some of the individual meanings being 
conveyed by each respondent’s ratings can be used (Jankowicz, 2004). Thus, 
the respondents are also asked to rate each of the constructs on a Likert scale, 
where 1 represents “Overall more important” and 5 represents “Overall less 
important”. The Honey content analysis is described in detail in (Jankowicz, 2004 
pp. 169-177). In brief, it aggregates constructs across the sample by employing 
an overall score of quality. 
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4.4 Results 
In this section, the results of research project two are provided. First, the results 
from the pilot study are presented, before sample and data collection is 
addressed. Finally, a section on data analysis is included.    
4.4.1 Pilot Study 
The interview guide was piloted and amended before being employed in the study 
setting. The pilot study was conducted using the interview guide from the 
protocol. A total of three 90 minutes interviews were performed, following the 
protocol. The interviews were recorded and transcribed in Norwegian. During a 
meeting between the researcher and three academics (study panel) on July 4th 
2012, the interview guide was discussed and finally agreed upon, based on the 
experience and results from the pilot.  
Two main areas of concern surfaced. First, to what extent did the process for 
elicitation of elements work as envisaged? The pilot uncovered that it took 
between 10 and 15 minutes for the respondent to write down enough information 
on the supplied cards to be confident that they could remember and distinguish 
the cases from each other during the interview process. However, an average of 
more than 8 constructs were elicited, and it was felt that this would be sufficient 
(Goffin, 2002). Second, how well did the respondent understand the technique? 
The standard explanation in the guide worked for the technique. However, the 
original question, “How are two of these similar and at the same time different 
from the third?”, did not contain enough information to get the respondents to 
focus on quality of health care delivery. Therefore, the question was changed to: 
“How are two of these similar and at the same time different from the third, with 
respect to quality of health care delivery?” 
4.4.2 Sample 
The aim of the study was to include 30 physicians across different specialties in 
a university hospital. In total, 70 physicians were invited to participate in the study, 
and 43 accepted the invitation. Due to demand for physicians’ services in the 
clinic, it was difficult to coordinate the attendance of physicians with the 
researchers schedule during the study period (September 2012 to October 2012). 
Several physicians required rescheduled appointments a number of times, and 
only about 40 % (27) of the scheduled appointments by the researcher were 
eventually used for data collection.  
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Table 4-2 Respondents nominal data 
ID # Date Time Gender Age (years) Specialty 
1 12/09/12 14:30 Female 55 Psychiatry 
2 13/09/12 11:30 Male 53 Anaesthesiology 
3 14/09/12 13:00 Male 55 Surgery (ENT) 
4 18/09/12 14:30 Female 46 Infectious diseases 
5 18/09/12 16:00 Male 58 Geriatrics 
6 02/10/12 10:30 Male 43 Oncology 
7 02/10/12 13:00 Male 60 Cardiology 
8 02/10/12 15:00 Male 52 Pulmonology 
9 04/10/12 10:00 Female 36 Intern (general medicine) 
10 05/10/12 10:30 Male 58 Cardiology 
11 17/10/12 09:30 Male 50 Infectious diseases 
12 17/10/12 12:00 Female 33 Intern (general medicine) 
13 22/10/12 12:30 Male 53 Neurology 
14 22/10/12 14:00 Male 66 Gastroenterology 
15 23/10/12 14:30 Male 70 Infectious diseases 
16 24/10/12 08:00 Male 60 Pulmonology 
17 25/10/12 09:30 Male 63 Haematology 
18 25/10/12 11:00 Male 65 Cardiology 
19 26/10/12 09:00 Male 37 Intern (general medicine) 
20 26/10/12 10:30 Male 54 Paediatrics 
21 26/10/12 13:30 Male 53 Psychiatry 
22 29/10/12 11:00 Male 51 Anaesthesiology 
23 29/10/12 12:30 Male  47 Anaesthesiology 
24 29/10/12 14:00 Male 34 Intern (general Medicine) 
25 01/11/12 9:30 Male 32 Intern (general Medicine) 
26 02/11/12 11:30 Female 60 Cardiology 
27 02/11/12 14:00 Female 46 Neurology 
A sample of 27 physicians across four clinical divisions (medicine, paediatrics, 
psychiatry and surgery) at a university hospital in Norway was used. 
Respondents covered a spread of gender, age and medical specialties, ensuring 
extensive experience with patient care in a hospital setting; please see Table 4-2 
Respondents nominal data. All the respondents were native Norwegian 
speakers. Respondents were invited to participate through a structured invitation 
in Microsoft Outlook, including a copy of the consent form (see Appendix B.1.14 
Written consent form in Norwegian on page 342). The written and signed consent 
forms will be stored for 5 years, in accordance with hospital and university 
regulations. 
4.4.3 Data Collection: Operationalization of the Repertory Grid 
Technique 
The interviews were conducted using the repertory grid technique based on 
Kelly’s Personal Construct Theory (Kelly, 1955). This technique involves a form 
of structured interviews and has been found to be a powerful tool in management 
research (Goffin, 2002). Furthermore, the technique is useful for limiting jargon 
and social desirability (Goffin, 2002, Szwejczewski et al., 2005, Lemke et al., 
2011). 
The operationalization followed Goffin (2002) by using six elicited “elements”. 
Each respondent was asked to provide two examples of patient encounters 
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where the respondent had been involved and where he/she was very satisfied 
with the quality of health care delivery, two examples of patients encounters 
where the respondent had been involved and where he/she was medium satisfied 
with the quality of health care delivery, and two examples of patients encounters 
where the respondent had been involved and where he/she was unsatisfied with 
the quality of health care delivery. Each of the six elements was written down on 
randomly numbered cards by the respondents and presented to the respondents 
by the researcher during the interview.  
Using the triad method from (Kelly (1955), Kelly (1963)), as described by 
(Fransella et al., 2003), the interviewer presented the respondents with three 
cards, asking: “How are two of these similar and different from the third in terms 
of quality of health care delivery?” The results were captured on a data capture 
sheet (repertory grid) by the researcher; please see Table B-5 Repertory Grid. 
Each captured response resulted in a bi-polar construct; for example, construct 
“patient adapted communication” and construct pole “patient un-adapted 
communication”. The pole was elicited by asking what the respondent feels is the 
opposite of the construct. 
After the meaning of the constructs had been discussed, the respondents were 
asked to rate all six elements on a 5-point Likert scale (Fransella et al., 2003) 
where 1 represents the construct and 5 represents the construct pole. The 
researcher then repeated the process by presenting the respondent with another 
set of three cards restating the original question. The respondents were 
encouraged not to repeat constructs which had already been elicited. This 
process continued until further constructs could no longer be elicited or the time 
limit of 60 minutes expired. The use of fresh triads ensures variation and has 
been shown to facilitate the uncovering of unconscious constructs (Bender, 
1975).  
A given construct was also used to gain information about the overall quality of 
each of the elements. The respondents were asked to rate the elements on the 
same Likert scale where 1 represents “Overall quality of care delivered was high” 
and 5 represents “Overall quality of care delivered was low”.  
Analysis of a repertory grid using the approach outlined above gives information 
about “how to say something about the different meanings being expressed in a 
set of grids, making general statements about the sample as a whole, while 
reflecting the particular meanings being offered by individual interviewees as they 
express their personal and, at times, idiosyncratic knowledge” (Jankowicz, 2004 
p. 169). However, by employing this approach, information is lost concerning 
what the individual respondent was saying about the topic. By using Honey’s 
(1979) content analysis in addition to traditional bootstrapping, it is possible to 
aggregate different constructs across a sample, and this approach provides a 
way in which some of the individual meanings being conveyed by each 
respondents’ ratings can be used (Jankowicz, 2004). Thus, the respondents were 
also asked to rate each of the constructs on a Likert scale where 1 represents 
“Overall more important” and 5 represents “Overall less important”.  
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4.4.4 Data Analysis 
The interviews produced rich and copious qualitative and quantitative data, 
captured on pre-prepared grids, and tape recording (Olympus DM-550 digital 
recorder) of the interviews and workshops. Recordings were transcribed in 
Norwegian and selected quotes were translated into English for reporting 
purposes by the researcher (native Norwegian speaker). One interview was 
translated in full by the researcher as a base for discussion with the study panel. 
Data analysis closely followed (Goffin et al., 2006) and also included elements 
from Lemke et al. (2011). 
4.4.4.1 Standardization of Constructs 
Some constructs were provided by more than one respondent, and therefore 
appeared on more than one grid. The grids were examined by the researcher to 
identify repetition of constructs.  
4.4.4.2 Categorization of Constructs 
These constructs were categorized into 33 categories, using multiple coders and 
inter-coder reliability checks according to Lemke et al. (2011). Inter-coder index 
was calculated as a percentage of agreement of allocation of the constructs 
between coders. The coders (1 & 2) agreed on the placement of 168 out of 227 
constructs. The inter-coder index was calculated by taking the number of 
constructs with agreed placement (168), dividing by the total number of 
constructs (227) and finally multiplying by 100 to yield an inter-coder index of 
74%.   
4.4.4.3 Identification of Key Constructs 
The most important constructs were identified using frequency count and average 
normalized variability, following the methodology of Lemke et al. (2003) and 
Goffin et al. (2006). The threshold for key construct was set at 25 % responder 
mention (Lemke et al., 2003). However, frequency of mention is widely stated not 
to be sufficient to identify key constructs. Variability is stated to be related to how 
important a given construct is to the respondent. A high degree of variability 
indicates that the respondent differentiated between the elements and that the 
construct is therefore more important. Thus, further selection based on variability 
was performed. Variability for each construct was calculated using Idogrid 2.4 
and normalized by employing the methodology described by Goffin et al. (2006). 
Average normalized variability was calculated using SPSS 19.1. The average 
number of constructs elicited per respondent was 8.4. So, the average variability 
in the sample is 100/8.40 = 11.90. Constructs with ANV above 11.90 were 
considered key constructs if the 25 % responder mention threshold was met. 
4.4.4.4 Honey’s Content Analysis 
Data on overall importance was also collected in order to be able to maintain 
information on an individual level through bootstrapping. The methodology was 
first employed by Honey (1979) and is described in detail in Jankowicz (2004) p. 
169-180. In brief, Honey’s content analysis is based on two basic assumptions. 
First, elicited constructs express personal ways by which each respondent 
understands the supplied construct. Second, this personal meaning can be 
expressed as a matter of degree. For each interviewee, the sum of differences 
 187 
between the ratings of the elements on each elicited construct, and the ratings of 
the elements on the supplied construct, are computed and transformed to % 
similarity scores. “Honey’s procedure acknowledges that % similarity scores are 
relative, and as well as noting their actual percentage value” (Jankowicz, 2004 p. 
171). The researcher then divides the result into three equal groups and denotes 
them high, intermediate or low (H-I-L) values.  
4.5 Findings 
The researcher, a native Norwegian speaker, conducted 27 interviews in the 
months of September and October 2012. Over 27 hours of interview data 
employing repertory grid technique were collected. Elements were elicited from 
the respondents, and this process accounts for approximately 20 % of the 
interview time. The average number of constructs elicited from each respondent 
was 8.4.      
4.5.1 Full Construct Listing  
From the 27 interviews, a total of 227 constructs were elicited. Several of the 
constructs were common, as they were mentioned by several respondents. In 
total, 14 constructs were mentioned by 7 (> 25%) or more respondents. Table 
4-3 Collation of constructs and label generation is an example of how the 
constructs were collated and labels generated. 
Table 4-3 Collation of constructs and label generation 
ID Construct label Poles Example quote Freq 




“Patient X was admitted to intensive care with a SAPS score of 65% 
which also indicates he risk for mortality. In this case the things went 
according to plan and we managed to get a firm diagnosis right away 
and start correct therapy early. The consequence was that the 
patient could be discharged alive.”  “Patient X was also admitted to 
intensive care. Management had decided that the day the 
experienced intensive care physicians would assist in operations 
leaving less experienced physicians in charge. The result was a 
delay in diagnosis and consequently treatment. The consequence 
was several more respirator days for the patient. This could have 
been avoided if the diagnosis had been made right away.” 
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The full construct listing is provided in Table B-4 Full listing. The constructs were 
grouped into categories, employing “bootstrapping” (Holsti, 1968) as a 
methodology for content analysis, and were further refined for use with the 
repertory grid technique of Jankowicz (2004) and Goffin and Koners (2011).  
The 227 constructs were written on separate 3M post-it cards, including the 
construct term, construct poles and a representative quote. The first 
categorization was the result of a categorization performed by Coder 1 
(researcher). The post-it cards were categorized by coder, thus generating a 
rough categorization. Each of the constructs was the subject of re-evaluation by 
the coder before yielding a final category scheme for the constructs. Each 
construct was given a name and defined. The result was a category scheme with 
names (labels), definitions and constructs allocated to each of the categories.  
The next step was to involve a scholar (medical doctor), Coder 2, who had not 
been involved in the primary research. The scholar was given a list of categories 
with names and definitions and asked to categorize each of the constructs into 
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the categories. The researcher and Coder 2 discussed the differences and 
refined the allocation to categories and category definitions. Inter-coder reliability 
index was 74%, as the researcher and coder 2 agreed on the allocation of 168 of 
the 227 constructs; please refer to Section 4.3.3.1 on page 181 for further details 
on method for calculation. Inter-coder reliability index was comparable to that 
found by Lemke et al. (2011) p. 856, and further iterations of the process were 
therefore not performed. 
4.5.2 Key Constructs 
Key constructs were identified employing the methodology of Goffin et al. (2006). 
The lower limit threshold for key constructs was set at a mention by a minimum 
of 25% (25 % of 27 = 7) of the respondents. In addition, for key constructs, an 
average normalized variability (ANV) threshold above average was set, which for 
this study corresponds to an ANV greater than 11.90. Idogrid 2.4, SPSS 19.1 and 
Microsoft Excel 2010 were used for the calculations. 
The findings show that 11 of the 33 constructs met the criteria for lower threshold 
> 25% and ANV > 11.90; please see Table B-3 Construct categories for 
explanations and further details. The remaining constructs did not meet the 
criteria of key constructs, as the ANV was less than 11.9. This finding shows that 
although these constructs were mentioned by more than 25 % of the 
respondents, they do not differentiate strongly  
Data on overall importance were also collected in order to be able to maintain 
information on an individual level through bootstrapping. The methodology was 
first employed by Honey (1979) and is described in detail in Jankowicz (2004) p. 
176. The cross tabulation of key constructs against overall importance gives the 
reader a chance to see the distribution of scores across the constructs; see Table 
4-4 Cross tabulation of construct label * overall importance. 
Theoretical saturation was evaluated by calculating the cumulative number of 
constructs elicited by the cumulative number of respondents (modified Lorenz 
curve); please see Figure 4-3 Theoretical saturation for a graphical 
representation. New constructs did not emerge beyond respondent 17, as shown 
in Table B-6 Theoretical saturation. Thus, theoretical saturation was reached, and 
further sampling beyond the 27 respondents was not deemed necessary.  
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Table 4-4 Cross tabulation of construct label * overall importance 




Total 1 2 3 4 5 
Construct Label Acute disease 2 3 1 0 1 7
Clear presenting problem 1 2 2 0 2 7
Communication 7 4 2 0 0 13
Comorbidity 1 2 0 0 0 3
Competency 8 11 0 0 0 19
Complexity 3 2 1 2 0 8
Context 0 3 0 0 3 6
Continuity 8 6 1 2 0 17
Coordination and logistics 3 3 0 0 0 6
Correct interpretation 7 1 1 0 0 9
Decision base 1 0 1 0 0 2
Disease severity 2 2 2 2 0 8
Early diagnosis and treatment 13 3 2 0 0 18
Effect of therapy 4 3 4 1 0 12
Information 2 1 0 3 0 6
Intervention 0 0 4 0 0 4
Patient activate transfer 1 5 4 2 1 13
Patient adherence 1 2 1 0 0 4
Patient driven 1 5 2 1 0 9
Physician-patient relationship 2 4 3 0 0 9
Resource availability 7 10 2 1 0 20
Resource control 0 1 0 0 0 1
Resource utilization 0 2 3 0 1 6
Responsibility 1 2 0 0 0 3
Risk 1 1 0 0 0 2
Team approach 1 2 0 0 0 3
Time 3 3 3 0 0 9
Total 80 83 39 14 8 227
	 
 























4.5.3 Explanation of Constructs 
In this section, a detailed explanation of each of the key constructs is provided. 
Please also see Table B-7 Key constructs on page 364 for a summary.  
4.5.3.1 Communication 
Emphasis on patient communication in clinical medicine is growing, but a clear 
definition is elusive. However, participants in the Bayer–Fetzer Conference on 
Physician–Patient Communication in Medical Education reached a consensus 
statement on essential elements of communication in medical encounters 
(Makoul, 2001). The consensus includes 6 main elements: open the discussion, 
gather information, understand the patients’ perspective, share information, 
reach agreement on problem and plan, and provide closure.  
Three aspects of communication are included in the findings of this study: 
physician-patient, physician-physician and technology. When addressing 
communication in the context of quality of health care delivery, physician 
perspectives are related to the quality of communication (good quality – poor 
quality) and are best exemplified by the following quote: 
"It was very easy to get contact with this patient. The patient had a good 
understanding of his condition and was able to communicate his 
symptoms clearly. This other patient had a poorly developed vocabulary 
and did not understand that the symptoms were related to disease. It was 
very difficult to get through to him." (ID# 6) 
Physician-patient communication is the most prevalent component of this key 
construct. Correlation between effective physician-patient communication and 
improved patient health outcomes has been demonstrated (Stewart, 1995, 
Jensen et al., 2011). Furthermore, training in medical communication can 
improve physician communication skills (Jensen et al., 2011). Thus, this study 
supports previous findings on the importance of good quality physician-patient 
communication. 
Physician-physician communication is essential to ensure the flow of information 
in medical practice involving several physicians responsible for the care of a 
patient. Communication in this setting is addressed by two other key constructs: 
continuity and responsibility. Continuity addresses how many physicians are 
involved in the care of a patient. Many exchanges of information decrease the 
chance of quality health care being delivered.  
“This patient had been to several of my colleagues with stomach pain for 
months. A few tests had been done and the patient repeatedly sent home 
without further to do. When he came to me I ordered a computer 
tomography of the abdomen and it showed liver cancer with widespread 
metastasis. He died two weeks later and ….” (ID # 19) 
Responsibility is related to the feeling of obligation to follow a course or take 
action in order to prevent the loss of health or improve health. Full responsibility 
denotes the fact that one physician is in charge of coordinating or providing care 
to the patient. 
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"I think this patient would have had a better outcome if I would have had 
the full responsibility. The problem was that I felt like a consultant without 
full responsibility and gave advice. If I would have had all the information 
and been involved from the beginning my advice would have been 
stressed differently. Unfortunately the poor boy died." (ID # 20) 
Communication is about the flow of information, and in this context, information 
is the message being expressed. Information availability during the process of 
diagnosing and treating patients is viewed as important.  
"...I had seen this patient before and had extensive knowledge about his 
previous diagnosis and therapy. The fact that this information was 
available made it simpler to treat his current problem." (ID# 12) 
However, it is not only the availability of information that is important. Information 
is also frequently not communicated effectively by physicians (Azoulay et al., 
2000). 
Technology is an important and integral part of modern health care. Electronic 
patient journals, as information repositories and communication channels, are 
designed to ensure flow of information. The flow of information, or lack thereof, 
may impact quality of health care delivery. 
“…it is not possible to order x-rays through the digital patient journal. This 
still has to be done the old way on paper. When the results come back 
from the radiologist they are not assigned to the requesting physicians and 
follow up based on the information becomes difficult. …….some patients 
have waited too long for cancer treatment as a direct result.” (ID# 6) 
Communication is therefore a tool to ensure correct flow of information. Both the 
availability and flow of information may influence the quality of health care 
delivery. Enhancing physician-patient communication has been widely stated to 
improve adherence to prescribed medical therapy (Ross, 1991, Misdrahi et al., 
2002, Osterberg, 2005). Patient adherence in this study is not considered a key 
construct, but may be viewed as a possible mechanism influencing quality of 
health care delivery.  
"I consider patients who abuse drugs or medicines to be unreliable. 
Sometimes they come to their follow-up appointments and sometimes they 
do not. This is a group of people requiring a lot of energy from us in order 
to make sure they come and get the necessary treatment." (ID# 11) 
4.5.3.2 Continuity of Care 
Continuity is related to how many physicians or other health care workers are 
involved in the care. When many are involved, information is lost during 
numerous exchanges. The moral obligation to perform or not to perform certain 
behaviours is expected to influence behavioural intent (Ajzen, 1991 p. 199). 
When many physicians are involved in the provision of care, information may be 
lost during numerous exchanges. Furthermore, feeling of responsibility may also 
be affected; see Section 4.5.3.8. 
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“…as few people as possible should participate in the treatment, exchange 
of information should be kept at a minimum to ensure continuity and 
preserve quality.” (ID#19) 
This finding is in agreement with the literature, as it is widely stated that continuity 
is important for quality of care (Adler et al., 2010, Stiell et al., 2005, Love et al., 
2000, Becker et al., 1974), but the effect is found to be variable (Adler et al., 
2010). Lack of continuity is connected to another key construct, as early diagnosis 
and therapy may be influenced by lack of continuity of care. 
“Patient X was admitted to intensive care with a SAPS score of 65% which 
also indicates the risk for mortality. In this case the things went according 
to plan and we managed to get a firm diagnosis right away and start correct 
therapy early. The consequence was that the patient could be discharged 
alive.”  “Patient X was also admitted to intensive care. Management had 
decided that the day the experienced intensive care physicians would 
assist in operations leaving less experienced physicians in charge. The 
result was a delay in diagnosis and consequently treatment. The 
consequence was several more respirator days for the patient. This could 
have been avoided if the diagnosis had been made right away.” (ID# 22) 
4.5.3.3 Cooperation 
Cooperation among physicians and health care workers is necessary for a team 
approach and its synergies of effect. The results of this study indicate that 
cooperation is an important element in how physicians construct quality of health 
care delivery.  
"The ER is not very effective, the nurse and physician see the patient at 
different times and ask the same questions. It would be much better if we 
were there at the same time. Information would flow easily and the patient 
would not have to answer the same question twice." (ID# 25) 
Delivery of health care in the context of modern medicine may be considered a 
cooperative effort. According to Eisenhardt (1989) p. 72, “Agency Theory 
provides a unique, realistic, and empirically testable perspective on problems of 
cooperative effort”. Thus, the principal-agent dyad may be considered a 
cooperative effort. The main tenet of Agency Theory holds that there is a conflict 
of interest between the principal and the agent. On one hand, asymmetry of 
information may drive a condition of moral hazard, and on the other, risk may 
cause adverse selection to occur. Even though the findings of this study support 
patient-physician cooperation, the main focus is on the quality of the cooperative 
effort among physicians and other health care workers. In this context, economic 
interest would drive a possible conflict of interest. However, this is not felt to be 
the case in this study due to the lack of evidence in support of this notion. 
4.5.3.4 Interpretation 
Correct interpretation of information is central to the process of diagnosing and 
deciding on the appropriate therapy. 
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“…this particular patient was a young boy with down syndrome. I was 
dependent on his parent’s information to make a correct diagnosis. 
Fortunately, his parents had a high social status and it made it easy to 
communicate. I think this was important in getting the correct information 
and making the diagnosis. It has also helped in the follow-up. At the time I 
had two such patients with genetic heart disorders and they both lived 10-
15 years longer than they might otherwise have done.” (ID# 26) 
Focus of attention to what the physician prefers results in differential weighting of 
information features. For naturally occurring phenomena, it is not clear whether 
people do consider base rates (Goldsmith, 1980). However, information that 
receives a causal interpretation is weighted more heavily in judgment than 
information that is diagnostic (Einhorn and Hogarth, 1981 p. 65) . Thus, correct 
interpretation of information may be dependent on the physician’s preference of 
information features. 
4.5.3.5 Early Diagnosis and Treatment 
Early diagnosis and treatment is frequently mentioned and variability is high, 
indicating strong relevance. In this study, it is clear that this construct plays an 
important role in quality of health care delivery.  
"Due to delay in diagnosis, this patient did not receive the therapy needed 
to save his life." (ID# 13) 
Focus of medical research is on early diagnosis and treatment for different 
disease states. For example, the vast amount of research done on cancer in 
recent years have made it possible to detect, diagnose and treat cancer 
conditions that a few decades ago would lead to death in most patients. It has 
been shown that for 20 tumour types, the 5-year survival rates have increased 
from 1950 to 1995 (Welch et al., 2000). The main reason for this is attributed to 
screening, better diagnostic procedures, and resources. 
“This is a case I am uncomfortable talking about. Due to a clear focus on 
only part of the problem the diagnosis was missed and the patient died 
after about two months. I can also say that this may have been attributable 
to the competency of the physician doing the diagnostic procedure.” (ID# 
4) 
Thus, early diagnosis and effective and timely treatment reduces morbidity and 
prevents premature death from disease. Early diagnosis and consequent 
treatment depends on the patient and the physician’s ability to interpret 
information correctly.  
The patient plays a central role in the quality of health care delivery. Whether to 
seek medical attention for a problem or condition primarily relies on the patient’s 
ability to recognize symptoms as a sign of disease. 
"...it is central for the patient to associate symptoms with disease. If not the 
patient will not get in touch with the physician. Furthermore, I think this is 
one aspect of patient-delay." (ID# 6) 
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Physicians are the experts and must make sense of information from many 
potential sources when diagnosing and deciding on appropriate therapy. If the 
interpretation is not correct, then the diagnosis may be missed and appropriate 
therapy not given.  
“The patient was complaining of chest pain after a fall. I examined the 
patient, but did not find anything abnormal except for pain in the region 
that was involved during the fall. She was later admitted to hospital with 
pneumothorax and was treated with a chest drain.” (ID# 5)  
4.5.3.6 Effect of Therapy 
Effect of therapy can be more or less effective in solving the presenting problem. 
Differentiation is made between curative effect and symptomatic effect. In some 
cases, the symptomatic effect may be just as important, dependent on the 
availability of curative therapies; for example, palliation for terminal cancer 
patients. 
 “Availability of effective therapy is definitely important for quality. In 
oncology we have quite a few patients that will have a good chance of 
survival in a few years, but today medicines that are effective are not 
available.” (ID# 6) 
Physicians associate effective therapy with quality of care. The main premise is 
that there is a correlation between the availability of effective therapy and quality 
of care. Thus, it may be argued that effective therapy is necessary for positive 
outcomes related to the presenting problem. Furthermore, the effect of available 
therapy is not the only factor influencing outcomes. Complications of therapy are 
also of major concern. In 1999, the Institute of Medicines published a report 
documenting that 1 million people per year are injured and 100 thousand die as 
a result of preventable medical errors in hospitals in the USA (Kohn et al., 1999). 
“For young patients, with a lot to lose, I sometimes choose to go outside 
the guidelines to give the patient a chance and get acceptable results.” 
(ID# 17) 
4.5.3.7 Experience 
Experience is a key construct informing physician perception of quality of health 
care delivery. From the data in this study, it is evident that physicians perceive 
more experience beneficial to quality of health care. This is in contrast to the 
findings of Choudhry et al. (2005) p.271, where the results of a systematic review 
on the topic “suggest that physicians with more experience may paradoxically be 
at risk for providing lower-quality care”. The authors suggest several possibilities 
for their finding, but the most plausible is that a physician’s “tool-kit” is developed 
during training and not updated on a regular basis (Choudhry et al., 2005, Carthy 
et al., 2000).  
Experience in this study is defined as the knowledge or skill necessary to apply 
scientific medical knowledge to practice, gained through exposure to similar 
events or cases. However, in the literature, clinical experience often equates to 
time in practice. Time in practice was suggested by Bradley (1991) to be a 
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contextual component that may influence physician prescribing. However, time in 
practice constitutes a temporal dimension that may be further informed by 
investing literature addressing physician age and habit persistence.  
"The patient came to the ER after a fight at a local bar. He was not 
conscious and the consultant did not come to see the patient. The hospital 
was full that night, but I managed to get the patient a bed on a ward. I felt 
uneasy about the whole thing. Later during the night I went to check on the 
patient and found him in a deep coma. A CT was requested and an 
intracranial bleeding was found. The patient was flown by helicopter to the 
nearest trauma centre and died on the operating table. This is a case that 
has been with me for years and my lack of experience made me accept 
the cursory advice from the consultant even though my gut feeling told me 
otherwise." (ID# 21) 
4.5.3.7.1 Physician Age 
In a study by Bauer et al. (2008), antidepressant prescribing patterns and factors 
influencing the choice of antidepressant for the treatment of depression were 
examined. The authors found that older investigators were associated with a 
decreased likelihood of a serotonin-reuptake-receptor-inhibitor (SSRI) being 
prescribed. In another study, Biga et al. (2007) characterized profiles of 
physicians (GPs and rheumatologists) prescribing cyclo-oxygenase-2 inhibitors 
in France in 2002. A negative statistical link was found between a high level of 
cyclo-oxygenase-2 inhibitors prescriptions and physician age below 44 years. 
Harries et al. (2007) investigated whether, and how, individual doctors are 
influenced by a patient's age in their investigation and treatment of angina 
pectoris (chest pain). Physicians who were influenced by age were on average 
five years older than those who were not. They were significantly positively 
influenced by old age on decisions to change prescriptions for ischemic heart 
disease, in particular nitrates. It is also worth noting that female physicians were 
underrepresented in the study population, creating a male bias. In an Australian 
study aimed at investigating the effect of remuneration changes on physician 
prescribing behaviour, it was found that GPs aged over 55 years old were less 
likely to counsel their patients and more likely to prescribe medication than GPs 
aged under 35 years old (Scott and Shiell, 1997). Hamann et al. (2004) 
interviewed 100 psychiatrists on drug choice for 200 patients suffering from 
schizophrenia, and found that older physicians were up to five times more likely 
to prescribe first-generation antipsychotics. Furthermore, the authors found that 
patient variables did not influence treatment decisions significantly.  
4.5.3.7.2 Time in Practice 
Time in practice has been mentioned as a possible factor influencing physician 
prescribing behaviour. However, few studies addressing this issue have been 
found in the literature. de Jong et al. (2009) investigated the influence of child, 
parent and physician factors on drug prescriptions for respiratory symptoms in 
primary care in infancy, as respiratory symptoms account for the majority of drug 
prescriptions in the first year of life.  The authors found that physicians with more 
than 15 years’ experience prescribed more. In another study, Mamdani et al. 
(2002) examined the association between socioeconomic status, as indicated by 
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neighbourhood median income levels, and physician drug selection between 
older, less expensive generic drugs and newer, more expensive brand-name 
drugs for elderly patients initiating drug therapy in a universal health care system. 
The authors found that physician graduation year was inconsistently associated 
with newer brand-name drug prescribing across the three drug classes 
investigated in the study.  
4.5.3.7.3 Habit Persistence 
Janakiraman et al. (2008) explored the effects of habit persistence on prescribing 
behaviour by examining 9672 prescriptions written for depression by 108 
physicians of non-specified specialities over a four-year period in the USA. A two-
state model was adopted based on the assumption that physicians can be either 
persistent or non-persistent. The authors investigated whether persistent 
physicians responded differently to detailing, out-of-office meetings, and 
symposium meetings. There is compelling evidence to show significant cross-
sectional levels of persistence in decisions concerning the prescription of 
medicines. Practice type may play a role, as it was found that physicians working 
in smaller practices are more likely to be persistent. Furthermore, age and 
detailing acceptance also play a role in defining persistence. Older physicians 
and those more accepting of detailing stand a higher chance of being persistent. 
Both persistent and non-persistent physicians appear to be responsive to 
symposium meetings. However, only non-persistent physicians were found to be 
responsive to detailing. Out-of-office meetings had no effect on prescribing 
behaviour. In another study, Venkataraman and Stremersch (2007) also found 
that there is substantial habit persistence in physician decision making. Lilja 
(1976) performed an empirical study utilizing a mailed questionnaire examining 
how GPs (180) in Sweden chose medicines. The data were analysed using linear 
regression modelling. The author found a positive effect on habitual choice with 
increasing age. Highest weight was given to curing effect of medicines 
prescribed. In addition to physician age, it was found that disease severity was a 
determining factor. Moreover, no significant relationships for background 
variables of physician were found. “The unique contribution of habit would lie in 
finding a residue of past experience that leads to habitual rather than reasoned 
responses” (Ajzen, 1991). Further support is provided by Coscelli (2000), who 
also notes that doctors' prescribing behaviour shows habit persistence. 
Furthermore, personal experience combined with social meaning of medicines 
drive prescribing behaviour during the end of life therapies (Zerzan et al., 2011); 
and early experience of using a new medicine seems to strongly influence future 
prescribing (Jones et al., 2001). 
Evidence supporting the effect of age and time in practice as individual 
components influencing physician choice behaviour is limited. However, both age 
and time are temporal, and it may therefore be argued that time is a factor 
influencing physician choice. This review has, however, not identified any 
evidence to link time to physician choice directly. The third component in this 
section is also temporally related, as habit represents residues of past behaviour 
and experiences (Ajzen, 1991). Age and time in practice may therefore merely 
represent the temporal axis on which past behaviours and experiences are 
placed. The key to understanding temporal effects can thus be found in the 
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literature addressing habit persistence. From a theoretical perspective, temporal 
effects may simply reflect the sum of past behaviour, and as such, are best 
characterized as a reflection of all factors that determine the behaviour. The 
correlation between past and later behaviour is an indication of the behaviour’s 
stability or reliability (Ajzen, 1991). Furthermore, Ajzen (1991) notes that residual 
effects of past behaviour may constitute habit, but can also be the result of 
missing or unrecognized attributable factors. However, evidence presented in this 
review suggests a strong influence of habit persistence on physician choice 
behaviour. Thus, evidence of temporal components influencing physician choice 
is considered high. 
4.5.3.8 Full Responsibility 
Full responsibility denotes the fact that one physician is in charge of the care of 
the patient. In other words, one person is responsible for ensuring that all the 
patient’s needs are met. When responsibility for care is shared, roles may 
become unclear and the quality of care may suffer as a consequence. 
"The problem was that I felt like a consultant without responsibility and just 
gave advice." (ID# 20) 
4.5.3.9 Resource Availability 
Resources in this context are both human and technical in nature. Human 
resources are physicians and other health care personnel such as nurses and 
physiotherapists. Technical resources are represented by medicines, equipment 
and buildings. Human resources are linked to time, which will be covered in 
Section 4.5.3.11. The availability of requisite opportunities and resources (e.g. 
time, money, skills, cooperation of others) collectively represent physicians’ 
actual control over behaviour related to health care service delivery (Ajzen, 1985, 
Ajzen, 1991 p. 182). 
 “Not having enough echo–resources in the cardiology department is like 
not having enough hammers for the carpenter” (ID# 18) 
4.5.3.10 Resource Utilization 
The use of resources is related to diagnostic and therapeutic resources. 
Resources refer to a wide variety of resources, ranging from buildings, technical 
installations, IT, diagnostic and therapeutic modalities. Availability of resources is 
in itself not enough to ensure quality health care delivery; resources must also be 
used appropriately. 
"This patient got more than what could be expected. All possible diagnostic 
and therapeutic avenues were tried. In other words, the health care system 
had no more resources available that could be used." (ID# 11) 
4.5.3.11 Time 
Available time is important in order to do what is necessary; thus, time available 
is often determined by patients/physicians per time unit. 
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“I always make sure that a colleague answers my phone when I am on call 
and have an important patient interaction. Having the time necessary to 
make an evaluation and administer therapy is important.” (ID# 21) 
In the literature, time as a factor having an impact on quality of health care is 
infrequently mentioned. However, in a study investigating physicians’ views on 
quality of health care, surveying 100 physicians,  most physicians (52%) cited 
time spent with patients as an effective strategy in improving quality of care 
(Audet et al., 2005 p. ix). 
In the present sample, time is related to two main paths concerning quality of 
health care delivery; first, time spent on direct patient care, and second, time 
spent indirectly on patient care.  
 
Time spent directly on patient care is related to the time available for interaction 
with patient and physician or other health care workers. This is related to the 
communication between patient and physician and to diagnostic or therapeutic 
procedures, as illustrated by the following quotes. 
 
«...I was on call and it was very hectic. I did not have enough time to 
evaluate the patient fully and therefore overlooked a fracture in the tibia 
(leg bone)...» (ID# 23) 
 
«...I did not have enough time to explain fully the therapy to the patient and 
the patient’s family. The patient initially denied therapy and diagnosis and 
treatment were delayed and the patient died later the same day on the 
operating table in another hospital. » (ID# 15) 
 
«During a hectic day with many consultations, the colleague performing 
the initial echo of the heart only paid attention to the replacement valve 
and not to the whole heart. Only two months later, after looking at the 
recorded echo film, was it evident that the left ventricle was barely moving. 
At this point he was dying and therapy at this point did not have any effects. 
He died shortly thereafter. » (ID# 26) 
 
Time spent indirectly on patient care is also evident from the sample. This use of 
time follows two main paths: first, time is spent on maintaining or improving 
clinical or academic competencies; and second, time is spent on reflection and 
evaluation of information, especially when dealing with complicated cases.  
 
Time spent on improving or maintaining clinical or academic competencies can 
be illustrated by the following quotes.  
 
«..We do not have enough time to supervise our interns. In the hospital 
where I worked before we had control of what our interns knew and did. 
Here, we do not have the time for appropriate supervision. What type of 
cardiologists are we getting? I honestly can’t tell you....» (ID# 26) 
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“...I have a lot of data on the 2000 hepatitis C patients in our policlinic, but 
I never have the time to analyse the data. We don’t know if our practice is 
appropriate given national and international guidelines. This is especially 
important for some of the patients as immune therapy can be very costly 
for the hospital and for the patient…” (ID# 11) 
 
"...this one patient was admitted for COPD and treated accordingly, but the 
heart was not considered. If more attention had been given to the whole 
patient then maybe the outcome had been better." (ID# 25) 
4.5.4 Patient Influence 
The patient plays a central role in the provision of health care. In other words, 
there is no need for a health care service without patients! Even though this 
construct did not meet the minimum criteria for key construct, it is felt necessary 
to include the topic in this section to ensure a complete set of findings. The 
evidence in this study informing the topic can be divided into three categories. 
First, patients exhibit state dependence. Second, patient expectations influence 
physician decisions. Finally, patient delay is related to the ability to recognise 
symptoms as disease.  
The physician’s desire to preserve the physician-patient relationship as a factor 
that may influence physician decision behaviour has been described in the 
literature (Bradley, 1992). In an agency context, patient expectancy may clearly 
influence physician decisions. However, only a few authors included in this review 
address the question. Furthermore, the origin of patient expectancy is not clearly 
identified in the included literature, but is has been shown that patients exhibit 
strong state dependence (Coscelli, 2000).  
“...this patient had detailed information about how to use the system to get 
what she wanted. She got more resources than she should have.” (ID# 1) 
Lundin (2000) investigated the effect of moral hazard on physician prescribing 
and found that patient acquired taste (preference) is an important factor, giving 
further support to the findings of Coscelli (2000). In addition, Naik et al. (2009) 
note that patients’ requests for specific brands may influence physician 
prescribing behaviour. In a study by Tett (2003), it was found that 66.1% of GPs 
felt that patient expectations influence prescribing. Webb and Lloyd (1994) 
examined the effect of patient expectations of physician prescribing and hospital 
referrals. The investigators employed a self-administered survey, covering 1080 
consultations with 12 GPs. Results showed that physician prescribing behaviour 
was most strongly associated with patients’ expectations. The level of influence 
exerted by patient expectations on physician prescribing behaviour may be 
strong, as was found in a study assessing the influence of non-medical factors in 
the context of upper respiratory infections (Hummers-Pradier et al., 1999). The 
authors conclude that patient expectations are extremely important when 
prescribing medicines for cold and cough. This notion is further supported in a 
similar study investigating the prevalence of patient expectations for upper 
respiratory infections (Faber et al., 2010). In another study, Macfarlane et al. 
(1997) investigated patient expectations in the context of antibiotic prescribing, 
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and found that 85% of patients felt that symptoms were related to infections and 
that antibiotics would help (87%). The authors found that most (72%) patients 
wanted antibiotics and the same number of patients expected a prescription for 
antibiotics.  
”...demanding patients create negative feelings and I fear I may give 
suboptimal therapy due to this fact...” (ID# 11) 
The literature suggests that there may be a poor correlation between patient 
expectation and physician perception of this expectation. Whether it is the patient 
expectation or the physician’s perception of the patient expectation that is the 
influencer becomes a key question to address. Mangione-Smith et al. (1999) 
investigated the expectation of parents among children diagnosed with a 
probable viral cause. The authors found that the actual parent expectation did not 
influence the decision to prescribe. The authors note that there was poor 
agreement between actual pre-visit expectations reported by parents and the 
perception of expectation by the physician. In a study exploring how GPs decide 
to prescribe, it was found that the decision is shaped by the perception of patient 
expectation (Hyde et al., 2005). Lado et al. (2008) conclude along the same lines 
and claim that there is no association between patient expectations and physician 
perception of such expectations. In an observational study, von Ferber et al. 
(2002) found that patients’ needs and expectations are lower than observed 
prescribing behaviour by physicians. More recently, further support to the 
perception of expectation is given by the work of Tusek-Bunc et al. (2010), where 
it was found that the physician perception of patient expectation was a significant 
factor influencing statin prescribing. 
There is evidence suggesting that the patient pathway from symptom to diagnosis 
is a key determinant of outcomes in cancer patients (Walter et al., 2012). Most 
diseases present with symptoms, but the symptoms may be associated with 
common ailments and therefore not considered a sign of serious disease by the 
patient.  
“The patient was admitted to hospital due to a large wound on her chest. 
It turned out that she had felt a lump in one breast a couple of years prior 
to being admitted. The lump had become larger and a wound developed. 
The reason she contacted her GP was the smell from the wound. It turned 
out to be a case of terminal breast cancer.” (ID# 6) 
From the evidence presented, patient expectation, as an influencer, is not well 
established. However, the evidence points in the direction of the physicians’ 
perceptions of patient expectation as an influencer of physician decisions. 
Furthermore, it has been suggested that there may be differences in the level of 
reliance on these perceptions dependent on physician specialty (Lapeyre-Mestre 
et al., 1998).  
4.6 Discussion 
The objective of the study was to investigate how physicians perceive quality of 
health care delivery. Although this research is exploratory, it has made several 
contributions to the understanding of how physicians perceive quality of health 
 201 
care delivery. First, this study provides evidence on how physicians construct 
quality of health care delivery, and therefore represents a window into the hitherto 
unobservable effort (quality) input by physicians. Second, the theoretical link to 
the Theory of Planned Behaviour has been identified. More specifically, evidence 
of a link to control belief and consequent perceived behavioural control is strong. 
This may indicate a conflict between process management on one hand and 
physician effort to produce quality health care services on the other. Finally, the 
results from this study are homogenous in that theoretical saturation was 
achieved early, indicating that there is a high degree of agreement within the 
physician community as to the construct of quality. The most probable 
explanation for this last finding is that the “institution” of medicine is strong, 
indicating socialization and common perceptions of quality. 
This study explicates some aspects of quality of health care delivery that go 
beyond prior related studies. Theory is advanced in this area by the exploration 
of how physicians construct quality of health care delivery in a hospital setting. 
The model presented integrates the study findings with elements of theory from 
different academic areas, such as medicine, economics, management and 
psychology.  
The discussion will be structured around the identified key constructs 
representing physician perception of quality health care delivery, compared and 
contrasted with evidence from the literature. This begins by considering quality in 
health care, and then addresses what this study has confirmed. Next is a 
discussion on what the study has added, followed by what has been challenged. 
Following this, paradoxical findings are discussed, before the study findings are 
examined from a theoretical perspective. Finally, a conceptual framework for 
quality in health care delivery is proposed. 
4.6.1 Quality in Health Care 
The focus on quality of health care provision follows two main paths. First, 
improvement of clinical quality where clinical quality refers to performance relative 
to process of care performance measures, which are represented by clinical 
protocols of best practice to achieve high levels of patient safety 
(Chandrasekaran et al., 2012). Second, experiential quality is represented by the 
quality of care as experienced by the patient (Donabedian, 1988). It focuses on 
how care is provided and is distinct from the clinical quality, as it is focused on 
what is provided. 
Tension between the two outcome paths occurs when hospital management try 
to balance the two, as focus on clinical quality will reduce variation and focus on 
experiential quality increase variation (Chandrasekaran et al., 2012).  Clinical 
quality has been shown to be closely linked to experiential quality (Blackwell, 
1973, Butler et al., 2002, Camron, 1996) and vice versa. Thus, the quality of care 
is dependent on both clinical and experiential quality.  
The described tension between clinical and experiential quality creates a 
contradiction at the strategic level of health care provision. Managing strategic 
contradictions has been addressed by Smith and Tushman (2005), and the 
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authors proposed a framework for managing strategic contradiction involving 
paradoxical cognition:  
 Articulating a paradoxical frame 
 Differentiating between architecture and strategy 
 Integration between architectures and frames 
Articulating a paradoxical frame involves ”mental templates in which managers 
recognize and accept the simultaneous existence of contradictory forces” (Smith 
and Tushman, 2005 p.  527). Differentiating between architecture and strategy 
involves a cognitive process of differentiation and integration, thus enabling 
balanced strategic decisions (Smith and Tushman, 2005 p. 526). Even though 
most of the literature on the topic addresses business issues related to 
innovation, balancing financial and social goals has also received attention in the 
literature (Margolis and Walsh, 2003). Smith and Tushman (2005) p. 533, claim 
that managing contradiction is a window into a range of important and 
understudied organizational challenges.  
Focus on health care delivery in a context defined by an ever increasing demand 
by an aging population and with limited funds makes the effective management 
of contradiction and paradox even more salient than before. Thus, understanding 
how organizations effectively manage contradictions in the health care sector 
remains a critical question. 
It has been shown that management focused on patient centred health care 
delivery can mitigate the effects of the tension described above (Chandrasekaran 
et al., 2012). However, these findings are a result of a post hoc analysis and 
should therefore not be considered scientifically rigorous evidence of such an 
effect and require further investigation. 
Overall, the findings of this study favour technical quality. The way medical 
education is structured may be a factor; however, physicians may learn from 
experience to favour behaviours which are believed to have largely desirable 
consequences (Ajzen, 1991 p. 191). Thus, positive attitudes are formed through 
clinical experience which in turn may influence behavioural intent. Furthermore, 
Bandura (1989 p. 1178) states that “Any factor that influences choice behaviour 
can profoundly affect the direction of personal development because the social 
influences operating in the environments that are selected continue to promote 
certain competencies, values, and interests long after the decisional determinant 
has rendered its inaugurating effect. Thus, seemingly inconsequential 
determinants can initiate selective associations that produce major and enduring 
personal changes”. Therefore, experiences early in a physician’s career may be 
determinant of later choice behaviour. 
The effect of guidelines on physician prescribing behaviour has been extensively 
studied and reported in the literature. It is widely stated that the level of guideline 
adherence is variable (Smolders et al., 2007, Lagerlov, 2000, Chauhan and 
Mason, 2008, Nast et al., 2009, Rashidian and Russell, 2011).  In fact, it has been 
found that in some cases, more than 50% of decisions resulting in a prescription 
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contradict clinical practice guidelines (Ventelou, 2010). Furthermore, outcomes 
measures of guideline implementation are largely lacking (Gill et al., 1999).  
4.6.2 What has been Confirmed 
In this section, the findings of the study where agreement with evidence 
presented in literature is high are discussed.  
4.6.2.1 Communication 
The effect of communication on health outcomes is widely stated (Altiner et al., 
2007, Makoul, 2001, Makoul et al., 1995, Zacharie et al., 2003, Street et al., 2007, 
Stiell et al., 2005, Stewart, 1995, Azoulay et al., 2000, Mack et al., 2005, Kenny 
et al., 2010, Kaplan et al., 1989, Jensen et al., 2011). In this study, communication 
is a key construct, and thus represents an important aspect of physicians’ 
perspectives on quality of health care. Therefore, this study confirms previous 
theory and supports prior findings on the importance of good quality physician-
patient communication. 
In a review of the literature, Stewart (1995) p. 1423, concludes that “most of the 
studies reviewed demonstrated a correlation between effective physician-patient 
communication and improved patient health outcomes”. This is further supported 
by the findings in this study, as correlation between effective physician-patient 
communication and improved patient health outcomes has been demonstrated 
(Stewart, 1995, Jensen et al., 2011). Furthermore, training in medical 
communication can improve physician communication skills (Jensen et al., 2011).  
"It was very easy to get contact with this patient. The patient had a good 
understanding of his condition and was able to communicate his 
symptoms clearly. This other patient had a poorly developed vocabulary 
and did not understand that the symptoms were related to disease. It was 
very difficult to get through to him." (ID# 6) 
In 1999, 21 leaders of medical education and professional organisations 
convened to discuss medical communication, with the intent to identify elements 
of medical communication in order to facilitate inclusion of medical 
communication in medical curricula and to inform development of standards of 
medical communication (Makoul, 2001). The group identified seven elements of 
medical communication (Makoul, 2001 p. 390):  build the doctor–patient 
relationship,  open the discussion, gather information, understand the patient’s 
perspective, share information, reach agreement on problems and plans, and 
provide closure. Jensen et al. (2011) undertook a crossover randomized 
controlled trial in a 500-bed hospital to test whether a 20 hour communication 
skills course based on the Four Habits model could improve doctor-patient 
communication among hospital employed doctors across specialties. The Four 
Habits are: Invest in the Beginning, Elicit the Patient's Perspective, Demonstrate 
Empathy, and Invest in the End (Frankel and Stein, 1999 p. 79). Each Habit refers 
to a family of skills. Jensen et al. (2011) found that the Four Habits model is 
suitable for communication-training courses in hospital settings.  
Medical communication is widely stated to be important, and correlation between 
effective physician-patient communication and improved patient health outcomes 
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exist. Furthermore, a model for effective communication exists, and training 
based on the model is both suitable and effective when applied to physicians in 
a hospital setting. 
4.6.2.2 Early Diagnosis and Treatment 
The findings of this study suggest that early diagnosis and treatment is an 
important factor influencing quality of health care delivery. In the UK, cancer 
survival rates are poorer when compared with other countries in Europe with 
similar health care expenditure (Berrino et al., 2007). Evidence suggests that 
pathways to initial presentation and initial management are linked with patient 
outcomes (Richards et al., 1999). Investigating diagnostic delay could be 
facilitated by use of a robust theoretical framework (Walter et al., 2012). The first 
and most widely cited framework, a three stage model to account for the total 
time from first noticing a symptom to seeking treatment, was proposed by Safer 
et al. (1979) and subsequently developed by Andersen et al. (1995) – the 
Andersen Model. The model proposed by Andersen et al. (1995) is a general 
model of total patient delay, which can be applied across medical disorders; see 
Figure 4-4 Andersen model. Findings from this study are directly related to 
aspects of the Anderson model, as exemplified by the quote below; thus, the 
study confirms previous theory. 
“This patient came to see me regarding a rash on her left breast that she 
had noticed during the past few days. It turned out to be a rare form of 
breast cancer.” (ID# 9) 
 
Figure 4-4 Andersen model 
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Walter et al. (2012) reviewed the literature reporting the use of Andersen’s Model 
in studies assessing cancer diagnosis. The authors found that the vast majority 
of studies did not use a theoretical model informing data collection or reporting. 
Systematic focus on reducing diagnostic delays may result in improved 
prognosis, increase the proportion of early stage cancers identified, improve 
prognosis and reduce psychological distress (Risberg et al., 1996). The 
Norwegian system of compensation to patients claims that 160 patients died in 
Norway during the past five years as a direct result of delayed cancer diagnosis 
(Svendsen, 2012). 
4.6.2.3 Continuity of Care 
The results of this study suggest that continuity of care is an important factor 
influencing quality of care. This study provides confirmation of previous theory, 
as it is widely stated that continuity is important for quality of care (Adler et al., 
2010, Stiell et al., 2005, Love et al., 2000, Becker et al., 1974), but the effect is 
found to be variable (Adler et al., 2010). Evidence provided in this study is directly 
indicative of quality of care being influenced by continuity, as exemplified by the 
quote below. 
“This patient was in the ICU and had complications. Several physicians 
were involved in the care of this patient. He ended up staying longer in the 
ICU than what would normally be expected due test not being taken, 
medicines not being ordered, etc. “(ID# 4)  
Providing quality health care in an environment characterized by ever increasing 
demands on specialized disciplines makes modern medicine a complex exercise 
in logistics. Health care systems evolve to account for the complexities, and 
continuity of care is challenged as a result (Adler et al., 2010). Definitions of 
continuity of care are numerous, but are exceeded by the number of techniques 
used to measure continuity (Saultz, 2003, Jee and Cabana, 2006, Saultz and 
Locbner, 2005). Saultz (2003) proposed a hierarchical definition of continuity, 
ranging from informational to longitudinal to interpersonal. (Freeman et al. (2003), 
Haggerty et al. (2003)) described continuity of care from the patient perspective. 
However, attempts at providing a uniform definition and technique for 
measurement of continuity of care has yet to be accomplished (Haggerty et al., 
2003, Saultz, 2003, Starfield, 1980, Wall, 1981, Adler et al., 2010). Thus, as 
global definition is lacking and numerous techniques are used to measure 
continuity, it is not surprising that the effect has been found to be variable.  
The findings in this study suggest that continuity of care is an important 
contributor to quality of health care delivery. The difference between the findings 
in this study and evidence reported in the literature is the link between continuity 
of care and communication. Communication has been widely stated to be an 
important factor influencing the quality of care delivered(Altiner et al., 2007, 
Makoul, 2001, Makoul et al., 1995, Zacharie et al., 2003, Street et al., 2007, Stiell 
et al., 2005, Stewart, 1995, Azoulay et al., 2000, Mack et al., 2005, Kenny et al., 
2010, Kaplan et al., 1989, Jensen et al., 2011), thus further supporting and 
confirming pervious theory.  
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4.6.2.4 Resources 
Resources are necessary to provide modern health care, and their availability 
may influence the quality of health care delivered. Resource in this context is 
related to the total means available to solve the tasks and challenges faced by 
modern health care facilities.  
“Not having enough BIPAP machines available during flu season is like 
asking for trouble”  (ID# 16) 
This is, in other words, a necessary investment. “The most successful health care 
organizations must not only deliver high-quality care, but also do so with minimum 
waste” (Martin et al., 2009 p. 25). However, geographical variations in the delivery 
of health care have been described in the literature by several authors (Wennberg 
et al., 2002, Calleri et al., 2008, Sturm et al., 2007, Webster et al., 2009). 
Birkmeyer et al. (2002) note that Medicare spending varies across regions and 
that these variations persist after differences in health status are accounted for. 
This would suggest that increased spending does not necessarily lead to better 
health outcomes. Furthermore, the authors note that the main drivers for variable 
spending are increased use of supply-sensitive physicians’ services, specialist 
consultation, and hospitalization for patients with chronic disease. Calleri et al. 
(2008) claim that geographical variations in prescribing of malaria 
chemoprophylaxis in Europe can largely be accounted for by variability in 
evidence based on efficacy and tolerability. Sturm et al. (2007), on the other hand, 
conclude that it remains to be established which factors within a given health-
care system are responsible for the observed effects. Finally, Webster et al. 
(2009) find that early opioid prescribing for low back pain is almost fully explained 
by state-level contextual factors.   
Quality of health care comprises three elements: structure, process and 
outcomes (Donabedian, 1979) (Peabody et al., 2006 p. 1294). Evidence 
suggests that differences in quality may be based on the process of care (defined 
as what a physician or others do when seeing a patient). Physician effort, which 
comprises a major element of the process of care is of particular interest as a 
policy variables, as it is sensitive to change made in the present (Peabody et al., 
2004 p. 1952). 
The stated variability in health care spend and delivery without apparent health-
outcome effects makes it reasonable to argue that resource availability does not 
necessarily equate to better quality care. However, “Adequate nurse staffing and 
organizational/managerial support for nursing are key to improving the quality of 
patient care…” (Aiken et al., 2002 p. 187).  
From a process design perspective, Kano (1996) provides three possible 
approaches to improving the quality of a service (Martin et al., 2009 p. 33). First, 
“eliminate the quality problems that arise because the customers’ expectations 
are not met”. Second, “reduce cost significantly while maintaining or improving 
quality”. Finally, “expand customers’ expectations by providing products and 
services perceived as unusually high in value”. 
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The process design perspective of Kano (1996) cannot be implemented in health 
care without due consideration of three critical factors highlighted previously. 
First, there is a paradoxical relationship between technical and experiential 
quality (Chandrasekaran et al., 2012). Thus, eliminating quality problems arising 
from unmet customer expectations may reduce technical quality and have an 
overall negative effect on total quality. Second, cost reduction in health care is 
challenging due to the fact that outcomes are non-contractible (Ajzen, 1991). 
Finally, expanding customer expectations in the context of cost saving and 
necessary focus on technical quality indicates the challenge of a second paradox.  
4.6.2.5 Time 
Time is an important factor in medicine, and in this study, time is related to two 
other key constructs. First, time is related to early diagnosis and treatment. In this 
context, time is the time it takes from symptoms being recognized until treatment 
starts. Second, time is related to resources, as it is a function of resources 
available per unit time. For example, the number of physicians available in the 
ER at any given time will define the physician resource available to treat patients 
at that time.  
“When the ER is overcrowded with patients, I do not have enough time to 
provide the care I feel is necessary.” (ID# 25) 
Time as a variable in relation to the construct “early diagnosis and treatment”, 
has been discussed in Section 6.2.2 and will not be discussed further in this 
section. 
Time as a variable of resource, however, merits further attention. It is widely 
stated that evidence from the literature on the quality of care in general practice 
has centred on the availability and use of time at consultations (Butler and 
Calnan, 1987, Howie et al., 1989, Howie et al., 1991, Wilkin and Metcalf, 1986, 
Morell et al., 1986, Risdale et al., 1989). From the general practice literature, it is 
evident that time as a factor influencing quality of care is related to the physician 
as a resource. Thus, time in this context may be considered the relationship 
between quantity and quality of care where the physician is the resource. 
Physicians are concerned that health care payments systems encourage quantity 
rather than quality. From the patient perspective, it is clear that patients are in 
general more satisfied with longer consultations (Howie et al., 1991).  
The physician is the decision maker on behalf of patients, payers, providers and 
producers. This makes the physician a central resource in modern health care. 
Available time is therefore directly related to the availability of physician resources 
to complete different tasks associated with health care. The evidence from this 
study confirms prior research on the topic. 
4.6.2.6 Effect of Therapy 
The findings in this study suggest that effect of therapy is considered by 
physicians to influence quality of health care. Physicians associate effective 
therapy with quality of care. The main premise is that there is a correlation 
between the availability of effective therapy and quality of care.  
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"...effect of medication which can be measured.” (ID# 7) 
Thus, it may be argued that effective therapy is necessary for positive outcomes 
related to the presenting problem. Furthermore, the effect of available therapy is 
not the only factor influencing outcomes. Complications of therapy are also of 
major concern. In 1999, the Institute of Medicines published a report documenting 
that 1 million people per year are injured and 100 thousand die as a result of 
preventable medical errors in hospitals in the USA (Kohn et al., 1999). 
Several authors have investigated the origin of these concerns and found that 
efficacy and safety are the main constituents, thus addressing the benefit-risk 
profile of medicines. Uncertainty is stated as the main driver of physician 
behaviour (Arrow, 1963), and it is therefore unreasonable to expect the benefit-
risk profile of a medicine not to influence physician prescribing behaviour. Indeed, 
safety and effectiveness were considered highly influential by all participants in a 
study describing and comparing the opinion of physicians, clinical pharmacists, 
and formulary committee members with respect to key factors that influence 
medication prescribing in community hospitals (Schumock et al., 2004). 
Physicians, however, may not be risk averse. Pinto et al. (2010) analysed the 
main reasons physicians give for their prescription choices. It was found that the 
effectiveness of the product, tolerability, which is directly related to the 
abandonment rate of a given course of treatment, was considered less important 
by doctors in this study. The authors argue that this proves that members of the 
medical profession are willing to take certain risks by using more effective 
medicines, even if they cause more reactions that are adverse. In another study, 
Choudhry et al. (2006) found that adverse events that are possibly associated 
with underuse of warfarin may not influence subsequent prescribing. When 
analysing trends in rosuvastatin prescribing, Ohlsson et al. (2009) realized that 
the medicine was the subject of safety concerns and subsequent regulatory 
warnings during the observation period of the study. The authors note that these 
warnings may have influenced the patterns of prescription. This conclusion was 
drawn on the basis of an overall reduction in the prevalence of rosuvastatin 
prescriptions in the latter third of the study. However, the clustering of 
rosuvastatin prescriptions was not substantially affected by the warnings.  
When Prosser and Walley (2006) investigated the range of factors influencing the 
prescription of new medicines, the key factors behind the first prescription of a 
new medicine were found to be an absence of current available treatment or 
expectation of better outcomes based on a medicine’s alleged relative advantage 
over current treatment. This was largely attributed to increased effectiveness and 
fewer side effects (Prosser and Walley, 2006). In another study, Schneeweiss et 
al. (2005) quantified the relative contributions of patient versus physician factors 
to the decision to prescribe selective COX-2 inhibitors during the first 2 years of 
their availability. The authors found that twice as much variability in COX-2 
prescribing could be explained by physician preferences than by the five 
gastrointestinal toxicity risk factors alone, indicating that safety may not be an 
overriding concern. One explanation may be that if a medicine has a novel 
mechanism of action, or belongs to a class of medicines with few alternatives, 
clinicians are more likely to consider it favourably as a prescribing option 
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(Chauhan and Mason, 2008). In support of this notion, Tett (2003) found that a 
strong majority of participants in the study agreed that they would prescribe a 
new medicine based on its comparative efficacy to others (76.1%). However, 
even though physicians are not risk averse, safety concerns may influence 
prescribing. In a study aimed at investigating which factors influence physician 
prescribing behaviour regarding stress ulcer prophylaxis, concerns about side 
effects (OR = 0.24, 95% CI 0.09, 0.61) were associated with a decrease in 
prescribing (Hussain et al., 2010). Even though adverse drug reactions may not 
appear very often, they do have a profound effect on a physician’s prescribing 
patterns (Banjo et al., 2010, Theodorou et al., 2009).  
Calvo and Rubinstein (2002) evaluated the impact of the publication in a leading 
journal of different drug studies (metformin, alendronate, terazosin, and 
finasteride) on the prescription behaviour of generalists and specialists. In the 
study, three studies showed efficacy and one study showed lack of efficacy. The 
proportions of new prescriptions changed between a 6-month period before 
publication and a 6-month period after publication. Others have also found that 
efficacy influences physician prescribing behaviour; for example, efficacy and 
utility of the drug was found to be a distinctive factor influencing prescribing of 
statins (Tusek-Bunc et al., 2010). Furthermore, Theodorou et al. (2009) found 
that clinical effectiveness is the most important factor, reaching 94.9% and 93.3% 
in Greece and Cyprus, respectively, and that there was no statistically significant 
difference between the two countries.  
In a seminal study addressing the issue of attributes of medicine as a factor 
influencing physician prescribing behaviour, Venkataraman and Stremersch 
(2007) investigated  the effect of promotional effect across brands. The database 
used for the study included, at the monthly level, all prescriptions within the 
examined medicine categories by a panel of 2774 physicians. This resulted in 
just under 40 000 observations for the 12 brands included in the study. Detailing 
was found to have a more positive effect on prescriptions for more effective 
medicines as compared to less effective medicines, and for medicines with more 
side effects as compared to medicines with fewer side effects. In other words, it 
was found that that the effects of marketing efforts and patient requests on 
physician prescription behaviour do indeed vary by brand. Furthermore, medicine 
attributes, such as effectiveness and safety, moderate the response by 
physicians to promotional efforts on physician prescribing behaviour.  
Kurdyak et al. (2007) studied whether five regulatory agency advisories 
concerning the possible increased risk of suicidal behaviour during 
antidepressant therapy had an effect on antidepressant prescription trends in 
Ontario. The authors claim that safety advisories did not influence physician 
prescribing in North America, but similar advisories led to a decrease in 
prescribing in the UK in 2003. Thus, there may be geographical variations in the 
effect of safety advisories provided by regulatory agencies. In another study, 
Saad et al. (2010) investigated the warnings from the Food and Drug 
Administration (FDA) on the use of antipsychotics in the management of 
dementia. The authors found that information about medicine attributes may be 
effective and that the main barrier to change is the lack of treatment alternatives. 
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However, medicine attributes may not be the only moderator. Weatherby et al. 
(2002) retrospectively investigated the effect of FDA warning letters in order to 
determine how such letters may be improved. The authors conclude that explicit 
wording can aid in changing physician prescribing behaviour.  
On the basis of biopharmaceuticals being one of the fasted growing segments of 
the pharmaceutical industry, Nonis and Hudson (2009) investigated the effect of 
physicians’ beliefs about genetic engineering on physician prescribing. There 
appears to be a lack of trust in the technology, driven by a fear of unknown 
consequences. On this basis, the authors claim that genetic modification as an 
attribute influences physician prescribing behaviour by decreasing the likelihood 
in the decision making process leading to a prescription. 
From the results of this study and evidence from literature, there appears to be a 
consensus on physicians placing great value on clinical efficacy and seeming 
willing to take risks under certain conditions. Thus, the benefit-risk profile of 
medical therapy is not a static factor, but a dynamic one moderating physician 
choice behaviour. The findings of this study are therefore confirming previous 
theory.  
4.6.3 What has been Added 
The moment of truth in health care is complex for five main reasons. First, 
physicians are the decision makers on behalf of patients, payers, providers and 
producers. Second, decisions are made in the context of information asymmetry 
and uncertainty; and no unified theory of medical decision exists. Thus, deciding 
how to decide is important. Third, quality is non-contractible and physician effort 
is unobservable. Models abstracting the complexity of medical decisions into a 
single measurable item give the impression that treatment decisions are more 
easily monitored and controlled than they really are (McGuire, 2001 p. 527). 
Physicians are experience goods; patients must experience the physician and 
make an inference about quality. Fourth, physicians may set levels of quality to 
influence demand, and may do so motivated by self-interest. Finally, a unified 
definition of quality of health care does not exist, and there are more techniques 
to measure it than definitions. This study adds the physician perspective of this 
complex and cloaked moment, employing personal construct theory. In this study, 
physician perspectives include the following key constructs: communication, 
continuity, cooperation, interpretation, early diagnosis and treatment, effect of 
therapy, experience, full responsibility, resource availability, resource utilization 
and time. Furthermore, a theoretical link to the Theory of Planned Behaviour and, 
specifically, control belief and consequent perceived behavioural control is found 
to be strong. This may indicate a conflict between process management on one 
hand and physician effort to produce quality health care services on the other. 
Finally, the results from this study are homogenous in that theoretical saturation 
was achieved early, indicating that there is a high degree of agreement within the 
physician community as to the construct of quality. The most probable 
explanation for this last finding is that the “institution” of medicine is strong, 
indicating socialization and common perceptions of quality. 
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4.6.4 What has been Challenged 
Chandrasekaran et al. (2012) investigated the effect of Centres for Medicare and 
Medicaid Services (CMS) process management on quality. CMS developed a set 
of core measures for common and serious health conditions. The authors found 
a positive effect on technical quality and a negative effect on experiential quality. 
CMS process management aims to reduce variation, and thus experiential quality 
suffers as the variability necessary for meeting patient expectations is reduced 
(Pettersen et al., 2004).  
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, it is widely 
recognized that because medical decisions have an impact on patient health, 
they should be of high quality (Klein, 2005). Thus, the physician supplies into the 
production of health care for the patient (McGuire, 2001). The effort supplied by 
physicians may also be understood as quality and is not contractible (Ma and 
McGuire, 1997). Therefore, focusing on CMS process management implies that 
the very effort of producing quality is ignored. Herein lays the challenge provided 
by this study; i.e. the process element of quality is dependent on physician effort, 
and ignoring this fact is counterproductive.  
In this context, the study makes three important points. First, this study provides 
evidence on how physicians construct quality of health care delivery, and 
therefore represents a window into the hitherto unobservable effort (quality) input 
by physicians. Second, the theoretical link to the Theory of Planned Behaviour 
and, specifically, control belief and consequent perceived behavioural control is 
strong. This may indicate a conflict between process management on one hand 
and physician effort to produce quality health care services on the other. Finally, 
the results from this study are homogenous in that theoretical saturation was 
achieved early, indicating that there is a high degree of agreement within the 
physician community as to the construct of quality. The most probable 
explanation for this last finding is that the “institution” of medicine is strong, 
indicating socialization and common perceptions of quality. 
Thus, the findings of this study challenge the simplicity by which surrogates of 
quality are being used to measure quality. The complexity of clinical medicine, in 
a context where the physician is the decision maker on behalf of the stakeholders, 
and the effort is non-retradable and often unobservable, cannot be measured 
using simple econometric models and process management. 
4.6.5 Paradoxical Findings 
4.6.5.1 Experience 
In this study, experience is found to have a positive influence on quality of health 
care delivery. However, in a literature review on the topic, it has been found that 
“physicians who have been in practice longer may be at risk of providing lower-
quality care” (Choudhry et al., 2005 p. 260). Thus, the findings in this study and 
that in the literature may be contradictory.  
 212 
“I was experienced in evaluating patients breathing patterns and could 
immediately see that the patient had an obstructed airway. A foreign body 
was promptly removed and the patient could be discharged.” (ID# 23) 
There may be several explanations for this finding. First, the physicians’ “toolkits” 
are created during training and may not be updated regularly (Carthy et al., 2000). 
Second, older physicians seem less likely to adopt newly proven therapies and 
may be less receptive to new standards of care (Choudhry et al., 2005). In 
addition, practice innovations that involve theoretical shifts, such as the use of 
less invasive medical interventions (i.e. laparoscopic versus open surgical 
techniques), may take longer to adopt due to habit persistence (Coleman et al., 
1957, Coleman et al., 1959, Menzel and Katz, 1955, Kwong and Norton, 2007). 
However, when it comes to treating a particular disease, experience is an 
important indicator of quality. Studies show that physicians/hospitals that treat a 
high number of patients for a particular disease and perform large numbers of 
procedures/surgeries to treat it have better results (Birkmeyer et al., 2002).  
Thus, consensus on the effect of experience on quality in the literature is 
therefore lacking. The literature points in two directions when it comes to 
experience. First, a body of evidence investigates experience at the physician 
level measured by time in practice and finds a paradoxical effect. Second, a body 
of evidence has examined experience in relation to specific disease and 
procedures and found that higher numbers of patients treated reduces mortality. 
This may indicate that years in practice as a measure of experience is an 
inaccurate measure.    
4.6.5.2 Resources 
In this study, resources and resource utilization are found to be key constructs, 
as the respondents rate these factors as high. However, there is little evidence in 
the literature suggesting that increased resource utilization improve outcomes 
(Wennberg et al., 2002, Fisher et al., 2003, Fisher et al., 2003, Sirovich et al., 
2006).  
Fisher et al. (2003) investigated whether regions with higher Medicare spending 
provide better care. The authors found that regional differences in Medicare 
spending are largely explained by the more inpatient-based and specialist 
oriented pattern of practice observed in high-spending regions, and that neither 
quality of care nor access to care appear to be better for Medicare enrolees in 
higher-spending regions (Fisher et al., 2003 p. 273). Furthermore, “Medicare 
enrolees in higher-spending regions receive more care than those in lower-
spending regions, but do not have better health outcomes or satisfaction with 
care” (Fisher et al., 2003 p. 288). 
Physicians may influence quantity of care provided to patients by quantity setting 
of a non-retradable service, influencing demand by setting the level of a non-
contractible input ("quality"), and influence patient preferences. In this context, it 
is the quantity setting of non-retradable services and setting the level of quality 
that merits focus.  
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Physicians may influence quantity of care by setting the level of non-retradable 
services. This may explain why health care expenditure does not necessarily 
equate to better outcomes. The physician may in this instance perform more 
procedures than is warranted; for example, guideline adherence by physicians is 
in general low, suggesting that physicians may practice in a context of information 
asymmetry. “Economic models, abstracting the complexity of medical decisions 
into a single dimension of "quantity," give the impression that treatment decisions 
are more easily monitored and controlled than they really are.” (McGuire, 2001 p. 
527). Thus, a moral hazard situation is likely to occur due to the fact that the 
physician is insulated from the economic realities of the diagnostic and 
therapeutic decisions being made.  
The physician may also influence quantity by setting the level of quality. If 
resource levels are high, the physician may be tempted to set the quality 
accordingly, and increase resource utilization as a consequence. However, if 
resource levels are low, the opposite may occur. Physicians have been shown 
not to be risk averse and will, in certain circumstances, accept increased risk. 
Payers may even gamble on the fact that physician ethics will drive the physician 
to make more effort to provide appropriate care. However, the findings in this 
study would indicate that there is a limit at which quality will be reduced, even 
though physician effort may be a mitigating factor. 
4.6.6 Theoretical Perspectives 
In this section, the findings of the study are discussed in relation to the theoretical 
domains reviewed in Section 4.2. The key constructs and their theoretical 
foundations are summarised in Table 4-5 Key constructs by quality elements and 
relation to theory. The section covers Agency Theory, Decision Theory and the 
Theory of Planned Behaviour, before offering a summary and a conceptual 
framework. 
In this study, the key constructs may be categorized into three separate groups, 
according to quality elements as defined by (Peabody et al., 2006 p. 1294): 
structure, process and outcome. First, constructs representing structure, referring 
to stable, material characteristics and the resources of the organizations that 
provide care and the financing of care. Constructs in this category include 
resources (resource availability, resource utilization and time), experience and 
effect of therapy. Second, constructs representing process, referring to the 
interaction between physicians and patients during which structural inputs from 
the health care system are transformed into health outcomes. These constructs 
include communication, correct interpretation of information, continuity and 
responsibility of care provision, and cooperation. Finally, constructs representing 
outcomes, which may be measured in terms of health status, deaths, or disability-
adjusted life year. Only one construct, early diagnosis and treatment, is found in 
this category.   
4.6.6.1 Agency Theory 
Five key constructs from this study are related to Agency Theory; see Table 6: 
Key constructs by quality elements and relation to theory for details. First, 
communication is related to risk through mechanism of monitoring and 
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negotiation. Second, cooperation is related to moral hazard and adverse 
selection. Third, early diagnosis and treatment is related to risk through random 
market effect. Fourth, experience is related to adverse selection. Finally, time is 
related to moral hazard and adverse selection.  
Communication is found to be an important element in how physicians construct 
quality of health care delivery. The main tenet of Agency Theory holds that 
asymmetry of information and uncertainties are the main influencers of agent 
behaviour. Asymmetry of information and uncertainty may in certain 
circumstances make it impossible for the principal to know what the physician 
knew or even did, and hence difficult to measure. Mooney and Ryan (1993) made 
the same point by stressing how health markets deviate from a standard principal-
agent model because of the inability to contract on outcome. Thus, health 
outcomes may be considered non-contractible. In the standard agent-principal 
model where an outcome is observable and hence contractible, risk may be 
transferred to the agent (McGuire, 2001). Risk in the context of the findings of this 
study is related to communication. In order to manage risk, the principal will 
engage in monitoring of output. However, monitoring has been shown to affect 
communication in principal-agent dyads (Conlon and Parks, 1990 p. 607).  
Uncertainty is stated as the main driver of physician behaviour (Arrow, 1963), and 
it is therefore unreasonable to expect the benefit-risk of clinical medical practice 
not to influence physician choice behaviour. Indeed, safety and effectiveness 
were considered highly influential of quality health care delivery in this study. If 
the physician (agent) is risk averse, this would require the principal to 
compensate the agent for accepting the risk. However, this would not apply to 
the patient, as the patient would carry the full biological risk of any outcome. 
Physicians, however, may not be risk averse. Pinto et al. (2010) argue that  
members of the medical profession are willing to take certain risks by using more 
effective medicines, even if they cause more reactions that are adverse. Thus, a 
situation characterised by adverse selection may arise.  
Outcomes are not contractible, so the standard agent-principal model may not 
apply in health care where an agent serves multiple principals (Gaynor, 1994). 
However, time has been shown to be contractible in principal-agent dyads 
(Conlon and Parks, 1990 p. 619), but a principal may be unable to accurately 
indicate an agent's contributions because of the random market effect (Conlon 
and Parks, 1990 p. 610). According to Gaynor (1994), physicians may be 
considered “experience goods”. A patient literally has to experience a physician, 
and then make an inference about the quality, including any issues about a match 
with the patient's preferences (McGuire, 2001). The inference and consequent 
learning is not perfect and may in addition be slow. The reward for higher quality 
is therefore likely to be inadequate (Ma and McGuire, 1997, McGuire, 2001). The 
presence of an active payer (principal) has been suggested to challenge 
physician loyalties to patients (Ma and McGuire, 1997).  Medical ethics has 
therefore been suggested to play a role in medical care (Mechanic and 
Schlesinger, 1996).  If medical ethics operate in the way that the physician always 
chooses the medically correct way to proceed, financial incentives would be 
ineffective (McGuire, 2001). Hillman et al. (1989) p. 87, state “whereas most 
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physicians will act in the patients' best interests when the medical decision is 
clear-cut, the effect of financial incentives may be more important in areas where 
the correct decision is not clear." This notion was investigated by Ma and McGuire 
(1997), and the authors concluded that “a payer can take advantage of a 
physician's ethical constraint by setting up a payment system that puts the 
physician in the position of being forced to take more effort to make sure the 
patient attains an acceptable outcome” (McGuire, 2001 p. 521). This could 
potentially be the case when resources are scarce and management gamble on 
the physician ethics to deliver necessary effort by physicians to provide 
acceptable quality of care.  
Cooperation is found to be an important element in how physicians construct 
quality of health care delivery. Delivery of health care in the context of modern 
medicine may be considered a cooperative effort. According to Eisenhardt (1989) 
p. 72, “Agency Theory provides a unique, realistic, and empirically testable 
perspective on problems of cooperative effort”. Thus, the principal-agent dyad 
may be considered a cooperative effort. The main tenet of Agency Theory holds 
that there is a conflict of interest between the principal and the agent. On one 
hand, asymmetry of information may drive a condition of moral hazard, and on 
the other, risk may cause adverse selection to occur. Even though the findings of 
this study support patient-physician cooperation, the main focus is on the quality 
of the cooperative effort among physicians and other health care workers. In this 
context, economic interest would drive a possible conflict of interest. However, 
this is not felt to be the case in this study, as evidence supporting the notion is 
lacking.  
4.6.6.2 Decision Theory 
Three key constructs from this study are related to Decision Theory; see Table 
4-5 for details. First, correct interpretation of information is related to causal and 
diagnostic interpretation of information. Second, experience is related to habit 
persistence and learning. Finally, effect of therapy is related to learning. 
Correct interpretation is found to be an important element in how physicians 
construct quality of health care delivery. Focus of attention to what the physician 
prefers results in differential weighting of information features. For naturally 
occurring phenomena, it is not clear whether people do consider base rates 
(Goldsmith, 1980). Base rate is critical in medicine and is often used to make 
comparisons. For example, this winter in a certain hospital, 220 people have 
tested positive for swine flu; the number in itself may seem high, but the 
population base is 470 000, so the base rate of positive swine flu tests this winter 
is 220/470 000. Information that receives a causal interpretation is weighted more 
heavily in judgment than information that is diagnostic (Einhorn and Hogarth, 
1981 p. 65). Thus, correct interpretation of information may be dependent on the 
physicians’ preference of information features. 
Experience is found to be an important element in how physicians construct 
quality of health care delivery. Physician-level habit persistence has been widely 
stated (Janakiraman et al., 2008, Venkataraman and Stremersch, 2007, Jones et 
al., 2001, Lilja, 1976, Coscelli, 2000). The Theory of Planned Behaviour predicts 
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behaviour by proxy of behavioural intent, which is modulated by cognitive 
processes focused on the balance between attitude, social norm and control 
beliefs (Ajzen, 1991). Habit persistence, on the other hand, is the residue of past 
behaviours and experiences, and by definition, does not involve conscious 
processing. From a decision theoretical perspective, it can be argued that habit 
reduces the effort associated with decision making in complex clinical settings 
(Payne et al., 1993). Furthermore, it is widely stated that physicians make 
extensive use of heuristics when making clinical decisions, including those 
pertaining to the prescription of medicines (Bornstein and Emler, 2001).  Thus, 
habit persistence may simply be driven by the economy of decision-making; in 
other words, it is necessary for the physician to form habits to reduce the burden 
of decision making related to the act of prescribing. When combining the two 
theoretical perspectives, Theory of Planned Behaviour and decision under 
uncertainty, it can be further argued that the mechanism by which habit 
persistence modulates physician choice behaviour is related to attitude formation. 
This can be explained by the fact that that the physicians’ beliefs about 
consequence play a central role when evaluating benefit-risk of any treatment 
prescribed in a clinical setting. For example, Janakiraman et al. (2008) claim that 
only non-persistent physicians are sensitive to detailing.  
Learning can account for most attitudes (Doob, 1947), and unlike personality, 
attitude is expected to change with experience (Tesser and Shaffer, 1990). 
Dissonance-reduction theory holds that components of an attitude may be 
adjusted to match the other in order to reduce dissonance (Festinger, 1957). The 
purpose of perception is to guide action (Confer et al., 2010, Gaulin and 
McBurney, 2004 pp. 81-101). Furthermore, Bandura (1989) p. 1178, states that 
“Any factor that influences choice behaviour can profoundly affect the direction of 
personal development because the social influences operating in the 
environments that are selected continue to promote certain competencies, 
values, and interests long after the decisional determinant has rendered its 
inaugurating effect. Thus, seemingly inconsequential determinants can initiate 
selective associations that produce major and enduring personal changes”. Thus, 
experiences early in a physician’s career may be determinant of later choice 
behaviour.  
Both experience and treatment effects are found to be important elements in how 
physicians construct quality of health care delivery, and are linked to learning in 
a Decision Theory context. Learning from experience holds that the role of 
awareness of the task factors that can influence outcomes influence learning 
through positive outcome feed-back (Einhorn and Hogarth, 1981 p. 79). Thus, 
experience facilitates learning, but the self-fulfilling treatment effects of taking 
action per se can combine to produce reinforcement through positive outcome 
feedback. Thus, one can receive positive feedback in spite of, rather than 
because of, one's judgmental ability (Einhorn and Hogarth, 1981 p. 79). It is 
therefore possible for a physician to learn inappropriate decision rules 
(heuristics). In fact, physicians do make mistakes, and Klein (2005) has identified 
heuristic pitfalls and made suggestions on how to avoid them.  
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4.6.6.3 Theory of Planned Behaviour 
Ten key constructs from this study are related to Decision Theory; see Table 4-5 
Key constructs by quality elements and relation to theory, for details.  
The Theory of Planned Behaviour at its simplest, predicts behaviour on the basis 
of intent (Ajzen, 1991). The theory holds that attitude toward behaviour, 
subjective norms, and perceived behaviour frame behavioural intention. In this 
study, the key constructs may be categorized into three separate groups, 
according to quality elements as defined by (Peabody et al., 2006 p. 1294): 
structure, process and outcome. First, constructs representing structure, referring 
to stable, material characteristics and the resources of the organizations that 
provide care and the financing of care. Constructs in this category include 
resources (resource availability, resource utilization and time), experience and 
effect of therapy. Second, constructs representing process, referring to the 
interaction between physicians and patients during which structural inputs from 
the health care system are transformed into health outcomes. These constructs 
include communication, correct interpretation of information, continuity and 
responsibility of care provision, and cooperation. Finally, constructs representing 
outcomes, which may be measured in terms of health status, deaths, or disability-
adjusted life year. Only one construct, early diagnosis and treatment, is found in 
this category. In Table 4-5, key constructs are summarised per category, 
indicating the theoretical construct associated with theory and suggested 
literature reference. 
Table 4-5 Key constructs by quality elements and relation to theory 
Quality 
element 
Construct Theory Theoretical 
construct 
Reference example
Process Communication TPB Attitude Ajzen 1991, p. 198 
Agency Risk: monitoring and 
negotiation 
Conlon & Parks 1990, p. 607 
Correct interpretation of 
information 
TPB Control belief Ajzen 1991, p. 204 
Decision Causal vs diagnostic 
interpretation 
Einhorn & Hogarth 1981, p. 65 
Continuity  TPB Control belief Ajzen 1991, p. 199 
Responsibility for provision 
of care 
TPB Control belief  & 
Social norm 
Ajzen 1991, p. 199 
Structure Resource availability TPB Control belief Ajzen 1991, p. 188 
Resource utilization TPB Control belief Ajzen 1991, p. 188 
Time TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Conlon & Parks 1990, p. 619; 
Eisenhart 1989, p. 70 
Cooperation TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Eisenhart 1989, p. 72 
Experience TPB Control belief Ajzen 1991, p. 203 
Agency Adverse selection Eisenhart 1989, p. 61 
Decision Habit persistence Ajzen 1989, p. 203 
Outcome Early diagnosis and 
treatment 
TPB Control belief Ajzen 1991, p. 204 
Agency Risk: random market 
effect 
Conlon & Parks 1990, p. 610 
Effect of therapy TPB Control belief Ajzen 1991, p. 204 
Decision Reinforcement: 
positive  outcome 
feedback 
Einhorn & Hogarth 1981, p. 79 
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The constructs providing information about process are felt to be the most 
important, as this is where the interaction between patient and health care service 
providers takes place (moment of truth). Four key constructs are included in this 
category; communication, continuity of care, responsibility and correct 
interpretation of information.  
First, communication is related to attitude. Evidence from research suggests that 
persuasive messages that attacks beliefs about an object may produce changes 
in attitudes toward the object (Petty et al., 1983). According to Ajzen (1991) p. 
198, “it is highly likely that persuasive communications directed at particular 
normative or control beliefs will influence subjective norms and perceived 
behavioural control”. Communication may therefore influence attitude, subjective 
norm and perceived behavioural control. However, of special interest is the 
construct related to transfer; this highlights the fact that communication is not just 
verbal. Other factors of communication may also influence attitude, as 
exemplified by the quote below. 
"Everyone knows this patient. She has been in and out of institutions her 
whole life. When I became responsible for her care I thought I could make 
a difference. It is very difficult to deal with the patient that eats needles and 
razor blades when you have spent so much time and effort trying to help. 
I felt so angry and disappointed" (ID# 1) 
Second, continuity of care is related to how many physicians or other health care 
workers are involved in the care. However, continuity is also strongly linked to 
responsibility and may even partly be driven by responsibility. The moral 
obligation to perform or not to perform certain behaviours is expected to influence 
behavioural intent (Ajzen, 1991 p. 199). When many physicians are involved in 
the provision of care, information may be lost during numerous exchanges. 
Furthermore, feeling of responsibility may also be affected. 
Lack of continuity is connected to another key construct, early diagnosis and 
therapy. These constructs are interlinked as the time from symptom to diagnosis, 
and hence therapy may be influenced by lack of continuity of care. 
Third, full responsibility of care denotes the fact that one physician is in charge of 
the care of the patient. This is often not the case, as a patient may see many 
physicians during one hospital visit.  
There are a number of reasons why a patient will encounter many physicians 
during a stay in the hospital. First, modern medicine is complex and 
multidisciplinary, involving many sub-specialties. For example, upon entry to the 
emergency room (ER), a patient with pneumonia will first meet the attending ER 
physician. Depending on the condition, x-rays may well be required, and the 
patient will then be in contact with the radiologist. After the diagnostic work-up is 
complete, the patient will most likely be sent to a ward for treatment and followed 
up by physicians in training during the remainder of the stay. However, the senior 
physician in charge of the ward will also likely be in contact with the patient. Upon 
discharge, the patient may be required to come back for a control, thus seeing 
the physician attending to policlinic patients that day.  
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Finally, correct interpretation of information is central to the process of diagnosing 
and deciding on the appropriate therapy. Processing of available information 
mediates the effects of clinical contexts on behaviour. Past experience with 
behaviour is the most important source of information about behavioural control 
(Bandura, 1986). It thus stands to reason that perceived behavioural control can 
play an important role in mediating the effect of past on later behaviour. 
Evidence suggests that early experience of using a new medicine seems to 
strongly influence future prescribing (Jones et al., 2001, Jones et al., 2001). 
Bandura (1989) p. 1178, states that “Any factor that influences choice behaviour 
can profoundly affect the direction of personal development because the social 
influences operating in the environments that are selected continue to promote 
certain competencies, values, and interests long after the decisional determinant 
has rendered its inaugurating effect. Thus, seemingly inconsequential 
determinants can initiate selective associations that produce major and enduring 
personal changes”. As such, experiences early in a physician’s career may be 
determinant of later choice behaviour.  
“The patient came to the ER complaining of a tight chest. It was early in 
my career as a physician and I was inexperienced. I figured it must be a 
myocardial infarction and did not involve the consultant. I gave the 
prescribed treatment for myocardial infarction, but the patient got worse. 
Finally, I called the consultant and pneumonia was diagnosed and 
treated." (ID# 20) 
From a TPB perspective, it is therefore clear that most of the key constructs 
framing physicians’ perceptions of quality of health care delivery are related to 
control beliefs. Ajzen (1991) p. 184, makes a distinction between actual and 
perceived behavioural control. Actual behavioural control relates to the 
availability of resources and the opportunity to perform the desired behaviour; 
thus, actual behavioural control is observable. Perceived behavioural control, on 
the other hand, relates to perception and its impact on intention and action; and 
is unobservable. If the accuracy of perceived behavioural control is high, then it 
may substitute for actual behavioural control. Information asymmetry and 
uncertainty may influence the accuracy of behavioural prediction (Ajzen, 1991 p. 
185). However, if the perception is realistic, it may be used to predict the 
probability of behaviour (Ajzen, 1985). In a meta-analytic review of efficacy of the 
Theory of Planned Behaviour, Armitage and Conner (2001) p. 471, conclude that 
“the perceived behavioural control (PBC) construct accounted for significant 
amounts of variance in intention and behaviour, independent of theory of 
reasoned action variables.” Furthermore, Eccles et al. (2006) p. 9, concluded that 
intention is a valid proxy measure for behaviour among clinicians.  
4.6.6.4 Theory Summarized 
From a theoretical perspective, the findings of this study are mainly related to 
behavioural control in a context of risk modulated by information asymmetry. 
Thus, the probability of predicting behavioural action and consequent outcome is 
dependent on unobservable factors. Influencing quality of health care will 
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therefore depend on the ability to manage factors influencing perceived 
behavioural control of physicians, information asymmetry and uncertainty. 
Furthermore, it is possible that physician behaviour may be categorized as 
habitual, as it is typically performed in a stable context (Godin et al., 2008). This 
notion stems from the observations made by Verplanken and Wood (2006), who 
demonstrated that habitual behaviour performed in a stable context is more 
difficult to change. In conclusion, physician effort is largely unobservable and 
takes place in a stable context; thus, improving quality of health care delivery by 
influencing physician behaviour may be difficult. It is therefore important that any 
intervention be designed so that the constructs of quality perceived by physicians 
are taken into due consideration.   
In conclusion, it is evident that the constructs of health care delivery quality are 
strongly influenced by perceived behavioural control. Thus, the Theory of 
Planned Behaviour has the strongest predictive power of how quality is 
constructed when viewed through the physician lens.  
4.6.7 Proposed Conceptual Framework 
In this section, a conceptual framework for quality in health care delivery is 
proposed, based on how physicians construct quality of health care delivery. The 
framework takes into account the findings from this study, elements of quality and 
the three theoretical domains identified in Project One, see Figure 4-5 Conceptual 
framework.  
Structure is comprised of resource availability, resource utilization, time, 
cooperation and experience. All five constructs are grounded in the Theory of 
Planned Behaviour and related to control beliefs and perceived behavioural 
control. Three of the constructs are also grounded in Agency Theory; experience, 
cooperation and time. Information asymmetry and risk are defining constructs of 
influence in the Agency Theory context. Finally, experience is grounded in 
Decision Theory and related to habit persistence. 
Process is comprised of communication, correct interpretation of information, 
continuity of care and responsibility of care. All constructs are grounded in Theory 
of Planned Behaviour and related to control beliefs and perceived behavioural 
control. Communication is also grounded in Agency Theory and related to risk 
through monitoring and negotiation. Correct interpretation is grounded in 
Decision Theory and linked to causal and diagnostic interpretation of information.  
Outcome is comprised of early diagnosis and treatment, and effect of therapy. 
Early diagnosis and treatment are grounded in Theory of Planned Behaviour and 
Agency Theory. The link to theory is through control beliefs and perceived 
behavioural control, and information asymmetry and risk, respectively. Effect of 
therapy is grounded in Theory of Planned Behaviour and Decision Theory. From 
a Theory of Planned Behaviour perspective, effect of therapy is associated with 
control beliefs and perceived behavioural control. From an agency perspective, 
effect of therapy is linked with reinforcement through positive outcome feedback. 
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Figure 4-5 Conceptual framework 
4.7 Summary & Conclusions 
In this section the key findings, contributions, limitations and personal reflections 
are summarised.  
4.7.1 Key Findings 
The moment of truth in medicines is complex for five main reasons. First, 
physicians are the decision makers on behalf of patients, payers, providers and 
producers. Second, decisions are made in the context of information asymmetry 
and uncertainty; and no unified theory of medical decision exists. Thus, deciding 
how to decide is important. Third, quality is non-contractible and physician effort 
is unobservable. Models abstracting the complexity of medical decisions into a 
single measurable item give the impression that treatment decisions are more 
easily monitored and controlled than they really are  (McGuire, 2001 p. 527). 
Physicians are experience goods; patients must experience the physician and 
make an inference about quality. Fourth, physicians may set levels of quality to 
influence demand, and may do so motivated by self-interest. Finally, a unified 
definition of quality of health care does not exist, and there are more techniques 
to measure it than definitions.   
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It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, it is widely 
recognized that because medical decisions have an impact on patients’ health, 
they should be of high quality (Klein, 2005). Thus, the physician supplies into the 
production of health care for the patient (McGuire, 2001). The effort supplied by 
physicians may also be understood as quality and is not contractible (Ma and 
McGuire, 1997). Therefore, focusing on CMS process management implies that 
the very effort producing quality is ignored. Herein lays the challenge provided by 
this study; i.e. the process element of quality is dependent on physician effort, 
and ignoring this fact is counterproductive.  
Thus, the findings of this study challenge the simplicity by which surrogates of 
quality are being used to measure quality. The complexity of clinical medicine, in 
a context where the physician is the decision maker on behalf of the stakeholders, 
and the effort is non-retradable and often unobservable, and cannot be measured 
using simple econometric models and managed through a unilateral focus on 
process management. 
4.7.2 Contributions 
In this section, the contributions made by this study, implications for stakeholders 
in health care, limitations, suggestions for future research and personal 
reflections are all highlighted. 
4.7.2.1 What has been Added 
This study explicates some aspects of quality of health care delivery that go 
beyond prior related studies. The researcher advances theory in this area by 
exploring how physicians construct quality of health care delivery in a hospital 
setting. The model presented integrates the study findings with elements of 
theory from different academic areas, such as medicine, economics, 
management and psychology.  
More specifically, the study explicates three main aspects of health care quality. 
First, this study provides evidence on how physicians construct quality of health 
care delivery, and therefore represents a window into the hitherto unobservable 
effort (quality) input by physicians. Second, the theoretical link to the Theory of 
Planned Behaviour and, specifically, control belief and consequent perceived 
behavioural control is strong. This may indicate a conflict between process 
management on one hand and physician effort to produce quality health care 
services on the other. Finally, the results from this study are homogenous in that 
theoretical saturation was achieved early, indicating that there is a high degree 
of agreement within the physician community as to the construct of quality. The 
most probable explanation for this last finding is that the “institution” of medicine 
is strong, indicating socialization and common perceptions of quality. 
4.7.2.2 Implications for Stakeholders in Health Care 
In this section, implications for stakeholders in the health care value chain are 
discussed, who are: payers, providers and producers. Payers refers to 
policymakers, regulators and payers. Providers refers to hospital management 
and practitioners (physicians). Producers refers to the pharmaceutical and 
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technological industry. In addition, institutions are added as there may be 
implications for medical education and research. Finally, implications for patients 
are provided.  
4.7.2.2.1 Implications for Payers 
Payers in this context refers to payers in the health care value chain as defined 
by Burns et al. (2002). However, in addition to payers and financial 
intermediaries, policy makers and regulators are considered in this section. The 
reason for the inclusion of policymakers and regulators is that they influence and 
regulate the fiscal platform supporting the health care value chain.  
The findings of this study may be of interest to payers for three main reasons. 
First, payers by way of simple monitoring and incentives leave a great deal of 
authority about diagnosis and treatment with the physician (McGuire, 2001 p. 
527). Second, reliance on medical sub-specialization and physician experience 
may have a paradoxical effect on quality of health care delivered (Choudhry et 
al., 2005). Finally, there is a lack of evidence supporting the hypothesis that more 
is better when it comes to cost of health care (Wennberg et al., 2002).  
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, simple 
monitoring and incentives leave a great deal of authority about diagnosis and 
treatment with the physician (McGuire, 2001 p. 527). Thus, the physician is the 
decision maker on behalf of the patients and stakeholders in the health care value 
chain. The findings of this study imply that physicians place great emphasis on 
early diagnosis and treatment as an influencer of quality health care. Payers 
should therefore pay more attention to the process of clinical medicine and how 
monitoring and incentives influence the time from symptom to start of therapy.  
In a systematic review of the literature, Choudhry et al. (2005) p. 260, found that 
“physicians who have been in practice for longer may be at risk of providing lower 
quality of care”. In this study, the findings suggest that physician perception is 
contradicting evidence in the literature. There are several possible explanations 
for this contradiction, but only three merit further mentions in this context. First, it 
has been suggested that the physician’s “tool-kit” is developed during training 
and not updated on a regular basis (Choudhry et al., 2005, Carthy et al., 2000). 
Second, older physicians have a higher threshold for adopting new standards of 
care (Young et al., 1987). Finally, the adaptation of new technologies may be 
affected by habit formation (Greer, 1988). 
4.7.2.2.2 Implications for Providers 
The findings in this study should be of particular interest to physicians in clinical 
medicine. It is evident that physician perspective and weighted importance of 
experience is at odds with evidence in the literature. Thus, physicians should be 
cognisant of the potential paradoxical effect of experience on patient outcome. 
Experience in clinical decision making may have two main effects: it may inform 
on a conscious level or on an unconscious level. Unfortunately, one of the 
strongest influencers of physician choice behaviour is habit persistence. Habit 
does not involve conscious thought, so decisions based on habit may therefore 
represent a pitfall in decisions related to diagnosis and treatment (Klein, 2005).   
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 “When I was a young physician I wanted to be consulted. Being asked by 
other colleagues is a nice experience. Now, I am being consulted and it 
feels good.”  (ID# 17) 
Physician perspectives on quality health care are a reflection of the “institute” of 
medicine. Since asymmetry of information and uncertainty are strong influencers 
of physician choice behaviour, it is reasonable to assume that the perspectives 
identified in this study represent key areas of potential conflict between hospital 
management and physicians. It may therefore be advisable to build change and 
key performance metrics grounded in the physician perspectives, as this will give 
legitimacy and ease implementation.  
The findings of this study suggest that experience is positively correlated with 
quality of health care delivery. However, a systematic review of evidence linking 
experience with quality of health care has shown paradoxical effects (Wu et al., 
2012, Choudhry et al., 2005) or no effect (Pieske et al., 2010). There are several 
possible explanations for this divergence, but habit persistence may be the 
strongest predictor. This should concern managers of health care institutions. 
Physicians with more experience will in most cases be more senior due to the 
length of time it takes from entering medical school until a physician is a certified 
specialist and respected by peers. Thus, the most experienced physicians are 
more likely to be in positions of influence with respect to the provision of health 
care.  
4.7.2.2.3 Implications for Producers 
It can be argued that the two sides of the health care value chain are driven by 
different logics in the contest for flow of products, money and information.  
Payers are focused on welfare, and producers on profit maximisation. In the 
middle sits the provider, acting out of self-interest. Mechanisms to regulate the 
flow of information, money and products are therefore central to the future of 
health care, where prescription medicines will continue to play an important role. 
The model successfully utilized by the pharmaceutical industry for more than a 
century is at odds with the future needs of patients, payers and providers. This is 
highlighted by the recent McKinsey report (Q4 2011) addressing the 
pharmaceutical industry, where it is evident that change must come swiftly if 
competitive advantage is to be maintained. Loss of exclusivity of block buster 
medicines and generic competition combined with a lean pipeline of new and 
promising products have led the industry down the path of extensive cost cutting 
(Hunt et al., 2011). However, cost cutting alone will not sustain investor relations 
in the long term. Thus, a new model must be successfully implemented. The main 
ingredients are innovative partnerships and technology.   
4.7.2.2.4 Implications for Institutions 
Communication is central to gathering and sharing information in a clinical setting, 
and thus central in diagnosing and treating patients. The literature on 
communication is abundant, and it is widely stated that good quality 
communication between patient and physician is key to quality of care (Jensen 
et al., 2011). In a randomized controlled trial, it has been shown that a 20 hour 
course in clinical communication can improve the quality of care, and that these 
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changes are measurable three years after the course (Jensen et al., 2011). Focus 
on clinical communication should therefore be a part of the core curriculum in 
medical schools. Furthermore, it is evident that short courses can improve quality 
of care in a clinical setting. As such, continuous focus on communication needs 
to be on any health care manager’s agenda. 
Lai (2002), has defined competency as the ability to meet today’s and tomorrow’s 
challenges; in other words, to have knowledge, skills, abilities and attitudes suited 
to accomplish tasks and challenges. Being competent is not a state, but a 
condition related to a given situation. Therefore, in clinical medicine, it is 
imperative that competent health care workers are matched to the situational 
requirement of patients. Since the course of a disease is dynamic, competency 
requirements may change over time, and this mandates adaptation in the 
competency mix providing care. Clinical competencies in medicine take a long 
time to develop; from the time a hopeful student enters medical school till the 
same person is a fully fledged sub-specialist within a field of medicine, two 
decades will have passed. Making sure that this investment is not wasted 
necessitates further investment in tweaking and maintaining the competencies of 
the individual. However, this needs to be put into a larger strategic context where 
hospital management plans for the future requirements of the population base 
being served. 
It is argued that although uncertainty can be reduced, it can never be completely 
eliminated from decision-making. Therefore, most decision-making performed in 
medicine contains an irreducible intuitive element, and is thus vulnerable to these 
biases and heuristics. Given that few medical curricula overtly address the 
process of medical decision-making, both medical students and physicians 
remain vulnerable to these effects on their own (and their patients') decision-
making. Insight via education appears to be the major means through which to 
avoid distorting decision-making processes. 
4.7.3 Limitations 
The study was designed to capture how physicians frame quality of health care 
delivery in a hospital setting. A repertory technique was employed, yielding data 
from 27 physicians (respondents) based on 162 actual patient cases (elements) 
provided by the respondents. Theoretical saturation, as measured by employing 
a modified Lorenz curve, was reached at 17 respondents. Thus, the sample size 
is deemed to be adequate.  
The methodology in this study closely followed that described in the literature. 
Repertory grid technique has been used in health care settings; however, it has 
not been used to investigate how physicians construct quality of health care 
delivery. The focus was on identifying the important constructs across the 
sample, and this was accomplished by using an additional technique devised by 
Honey (1979) to retain the meaning of the individual across the sample. However, 
it has not been possible to differentiate answers based on nominal responder 
data against the overall importance rating in accordance with Honey (1979).  
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Three main limitations to repertory grid technique are of interest in this study. 
First, RGT is a method that is time consuming, which makes it difficult to generate 
large amounts of data and so produce general knowledge. Second, RGT may be 
of limited use if the respondents find it difficult to understand the technique or if 
the constructs elicited are not handled in a sensitive manner (Cassell and Walsh, 
2004).  Finally, interpretation of the data may be problematic and due to the fact 
that interviews are subject to researcher bias (Goffin, 2002). 
4.7.4 Suggestions for Future Research 
This study has identified how physicians frame quality of health care delivery, and 
may serve as a framework for further studies into the field of quality in health care 
delivery. The study does not, however, inform on facilitators or barriers to quality 
of health care delivery. In order to design and implement interventions to improve 
the quality of health care delivery, it is important to understand the facilitators and 
barriers. It is therefore proposed that a further study should be undertaken to 
provide additional evidence on the topic. The following research question is thus 
posed for Project Three: 
RQ: What are the barriers and facilitators of quality of health care delivery 





 CHAPTER FIVE: PROJECT THREE 
Chapter Four set out the research question for this study. The research strategy 
and method are detailed in Appendix C, and this chapter uses them to explore 
the gap identified in the second project of the Executive Doctorate Programme. 
The academic and business context of the project forms the introduction of the 
chapter. Following this introduction, the detail of the research question for Project 
Three and the research strategy and methods used during Project Two are 
discussed. The chapter further describes the pilot study that was conducted, 
which is followed by the description of how the main study was carried out. The 
findings and the results of Project Three are then discussed in detail. The chapter 
concludes by identifying the limitations of the study and offering suggestions for 
further research 
5.1 Introduction and Background 
Physicians are primarily dedicated to the process of diagnosing and treating 
patients; during this process, decisions are being made. Physician decision 
making during the process of diagnosing and treating patients has direct and 
indirect influences on patient health. It is therefore important that these decisions 
are of high quality. Any factors affecting the decision may also influence patient 
health, so it is of interest to understand what factors influence physician 
decisions, by what mechanism these factors assert influence and under which 
contexts.  
In order to understand what factors influence physician decision behaviour, a 
systematic literature review was undertaken. This review (Project One) took 
prescribing behaviour as a proxy. The review identified two sets of categories of 
key influencers of physician decisions: interventions and contexts. Interventions 
refer to proactive techniques, processes or actions introduced to create change 
in physician decisions. Contexts are the set of circumstances surrounding 
decision events. Furthermore, the review found that existing evidence was limited 
in providing an understanding on how the influencers on physician decisions 
affect the quality of health care delivered.  
The effort undertaken to enhance medical decision making is difficult to observe, 
as it occurs in the physician’s mind. Therefore, in order to gain an understanding 
of how factors affect quality of health care delivery by influencing physician 
decisions while performing their duties, it is necessary to understand how 
physicians construct quality. Thus, Project Two was focused on identifying how 
physicians construct the perception of quality in health care delivery. Repertory 
grid interviews with 27 physicians were performed. The analysis of data followed 
established and well-documented practice in the literature and yielded eleven key 
constructs, identified based on their frequency of mention and variability. These 
key constructs are communication, continuity of care, cooperation, correct 
interpretation of information, early diagnosis and treatment, effect of therapy, 
experience, responsibility for care provision, resource availability, and resource 
utilisation and time. From this project, it emerged that how physicians construct 
quality of health care delivery provides a static picture of physicians’ quality 
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conception. Thus, a third DBA project was undertaken to gain a fuller 
understanding of the dynamics of quality in health care by exploring enablers and 
barriers from the physician perspective.  
The focus of the current project (Project Three) is to gain an in-depth 
understanding of what facilitates and what prevents physicians from delivering 
quality health care services. The study is driven by the following research 
question:  
RQ: What are the enablers and barriers physicians perceive in their role 
of providing health care? 
Each patient-physician encounter is different and forges a set of temporal 
experiences unique to each physician. In order to explore and identify enablers 
and barriers for high quality health care service delivery, a semi-structured 
interview technique was adopted to address the research question.  
5.2 Theoretical Positioning 
The theoretical positioning has been covered in Project One and Two, and will 
therefore not be examined in detail in this document.  However, the reader is 
provided with the main tenets of the theoretical domains initially identified in 
Project One. A reference to definitions of quality is also presented in this section. 
5.2.1 Main Tenets of Theory 
In the preceding systematic literature review, three theoretical domains of 
physician decision behaviour were identified; see Figure 5-1 Theoretical 
Domains. The theoretical domains have been presented in-depth in Project Two; 
please see Section 4.2 Theoretical positioning on page 169 for further details.  A 
brief description of the main tenets follows.  
 
Figure 5-1 Theoretical Domains 
5.2.1.1 Agency Theory 
The basis for agency is that one party (principal) delegates work to another 
(agent);  and Agency Theory is concerned with two problems occurring in agency 
relationships (Eisenhardt, 1989). The first problem relates to conflict of interest 
(moral hazard) and the second to risk sharing (adverse selection). Moral hazard 
and adverse selection lie at the core of Agency Theory, and both presume a 
conflict of interest between agent and principal (Mitnick 1994). Moral hazard 









exposed to the risk (Arrow 1963). Adverse selection refers to a situation when 
undesired results occur on the bases of the principal and agent having different 
information (asymmetry of information) (Arrow 1963). It has been argued that 
physicians operate in an environment characterised by both information 
asymmetry and uncertainty. Uncertainty has been stated to be a powerful 
influencer of physician behaviour (Arrow, 1963). 
5.2.1.2 Theory of Reasoned Action and Theory of Planned Behaviour 
Theory of reasoned action (TRA) is concerned with what determines intention. 
Intention to perform a certain action is a function of two factors: attitude and 
subjective norm (perception of importance). Determinants of attitude have been 
identified as: evaluation of belief and strength of belief (O'Keefe, 2002 pp. 103-
109). Perceived lack of ability may have a negative impact on intention to perform 
an action. In 1991, Ajzen revised the theory, and in so doing added a third factor, 
perceived behavioural control, leading to the Theory of Planned Behaviour (TPB) 
(Ajzen, 1991). Persuasive efforts from a TRA perspective may take three forms: 
changing the attitudinal component, changing the normative component or 
changing the relative difference.  
Physicians’ behaviours can be explained by considering the physician’s role as 
an expert in health care. The expert role is significant due to information 
asymmetry. Being the most knowledgeable in the agency relationship, attitude 
and social norm play a lesser role than does perceived behavioural control. Thus, 
physicians’ behavioural control and its influencers are significant. 
5.2.1.3 Decision Theory 
Several factors influence decision making, and understanding these factors helps 
understand the decision making process and potential outcomes in the context 
of HCOs. Because medical decisions have an impact on patients’ health, they 
should be of high quality (Klein 2005). However, medical practice is complex and 
time is often limited, leading to the use of heuristics, a substitute for the logical, 
scientifically based, peer-reviewed approach to decision making. Unfortunately, 
the use of heuristics also brings with it some pitfalls (Klein 2005). Despite being 
highly trained in the practice of medicine, physicians are prone to making 
mistakes (Bornstein and Emler 2001). Cognitive biases may detract them from 
the use of logical and statistically-based decisions (Hershberger et al. 1994).  
Decision theories are developed to explain decisions under three main conditions 
of consequence of choice: certainty, risk and uncertainty. Decision under 
certainty applies when all decisions will lead to only one consequence. Decision 
under risk applies when a choice will have one of several possible consequences 
and the probabilities of the consequences are known (Heylighen 2010). Contrary 
to decision under risk, decision under uncertainty applies when a choice will have 
one of several possible consequences, but the probabilities of the consequences 
are not known.  
5.2.2 Definition of Quality in Health Care Delivery 
Before discussing the findings of the study, it is important to define quality in 
health care. Several authors and institutions have made attempts at defining 
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quality in health care; see Section 1.3 starting on page 3. The definition employed 
in this research is covered in the next section (Methodology) of this chapter.  
It is clear that a global or unified definition of quality in health care does not exist. 
Human health is dynamic and represented by individuals carrying unique 
expectations. Thus, global objective measures of health quality may be 
impossible. However,  Donabedian (1978) has defined three elements of quality 
(see Section, 1.3 for full details) - structure, process and outcomes.  
At the core of clinical medicine is the decision making process, leading to 
diagnosis and treatment for individual patients and populations. The American 
College of Medical Quality has defined the medical decision process as:  
“The medical decision-making process used in medical quality 
management reflects a consensus of opinion of clinical judgment that is 
supported by published peer reviewed scientific literature.” (American 
College of Medical Quality, 2010) 
The definition of the decision-making process makes it reasonable to assume 
that the process is as dynamic as is medical quality. Each physician-patient 
encounter is a unique experience for both the patient and the physician. 
Aggregation of experiences over time may therefore form constructs defining 
future outcome expectations. The variation created by different encounters may 
thus create a unique set of perceptions of quality for both the patient and the 
physician. However, since concordance between patient and physician in general 
is low (Stevenson et al., 2004), the physician is the main decision maker. As such, 
physician perception represents a window into the “moment of truth” (Sokol, 
2010), that is the encounter between the physician and the patient in health care 
delivery.   
5.3 Methodology 
The preceding two DBA projects pointed at the opportunity to investigate what 
enablers and barriers for quality in health care delivery exist, and how the 
physicians’ influence is exerted. Thus, the RQ formulated for this study is: 
RQ: What are the enablers and barriers physicians perceive in their role 
of providing health care?  
5.3.1 Definition of Quality Employed in the Research 
In this section, quality is defined for use in this research, and a systems approach 
is adopted for its definition. The definition employed is similar to Donabedian’s 
three element model, but it differs on two main points. First, Donabedian’s 
definition of structure excludes patient or population level bio-medical contexts. 
Project One revealed that patient level bio-medical context is an influencer on 
physician decision making when prescribing. The bio-medical context defines the 
spectrum of possible clinical outcomes given current medical knowledge and 
technology. Second, Donabedian (1988), p. 1745, defines outcome as “the effect 
of care on the health status of patients and populations”. However, this definition 
is problematic for two main reasons. The first reason is that clinical outcomes are 
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dependent on patient level bio-medical contexts, and may therefore be 
independent of process; for example, penetrating wounds to the chest have been 
reported to have a mortality rate of 0.8 – 18.1 %, with wounds not involving the 
heart having a greater chance of survival (Mandal and Oparah, 1989). Thus, 
patient level bio-medical contexts define the spectrum of possible clinical 
outcomes. The second reason is that normally perceived poor clinical outcome, 
such as death, does not alone define quality of healthcare delivery; in other 
words, meeting contextualized expectations, irrespective of clinical outcome, 
provides grounds for positive quality perceptions. Therefore, in addition to effects 
on health status of patients and populations, outcome is about the provision of a 
correct and timely diagnosis and institution of appropriate treatment for patients 
and populations, on both a system and individual level. As such, the adopted 
definition of quality consists of three elements: context, process and outcome; 
see Table 5-1 Definition of quality adopted.  
Table 5-1 Definition of quality adopted 
Quality in healthcare defined 
Elements Definition 
Context A set of circumstances or facts surrounding a particular event or situation, 
such as resource attributes (material, human, organizational) and bio-medical 
status 
Process All activities involved in providing care  
Outcome Antecedents to clinical and experiential effects: diagnosis and therapy, 
clinical effects on health status and experiential effects 
5.3.2 Extending Physicians’ Conception of Quality 
In this section, the differences between Project Two and Three are explained, 
along with the reasons why quality is re-examined in this research; see also Table 
5-2 Differences between Project Two and Three.  
Project Two explored the physicians’ conception of quality. The study employed 
repertory grid technique to explore in-depth how physicians construct quality of 
health care while providing care for patients, resulting in eleven key constructs 
representing a static map of physicians’ conception of quality. Project Three sets 
out to further extend the understanding of quality by exploring enablers and 
barriers, thus adopting a dynamic approach. Since Project Two is the first study 
exploring physicians’ conception of quality, Project Three sets out to validate and 
extend the granularity of the constructs identified. By employing a different 
method (semi-structured interview technique), triangulation is possible, so 
validating the results from Project Two. Furthermore, the semi-structured 
interview technique provides an opportunity for laddering, which may provide 
further granularity. In Project Two, no information about physician perception of 
enablers and barriers (influencers) of quality, or mechanism of influence 
emerged. Therefore, in addition to validation and extending granularity to the 
findings of Project Two, this project sets out to explore enablers and barriers of 
quality of health care from a physician’s perspective, and to identify the 
mechanism by which influence is exerted. 
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Table 5-2 Differences between Project Two and Three 
 Project Two Project Three 
Aims Explore physicians’ 
conception of quality 
Validate and extend constructs from Project Two 
Explore physicians’ perception of enablers and 
barriers to quality 
Identify mechanism by which influence is 
exerted 
Method Repertory Grid 
Technique 
Semi-structured Interview Technique  
5.3.3 Description of the Method 
In this project, the topic of interest is quality of health care service delivery. 
However, the effort supplied by physicians in contributing to quality is 
unobservable (Ma and McGuire, 1997, McGuire, 2001).  
In order to gain insight into the unobservable, it is necessary to include 
physicians, as the main decision makers in health care provision, in this study. In 
order to obtain insights regarding physicians’ perceptions of enablers and barriers 
to quality in health care, a semi structured interview technique was employed, as 
this was deemed suitable for the purpose of this project. Kvale and Brinkmann 
(2009) p. 1, express that “the qualitative research interview attempts to 
understand the world from the subjects’ point of view, to unfold the meaning of 
their experiences, to uncover their lived experiences prior to scientific 
investigation”.  
The interview guide (see Appendix C.1.13 Interview Guide) includes an outline of 
topics to be covered during the interview and suggested approaches outlined by 
Kvale and Brinkmann (2009) p. 130. In the protocol, the terms enablers and 
barriers are used. However, the phenomenon of interest is influencers, which can 
be defined as something that has the capacity to produce effects on physicians’ 
actions, behaviours, opinions, etc. Using enablers and barriers in the research 
makes it easier to tease out the deeper meaning of influence. 
5.3.4 Content Analysis 
In this study, interviews generated copious and rich amounts of data in the form 
of text. Krippendorff (2013) p. 24, defined content analysis as “a research 
technique for making replicable and valid inferences from texts to the contexts of 
their use”. Thus, content analysis was deemed to be an appropriate 
methodological approach for analysis of textual data generated in this study. 
Content analysis technique was employed to gather insights from the informants 
about the subject of the study. 
According to (Krippendorff, 2013 p. 41), at least three types of inferences can be 
distinguished: 
 “Deductive inferences are implied in their premises. They proceed from 
generalization to the particular.” 
 “Inductive inferences are generalizations to similar kinds. They proceed 
from particulars to generalizations.” 
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 “Abductive inferences proceed across logically distinct domains, from 
particulars of one kind to particulars of another kind.”  
 
An additional type of inference is retroductive. According to (Sayer, 1992 p. 107), 
retroduction is a "mode of inference in which events are explained by postulating 
(and identifying) mechanisms which are capable of producing them". 
The phenomenon of interest in this study is the quality in health care delivery, 
which is a highly inaccessible phenomenon. The reason for this is that the effort 
involved in producing health care is in part unobservable, so quality is non-
contractible (Ma and McGuire, 1997, McGuire, 2001). An underlying assumption 
in this study is that the research question can be addressed by abductively 
inferring insights from the analysis of bodies of text. Furthermore, substantiation 
of inference is possible by comparing inferences with previous DBA projects: the 
systematic review of the literature (Project One) and the first empirical project 
(Project Two). Thus, the criteria according to Krippendorff (2013) p. 38, for 
content analysis are satisfied; see Table 5-3 Krippendorff’s criteria for further 
details. 
Table 5-3 Krippendorff’s criteria 
Krippendorff’s criteria Criteria satisfied 
They are believed to be answerable by examining a body of text. Yes 
They delineate a set of possible answers among which analysts may 
select Yes 
They concern currently inaccessible phenomena Yes 
They allow for (in)validation by acknowledging  another way to 
observe or substantiate the occurrence of the inferred phenomena. Yes 
An open coding approach was initially adopted for this project, as it is well suited 
for understanding phenomena (Kvale and Brinkmann, 2009). The coding process 
went as follows: transcript of the first interview was studied in detail and concepts 
identified line by line; the concepts were given rudimentary codes in the margin 
of the written transcript; these codes were compared to new codes from the next 
transcript, continuously going back and forth comparing the data; and the process 
was repeated until all transcripts were analysed.  
During the process, concepts were merged into new concepts, grouped into 
categories, and finally labelled as tentative categories. Using the tentative 
categories as a guide, transcripts and interview notes were revisited, establishing 
the final categorical coding, reflecting a cognitive map of how physicians perceive 
the enablers and barriers to quality health care service delivery.   
The categories were then probed for properties and dimensions by using a 
process called constant comparison, in which each item is checked or compared 
with the rest of the data to establish analytical categories (Pope et al., 2000). This 
was achieved by going back and forth comparing data from transcripts, interview 
notes and re-listening to the recordings for additional data granularity. The 
resulting coding structure consists of four levels that are referred to as: category, 
sub-category, property and dimension. The coding was captured in NVIVO 10 for 
further analysis.  
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Finally, the resulting categories were evaluated and grouped according to the 
definition of the elements of quality as defined by (Donabedian (1978), Peabody 
et al., 2006); structure, process and outcome. This process yielded a further 
dimension of the categories: quality element. Furthermore, once all the codes 
were derived, analysis of frequency distribution was considered, and this is 
reported below. This complements the qualitative analysis since “a construct’s 
frequency count is a good indication of its importance” (Lemke et al., 2003 p. 15). 
A worked example (NVIVO screen shot) is provided in the appendix, please see 
Table C-3 NVIVO screen shot. 
5.3.5 Triangulation 
(Easterby-Smith et al., 2008) address how research can withstand external 
scrutiny and distinguish between internal and external validity. Internal validity is 
concerned with systematic factors of bias. External validity is concerned with 
generalizability across different contexts. A technique to mitigate questions 
regarding validity is called triangulation. Triangulation has been suggested to be 
accomplished in social research by using multiple and different sources, 
methods, investigators or theories (Denzin, 1988) p. 290. In this research, the 
semi-structured interview technique has been used on the same respondents and 
patient cases to gain a deeper understanding of the constructs representing a 
map of physicians’ conception of quality of health care, which was revealed in 
Project Two employing repertory grid technique. Other sources used in 
triangulation are theories and literature.  
5.4 Results of the Empirical Work 
In this section, the results from this empirical research are detailed. First, the 
results from the pilot study are presented. Next, the sample included in the study 
is provided before the data collection is described. Finally, the results from the 
data analysis are presented. 
5.4.1 Pilot Study 
The interview guide was piloted and amended before being employed in the main 
data collection. The pilot study was performed using the interview guide from the 
protocol. A total of three, 90-minute interviews were performed, recorded and 
transcribed in Norwegian. During a meeting between the researcher and three 
academics (study panel) on July 4th 2012, the interview guide was discussed.  
Two main areas of concern were surfaced. First, was the time sufficient to allow 
for all the questions and laddering of questions to take place? The experience 
from the pilot study indicated that there would not be sufficient time to allow for 
all the questions to be sufficiently explored. One question was therefore removed 
from the interview guide in order to allow more time for the remaining questions; 
the question removed was: “Please tell me, how you would describe Quality of 
Health Care provision”, resulting in the final interview guide used in this study, 
see Appendix 5.7.4C.1.13 Interview Guide on page 377. Second, elicitation of 
mechanisms from physicians did not extract information in line with the CIMO 
(context, intervention, method and outcome) methodology proposed by Pawson 
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(2006); therefore, CIMO was abandoned as a methodology, but data was 
collected in line with the original interview guide as it was felt it would provide 
valuable data informing the phenomenon of interest. The DBA panel (see Table 
C-1 Study panel for Project Three) agreed to the final interview protocol as 
presented in this document. 
5.4.2 Sample 
The aim of the study was to include 30 physicians across different specialties in 
a university hospital, i.e. non-randomized selection. Department leaders in four 
clinical divisions (medicine, surgery, paediatrics and psychiatry) were requested 
to provide names of potential participants in the study. In total, 70 physicians were 
invited to participate in the study, and 43 accepted the invitation. Due to the 
demand for physicians’ services in the clinic, it was difficult to coordinate the 
attendance of physicians with the researcher’s schedule during the study period 
(September 2012 to October 2012). Several physicians required rescheduled 
appointments on a number of occasions, and only about 40 % (27) of the 
appointments scheduled by the researcher were finally used for data collection.  
Respondents covered a spread of gender, age and medical specialties, ensuring 
extensive experience with patient care in a hospital setting; please see Table 5-4 
Respondents nominal data. All the respondents were native Norwegian 
speakers. Respondents were invited to participate through a structured invitation 
in Microsoft Outlook including a copy of the consent form (see page 377). The 
written and signed consent forms will be stored for 5 years in accordance with 
hospital and university regulations. 
Table 5-4 Respondents nominal data 
ID # Date Time Gender Age (years) Specialty 
1 12/09/12 14:30 Female 55 Psychiatry 
2 13/09/12 11:30 Male 53 Anaesthesiology 
3 14/09/12 13:00 Male 55 Surgery (ENT) 
4 18/09/12 14:30 Female 46 Infectious diseases 
5 18/09/12 16:00 Male 58 Geriatrics 
6 02/10/12 10:30 Male 43 Oncology 
7 02/10/12 13:00 Male 60 Cardiology 
8 02/10/12 15:00 Male 52 Pulmonology 
9 04/10/12 10:00 Female 36 Intern (general medicine) 
10 05/10/12 10:30 Male 58 Cardiology 
11 17/10/12 09:30 Male 50 Infectious diseases 
12 17/10/12 12:00 Female 33 Intern (general medicine) 
13 22/10/12 12:30 Male 53 Neurology 
14 22/10/12 14:00 Male 66 Gastroenterology 
15 23/10/12 14:30 Male 70 Infectious diseases 
16 24/10/12 08:00 Male 60 Pulmonology 
17 25/10/12 09:30 Male 63 Haematology 
18 25/10/12 11:00 Male 65 Cardiology 
19 26/10/12 09:00 Male 37 Intern (general medicine) 
20 26/10/12 10:30 Male 54 Paediatrics 
21 26/10/12 13:30 Male 53 Psychiatry 
22 29/10/12 11:00 Male 51 Anaesthesiology 
23 29/10/12 12:30 Male  47 Anaesthesiology 
24 29/10/12 14:00 Male 34 Intern (general Medicine) 
25 01/11/12 09:30 Male 32 Intern (general Medicine) 
26 02/11/12 11:30 Female 60 Cardiology 
27 02/11/12 14:00 Female 46 Neurology 
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5.4.3 Data Collection 
Twenty-seven physicians were interviewed in the months of September and 
October 2012, using a semi-structured interview technique. The interviews were 
recorded using an Olympus DM-550 digital voice recorder. Notes were also taken 
by the interviewer during the interviews in order to aid in follow-up questions and 
laddering, as suggested by Kvale and Brinkmann (2009) p. 179. The interview 
recordings were transcribed and translated for meaning by the interviewer (native 
Norwegian speaker), resulting in a data set comprised of approximately 130 
pages and 54,000 words. On average, interviews lasted for 30 minutes. Microsoft 
Word 2013 was used for word processing, and each interview was stored in a 
separate file with an individual file name: Interview 1 – 27. The interview file 
names correspond to the respondent ID # in Table 5-4 Respondents nominal 
data.   
5.4.4 Data Analysis 
Text data resulting from the transcribed and translated interviews were imported 
into NVIVO 10 for coding and data analysis. An open coding approach was 
chosen, as described in Section 5.3.4. The resulting coding structure consists of 
four levels comprised of: category, sub-category, property and dimension; see 
Table 5-5 Coding structure generated from data for further details. Evolution of 
the coding process was automatically tracked in NVIVO 10 (user event log), 
resulting in a detailed coding log. Word frequencies for the 100 most commonly 
occurring words were calculated using NVIVO 10; please see Table C-4 Word 
frequency of the 100 most common words for further details. In order to illustrate 
the word frequency, a word cloud was generated using NVIVO 10; please see 
Table C-5 Word Cloud.  
Furthermore, a word frequency tree map was created employing NVIVO 10, and 
the result can be seen in Table C-6 Word frequency tree map. The word 
frequency counts and corresponding word tree map were employed as aids in 
the coding process. The constructs were grouped into categories employing 
“bootstrapping” (Holsti, 1968) as a methodology for content analysis coding. 
The coding process yielded a coding structure that is presented in Table 5-5 
Coding structure generated from data, with distribution frequency by interviewees 








Evaluation Feedback Level of feedback and ability to change based on 
feedback received 
High - Low 
Measures Being able to objectively measure  High - Low 
Intervention Diagnosis Ability to make a correct diagnosis without delay High - Low 
Treatment Ability to give appropriate treatment without delay or 
undue risk to patients 
High - Low 
Procedure Ability to perform procedure correctly High -Low 
Communication Quality of communication High - Low 
Mechanism Time Availability of time to do what is necessary High - Low 
Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High - Low 
Diagnostics Ability to correctly diagnose patients without delay High - Low 
Treatment Ability to correctly treat patients without delay High - Low 
Resources Availability of necessary technical, building and 
human resources 
High - Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High - Low 
Physician attitude Ability to show and real interest and level of curiosity High - Low 
Patient Willingness to cooperate and adhere to medical 
advice given  
High - Low 
Barriers Availability of time Having enough time to do what is necessary High – Low 
Resource 
availability 
Adequate resources available High – Low 
Competency  Level of competency available on the personal level High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Enablers Evaluation Ability to evaluate  High – Low  
Time Availability of time to do what is necessary High – Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High – Low 
Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Physician Physician attitude High – Low 
Patient Willingness to cooperate and adhere to medical 
advice given 
High – Low 
Diagnostics Ability to correctly diagnose patients without delay High – Low 
Treatment Ability to correctly treat patients without delay High – Low 
Quality Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High – Low 
Resources Adequate resources available High – Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High – Low 
Diagnostics Ability to correctly diagnose patients without delay High – Low 
Treatment Ability to correctly treat patients without delay High – Low 
Patient Willingness to cooperate and adhere to medical 
advice given 
High – Low 
Physician Physician attitude High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Evaluation Ability to evaluate and learn High – Low 
Continuity Level of continuity of care High – Low 





In this section, the findings of this research are presented. Overall, the findings 
may be summarized in three points. First, the findings validate and extend the 
quality constructs revealed in Project Two. Second, physicians’ constructs of 
quality and perception of enablers and barriers were found to be closely related; 
in fact almost identical. Project Two explored physicians’ conception of quality in 
health care, and identified eleven key constructs; a static picture of quality as 
perceived by physicians. Project Three aimed to extend this understanding by 
exploring enablers and barriers, hence taking on a dynamic perspective. The 
project found that enablers and barriers were polar opposites of factors 
influencing quality; thus, enablers and barriers are polarized limits of influencers. 
Influencers are defined here as something that has the capacity to produce 
effects on physician actions, behaviour, opinions, etc. Finally, the mechanism of 
influence is found to be physicians’ perceived behavioural control.   
Frequency of mention may impart information about relevance (Goffin et al., 
2006, Lemke et al., 2003). Thus, references to word frequencies are provided in 
this section. Two forms of frequency presentation were chosen to be used, 
tabular and visual (word cloud), as a means to provide information about 
relevancy.  
This study revealed that constructs and influencers are identical. Having adopted 
a systems definition of quality, the presentation of findings is structured by quality 
element, as in Table 5-6 Project three findings. Table 5-6 shows element, 
construct, activity, mechanism and impact. The “Element” column is related to the 
definition of quality used in this research (see Section 1.3 on page 3), and 
represents the model proposed by Donabedian (1979). In the next column, 
“Constructs”, the empirically derived constructs representing physicians’ 
conception of quality, is grouped by the researcher according to the best fit with 
the definitions provided by Donabedian (1979). The “Activities column” 
represents empirically identified activities associated with the derived constructs. 
In the “Mechanism” column is the mechanism by which influence is exerted. The 
last column, “Impact” reflects the effect the activity associated with the construct 
has on the quality construct.  
The Findings section is structured as follows. First, findings related to the quality 
elements of context, process and outcome are presented, followed by enablers 
and barriers. Then, the findings related to mechanism of influence are detailed. 
Finally, a summary of the key findings of this study is offered. Quotes are 
attributed using the ID# found in Table 5-4 Respondents nominal data. 
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Table 5-6 Project three findings 
Element Construct Activities Mechanisms Impact 
Context Resources 
availability 
Available resource for 
patient care 
Boundaries of choice Resource utilization 
Competency Formal training, on the 
job training, own 
experience, feedback 
from patients and 
colleagues 
Reduction of physician 
uncertainty 
Physician effort 
Time Time spent with 
patients 
Reduction of physician 
uncertainty 
Physician effort 
Standards of care Setting expectations Social norm Standardized 
physician supply of 
effort 







Co-operation Identifying necessary 
resources outside 





Evaluation Feedback from 






Process Patient Recognizes symptoms Level of concern reaches 
action threshold 
Seeks medical help 
Physician attitude Patient physician 
interaction 
Transfer of feelings from 
patient  
Physician perception of 
patient expectation 
Physician effort 





Continuity Number of physicians 
involved in care of a 
patient 
Information lost when 
information is exchanged 
Information integrity 
Diagnostics Gathering and 
interpretation of  
information 
Synthesis of information Diagnosis 
Therapy Deciding on 
appropriate medical 
intervention 
Bio-medical influence Change in health 
status 
Outcome Diagnosis Not applicable Not applicable Diagnosis 
Therapy Not applicable Not applicable Appropriate therapy 
initiated 




Not applicable Not applicable Patient satisfaction 
5.5.1 Context 
Overall, context is found to set the boundaries for what is possible, real or 
perceived. Resources, in a broad sense, including time and competency, are 
about what is available to do the job at hand. Standards of care set the 
expectations for the job, and organization concerns how best to allocate 
resources, in a broad sense, to best achieve the expectation. Level of HCP co-
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operation is a result of expectations and resource structure, which is the base for 
resource utilization. Evaluation refers to third party feedback and formal 
measures. Feedback is claimed to supplement own experience in learning, and 
shapes the experience component of competency. Thus, evaluation alters the 
context, and may therefore be argued to constitute learning. 
 
Figure 5-2 Internal dynamics of context 
In this section, the findings that map to the context element of quality in health 
care are detailed. The presentation of findings explains the empirical basis for 
Figure 5-2, and is structured as follows. First, findings related to resources in a 
broad sense are presented, followed by findings on standards of care, before 
data on organization and cooperation are provided. Then, findings on resource 
utilization are presented, and finally, data on evaluation of quality in health care.   
5.5.1.1 Resources 
In this section, findings related to resources are detailed, starting with findings 
about resource availability, then findings about standards of care and findings 
related to resource utilization, before data about organization are presented. 
Then, findings on cooperation are offered, and finally, findings related to 
evaluation. A short summary is included at the end of sub-sections when relevant.  
5.5.1.1.1 Availability of Resources  
In this study, resource availability has been found to be an important aspect of 
quality of health care provision. Insights about resources fell into two main 
categories: resource availability and resource utilization. Resources, whether 
human, technical equipment, building facilities, etc., were all deemed necessary 
for the provision of health care.   
“…by resources I mean people, technical equipment building facilities and 
things like that. It is necessary to have enough people, nurses and 
physicians especially with the right competency. Nurses and physicians 
must have access to enough technical equipment, diagnostic modalities, 
medicines, hospital beds to do their job.” (ID #: 26) 
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Resource availability is seen as critical for quality of health care service provision 
by physicians in this study. 
“I think in order to be able to do what I have already talked about, it is 
necessary to have adequate resources.” (ID #: 26) 
 “…well, it may be worthwhile mentioning resource access, well, actually 
that’s also very important, one of the patients we have discussed earlier 
was definitely an example of lack of resources, as he did not get access to 
a respirator, was placed in the hallway of a hospital and died.” (ID #: 8) 
“Lack of diagnostic modalities, especially MRI, which causes patients to 
have to wait for days, resulting in not being able to diagnose the patient 
while the patient is admitted and forcing us to discharge the patient without 
a clear diagnosis.”  (ID #: 13) 
5.5.1.1.2 Staff Competency Level 
In this study, the data suggest that other than the traditional knowledge, 
experience and skills, competency is about understanding what concerns the 
patient has and what the physician can do to develop professionally. 
Furthermore, the data suggest that availability of the right competencies at the 
right time is important to how physicians define quality.  
 “…should have a basic education, enough resources so that people 
develop academically while working, especially physicians in training.” (ID 
#: 9) 
“…quality is predictable, founded on knowledge and skills, it should be 
neutral in the way that we can agree that it is quality, it should be 
verifiable, we should be able to measure it and at the same time it should 
be something that the patient can experience.” (ID #: 6) 
Competency in this study is found to be highly relevant when considering quality 
in health care. In addition to the elements of competency (knowledge, skills, 
experience), competency is about the appropriate application of knowledge and 
skills gained through experience. In this study, competency is seen as a barrier 
when there is a lack of competency necessary for the delivery of health care 
service. 
 “My own knowledge level is always a limiting factor.” (ID #: 5) 
“…lack of knowledge and skills, lack of competency. I will have to define 
competency. The problem is we need to sort of often walk through the 
door. We can sit down and read. But the lack of competency in general, is 
a barrier.” (ID #: 17) 
5.5.1.1.3 Availability of Time 
Respondents in this study indicate that time is an influencer of quality in health 
care service delivery. The focus is on the availability of time.   
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“I had a lot of patients waiting in a waiting room and felt stressed due to 
lack of time; I didn’t spend enough time to evaluate the patient properly 
and missed the diagnosis.” (ID #: 26) 
The focus on availability of time from a physician perspective indicates that “time” 
is about the physicians’ perception of availability of physicians as a human 
resource. In this research, time is seen as a barrier when there is an imbalance 
between available time and necessary work relating to the delivery of health care 
service. 
“…often I feel it’s about not having enough time which could be caused by 
a combination of factors, one being that we have a lot of patients and 
therefore more patients per physician, both admitted and outpatients.” (ID 
#: 12) 
“…if there is too much to do at the same time. I managed to keep track of 
individual patients but not of the group of patients that I’m in charge of.” 
(ID #: 9) 
Lack of time may lead to shortcuts being taken and also result in stress, and is 
consequently regarded as a barrier. 
“…that a good example of what can happen in medicine when people take 
shortcuts.” (ID #: 4) 
“…stress and many different expectations can produce a situation where 
there is too much to do.” (ID #: 27) 
5.5.1.1.3.1 Time Spent Directly on Patient Care 
In order to deliver quality health care, the informants revealed that time spent 
directly on patient care is related to the time available for interaction with patient 
and physician or other health care workers. This is related to the communication 
between patient and physician and to diagnostic or therapeutic procedures. 
Available time is important in order to do what is necessary; thus, time available 
is often determined by patients/physicians per time unit. 
 
"The patient was left in the ER for 12 hours without care. There were simply 
too many patients to take care of and some had to wait a really long time. 
Longer than what is acceptable." (ID #: 11) 
“I must be given enough time to do the job within my professional limits.”  
(ID #: 26) 
Data suggest that the sub-category “time” is also related to time to diagnosis and 
treatment. Time to diagnosis is defined as time to primary diagnosis, ensuring 
that a diagnosis is established early. 
 




5.5.1.1.3.2 Time Spent Indirectly on Patient Care 
Time spent indirectly on patient care is also evident from the sample. This use of 
time is spent on maintaining or improving clinical or academic competencies; and 
reflection and evaluation of information, especially when dealing with complicated 
cases.  
“We do not have enough time to supervise our interns. In the hospital 
where I worked before, we had control of what our interns knew and did. 
Here, we do not have the time for appropriate supervision. What type of 
cardiologists are we getting? I honestly can’t tell you....” (ID #: 26) 
The findings in this study suggest that availability of time is either used directly or 
indirectly on patient care. However, time is linked with physicians’ perception of 
availability, thus indicating that availability of time may in fact be a resource. Since 
time is a non-tangible asset or resource, it may make more sense to consider 
time in this context as a temporal measure of physician availability. Time will for 
this reason be considered a resource. 
5.5.1.2 Standards of Care 
With the advent of evidence based medicine, standards have become an 
increasingly important part of clinical medicine and are often referred to as 
guidelines, as is found to be the case in this study. Guidelines represent “best 
practice” and form the basis for expectations.  
“…a basis for quality is an academic standard of practice that we adhere 
to national and international guidelines, and what is accepted within the 
medical community in Norway. “ (ID #: 16) 
Standards are also a way of ensuring quality control, as quality is defined by how 
close to the standard clinical medicine is being practiced. 
“…the standard is set and we measure to what degree you manage to 
apply or follow the standard.” (ID #: 18) 
“…quality is then defined as how well you managed to live up to the 
standard defined by the medical community. Decisions take place 
continuously and it is about how close to the standard you manage to 
practice.” (ID #: 12) 
Standardized operating procedures are found to be an aspect of quality in this 
research. Procedures define the standard of care and may be a useful tool for 
quality control and improvement. 
“…it is also necessary to have procedures, for example the work we are 
doing now is focused on standardizing diagnostic procedures as I am 
focused on improving the quality and precision of the diagnosis that we 
give to patients.” (ID #: 21) 
Standards of care set the prescribed expectation of how resources are to be 
used, which further guides how health care services are organized. Organization 
is covered in the next section. 
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5.5.1.3 Organization of Health Care Services 
The results of this study indicate that how the delivery of health care is organized 
is an element in how physicians define quality. Organization is comprised of 
several factors: equal access, cooperation, standardized procedures and working 
environment. Each of the factors is now briefly presented. 
5.5.1.3.1 Equal Access 
Interviewees indicated that the delivery of health care services should be 
organized in such a way that patients are ensured equal access. This finding is 
in line with the definition of quality found in the literature; see Section 1.3 
Definition of Quality in Health Care Delivery. 
“Access to health care should be equal, by that I mean we should not 
differentiate depending on age, sex or race. The patient should be met and 
offered an opportunity to get clarity around the cause other symptoms and 
what we have to offer to help them.” (ID #: 15) 
5.5.1.3.2 Organization 
Organization is mentioned in the context of barriers to quality health care service 
delivery by the respondents. Organization is indicated as a barrier and is related 
to management, inadequate logistics and bureaucracy.  
Management is related to poor management; focus on production and 
reorganization processes.  
“Poor bosses and things like that drain energy and can also affect quality 
negatively.”  (ID #: 1) 
“It could be a barrier that there is a higher focus on production…”  (ID #: 
27) 
“A state of continuous reorganization, new people with new thoughts, we 
are always changing to adapt to a new system. This is a situation creates 
problems. I want to do the best I can, but when I meet the same obstacles 
again and again I lose my motivation. Continuous change where I feel that 
I cannot control any aspect, what is important is that the people treating 
the patients can influence the structure and resource utilization.” (ID #: 25) 
It is important that the delivery of health care is efficient. Modern health care 
service delivery is a logistics challenge which may impact quality of health care.  
“…organizational issues could have an impact, if for example several 
physicians were involved creating a breach of continuity in the treatment. 
We have to admit that breach of continuity in treatment is the norm in the 
Norwegian health care system rather than the exception.” (ID #: 15) 
Bureaucracy and formalities create barriers for health care service delivery. The 
bureaucratic burden is seen to be driven by system and model needs rather than 
the needs of patients. 
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“The demand for reporting and documentation of what we do, the need for 
control from government agencies and politicians, which is largely 
designed to cover the needs for covering their own back side than the 
needs of physicians. This is in conflict with what aids patient care and 
ultimately outcome.” (ID #: 2) 
“The economic model increases the demands for reporting to satisfy the 
bureaucracy. This detracts from good quality health care services. “ (ID #: 
6) 
5.5.1.3.3 Working Environment 
Finally, working environment for physicians is also found to be an organization-
related factor when considering quality in a health care service delivery context.   
“I must have access to equipment, building facilities and support services. 
I must be free from administrative burdens. I must be given enough time 
to do the job within my professional limits. I must be encouraged to develop 
professionally. I need a good work environment and a work-life balance.” 
(ID #: 26) 
5.5.1.3.4 Summary of Organization 
The findings of this study suggest that organization of health care influences 
resource allocation in anticipation of expected health care needs. One of the 
defining factors of how resources are organized is claimed to be standard of care. 
Health care service delivery should be organized so that patients have equal 
access, ensure efficient and appropriate cooperation between different health 
care professionals providing health care according to standardised protocols, and 
ensure a supportive work environment.  
5.5.1.4 Cooperation 
The delivery of health care is complex and takes place under uncertainty. This 
complex task of caring for patients is seldom a “one man show”; a team effort is 
often necessary, as patients often suffer ailments from different organ systems. 
The continuous specialization of medicines narrows the scope of specialized 
physicians, thus driving the need for a cooperative effort. Indeed, the informants 
claim that cooperation among physicians and health care workers is necessary 
for a team approach and synergies of effect.  
 “Cooperation with other colleagues and other departments is very 
important and that cooperation is smooth. That I have personal contact 
with other colleagues and a low threshold for helping each other quickly, 
and that there is no waiting time for necessary diagnostic procedures such 
as blood tests, gastroscopy, colonoscopy and so forth.” (ID #: 8) 
Also, cooperation means that the team around the patient is coordinated and 
capable of communicating a common message. However, cooperation between 
different levels of care is an element of quality in health care as well. 
“Quality is also dependent on cooperation with primary care physicians, 
cooperation between different departments internally, personally I think 
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our hospital is too big, the hospital work came from was smaller so it was 
easier to get things to work smoothly.” (ID #: 25) 
This cooperative effort is driven by expectations, often derived from explicitly 
stated standards of care. 
“…a basis for quality is an academic standard of practice that we adhere 
to national and international guidelines...” (ID# 16) 
5.5.1.5 Resource Utilization 
The data in this research suggest that quality of health care is not only dependent 
on resources being available, but respondents claim that quality is also 
dependent on how the resources are used..  
“…necessary competency, aggressive with regards to diagnostics, 
aggressive with regards to deciding on the correct treatment and also on 
the level of treatment necessary, thus deciding on resource utilisation for 
that patient. It is also important that available resources are harmonised 
with regards to workload.” (ID #: 22) 
How resources are to be used is driven by explicit (prescribed) and implicit 
expectations. One such explicit expectation is the standard of care, often referred 
to as guidelines.  
5.5.1.6 Evaluation 
Evaluation is an important element in any quality system. However, the findings 
in this study suggest that physicians do not formally evaluate the quality of their 
own practice, but rely on feedback from patients and colleagues. Being able to 
evaluate health care delivery is found to be an element of quality in this study. In 
this data set, evaluation can be categorized into three categories: measures, 
feedback, documentation and control.  
Measurements are an element that the data in this research suggest may 
influence quality of health care provision. Measure may be anything that is 
measurable, such as outcomes, readmission rates, hospital infection rates, etc.  
“…it should be verifiable, we should be able to measure it and at the 
same time it should be something that the patient can experience.” (ID #: 
1) 
Feedback is suggested to influence quality of health care provision by the 
respondents in this study. The feedback may be own experience, feedback from 
patients and next of kin, and outcome. 
“Well, I think it is often based on feedback from patients and next of kin, 
and my own experience and observations.” (ID #: 8) 
Documentation and control is suggested to influence quality of health care 
provision by the respondents in this study. 
“Documentation, journal updates should be done on a regular basis. All 
this is designed to generate quality but it’s not necessarily a measurement 
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of quality. Well, actually maybe it is a measurement of quality after all“. (ID 
#: 6) 
Evaluation is found to be relevant in relation to quality in health care. 
Measurements and evaluation of different aspects of health care may contribute 
to continuous improvement both on an individual as well as on a system level.  
5.5.1.6.1 Feedback 
Feedback from patients and peers is an important part of learning, as clinical 
medicine relies heavily on experience. In this data set, feedback from patients, 
next of kin, colleagues and system is found to be an important source of 
information when evaluating quality of health care service delivery.  
“It’s largely based on direct feedback from patients, with this satisfied or 
not satisfied.  No matter what happened, if there are satisfied I feel that I 
have done some good.” (ID #: 12) 
5.5.1.6.1.1 Own Experience 
Own experience is found to be a source of information when physicians evaluate 
quality of health care service delivery.  
“…evaluation of quality is subjective, based on how I experience patient 
satisfaction compared against objective treatment outcomes” (ID #: 10) 
5.5.1.6.1.2 Patients and Next of Kin 
Direct and indirect feedback from patients and next of kin is an important source 
of information when physicians evaluate quality.  
“…it’s largely based on direct feedback from patients, with this satisfied or 
not satisfied.” (ID #: 12) 
Feedback from patients can be informal or formal. Informal feedback can be 
positive or negative; in contrast, formal feedback is most often negative.  
Informal feedback from patients takes the form of direct feedback and may be 
solicited or unsolicited. In its simplest form, physicians may ask about patient 
satisfaction during consultations. 
“…I may ask the patient if they are satisfied or not. Ask if there is something 
they would like to complain about or something that they would have liked 
to have different.” (ID #: 4) 
On a more formal level, questionnaires may be used to solicit information about 
patient satisfaction. 
“We may also use questionnaires to ask patients about their experience. 
Patients cannot evaluate the quality of technical medicine, but they can 
save do are satisfied or not.” (ID #: 19) 
Unsolicited formal feedback is often complaints. Even though formal complaints 
procedures are in place, complaints as a source of information for quality 
evaluation may not be a “good” indicator of quality. 
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“Even though we can get some information out of formal complaints, 
adverse event monitoring et cetera, I think overall our tools for measuring 
quality are poor.” (ID #: 15) 
Even though complaints may not necessarily be viewed as a good indicator of 
quality, they still represent an opportunity for individual and collective learning in 
the medical community.  
“With a formal complaint it is important to share the outcome with staff that 
has been involved in the case which formed the basis for the complaint. 
Sometimes it’s also a good idea to talk with a colleague one on one if 
negative information needs to be shared. Not everyone needs to hear it. 
However, I think it is important that we collectively learn from our 
mistakes.” (ID #: 14) 
5.5.1.6.1.3 Colleagues 
Feedback from colleagues is a source of information for evaluating quality of 
health care service delivery. Colleague feedback may be formal or informal. 
Formal feedback is often used in appraisals; for example, the General Medical 
Council (GMC) in the UK has developed validated formal colleague appraisal 
questionnaires (Campbell et al., 2012). However, such formal appraisals have 
not been developed for Norway. Feedback from colleagues in this data set 
therefore reflects informal feedback.  
“…it should be a reflection of all factors, how well has the physician 
performed, how satisfied are the hospitals staff with their own work.” (ID #: 
23) 
Furthermore, feedback in a teaching environment may be a useful tool for 
learning and quality improvement. 
“Discussions in the context of medical training, discussions on medical 
cases and so on are definitely a sign of quality, and help us become 
better.” (ID #: 12) 
5.5.1.6.1.4 Outcomes 
Outcomes of health care service delivery are indicated as a source of information 
for evaluation by the respondents in this study. 
“…it can be measured by looking at the treatment outcome, for example, I 
had a tumour and it was surgically removed.”  (ID #: 20) 
5.5.1.6.2 Measures 
This study provides data on measures of quality of health care service delivery. 
Quality measures can be divided into two main categories: patient and system 
level.  
5.5.1.6.2.1 Patient Level 
Patient level measures include function and satisfaction. Function is often 
measured as a change in activity after treatment (Stratford et al., 1995).  
“...I would measure patient function after treatment.” (ID #: 23) 
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Patient satisfaction is measured by simply asking the patient directly or using 
validated tools such as questionnaires.  
“I may ask the patient if they are satisfied or not. Ask if there is something 
they would like to complain about or something that they would have liked 
to have different.” (ID #: 4) 
“…We may also use questionnaires to ask patients about their 
experience.” (ID #: 19) 
5.5.1.6.2.2 System Level 
Publication rates are a measure of academic production and may be linked to 
quality. In the university hospital where this research was undertaken, publication 
rates are measured and points given in order to guide strategic investment in high 
yield research groups. Respondents in this study indicated that this is the case. 
“…we can measure publication rates.” (ID #: 12) 
Readmission rates are another measure that may provide information about 
quality. However, the use of all cause readmission rates has recently come under 
scrutiny (Monette, 2012). In a recent meta-analysis, the authors conclude that 
“Less than one in four readmissions were deemed avoidable. Health system 
planners need to use caution in interpreting all cause readmission statistics as 
they are only partially influenced by quality of care” (van Walraven et al., 2012 p. 
1211). 
“In today’s setting it would have been of interest to see readmission rates 
as a measurable factor of quality. It would say something about whether 
treatment before discharge represents an adequate solution to the 
problem leading to the initial admission.” (ID #: 23) 
Complications are also indicated to be a measure in this study. All the 
respondents indicating complications as a measure make reference to event 
rates. 
“If you have a system where you monitor and catch mistakes you may 
simply count the rate of unwanted events.” (ID #: 19) 
Also, complaints are suggested to be a measure. Complaints, in this context, from 
patients - other than spontaneous criticism - are processed employing formalized 
complaints procedures.  
“I think quality can be measured by looking at formal complaints,” (ID #: 
14) 
During a lecture held by the patient ombudsman for the municipality of Akershus 
in Norway in September 2012, he spoke on the topic of general statistics of 
complaints from patients. Informally, he had contacted his colleagues around the 
country and could conclude that about 80% of complaints are due to 
communication and the remaining 20% due to medical errors (Thorne, 2012). 
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Based on these findings, it can be concluded that the majority of formal 
complaints are based on experiential quality. 
Time to diagnosis is an important factor determining quality of health care 
services. It is also important to consider time to treatment, but treatment appears 
to be viewed as a consequence of diagnosis. Thus, time to diagnosis is a key 
factor when it comes to quality of health care service delivery.  
“…and when they are in a hospital they should be diagnosed quickly 
resulting in a correct diagnosis, and they should receive treatment. 
Treatment is more schematic in the way that once the diagnosis is 
established then the treatment is given.“ (ID #: 8) 
Implementing a systematic approach to the implementation of and compliance 
with guidelines can help reduce variation in core processes of organizations 
(Flynn et al., 1994), and at the same time increase the quality of health care 
provided (Leape, 1994). Guideline adherence was found in the dataset, but not 
given much credit as a source of information when evaluating or measuring 
quality of health care service delivery. 
“…there are many ways to measure quality, back in the old days with the 
all chief of quality, we were forced to measure adherence to guidelines 
with respect to use of statins, aspirin and beta-blockers after a myocardial 
infarction. When he left we stop measuring, because the measures 
showed an adherence rate of about 92%, and there was always a good 
reason why the last 8% did not use the medication according to guidelines, 
for example the patient might have an ulcer disease contraindicating the 
use of aspirin.“ (ID #: 18) 
5.5.1.6.3 Summary of How Physicians Evaluate Quality  
Evaluation is found to be a category of quality in health care delivery. The 
category has two subcategories: feedback and measures. From a simple 
frequency count perspective, measures seem to be given more relevance than 
feedback in this data set; see Table 5-7 Evaluation by frequency for details. The 
data indicate that physicians do not formally evaluate or measure quality when 
performing their duties. However, the data indicate that physicians rely on own 
experience and feedback from patients and peers. Literature on feedback is 
extensive, and a recent Cochrane Review concluded that feedback generally 
leads to small but potentially important improvements of quality in health care 
(Ivers et al., 2012).  
Furthermore, the data suggest that quality is measured on two levels: patient and 
system. Patient satisfaction is important, and may also be related to direct 
feedback from patients. Thus, patient level measures may be considered 
measures of experiential quality. The data indicate that system level measures 
are measures of clinical quality. 
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Table 5-7 Evaluation by frequency 
Evaluation 






Feedback Level of feedback and ability 
to change based on 
feedback received 
High - Low 13 21 1,62 
Measures Being able to objectively 
measure  
High - Low 21 50 2,38 
5.5.2 Process 
Process sets out what takes place during delivery of healthcare. Patients and 
physicians interact in an agency context where communication is the central 
mechanism of information exchange. The information resulting from the 
interaction is central to the process of health care delivery for two main reasons. 
First, patients and physicians do not exchange all available information; thus, 
information asymmetry exists. Second, the resulting information asymmetry 
creates a context of uncertainty where both patients and physicians must make 
choices. Continuity of care ensures information integrity, which is vital for correct 
interpretation of information in a given context. Furthermore, information integrity 
reduces uncertainty for both patients and physicians.     
 
Figure 5-3 Internal dynamics of process 
In this section, the findings that map to the process element of quality in health 
care are presented. The presentation of findings explains the empirical basis for 
Figure 5-3, and is structured as follows. First, findings related to patients are 
covered, followed by findings on physician, before data on continuity of care are 
detailed. Finally, findings on clinical intervention are presented, including 
diagnostics and therapy. 
5.5.2.1 Patient Participation 
Patient participation is important, as it is a cooperative process. From an agency 
perspective, the physician (agent) acts on behalf of the patient (principal). Thus, 
quality is dependent on the patient agreeing to participate in the process.  
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“It means that the patient agrees to participate in the process, that it is a 
cooperative process with the patient and a common understanding with 
the patient.” (ID #: 17) 
5.5.2.1.1 Patient Attitude 
In this study, patient attitude comes across as a factor that may affect quality of 
care. The explanation for this phenomenon is transfer of positive or negative 
feelings from the patient to the physician. This transfer of feelings may influence 
how a physician treats the patient, and consequently may affect quality of the 
health care provided.  
“Well I must be honest, you get extra motivated when you have a pleasant 
patient to deal with, the good relation with the patient helps, if you have a 
good relation with the patient then you unconsciously do a better job. I 
think we should be more open about this issue and talk to our colleagues 
about it. For example, maybe this patient should be seen by someone 
else.” (ID #: 8) 
5.5.2.1.2 Patient Engagement in Medical Care Summary 
Patients are central to quality in health care, in that they are the principals in the 
agency relationship. Thus, patients delegate work to the physicians who supply 
effort into the production of health care. The patients’ engagement in this process 
of health care production as the subject of intervention is therefore a potential 
influencer of quality in health care. In this research, the evidence suggests that 
patients may manipulate the system to gain greater benefit, and as such, 
represent a mechanism. 
“...this patient had detailed information about how to use the system to get 
what she wanted. She got more resources than she should have.” (ID #: 
1) 
Furthermore, the data suggest that patient compliance is a mechanism for quality 
of health care. 
“…good compliance at the patient level, she complied and took 
medicines.” (ID #: 10) 
5.5.2.2 Physician 
The results of this study indicate that physician is a sub-category of enablers. It 
is found that physicians who are professionally curious, respectful and interested 
in the patient may enable quality health care service delivery.  
“…respect the patient and the patient’s experience of his problem.” (ID #: 
2) 
…”believe that people are equal.” (ID #: 27) 
 “Being professionally curious and interested is important, the moment you 
stop being curious and believe you know everything you have lost.” (ID #: 
25) 
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 “…first that I am personally engaged and motivation” (ID #: 10) 
Furthermore, it is found that attention to detail is important, and honesty and 
compromise may be physician factors enabling quality.  
“What I’m satisfied with is the attention to detail and attitude making me 
able to catch the fact that the GP felt that this was something different than 
the regular issue with enlarged tonsils.” (ID #: 3) 
 “I am very honest when giving my advice, no compromise.” (ID #: 7) 
Finally, the results of this study indicate that the physician’s mood may enable 
quality, and that mood may be influenced by energy. 
“I deliver better quality the days I’m in a good mood; we are affected by 
mood, even though you work on it and are conscious of its effect you are 
still affected by your mood.” (ID #: 18) 
 “…if you feel that you have extra energy which is enough for the work that 
you have to do it will be easier to be in a good mood than if you don’t have.” 
(ID #: 18) 
5.5.2.2.1 Physician Attitude 
The results of this research indicate that physician attitude may be an important 
element of quality. Physician attitude can broadly be categorized into three 
categories: respect, humbleness and interest.  
Respect is suggested to be an element of physician attitude that may influence 
quality of health care provision.  
“…that you have time to speak with a patient, show empathy and sympathy 
for the patient’s condition, problems and concerns.” (ID #: 19) 
Being humble is suggested to be another element of physician attitude that may 
influence quality of health care provision by physicians.  
“It means to be open, humble and willing to admit having made a mistake. 
Try to solve problems and issues that arise with patients and next of kin 
using the way of least resistance or lowest level of conflict in order to 
prevent escalation.”  (ID #: 14) 
Showing interest in the patient and expressing empathy is another element that 
is suggested to influence quality of health care provision from a physician 
perspective.  
“…being present in the meeting with the patient. By that I mean being 
attentive, interested and awake. Have the ability to be present in the 
meeting would patients. I think this is very important for the real quality and 
also for the experience quality from the patient perspective. Also, to be 
able to convey regret and apologise for misunderstandings and when 
things did not work out that according to plan. Never be afraid of saying, I 
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did not understand you I was mistaken. I am sorry. The ability to be honest, 
truly honest.” (ID #: 27) 
Physician attitude in this context is an expression of favour or disfavour toward a 
patient or circumstance associated with the patient. In this study, the results may 
indicate that attitude may influence quality of health care service delivery. 
“…attitude towards people, attitude toward how things should be done and 
what standard is acceptable” (ID #: 3) 
Respect is suggested to influence quality of health care provisions. It is important 
for the physician to treat patients as “equals” and it is imperative that this is rooted 
in a genuine feeling of equality. 
“First, you need to respect the patient and the patient’s experience of his 
problem. Second, you need to respect the patient as an equal with respect 
to yourself. You need to believe that people are equal. This belief needs 
to be rooted deep in your soul. However, sometimes it may be very 
difficult“. (ID #. 2) 
Physicians are human and thus influenced by the trifles of everyday life in the 
same manner as everyone else. For example, having had a good night’s sleep 
and being well rested gives energy and may affect mood. 
“...if you feel that you have extra energy which is enough for the work that 
you have to do it will be easier to be in a good mood than if you don’t have.” 
(ID #: 18)  
The findings here suggest that physician mood may influence quality. Even 
though physicians are cognizant of mood and its effects, it may still influence 
quality of health care provision. 
“I deliver better quality the days I’m in a good mood; we are affected by 
mood, even though you work on it and are conscious of its effect you are 
still affected by your mood.” (ID #: 18) 
Interest in the patient and attention to detail are suggested to be important parts 
of the physician attitude related to quality of health care service delivery. Solving 
complicated medical problems involves being interested on a professional and 
on a personal level.  
“Being professionally curious and interested is important, the moment you 
stop being curious and believe you know everything you have lost.” (ID #: 
25) 
“Also, I think that I had an interest in this field of medicine and cared for 
the patient enough to go the extra mile.” (ID #: 26) 
Furthermore, the data suggest that physicians who enjoy their work deliver better 
quality.  
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 “I think as long as you enjoy your work you will also provide good quality. 
The moment you start to dislike your job you will likely start providing 
inferior quality work”.  (ID #: 18) 
“…the most important thing for me is that I love medicine, I love what I do, 
and I enjoy working with people from all walks of life“.  (ID #: 25) 
Finally, social context is also suggested to influence quality of health care service 
delivery. In order to focus on the work at hand, it may be important for physicians 
not to have to deal with social problems. 
“…that I feel good and that I don’t have problems socially, I think that is 
important.” (ID #: 14) 
5.5.2.3 Communication 
Analysis of the data revealed physicians’ emphasis on patient communication. In 
this research, communication is found to be about ability to establish a 
relationship with the patient in providing the basis for a mutual dialogue.   
 “…quality is something that we should be able to discuss and be the basis 
of a dialogue, I don’t have a good way to formulate that but it should be; 
quality is patient focus.” (ID #: 1) 
Good communication is found to be tailored to address patient needs, and 
therefore involves a decision based on subjectivity. Thus, the physician 
perception of patient needs becomes an important factor of communication 
quality. 
“By good communication I mean that we inform about the findings that we 
have made in a manner that the patient is able to fully understand its 
implications, communication must therefore be tailored to the individual. 
Some patients are capable of absorbing all information, and need the full 
information, whereas others do not have this capability. Consequently, 
communication and the way to proceed with communication becomes a 
subjective decision.” (ID #: 10) 
Communication may also being defined by what the patient experiences.  
“…the patient should experience that there are treated with respect, at the 
physician has communicated well the intention for what is planned, and 
that the patient is satisfied with the result.” (ID #: 2) 
In this study, communication with patients is found to be relevant. Good 
communication entails a good match between the physician’s perception of the 
patients’ needs, thus generating a positive experience for the patient. 
Communication is indicated to be an activity of conveying information through the 
exchange of thoughts, messages, or information, as by speech, visuals, signals, 
writing, or behaviour.  
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“I took a good case history, I didn’t buy the initial story, something didn’t fit 
and I spending time on getting information from the case history I was able 
to make a correct diagnosis.” (ID #: 4) 
Communication is referred to by interviewees as an enabler of quality in this 
study. Communication is a tool for exchange of information, and as such, 
dependent on messages being sent, received and understood in the manner 
intended. Being able to ask good questions to elicit necessary information and 
communicating in an open and honest manner is also suggested to facilitate 
quality.  
 “Communication must be good, which includes language. I must be 
clearly and the patient must understand what is being communicated. 
When this takes place by way of a translator information exchange may be 
insufficient. If we cannot have a good quality dialogue between physician 
and patient we have a problem.” (ID #: 15) 
“…it’s mostly about me listening and I am able to pose good questions, 
and that I am very honest when giving my advice, no compromise.” (ID #: 
7) 
Communication also necessitates an understanding on the patient level; thus, 
being able to communicate so that patients understand what is being 
communicated is suggested to enable quality. 
“I must communicate clearly and the patient must understand what is being 
communicated.” (ID #: 15) 
Communication is indicated by the interviewees to be an important part of both 
diagnostics and treatment.   
“I think that the fact that they have been very explicit in what they need has 
made it easy to be their physician and give them the support that they 
needed.” (ID #: 7) 
“The information was a very important part of the treatment. I informed the 
patient about her role and her responsibility, and ensured that she was 
willing to cooperate. Those were important things.” (ID #: 21) 
In this research, the data suggest that availability of information is critical when 
providing health care to patients. Consequently, lack of information may affect 
the outcome and hence quality of health care service delivery.  
“In the end the patient died. What irritates me with this type of case is that 
I did not have all the necessary information to explain his condition.” (ID #: 
16) 
5.5.2.4 Continuity of Care 
Continuity is related to how many physicians or other health care workers are 
involved in the care. When many physicians are involved in the provision of care, 
information may be lost during numerous exchanges. In this study, context was 
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found to be related to the number of exchanges of information during the delivery 
of health care.  
“It means that as few people as possible should participate in the 
treatment, exchange of information should be kept at a minimum.” (ID #: 
20) 
As mentioned above, when many physicians are involved in the provision of care, 
information may be lost during numerous exchanges.  
“This patient had been to several of my colleagues with stomach pain for 
months. A few tests had been done and the patient repeatedly sent home 
without further to do. When he came to me I ordered a computer 
tomography of the abdomen and it showed liver cancer with widespread 
metastasis. He died two weeks later and ….” (ID #: 19) 
In this sample, it seems that there is evidence to suggest that continuity may be 
an area for improvement. 
“…if for example several physicians were involved creating a breach of 
continuity in the treatment. We have to admit that breach in continuity of 
treatment is the norm in the Norwegian health care system rather than the 
exception.” (ID #: 15) 
5.5.2.5 Clinical Intervention 
Intervention may be considered the trigger for change (Pawson, 2006 p. 27). In 
this context, clinical interventions aim to change health status. From the data 
collected, interventions may be categorized into four main categories: 
diagnostics, treatment, procedures and communication. 
Table 5-8 Clinical intervention 
Clinical intervention 
Sub-category Property Dimension Sample quote 
Diagnostics Ability to make a correct 
diagnosis without delay 
High - Low “…in this case there were Max points and 
everything, working systematically, 
recognising the symptoms. This feels very 
good, we found something wrong, there was 
a consequence effect, everything fit and it 
was easy to treat.” 
Treatment Ability to give appropriate 
treatment without delay and 
undue risk to patients 
High - Low “I was the technician that solved the problem 
there and then by identifying the problem, 
deciding on treatment, putting the pacemaker 
in place.” 
Procedure Ability to perform procedure 
correctly 
High -Low “I examined him with echocardiography, 
talked with him, evaluated that he needed a 
pacemaker, and gave him information about 
the pacemaker…” 
Communication Quality of communication High - Low “I took a good case history, I didn’t buy the 
initial story, something didn’t fit and I 
spending time on getting information from the 
case history I was able to make a correct 
diagnosis.” 
Diagnostics is central to uncovering a causal relationship between a symptom 
and pathology causing the symptom. Treatment is the process of correcting 
pathology and improving health. For both diagnostics and treatment, procedures 
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are necessary and involve some form of purposeful action intended to achieve a 
result. Communication (see Section 5.5.2.3) governs the flow of information 
necessary for diagnostics, treatment and procedures.  
5.5.2.5.1 Diagnostics 
Diagnostics is an essential part of health care service delivery and may be 
regarded as a classification process. During the process, patient conditions are 
classified into distinct categories. The resulting categories are the basis for 
medical decision making pertaining to treatment and prognosis.  
“…in this case there were Max points and everything, working 
systematically, recognising the symptoms. This feels very good, we found 
something wrong, there was a consequence effect, everything fit and it 
was easy to treat.” (ID #: 5) 
5.5.2.5.2 Treatment 
Treatment is the process of remediation of a health problem following a diagnosis. 
In this data set, treatment is not so much about the process; the physicians are 
focused on deciding on treatment.  
“I was the technician that solved the problem there and then by identifying 
the problem, deciding on treatment, putting the pacemaker in place.” (ID 
#: 18) 
“I decided to use the resources and take the risk, as interferon treatment 
could drive the patient into a depression and ultimately suicidal behaviour.“ 
(ID #: 11) 
5.5.2.5.3 Procedures 
Procedures are a course of action intended to achieve a result in the care of 
persons with health problems. In this case, this may involve diagnostic 
procedures like echocardiography. 
“I examined him with echocardiography, talked with him, evaluated that he 
needed a pacemaker, gave him information about the pacemaker,” 
Procedures may also involve providing treatment in the form of prescriptions, or 
more technical procedures like injections or the placement of a pacemaker. 
“…yes, a prescription of controlled substances.” (ID #: 2) 
“…firstly I took the patient seriously, and provided injection therapy is that 
cured his pain condition.” (ID #: 2) 
“…we gave a temporary pacemaker and he’s given a permanent 
pacemaker a few days later.” (ID #: 19) 
With diagnostic and therapeutic procedures, it is important to think of the 
logistics so that the process is efficient and important aspects are not missed. 
“I evaluated the whole patient, making sure that everything fit, that the 
diagnostic workup was logical, that the patient had received enough 
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information, and that the logistics and practical aspects worked out okay.” 
(ID #: 9) 
5.5.2.5.4 Diagnostics 
In this research, the respondents indicate that diagnostics is an element of quality 
in health care. Diagnostics is an important part of clinical medicine as practiced 
by physicians, and is in most cases the precursor (decision base) for therapy.   
“Due to very aggressive diagnostics, we discovered that this patient has a 
cancer with metastasis.” (ID #: 22) 
5.5.2.5.5 Therapy 
Respondents also indicate therapy as an element of quality. Focus is on timely 
and appropriate therapy suited to address the patients’ needs.  
 “I didn’t diagnose the patient correctly and started inappropriate treatment 
which may have masked the symptoms. When I realised the patient was 
getting worse I contacted a more senior physician, a cardiologist, and he 
could make the correct diagnosis and start appropriate treatment but it was 
too late.” (ID #: 23) 
5.5.3 Outcome 
In this study, outcome is found to be comprised of the following two constructs: 
diagnosis & treatment and effects (clinical and experiential outcomes). Therefore, 
correct and timely diagnosis coupled with institution of appropriate and timely 
therapy constitutes the outcome. Quality in health care is therefore defined as the 
ability, on both a system and individual level, to provide a correct and timely 
diagnosis and institute appropriate treatment for individual patients and patient 
populations. 
In this section, the findings that map to the outcome element of quality in health 
care are covered. The presentation of findings explains the empirical basis for 
Figure 5-4, and is structured as follows.  Firstly, findings related to antecedent to 
clinical outcomes, diagnosis and therapy are detailed, followed by findings on 
clinical outcomes, and finally, data related to experiential outcomes are 
presented. 
5.5.3.1 Timeliness and Correctness of Diagnostics 
Early diagnosis and treatment is frequently mentioned, indicating strong 
relevance. In this study, it is clear that this plays an important role in quality of 
health care delivery. Furthermore, it is important that the diagnosis is correct and 
that the process is logical and efficient. 
Establishing a diagnosis quickly can in some cases be a matter of life and death. 
It is therefore not surprising that “early diagnosis” is an important element in how 
physicians define quality. 
"Due to delay in diagnosis this patient did not receive the therapy needed 
to save his life." (ID #: 26) 
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“For example, if you have a patient with an acute coronary syndrome my 
standard says that you should be able to make a diagnosis as quickly as 
possible, and inform the patient, and treat according to available guidelines 
within the time limits defined in our internal procedures.” (ID #: 18) 
In addition to establishing a diagnosis quickly, it is also important that the 
diagnosis is correct. Treatment is often dictated by the diagnosis, and if the 
diagnosis is wrong, the prescribed treatment may not help or may even make the 
situation worse.  
“…when they are in a hospital they should be diagnosed quickly resulting 
in a correct diagnosis, and they should receive treatment. Treatment is 
more schematic in the way that once the diagnosis is established then the 
treatment is given. The patient should receive the treatment that is deemed 
to be the correct treatment based on the diagnosis.” (ID #: 8) 
Informants suggest that in order to ensure early and correct diagnosis, the 
diagnostic process should be rational and efficient.  
 “…rational and efficient diagnostic workup. It is often the case that making 
a diagnosis is like going through different phases. When patients are 
admitted acutely, the focus is more on what needs to be done now, taking 
care of vital functions so that life and function is not lost. Then, it becomes 
more important to be more exact with regards to the diagnosis and 
deciding on treatment. For example, is the patient bleeding or not, in the 
next instance it might be a question about whether the patient has a Leiden 
mutation or not. The latter case is an example of a situation where more 
time can be spent on entering the question, also it does not have to happen 
while the patient is admitted, and it can be deferred to an outpatient 
setting.” (ID #: 13) 
Focus of medical research is on early diagnosis and treatment for different 
disease states. For example, the vast amount of research conducted on cancer 
in recent years has made it possible to detect, diagnose and treat cancer 
conditions that a few decades ago would lead to death in most patients. It has 
been shown that for 20 tumour types, the 5-year survival rates have increased 
from 1950 to 1995 (Welch et al., 2000). The main reason for this is attributed to 
screening, better diagnostic procedures, and resources. 
“This is a case I am uncomfortable talking about. Due to a clear focus on 
only part of the problem the diagnosis was missed and the patient died 
after about two months. I can also say that this may have been attributable 
to the competency of the physician doing the diagnostic procedure.” (ID #: 
6) 
Thus, early diagnosis and effective and timely treatment reduce morbidity and 
prevent premature death from disease. Early diagnosis and consequent 
treatment depends on the patient and the physician’s ability to interpret 




The effect of therapy can be more or less effective in solving the presenting 
problem. Differentiation is made between curative effect and symptomatic effect. 
In some cases, the symptomatic effect may be just as important dependent on 
the availability of curative therapies; for example, palliation for terminal cancer 
patients. 
"...intensive care is about two things: cure and palliation. Sometimes a cure 
is not available and then it is important to set therapy targets in line with 
what is the patient’s interest." (ID #: 22) 
“Availability of effective therapy is definitely important for quality. In 
oncology we have quite a few patients that will have a good chance of 
survival in a few years, but today medicines that are effective are not 
available.” (ID #: 6) 
In this study, treatment has emerged as an element of quality of health care 
service delivery. The results suggest that correct treatment should be given at the 
right time; it should be effective and tailored to suit the patients’ needs.  
“…that we give the best possible treatment within available resources 
limits” (ID #: 10) 
“…means that we deliver the best treatment available from a medical point 
of view with available resources.” (ID #: 2) 
“…that we can provide treatment tailored to suit the individual patient” (ID 
#: 11) 
Physicians strongly associate effective therapy with quality of care. The main 
premise identified in the data is that there is a correlation between the availability 
of effective therapy and quality of care, suggesting that effective therapy is 
necessary for positive outcomes related to the presenting problem. Overall, the 
results suggest that treatment should be given early; therapy should be correct, 
effective and tailored to suit the patients’ needs.  
5.5.3.3 Clinical Outcomes 
5.5.3.3.1.1 Improvement 
Some patients improve and live fulfilling lives as a result of the health care service 
provided.   
“We provided them with small backpacks with oxygen, this gave them a 
better life quality and they lived 15 years longer than what is normally 
expected with this condition.” (ID #: 25) 
This was a case where a special interest and curiosity led to experimental 
treatment for two children with downs syndrome.  
“It was a combination of being professionally interested and curiosity that 
made me solve the problem, and in addition it was enjoyable.” (ID #: 25) 
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5.5.3.3.1.2 No Change 
Some patients show no improvement even though resources and efforts are 
being made. Sometimes, parts of the health care delivery are below par, and 
quality may suffer as a result. As the proverb goes, ‘the chain is never stronger 
than the weakest link’.  
“The patient is readmitted to the ICU after a while on a normal ward due to 
a plugged tracheal cannula. This is caused by inappropriate care of the 
cannula. The patient has a white lung, and in order to put it right we need 
to do a bronchoscopy, and in order to do a bronchoscopy we must put the 
patient back on a respirator. Then we are back to square one, where we 
were nine weeks ago.” (ID #: 22) 
5.5.3.3.1.3 Worse 
Some patients get worse as a result of the health care service provided. For 
example, in interview 8, a previously healthy 65 year old Danish bricklayer 
suffered from complications due to premature discharge, which resulted in fibro 
thorax, and he can no longer work.  
“…in my opinion he was discharged way too early the first time he was 
admitted. He should have received longer course of intravenous 
antibiotics, the drain should have been kept longer and fibro lytic 
medication should have been instituted”. (ID #: 16) 
The reason for the premature discharge may have been due to an imbalance in 
the number of patients needing hospital admission and the available resources.  
“I think it was discharged early because there was a lot of pressure to 
discharge patients due to the sheer volume of patients coming into the 
hospital during this period, spring 2010”. (ID #: 8) 
5.5.3.3.1.4 Death 
The outcome in several of the patient cases provided is death. Death is the end 
of life and is not an optimal outcome by any means, but it is not synonymous with 
poor quality health care service delivery. In this study, death was the outcome in 
9 out of 54 patient cases provided by the subjects being interviewed. However, 2 
of the 9 cases represented situations where the interview subject was very 
satisfied with the quality of health care service delivery. One such case (interview 
20) involved a 3-year old boy with an aggressive form of leukaemia; everything 
in this case was done correctly and the patient still died.  
“The outcome was sad, in the end he died, because he had a very 
aggressive form of acute myelogenic leukaemia. The reason why I am 
satisfied with this case is because we came to a diagnosis very quickly 
and given the correct treatment very quickly.” (ID #: 20) 
This could indicate that physicians accept death as an inevitable and sometimes 
unavoidable consequence of disease. 
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5.5.3.4 Experiential Outcomes 
In this study, experiential outcome is found to be related to patient satisfaction; 
and patient satisfaction is found to be a patient’s expression of the experience 
and that he/she feels well taken care of. 
“…we have several patients with varying degrees of disease and 
symptoms and it’s not so much about the technical quality, in other words 
the results of the treatment, but more about how the patient experiences 
the result.” (ID #: 3) 
 “…it is the patient’s expression of his or her experience, at least the patient 
must feel that we haven’t done what is possible.” (ID #: 5) 
Patient satisfaction is related to experiential quality. In this data set, patient 
satisfaction refers to patients being able to present relevant problems, receive 
answers to the questions they wish answered, made aware of the plans that the 
health care service is making for them, and helping them understand what is 
going to happen and why. In other words, it is about a feeling of being respected 
and well taken care of.  
 “Quality is that the patient is seen, respected and treated as a whole 
person.” (ID #: 24) 
5.5.3.5 Patient Satisfaction 
In this research, patient satisfaction is a sub-category of how physicians frame 
quality of health care delivery.  
“I see a lot of patients every day, and I think that the patient should be the 
focus for our efforts, the patient should be satisfied, and the patient should 
have a correct diagnosis and good treatment.” (ID #: 12) 
The results of the study indicate that patient satisfaction is related to the patients’ 
experience with the health care service delivery.  
“Experiential quality often includes an element of feeling safe and that 
expectations are managed, and that the patient and next of kin has the 
same understanding and feeling of being well cared for“. (ID #: 15) 
The data here indicate that quality is something that the patient can experience, 
and is directly or indirectly related to the health care service provided.  
5.5.3.6 Clinical Outcome 
In this study, two categories of outcome are identified: clinical and experiential. 
Technical outcomes are related to the medical condition, and were found to lie 
along a continuum ranging from cure to death; please see Figure 5-4 Clinical 
outcome continuum. Experiential outcome is related to patient satisfaction and 
the dimension is high – low. 
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Figure 5-4 Clinical outcome continuum 
5.5.3.6.1 Clinical Outcome 
The frequency distribution of outcomes is of interest, as it shows that the 
physician perception of quality is likely to be higher with better outcomes (cured 
and improved), and lower if the outcome is worse or death. However, there are 
exceptions, as high quality was perceived in two cases where death was the 
outcome, and conversely, low quality was perceived in two cases where the 
outcome was cure; see Table 5-9 Frequency distribution of clinical outcomes for 
further details on distribution of outcomes. In the following sections, each of the 
outcomes will be described briefly and sample quotes provided; please also see 
Table 5-10 Clinical outcomes. 
Table 5-9 Frequency distribution of clinical outcomes 
 Cure Improved No change Worse Death 
High quality 15 9 1 1 2 
Low quality 2 2 2 8 12 
Total 17 11 3 9 14 
Table 5-10 Clinical outcomes 
Outcomes 
Sub-category Property Sample quote 
Cure Condition and/or function is full 
restored as a result of medical 
intervention and/or context 
“I took the patient seriously, and provided injection therapy that 
cured his chronic pain condition.” 
Improve Condition and/or function 
improve as a result of medical 
intervention and/or context 
“We provided them with small backpacks with oxygen, this gave 
them a better life quality and they lived 15 years longer than 
what is normally expected with this condition.” 
No change No change  in patients condition 
or function as a result of medical 
intervention and/or context 
“The patient is readmitted to the ICU after a while on a normal 
ward due to a plugged tracheal cannula. This is caused by 
inappropriate care of the cannula. The patient has a white lung, 
and in order to put it right we need to do a bronchoscopy, and 
in order to do a bronchoscopy we must put the patient back on 
a respirator. Then we are back to square one, where we were 
nine weeks ago.” 
Worse No change  in patients condition 
or function as a result of medical 
intervention and/or context 
“…in my opinion he was discharged way too early the first time 
he was admitted. He should have received longer course of 
intravenous antibiotics, the drain should have been kept longer 
and fibro lytic medication should have been instituted”. 
Death Death as a result of medical 
intervention and/or  context 
“the outcome was sad, in the end he died, because he had a 
very aggressive form of acute myelogenic leukaemia. The 
reason why I am satisfied with this case is because we came to 
a diagnosis very quickly and given the correct treatment very 
quickly.” 
5.5.3.6.1.1 Cure 
Some patients are fortunate and become cured or have their function (physical 
and/or mental) restored.  
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“I took the patient seriously, and provided injection therapy that cured his 
chronic pain condition.” (ID #: 2) 
A cure is often considered the best outcome; however, it is not necessarily 
synonymous with quality health care service delivery. Consider the four following 
situations in the context of a medical outcome defined as a cure. First, a situation 
where good medical quality is delivered, but the experience from the patient 
perspective is not good. Second, a situation where medical quality is poor and 
experiential quality is good. Third, a situation where medical quality and 
experiential quality are both rated as poor. Finally, a situation where medical 
quality and experiential quality are both rated as good. Thus, outcome is but a 
piece of a complex jig-saw puzzle making up quality health care service delivery.  
“…in the end we did not manage to make a diagnosis, the patient improved 
slowly over time, diagnostic workup did not work well. Everyone was 
dissatisfied.” (ID #: 15) 
In this section, the findings are presented from the 54 patient cases used to query 
the respondents about what influences quality in health care, under what 
circumstances and by what mechanisms. Two categories of patients were 
chosen. The first category, 27 patients, was chosen on the basis that the 
physician indicated that he/she was very satisfied with the quality of health care 
in these cases. The second category, also 27 patients, was chosen on the basis 
that the physician indicated that he/she was dissatisfied with the quality of health 
care in these cases. 
5.5.3.7 Classification of Medical Conditions 
Context was found to be related to the patients’ medical condition. In this 
research, medical condition was found to have two sub-categories: physical or 
mental disease. Each of the sub-categories was found to have several further 
layers defining the context at a more granular level, including acuteness, 
symptom and severity. The coding structure of medical condition is shown in 
Table 5-11 Classification of medical conditions. The table also provides 
frequency reporting as an indication of relevance in the # columns.  
Table 5-11 Classification of medical conditions 
Classification of medical conditions 
Disease type # Acuteness # Symptom # Severity # 
Physical 51 
Acute 38 
Clear 31 Life threatening 24 Non- life threatening 7 
Diffuse 7 Life threatening  2 Non- life threatening  5 
Chronic 13 
Clear 10 Life threatening  3 Non- life threatening  7 
Diffuse 3 Life threatening  1 Non- life threatening  2 
Mental 3 
Acute 2 
Clear 2 Life threatening  1 Non- life threatening  1 
Diffuse 0 Life threatening  0 Non- life threatening  0 
Chronic 1 
Clear 1 Life threatening  1 Non- life threatening  0 
Diffuse 0 Life threatening  0 Non- life threatening  0 
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5.5.4 Enablers and Barriers 
Two important findings emerged from the data. First, data in this study indicate 
that barriers and enablers are interconnected in the way that they are viewed as 
opposites of a spectrum. For example, availability of time may be considered an 
enabler and lack of time a barrier. Thus, availability of time takes on the 
dimension high (enabler) and low (barrier). Respondents report that enablers 
may be considered as absence of barriers.  
“….well, mostly the opposite of what we have already talked about. I don’t 
know if I can find something else to say. Now, I don’t think so.” (ID #: 15) 
Availability of time may therefore be considered an influencer. Second, constructs 
of quality and influencers are found to be identical.  
5.5.5 Mechanism of Influence 
A part of the interviews focused on asking respondents about what they would do 
differently if the mentioned barriers did not exist; the majority of physicians 
responded that they would do more of what they were already doing.  
“I would spend more time on diagnostics, making sure that we follow 
national and international standards for establishing diagnosis, more time 
on treatment and evaluation of effect and follow up, I would spend more 
time talking to the patients and next of kin ensuring better and more 
complete information. I would spend more time developing professionally 
and discussing cases with colleagues.” (ID #: 26) 
The consequence, as indicated in this data set by the projections, would be an 
improvement in health care service delivery in general.  
“I would probably make fewer mistakes, fewer complaints, patients would 
be more satisfied, expenses would probably go down, things would go 
smoother, we would use less time and may be able to treat more patients. 
It would be more fun to work, less complaints from colleagues, time to 
develop as a physician.” (ID #: 15) 
This was an unexpected finding, but quite intriguing. If physicians would simply 
do more of what they were already doing if the barriers did not exist, then barriers 
influence volition or at least the perception of perceived behavioural control at 
some level. This topic will be discussed in detail in the discussion section of this 
chapter. 
5.5.6 Summary of Findings 
In this section the findings in this study are summarised. A tabulated summary of 
the sub-categories suggested to be associated with quality in health care, 
influencers of health care and patient case validation, is presented in Table 5-12 
Summary of findings. It is worth noting that physicians’ conception of quality and 
influencers of quality are the same. This is relevant because medical care 
belongs to the category of commodities for which the product and the activity of 
production are identical (Arrow, 1963 p. 949). 
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The column labelled “Quality” in the table indicates the sub-categories associated 
with how physicians conceptually frame quality in health care. The column 
labelled “Influencers of quality” indicates the sub-categories associated with 
influencers (barriers and enablers) of quality in health care. The column labelled 
“Patient case validation” indicates which sub-categories have been validated 
from data in the 54 patient cases included in the data set. There are four sub-
categories where the patient cases in the data set do not provide validation: 
evaluation, patient satisfaction, standards of care and time. Time may be 
considered a subset of resource, as it is associated with the temporal availability 
of the physician as a resource in the production of health care. Thus, evaluation, 
standards of care and patient satisfaction are not validated sub-categories 
Table 5-12 Summary of findings 









experience and skill) 
High - Low 
X X X 
Context 
Communication Ability to 
communicate, get and 
give necessary 
information in a 
tailored manner 
High - Low 
X X X 
Process 
Continuity Level of continuity of 
care 
High – Low X  X Context 
Diagnostics Ability to correctly 
diagnose patients 
without delay 
High - Low 
X X X 
Process 
Evaluation Ability to evaluate and 
learn 
High – Low X   Process 
Organization Organization of work 
that support delivery of 
health care 
High – Low 
X X X 
Context 
Patient Willingness to 
cooperate and adhere 
to medical advice 
given  
High - Low 




Level of experiential 
quality 
High - Low X   Outcome 
Physician 
attitude 
Ability to show and 
real interest and level 
of curiosity 
High - Low 
X X X 
Process 
Resources Availability of 
necessary technical, 
building and human 
resources 
High - Low 








X   
Context 
Process 
Therapy Ability to correctly treat 
patients without delay 
High - Low X X X Process 
Time Availability of time to 
do what is necessary 
High - Low X X X Context 
Furthermore, the data suggest that influencers of quality in health care exert 
influence by modulating the perceived behavioural control of physicians while 
supplying effort into the production of health care.	
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Continuity of care is not considered to be an influencer. The reason for this finding 
may be due to the fact that continuity of care is related to organization.  It is noted 
that discontinuity is the rule rather than the exception in the dataset.  
“Theoretically, one could imagine that organisational issues could have an 
impact, if for example several physicians were involved creating a breach 
of continuity in the treatment. We have to admit that breach of continuity in 
treatment is the norm in the Norwegian health care system rather than the 
exception.” (ID #: 15) 
Evaluation is not considered to be an influencer and is not validated by patient 
cases. This may indicate that evaluation is necessary for developing quality in 
health care, but does not influence quality directly. However, logically, feedback 
should provide real time learning and be a basis for experience. This researcher’s 
personal experience is that feedback is received on an infrequent basis, and may 
therefore be missed during sampling. The same arguments can be made for 
patient satisfaction, another subcategory not considered to be an influencer; and 
not validated by patient cases.  
Also, standards of care (guidelines) were indicated not to be an influencer. This 
finding may be due to the fact that the link between standards of care and quality 
is by way of adherence.  
“Quality is then defined as how well you managed to live up to the standard 
defined by the medical community. Decisions take place continuously and 
it is about how close to the standard you manage to practice.” (ID #: 13) 
In order to gauge adherence, it is necessary to evaluate or measure. The data in 
this study indicate that physicians do not formally measure quality. Thus, it may 
be argued that physicians do not measure guideline adherence. The results for 
standards of care, therefore, follow those of evaluation.  
In this study, the findings suggest that bio-medical context is a differentiating 
factor of quality constructs. The most notable differentiating contextual factors are 
acuteness and severity of medical condition. However, these differentiating 
contextual factors may in themselves be influencers of quality. 
“If for example a patient comes in with chest pain, it is important that the 
physician can differentiate whether this is just due to pain and the muscles 
or if it is an acute myocardial infarction which potentially could kill the 
patient.” (ID #: 24) 
Bio-medical factors are therefore found to contextualize medical decision making, 
and thus supply of effort by physicians in the delivery of care for patients.  
5.6 Discussion 
The discussion is structured around the identified key findings representing 
physician perception of quality health care delivery, compared and contrasted 
with evidence from the literature. This starts by considering what has been added 
before discussing what has been confirmed.  Next, a discussion of what has been 
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challenged is provided. Then, the author discusses theoretical implications. 
Finally, a conceptual framework for quality in health care delivery is proposed. 
5.6.1 What has been Added 
Quality in healthcare is dependent on the interaction between physicians and 
patients. These interactions are complex for five main reasons. First, physicians 
are the decision makers on behalf of patients, payers, providers and producers. 
Second, decisions are made in the context of information asymmetry and 
uncertainty; and no unified theory of medical decision exists. Thus, deciding how 
to decide is important. Third, quality is non-contractible and physician effort is 
unobservable. Models abstracting the complexity of medical decisions into a 
single measurable item give the impression that treatment decisions are more 
easily monitored and controlled than they really are  (McGuire, 2001 p. 527). The 
physician is an “experience good”; patients must experience the physician and 
make an inference about quality. Fourth, physicians may set levels of quality to 
influence demand, and may do so motivated by self-interest. Physicians may 
therefore influence quality by adjusting effort in a situation where demand is not 
under physician influence. Finally, a unified definition of quality in health care 
does not exist and there are more techniques to measure it than definitions.   
This study adds the physician perspective of this complex and cloaked process 
of decision making, employing content analysis of textual data collected using a 
semi-structured interview technique. In so doing, this study makes six 
contributions by extending or adding to current knowledge. First, Donabedian’s 
system model of quality is extended. Second, bio-medical contexts are found to 
define the spectrum of possible clinical outcomes. Third, antecedents to clinical 
outcomes are found to be more stable indicators of clinical quality than health 
outcomes. Fourth, quality constructs are identified as influencers; in other words, 
physicians define quality by what defines their spectrum of choice. Fifth, the 
predominant mechanism by which influence is exerted on supply of effort is 
revealed to be perceived behavioural control. Finally, the semi-structured 
interview technique provides a richer data set than the repertory grid. 
5.6.1.1 Extending Donabedian’s Quality Model 
The study adds two extensions to Donabedian’s (1979) elements of quality. First, 
it is proposed that structure is a sub-set of context. Patient level bio-medical 
contexts define the spectrum of possible clinical outcomes given current available 
medical knowledge and technology. Project One identified patient-level 
biomedical contexts as an important influencer of physician decision making. 
Project Three identified and classified bio-medical contexts perceived by 
physicians to influence quality of health care.  Donabedian’s definition of 
structure, which is focused on resources (material and human) and organization, 
omits bio-medical aspects altogether. Thus, structure is a subset of context. The 
elements of quality in health care are therefore: context, process and outcome.  
Second, it is proposed that diagnosis and choice of therapy are valid measures 
of clinical quality. Clinical outcomes which are perceived to influence quality have 
been identified and classified in this project. Furthermore, the respondents claim 
that poor clinical outcomes do not translate to poor quality of healthcare (see 
Section 5.5.3.3.1.4 on page 262). This finding may at first seem contradictory, but 
 270 
is linked to biology and the physician’s understanding and expectation of bio-
medical consequences of clinical outcomes. Thus, change in health status on its 
own is not a valid measure of quality in healthcare. It is proposed that the 
antecedents to clinical outcome are a better measure of clinical quality; for 
example, if the correct diagnosis is made without delay and results in institution 
of appropriate therapy without delay, then the clinical outcome is dependent on 
the medical condition. Clinical outcomes can therefore not be evaluated without 
considering the bio-medical context. However, diagnosis and choice of therapy 
can be measured temporally and with respect to correctness. Thus, it is 
suggested that diagnosis and therapy are valid measures of clinical quality. 
5.6.1.2 Bio-Medical Contexts and Antecedents to Clinical Outcomes 
Empirically, the study revealed that bio-medical factors such as severity, 
acuteness and clarity of symptoms, contextualize medical decision-making. 
Severity of condition refers to the degree of organ abnormalities or 
decompensating of normal bodily functions. Severity is therefore an important 
determinant of when to institute medical intervention; for example, acute airway 
obstruction requires a resolution within a few minutes. Clarity of symptoms refers 
to the fit between symptom and diagnosis; for example, an uncharacteristic 
headache may indicate anything from stress to severe intracranial abnormalities. 
Acuteness refers to a rapid onset of symptoms and/or short course. It is easy to 
confuse acute with severe, but it is possible for a disease to be acute but not 
severe; for example, the common cold is considered an acute disease, but 
generally mild. On the other hand, acute myocardial infarction is both acute and 
severe in nature.  
Severity of condition is found to mandate a temporal course of action, and as 
such, influences supply of physician effort. In addition, clarity of symptoms and 
acuteness are found to modulate the effect of severity. For example, the 
respondents claim that chronic patients with diffuse symptoms transfer negative 
energy to the physician, influencing the supply of effort. Physicians may make 
decisions on choice of therapy based on either symptoms or diagnosis alone, or 
in combination. It has been shown that the use of both symptoms and diagnosis 
result in the lowest error rate with regard to choice of therapy (Adelhard et al., 
1996).  
It is proposed that maximum supply of effort occurs under conditions 
characterized by high degree of severity, clarity of symptoms and acute onset. 
However, the perception of these constructs during the course of disease is likely 
to vary from day to day and from physician to physician, thus making the supply 
of effort unpredictable.  
5.6.1.3 Quality Constructs and Influencers 
This study adds granularity to the quality constructs identified in Project Two. The 
second project of this DBA identified and classified constructs of physicians’ 
quality conception while providing care for patients. This project validated the 
findings from Project Two and provides information about the activities related to 
the constructs, the mechanisms and the impact. Thus, Project Three provides a 
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road map for stakeholders in health care, which provides valuable information 
when designing and implementing interventions.   
Project Three was designed to address the question of enablers and barriers in 
health care. Enablers and barriers were found to be identical to the quality 
constructs. Project Two set out to explore physicians’ conception of quality. The 
study resulted in eleven key constructs, representing a static map of how 
physicians construct quality. Project Three, on the other hand, set out to extend 
the understanding of quality by exploring enablers and barriers. The study 
revealed a set of quality constructs similar to that found in Project Two, but also 
found that enablers and barriers were represented polar opposites of a dimension 
of the identified quality constructs. Physicians supply effort into the delivery of 
health care, and this effort is considered equal to quality (Ma and McGuire, 1997, 
McGuire, 2001). Since the perspective of the phenomenon of interest is that of 
the physician, it is natural for the physician to consider influencers of physician 
effort as quality.  
5.6.1.4 Mechanism of Influence 
Project One revealed two sets of factors influencing physician decision making; 
however, the link to quality was missing. From a quality perspective, Project One 
provides information related to context and interventions influencing the process 
of health care delivery. Furthermore, the findings of Project One indicate that 
perceived behavioural control at the physician level is an important mechanism 
by which influence is exerted. However, a link to outcomes were found to be 
missing in extant literature. Project Two revealed eleven key constructs 
representing physicians’ conception of quality, and this project further informs the 
phenomenon of interest by exploring enablers and barriers of quality. The findings 
of this study reveal that physicians view the absence or presence of the 
constructs as enablers or barriers, thus adding a dimension to the construct. Also, 
this indicates that physicians’ perception of quality is shaped by the spectrum of 
choice available to them while making clinical decisions. In fact, when asked what 
they would do differently if the barriers did not exist, the respondents claim “more 
of the same”. Thus, this project provides empirical evidence to support the 
findings from Project One, that perceived behavioural control is the predominant 
mechanism of influence of supply of physician effort in the delivery of health care.  
5.6.1.5 Point of Influence 
The constructs mapping to the context element of quality are claimed to be 
influencers of quality by the respondents in this study, as covered in Section 5.5.1 
from page 239. Furthermore, context is found to define the spectrum of choice. 
The prevailing mechanism of influence is the perceived behavioural control, and 
context is found to influence quality by defining the spectrum of choice. Thus, it 
is proposed that the point of influence is context.   
5.6.1.6 Semi-Structured Interview 
Several scholars, for example Goffin (2002) and Lemke et al. (2011), claim that 
repertory grid technique is better suited to revealing granular data of complex 
phenomena. However, the finding of this study is that using a semi-structured 
interview technique provides a richer data set. Therefore, in the context of health 
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care quality, the semi-structured interview technique may be better suited to 
examining complex phenomena than repertory grid technique. 
5.6.2 What has been Confirmed 
In this section, the findings of the study are discussed where agreement with 
evidence presented in previous DBA projects and literature is high. First, there is 
evidence to support Donabedian’s systems approach to defining and assessing 
quality in health care. Second, there is evidence to support the use of the Theory 
of Planned Behaviour in a health care context. Third, there is evidence to support 
the use of Agency Theory in a health care context. Fourth, the semi-structured 
interview technique is found to be a valid method for investigating complex 
phenomena related to quality in health care. Fifth, bio-medical contexts are 
confirmed to be important factors in determining the spectrum of possible clinical 
outcomes and they influence physicians’ decisions. Finally, quality constructs 
identified in Project Two have been validated using triangulation of methods.  
Table 5-13 Comparison of constructs between Project Two and Three 
Element Construct P2 P3 Theory Theoretical 
concept 
Reference example 
Process Communication X X TPB Attitude Ajzen 1991, p. 198 
Agency Risk: monitoring and 
negotiation 





X  TPB Control belief Ajzen 1991, p. 204 
Decision Causal vs. 
diagnostic 
interpretation 
Einhorn & Hogarth 1981, 
p. 65 




provision of care 
X X TPB Control belief  & 
Social norm 
Ajzen 1991, p. 199 
Patient  X Agency Moral hazard & 
adverse selection 
Eisenhart 1989, p. 72 
Context Resource availability X X TPB Control belief Ajzen 1991, p. 188 
Resource utilization X  TPB Control belief Ajzen 1991, p. 188 
Time X X TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 
Conlon & Parks 1990, p. 




X X TPB Control belief Ajzen 1991, p. 188 
Agency Moral hazard & 
adverse selection 




X X TPB Control belief Ajzen 1991, p. 203 
Agency Adverse selection Eisenhart 1989, p. 61 
Decision Habit persistence Ajzen 1989, p. 203 
Standards of care  X Decision Causal vs. 
diagnostic 
interpretation 
Einhorn & Hogarth 1981, 
p. 65 
Evaluation  X Decision Reinforcement: 
positive  outcome 
feedback 
Einhorn & Hogarth 1981, 
p. 79 
Outcome Early diagnosis and 
treatment 
X X TPB Control belief Ajzen 1991, p. 204 
Agency Risk: random market 
effect 
Conlon & Parks 1990, p. 
610 
Effect of therapy,  
outcomes (clinical 
and experiential) 
X X TPB Control belief Ajzen 1991, p. 204 
Decision Reinforcement: 
positive  outcome 
feedback 
Einhorn & Hogarth 1981, 
p. 79 
Physicians frame quality in health care delivery in both Project Two and Project 
Three, as in Table 5-13 Comparison of constructs between Project Two and 
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Three similarities and differences. Since patient cases were used in both studies, 
physician conception of quality is linked with actual clinical practice, and the 
findings in Project Two and Three are homogenous.  
5.6.3 What has been Challenged 
This study provides two main challenges to currently accepted knowledge, and 
in addition, questions the traditional organization of health care service. First, 
evidence presented in this study indicates that Agency Theory and TPB alone 
are insufficient in predicting behaviour, and thus effort and quality, with respect 
to quality in health care. Second, the current approach to ensuring quality in 
health care is counterproductive because it discounts the influencers of effort 
supplied into its production and hence quality. Finally, the findings in the study 
challenge the current thinking and organization of health care services.  
The first challenge concerns the application of Agency Theory and TPB in the 
context of a patient-physician dyad. The evidence provided in this study suggests 
that both theories need to be combined in order to be able to predict effort. On 
one hand, Agency Theory, or more specifically, physician agency states that 
effort is not observable and hence quality non-contractible (Ma and McGuire, 
1997). However, TPB holds that behavioural intent is an immediate precursor to 
behaviour and has been shown in studies to have predictive power (Godin et al., 
2008). In this context, effort and behaviour are considered to be synonymous. 
Thus, TPB claims to predict what Agency Theory cannot. The evidence presented 
in this study indicates that information asymmetry and perceived behavioural 
control may be linked, and that a combined use of Agency Theory and TPB is 
necessary in order to overcome the challenge posed by the patient-physician 
dyad. 
The second challenge provided by this study is related to process management 
of quality in health care. Chandrasekaran et al. (2012) investigated the effect of 
Centres for Medicare and Medicaid Services (CMS) process management on 
quality. CMS developed a set of core measures for common and serious health 
conditions. The authors found a positive effect on technical quality and a negative 
effect on experiential quality. CMS process management aims to reduce 
variation, and thus experiential quality suffers as the variability necessary for 
meeting patient expectations is reduced (Pettersen et al., 2004).  
The results of this study suggest that if barriers to quality in health care service 
delivery did not exist, they would do more of what they were already doing. This 
finding suggests that perceived behavioural control is influenced by the barriers. 
The CMS process discounts the underlying mechanisms for influence of 
physician effort supplied into the production of health care, and focuses purely on 
measuring effort proxies retrospectively.  
The consequence of the traditional organization of medical services is that the 
patient first meets the most inexperienced physician. This research finds that 
physicians claim experience to be central to making a correct and timely 
diagnosis with the appropriate therapy. However, senior physicians are likely to 
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be found far from the ER. The consequence is that the patients must wait for 
decisions to be made, thus delaying diagnosis and appropriate therapy.   
5.6.4 Theoretical Implications 
In this section, the findings of the study will be discussed employing Agency 
Theory, TPB and realist synthesis (context, intervention, mechanism and 
outcome). First, a brief overview of the main tenets relevant to this discussion is 
provided. Next, the evidence presented in this study employing agency and TPB 
perspectives is examined.  
5.6.4.1 Agency Theory and TPB 
From a theoretical perspective, evidence presented in this study is of particular 
interest because it provides empirical evidence of a link between two theoretical 
frameworks (agency and TPB) when applied to the patient-physician dyad.  
In clinical medicine, the patient has a medical need and delegates work to the 
physician, who in turn supplies effort into the production of health care. How is 
effort to be understood in this context? Effort is defined as the physician’s input 
into the production of health care for the patient, and can also be understood as 
quality; and is simply non-observable and hence non-contractible (McGuire, 2001 
p. 466). If the input is non-observable, information asymmetry must exist. This is 
a natural consequence of the expert role the physician has when providing health 
care. In the context of the patient-physician dyad, Agency Theory posits that the 
physician supplies effort into the production of health care, information 
asymmetry exists and that effort is unobservable as a consequence.  
Control of volition is an underlying assumption of TPB (Ajzen, 1991). Evidence in 
this study strongly suggests that perceived behavioural control is the central 
mechanism by which enablers and barriers exert influence (see Enablers and 
Barriers) 
Two important findings emerged from the data. First, data in this study indicate 
that barriers and enablers are interconnected in the way that they are viewed as 
opposites of a spectrum. For example, availability of time takes on the dimension 
high (enabler) and low (barrier). Respondents report that enablers may be 
considered as absence of barriers. 
“…well, mostly the opposite of what we have already talked about. I don’t know if 
I can find something else to say. No, I don’t think so.” (ID #:15) 
Availability of time may therefore be considered an influencer. Second, quality 
constructs and influencers are found to be identical. 
5.6.4.2 Mechanism of influence  
In an ideal world where barriers do not exist, physicians will not do anything 
different other than more of what they are already doing. Thus, the evidence 
indicates that physicians will not change what they are doing, but effort supplied 
by physicians may be influenced. It can therefore be argued that “the will to act” 
(behavioural intent) is present in a clinical setting and may be considered a 
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constant. It is therefore possible for the TPB constituents, attitude and social 
norm, to be considered constant in a clinical setting.  
From a practitioner perspective and the researcher’s personal experience, this 
makes sense, as the drive to help others may be considered strong in the medical 
profession because there is a concern for medical ethics (Arrow, 1963). Thus, the 
combination of both intent and perceived behavioural control may be used to 
predict actual behaviour, as asserted by  Ajzen (1991) p. 184. Keeping 
behavioural intent constant, the probability of actual behaviour becomes 
dependent on perceived behavioural control, which in TPB is assumed to be 
dependent on prerequisite opportunity and resource. The availability of requisite 
opportunities and resources (e.g., time, money, skills, cooperation of others) 
collectively represents physicians’ actual control over behaviour related to health 
care service delivery (Ajzen, 1985, Ajzen, 1991 p. 182). 
5.6.4.3 Linking Agency Theory and TPB 
Linking effort from Agency Theory and behavioural intent from TPB will be the 
focus of the rest of this discussion. The argument has already been made that 
the physician supplies effort into the production of health care, information 
asymmetry exists and that effort is unobservable as a consequence. 
Furthermore, it has been argued that evidence provided in this study suggests 
that perceived behavioural control may be a variable factor when predicting actual 
behaviour in the context of the patient-physician dyad. How are these arguments 
to be understood together? 
The limit of information asymmetry may be described by considering a situation 
where the physician has full information; knows everything that is relevant to 
know in the situational context, i.e. has superior information. From the argument 
made above, the consequence would be that resulting physician effort would be 
non-observable. However, if information asymmetry did not exist, then both 
patient and physician would have full information, and effort would be observable. 
The underlying assumption of value in the patient-physician dyad is that the 
physician is the expert and has more information; hence, a natural situation of 
information asymmetry. Thus, information asymmetry may regulate level of 
physician effort available for observation.  
Information asymmetry in the context of patient-physician dyad is dependent on 
the physician having superior information. Thus, it may be argued that the more 
“expert” the physician is, the greater the information asymmetry. However, when 
a physician engages in decision making on behalf of the patient, uncertainty is 
reduced by having superior information. Uncertainty has been claimed to be a 
strong influencer of physician behaviour (Arrow, 1963).  
Having “superior” information touches on two findings, as evident in this study. 
First, communication is an important tool for exchanging information, and may 
both increase and reduce information asymmetry. Second, competency is related 
to how “expert” the physician is, and is central to information asymmetry in clinical 
practice. Thus, communication and competency may influence the level of 
information asymmetry in the patient-physician dyad. In this context, competency 
is of special interest, as it may be argued that with increased physician 
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competency, uncertainty is reduced and information asymmetry increased. Lai 
(2002) has defined competency as the ability to meet today’s and tomorrow’s 
challenges; in other words, to have knowledge, skills, abilities and attitudes suited 
to accomplish tasks and challenges. Thus, the more competent the physician is, 
the more likely it is that effort will be supplied, but the effort is also more likely to 
be non-observable. The implication is that with increasing specialisation of 
medical practice, effort supplied into its production becomes increasingly 
clouded. Thus, having insights into this issue is of importance. 
It has been argued in this study that information asymmetry may influence 
physician effort by modulating uncertainty. From a TPB perspective, it may 
therefore be argued that perceived behavioural control is in part influenced by 
information asymmetry. Perceived behavioural control is assumed to be 
dependent on prerequisite opportunity and resource, and the evidence provided 
in this study confirms this assumption; organization and resource are found to be 
influencers of quality.   
The study provides empirical evidence to support perceived behavioural control 
as the mechanism by which enablers and barriers exert influence on physician 
effort supplied in the production of health care. From an agency perspective, the 
patient-physician interaction is associated with information asymmetry, which 
may influence physicians’ uncertainty when making decisions on behalf of 
patients. Thus, information asymmetry may be considered a modulator of 
physician perceived behavioural control in clinical practice. Evidence provided in 
this study suggests that information asymmetry is influenced by communication 
and competency. From a TPB perspective, perceived behavioural control is 
influenced by organization and resource. Thus, the study provides evidence to 
support the need for both Agency Theory and TPB when considering quality in 
health care. 
5.6.5 Proposed Conceptual Framework 
In this section, a conceptual framework for quality in health care is proposed, 
based on how physicians conceptually frame quality of health care delivery. The 
framework takes into account the findings from this study, elements of quality and 
the three theoretical domains identified in Project One.  
5.6.5.1 Extension of Quality Elements 
The evidence in this study signals that context may be an element of quality; see 
Section 5.5.1 from page 239. Therefore, an extension is proposed to the three 
elements of quality originally suggested by Donabedian (1978): structure, 
process and outcome. The proposed extension is context, and it is defined by the 
acuteness of medical condition, clarity of symptoms and severity.   
When considering effort and elements of quality, it is logical that effort is part of 
the process, and that it may be influenced by elements including and preceding 
process; see Figure 5-5 Extended elements of quality. Thus, factors that are 
categorized within each of the elements of quality may influence the effort 
supplied by the physician.  
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Figure 5-5 Extended elements of quality 
Structure is comprised of resource availability, resource utilization, time, 
cooperation and experience. All five constructs are grounded in the Theory of 
Planned Behaviour and related to control beliefs and perceived behavioural 
control. Three of the constructs are also grounded in Agency Theory; experience, 
cooperation and time. Information asymmetry and risk are defining constructs of 
influence in the Agency Theory context. Finally, experience is grounded in 
Decision Theory and related to habit persistence. 
Process is comprised of communication, correct interpretation of information, 
continuity of care and responsibility of care. All constructs are grounded in Theory 
of Planned Behaviour and related to control beliefs and perceived behavioural 
control. Communication is also grounded in Agency Theory and related to risk 
through monitoring and negotiation. Correct interpretation is grounded in 
Decision Theory and linked to causal and diagnostic interpretation of information.  
Outcome is comprised of early diagnosis and treatment, and effect of therapy. 
Early diagnosis and treatment are grounded in Theory of Planned Behaviour and 
Agency Theory. The link to theory is through control beliefs and perceived 
behavioural control, and information asymmetry and risk, respectively. Effect of 
therapy is grounded in Theory of Planned Behaviour and Decision Theory. From 
a Theory of Planned Behaviour perspective, effect of therapy is associated with 
control beliefs and perceived behavioural control. From an agency perspective, 
effect of therapy is linked with reinforcement through positive outcome feedback. 
5.6.5.2 Proposing and Explaining the Conceptual Framework 
The discussion in this section follows the flow in the proposed framework visually 
represented in Figure 5-6 Proposed conceptual framework.  
The moment of truth in medicine takes place when patient and physician interact, 
and the primary reason for this interaction is that the patient has an unresolved 
medical need. Patient-physician interaction in an agency context that mandates 
patient engagement in the process of work delegation, as is evident from the 
findings of this study. When presented with a patient’s medical need, it is widely 
stated that it is the physician’s perception of this need (patient expectation) that 
is the main influencer (Mangione-Smith et al., 1999, von Ferber et al., 2002, Hyde 
et al., 2005, Lado et al., 2008). In the agency context, the patient (principal) 
delegates work to the physician (agent). The physician supplies effort into the 
production of health care, but the effort cannot be observed and can therefore 
not be predicted in advance.  
Why can effort not be predicted in advance? The patient interaction takes place 
in the context of information asymmetry and uncertainty. Since the physician is 
the “expert”, he/she holds more information than the patient, and this creates a 
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situation of information asymmetry.  However, the physician is not “all knowing”, 
and thus makes decisions under conditions of uncertainty. Since it is not possible 
to know what the physician knows when deciding to supply the effort, it is also 
not possible to predict the effort in advance, but it can be observed in retrospect. 
Evidence presented in this study suggests that contextual, structural and 
procedural influencers may determine the effort supplied by the physician in the 
production of health care. 
Since, according to Agency Theory, it is not possible to predict the behaviour of 
a physician in advance, the question of interest is: what influences physician 
behaviour (effort)? There are several theoretical frameworks to describe 
behaviour, but TPB is the one that is most widely studied and recognized to 
predict behaviour in a health care context (Godin et al., 2008).  
What is effort in this context? Physicians supply health care by diagnosing and 
treating patients when performing their duties; i.e., the physician does something 
that results in a diagnosis and treatment. Thus, effort in the context of health care 
may be considered behaviour associated with diagnosing and treating patients.  
TPB holds that attitude, social norm and perceived behavioural control influence 
behavioural intent, the antecedent to actual behaviour (Ajzen, 1991). The findings 
of this study suggest that perceived behavioural control is an influencer of 
physician behaviour while delivering health care. Perceived behavioural control 
is about the freedom to act. Consider the following excerpt from ID #11: 
“I: what facilitates you in delivering good quality health care services? 
R: freedom to act.” 
I: what you mean by freedom to act? 
R: that I have time, resources and a team to do the job. This is in line with 
new public management, where I believe that the most benefit will be 
achieved by giving me the freedom to act.” 
What influences the freedom to act? TPB is based on the assumption of volitional 
control, and holds that there are two levels of perceived behavioural controls: 
external and internal (Ajzen, 2002). The external level is related to external 
structural elements; for example, ‘I cannot perform the surgery because I do not 
have a knife’. The internal level is more abstract and relies on whether one 
believes that one can succeed when the external level is satisfied; for example, 
‘I have the knife, but I am not sure I am competent to perform the surgery’.   
Finally, the effort supplied into the production of health care results in an outcome 
at the patient level. However, the outcome does not influence the perceived 
behavioural control. Past behaviour, experience in this context, is important 
because perceived behavioural control may mediate past on later behaviour 







Figure 5-6 Proposed conceptual framework 
5.7 Summary and Conclusions 
In this section, a summary and conclusions are provided, starting with a summary 
of contributions, followed by the implications for policy and practice, the strengths 
and limitations of the study, and finally, suggestions for further research. 
5.7.1 Summary of Contributions 
The objective of this study was to gain a fuller understanding of quality in health 
care by exploring enablers and barriers from a physician’s perspective. This 
exploratory research has enabled making a contribution to the understanding of 
quality in health care:  
1. Findings in the study validate the systems approach to quality in health 
care. Furthermore, the quality model proposed by (Donabedian, 1979) is 
extended.  
2. The study integrates three hitherto separate theoretical domains, providing 
a lens to better understand the complexities of health care quality.  
3. The study validates the appropriateness of using semi-structured interview 
techniques when investigating complex individual, organisational and/or 
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managerial phenomena in health care; in fact, the semi-structured 
interview technique is found to provide data with valuable additional 
insights to the ones provided by the repertory-grid technique.  
4. Constructs identified in Project Two are validated.  
5. Enablers and barriers are found to represent polar opposites of a quality 
construct dimensions.  
6. The predominant mechanism of influence is revealed to be perceived 
behavioural control.  
7. Bio-medical contexts are found to define the spectrum of outcomes; thus, 
the direct antecedents to clinical outcomes are found to be a more stable 
base for quality assurance.  
8. Context is identified as the point of influence of physicians’ supply of effort 
when providing health care.  
9. A conceptual framework is proposed. The model presented integrates the 
study findings with elements of theory from different academic areas, such 
as medicine, economics, management and psychology. 
5.7.2 Implications for Policy and Practice 
In this section, implications for stakeholders in the health care value chain are 
discussed: payers, providers and producers. Payers refers to policymakers, 
regulators and payers. Providers refers to hospital management and practitioners 
(physicians). Producers refers to the pharmaceutical and technological industry. 
In addition, institutions are added, as there may be implications for medical 
education and research. Finally, implications for patients are provided.  
Deriving guidelines for policy making and practice from research is in itself a 
complex phenomenon. Realist synthesis and evaluation (Pawson et al., 2004) 
emerged as an approach to synthesise ‘what works, for whom, in which 
circumstances…’ The realist synthesis methodology suggested by Pawson et al. 
(2004) is where the focus is on gaining insights from the respondent perspective 
about the relationship between context, intervention, mechanism and outcomes 
(CIMO). Pawson (2006) states that “the generative model calls for a more 
complex and systemic understanding of connectivity. It says that to infer a causal 
outcome (O) between two events (X and Y) one needs to understand the 
underlying generative mechanism (M) that connects them and the context (C) in 
which the relationship occurs”. Thus, intervention may be considered the trigger 
for change (Pawson, 2006 p. 27). In this context, interventions aim to change 
health status. Mechanisms describe what it is about the intervention that triggers 
change to occur. Pawson (2006) p. 23, defines mechanisms “as engines of 
explanation in realist synthesis”, as “we rely on mechanisms to tell us why 
interconnections should occur”. Employing the CIMO logic to the results in this 
study is of value, as it helps derive clear implications for policy and practice.  
The context in which this study has been conducted is that of prepaid health care. 
When health care is prepaid, fees for service do not regulate demand (Friedman 
and Gould, 2007). The consequence for the physician in this context is that the 
physician does not have mechanisms at his disposal to regulate demand 
(McGuire, 2001). Thus, if demand increases and resource is fixed, the effort per 
patient may decrease as a result. Evidence from this study suggests that 
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physicians adjust effort into the production of health care in line with demand. 
Physicians therefore seem to accept variability in effort as a consequence of 
variability in demand. However, data suggest that the physicians’ view on this is 
that the result is lower quality.  
It is also possible for an employer to take advantage of a physician’s ethical 
constraints and organize health care delivery in such a way that the physician is 
forced to supply more effort to ensure the patient attains an acceptable outcome 
(McGuire, 2001 p. 61); this case would be an example of how the health care 
service delivery is organized and resourced.  
Intervention in the CIMO context is to be understood as physician effort supplied 
into the production of health care, and consequently, quality in health care. The 
underlying generative mechanism is the physicians’ perception of behavioural 
control. Outcome is considered as quality in health care. Therefore, in a context 
of prepaid health care, physician effort supplied into the production of health care 
is dependent on the physicians’ perception of behavioural control of that effort. 
5.7.2.1 Implications for Providers 
The findings in this study should be of particular interest to physicians in clinical 
medicine. This study indicates that physicians’ perceived behavioural control is 
tightly linked with quality in health care service delivery, and physicians need to 
be cognisant of this fact when performing their duties. The paradox is created by 
the coexistence of two opposing operational modes: systematic control on one 
side, and improvisation on the other. To resolve or reconcile this apparent 
paradox requires empowerment of physicians to make decisions on behalf of the 
stakeholders in the health care value chain. However, strategies to prevent moral 
hazard and adverse selection should be implemented at the physician level. 
In order to enhance quality of health care provided, physicians may need to 
consider  
 Patient communication  
 Organization and resourcing when contributing to define health 
management processes 
 Medical education and postgraduate training to ensure appropriate staff 
level competencies 
5.7.2.2 Implications for Health care Organizations 
This study provides important information for institutions for three main reasons. 
First, the supply of physician effort is linked to quality in health care delivery. 
Thus, factors influencing physician effort may be of interest for institutions from 
an organizational and research perspective. Second, how institutions are 
organized and resourced is claimed to influence quality in health care. Thirdly, 
physician competency is an influencer of supplied physician effort, and hence 
quality in health care. Thus, medical training at all levels should be a key focus. 
Finally, antecedents to clinical outcomes are found to be a more stable measure 
of outcome than change in health status. This finding could provide grounds for 
a validated tool to measure effect of change on quality. 
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Health care organisations may need to consider the findings of this study when 
 Structuring medical departments 
 Deciding on resourcing 
 When controlling physician 
 When planning physicians’ careers with respect to current and future 
competency needs 
5.7.3 Strengths and Limitations 
The study was designed to capture how physicians frame quality of health care 
delivery in a hospital setting. The interview subjects in this study provide real 
patient cases where the patient outcome was death, either indirectly or directly 
caused by the physician interviewed. This is a testimony to the first two criteria 
suggest by  (Gottschalk et al., 1945); see Table 5-14 Checklist of criteria 
suggested by Gottschalk et al (1945, p. 35). 
With respect to the third criteria, the author has been as diligent as possible to 
provide example quotes to substantiate every inference made from the data in 
this study. The use of low inference descriptors, such as quotes, is described as 
a strategy for improving quality of qualitative research (Johnson, 1997 p. 283). 
Finally, both the DBA Project Two and literature have been used to corroborate 
the evidence presented.  
Table 5-14 Checklist of criteria suggested by Gottschalk et al (1945, p. 35) 
# Description Checked 
1 Was the ultimate source of the detail (the primary witness) able to tell the 
truth? 
Yes 
2 Was the primary witness willing to tell the truth? Yes 
3 Is the primary witness accurately reported with regard to detail under 
examination? 
Yes 
4 Is there any external corroboration of the detail under examination? Yes 
Though qualitative research does not seek statistical generalizability, but 
generalizability to theory, there are elements that help establish the quality of the 
study. First, low inference descriptors (quotes) have been widely used. Second, 
theory triangulation has been employed; Agency Theory, TPB and Decision 
Theory have been used. Finally, discussions with peers and implementation of 
findings in practice have yielded accepted changes in the way emergency 
medical care is organized on a national level. This topic is now being keenly 
debated by the Prime Minister and Minister of Health as a run up to this autumn’s 
election. 
One weakness of the interview technique is that there may be a limited scope for 
the respondent to answer questions in sufficient detail or depth. In order to ensure 
sufficient detail and depth in the responses, a laddering technique was employed 
by asking follow-up questions. 
Furthermore, during the interview, the researcher may influence the way a 
respondent answers various questions, thereby biasing the responses. The 
researcher followed the interview guide closely and made every effort possible 
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not to influence the answers provided. Open ended questions with laddering were 
employed. 
The researcher (native Norwegian speaker) transcribed and translated all the 
transcripts. Both the transcription and translation process may be a potential 
weakness. Kvale and Brinkmann (2009) p.187, note that it is important to be 
mindful of the fact that “the publication of incoherent and repetitive verbatim 
interview transcripts may involve an unethical stigmatization of specific persons 
or groups of people”. Thus, the transcription and translation was performed for 
meaning - and not verbatim. 
Well established approaches to minimize bias were employed when capturing, 
reporting and analysing data, thus minimizing the risk of bias and ensuring 
quality.    
5.7.4 Suggestions for Future Research 
This study has identified how physicians frame quality in health care delivery, 
identified influencers in quality health care service delivery, and may serve as a 
framework for further studies in this field. The model presented in this study would 
benefit from further mathematical development and prospective testing; thus, 
further studies validating the framework presented in this research are warranted.   
Several scholars, for example Goffin (2002) and Lemke et al. (2011), claim that 
the repertory grid technique provides a deeper understanding of complex issues 
than exploratory investigations employing semi-structured interview techniques. 
This is not evidenced in this study, as Project Three provided greater granularity 
to the constructs of quality first identified in Project Two. Therefore, investigation 
of methodologies examining complex issues in health care is an opportunity for 
further research.  
Diagnosis and treatment were found to be more stable measures of clinical 
outcome than change in health status. This finding warrants further investigation 
and is currently being reviewed by this researcher as a possible avenue to 
validate a measure of quality. The utility of such as tool is the ability to measure 
change in a complex organization after interventions either to context or process 
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Appendix A PROJECT ONE  
This section contains appendices and tables for the systematic review (DBA 
project 1). 
A.1 Protocol 
A.1.1 Overview  
The protocol outlines the focus, methodology and tools to conduct a systematic 
review on influencers of physician prescription behaviour.  The purpose of the 
review is to study literature in order to gain an understanding of the above stated 
phenomenon of interest. Specifically the review will, identify and map factors 
under the influence of the pharmaceutical industry having a bearing on physician 
decision behaviour when prescribing.  
This protocol provides a background to frame the review. It then summarizes a 
scoping study aimed at mapping relevant bodies of literature, and justifies the 
need for this review based on findings from the scoping study. Then detailed 
accounts of the review panel, objectives, search strategy, selection criteria, 
quality assessment and reporting are provided. Thus, the protocol will provide 
transparency and facilitate an audit trial of the methods and findings. 
A.1.2 Background for the Review 
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire 2001). However, payer driven 
public policy is at odds with strategies employed by the pharmaceutical industry 
(Hurwitz and Caves 1988;Leffler 1981;McGuire 2001) within the context of a 
health care value chain (Stremersch 2008;Stremersch and van Dyck 2009). 
Furthermore, it is widely recognized that because medical decisions have an 
impact on patients’ health, they should be of high quality (Klein 2005). Any 
influence on the medical decision may therefore have an untoward effect on 
patients’ health. Factors influencing physician prescribing behaviour have been 
widely stated, but linkage between these factors and evidence of how and under 
which circumstances (contexts) influence is exerted is lacking (Bornstein and 
Emler 2001;Bradley 1992).  
The profit maximising hypothesis central to Agency Theory predicts that 
physicians’ act in a manner motivated by financial self-interest (Gaynor and 
Gertler 1995;McGuire 2001). Asymmetry of information may perpetuate self-
interest behaviour in a manner not beneficial either side of the value chain and 
thus lead to poor decisions being made on behalf of the principal (Eisenhardt 
1989;McGuire 2001). Loyalty issues having a bearing on patient health may arise 
as a consequence. The practice of medicine is further complicated by the context 
of ethical and legal constraints on decision choices (Ma and McGuire 
1997;McGuire 2001).  
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There appears to be consensus that decision making in medicine is made under 
uncertainty (Bornstein & Emler 2001;Elstein 1999;Elstein and Schwarz 
2002;Payne et al. 1993;Reyna and Rivers 2008;Spring 2008). However, no 
general theory of medical decision has been formulated, but the theory of 
reasoned action is the most studied theoretical framework informing on the topic 
of physician’s decision behaviour (Reyna 2008). Given the complexities and no 
grand theoretical framework, deciding how to decide is central (Payne, Bettman, 
& Johnson 1993). Despite being highly trained doctors are prone to making 
mistakes and cognitive biases may detract from use of logical and statistical 
decision heuristics (Hershberger et al. 1994). In general there is a lack of 
contextually sensitive evidence informing medical decision processes.  
The literature reviewed suggest that there is evidence that physician education 
and training, control and regulatory measures, peer effect, promotion and drug 
characteristics impact the quality and volume of prescribing in the short term 
(Hemminki 1975;Kremer et al. 2008;Manchanda and Honka 2005;Windmeijer et 
al. 2006). How these factors affect prescribing behaviour is largely unknown. 
However, source-, message-, receiver- and contextual factors have all been 
postulated to have persuasive effects (Cialdini 2007;O'Keefe 2002). There is 
evidence to support a positive persuasive effect of source factors, natural receiver 
factors, induced receiver factors, and contextual factors (O'Keefe 2002). There is 
inconclusive evidence to support such persuasive effects of message factors in 
general. However, there is evidence suggesting a positive effect of visual 
images(O'Keefe 2002).  
This review aims to summarize “how” context impacts factors having a bearing 
on physician prescribing behaviour.  The model used for this review is as outlined 
by (Fink 2010;Huff 2009;Tranfield et al. 2003). 
A.1.3 The Scoping Study 
A scoping study has been conducted in order to identify relevant areas and 
important factors having a bearing on prescription behaviour of physicians. The 
following areas were identified and subsequently investigated, see table A-1. 
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Table A-1 Results from scoping study 
Areas included  Topics Included Main Conclusions 
Health care value chain Opposing economic drivers 
operating within the value chain.  
 The concept of the health care value chain is 
useful in identifying stakeholders, points of 
influence and decisions  
 The health care value chain consists of two sides: 
payer and delivery. The two sides operate on 
opposing economic logics. Payers focus is on 
general well-being of individuals in need. Delivery 
side focus is on increasing profits. 
Agency Physician agency and loyalty 
conflicts  
 Behaviour motivated by self-interest 
 Loyalty conflict due to simultaneous principals 
 Legal and ethical constraints of choice 
Medical decision making Theoretical backdrop of medical 
decision making including use of 
heuristics and pitfalls 
 No grand theory of medical decision making exist 
 Deciding how to decide is important 
 Use of heuristics is widespread and may lead to 
mistakes 
 Diversity of decisions exists 
Factors affecting 
prescribing behaviour 
Factors affecting prescribing 
behaviour 
 There are numerous factors that affect physician 
prescribing behaviour: education, regulatory and 
control measures, price, peers, promotion, 
therapeutic area, attributes of medicines, ethical 
and legal constraints, patient expectations and  
physician characteristics 
Persuasion Theoretical framework and 
underpinnings of persuasion 
 Four main factors have been postulated to have 
persuasive effects. There is evidence to support 
that source; receiver and contextual factors have 
persuasive effects. There is inconclusive evidence 
to support a persuasive effect of message factors. 
A.1.4 Justification for the Review: Findings from the Scoping Study 
Though a good amount of research exists on physician prescribing behaviour, 
this review is justified, among others for the following reasons: 
 
Lack of grand medical Decision Theory 
Medical decision making has been given due attention due to the fact that such 
decisions may have a profound impact on patients’ health. Although there is wide 
agreement that medical decisions are made under uncertainty, as of yet, no grand 
theory of medical decision making exists (Reyna & Rivers 2008). Deciding how 
to decide is therefore important (Payne, Bettman, & Johnson 1993).  
 
Lack of understanding how identified factors interact 
Though evidence of factors having a bearing on physician prescribing behaviour 
have been identified (Hemminki 1975;Kremer, Bijmolt, Leflang, & Wieringa 
2008;Venkataraman and Stremersch 2007;Windmeijer, de Laat, Douven, & Mot 





Overall lack of information regarding outcomes  
Effect on patients’ health of any intervention designed to affect physician 
prescription behaviour is sadly lacking (Bornstein & Emler 2001;Bradley 
1991;Smith 1977). 
 
The need for understanding how factors influence prescription behaviour 
There is a wide body of evidence informing on the topic of influence and 
persuasion (O'Keefe 2002), but very little on effect in the context of physician 
prescribing behaviour (Lambert et al. 1997;O'Keefe 2002). Furthermore, there is 
a lack of contextual evidence and understanding of how factors affect physician 
prescribing behaviour. 
A.1.5 Review Panel 
The review panel will consist of the reviewer (Yngve Mikkelsen), his supervisor 
(Dr. Javier Marcos), a senior academic supervisor (Prof. Hugh Wilson) and senior 
academic supervisor (Prof. Simon Knox). In addition, other academics with whom 
the researchers have contact and are knowledgeable in the field may be 
consulted to discuss the approach and findings of the present review.  
Table A-2 Systematic review panel 
Person Role / Title and organization  
Dr. Javier Marcos Supervisor. Senior Research Fellow Cranfield School of 
Management.  
Prof Simon Knox Senior supervisor. Cranfield School of management 
Prof. Hugh Wilson  Senior supervisor. Cranfield School of management 
5B 
A.1.6 Objectives 
The purpose of the review is to study literature in order to gain an understanding 
of the factors that influence physician prescription behaviour. 
Specifically the review will: 
 Identify and map factors under the influence of the pharmaceutical 
industry having a bearing on physician decision behaviour when 
prescribing  
A.2 Search Strategy 
A.2.1 Sources of Information 
Several sources will be searched to locate all potential relevant studies. Focus 
will be to maximize coverage and minimize bias. In particular, the following will 
be used to retrieve relevant studies: 
 Citation databases 
 Internet: Meta-search engines, search engines, subject gateways 
 Grey literature (non-peer reviewed) 
 References from selected studies, suggested by peers and  
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 Available bibliographies 
 Manual searches of specific journals 
 Theses 
A.2.2 Information and Data Handling 
The details (database collections, search strings, number of documents retrieved 
and number of documents initially selected) of the searches will be captured and 
documented in Microsoft Excel using two by two tables for each database 
including a unique identifier for further tracking. Internet searches will be 
documented using the same methodology highlighted above. EndNote X4 will be 
used for citation storage and management. Microsoft Excel 2010 and NVIVO 8 
will be used for synthesis of data. 
Search Terms 
The search terms listed below will be used to locate relevant studies and 
documents. These search terms will be combined into search strings in the 
different databases to be combined as appropriate (see appendix 2 for details).  
Table A-3 Systematic review search terms 
Search terms 
Payer Delivery Provider 
Producer   
   
Marketing Promotion Instruments 
Price Price sensitivity Promotional Instruments 
Interaction Field force Detailing 
Promotional material Gifts Industry paid-meals 
Conference travel Honoraria Research funding 
Expenditures Formulary requests  
   
Public Policy Quality Safety 
Efficacy Financing Reimbursement 
Access Welfare Optimality 
Competition Supplier induced demand  
   
Information Knowledge Knowledge management 
   
Health Economics Agency Physician agency 
Asymmetry of information Physician Physician behaviour 
   
Medical  Decision Decision-making 
Shared decision  Theory Heuristics 
Intention Attitude Choice 
Constraints Legal Ethical 
   
Factors Attributes Therapeutic area 
Education Regulatory control Regulatory measures 
Demand Colleagues Peers 
   
Influence Persuasion Source 
Message Receiver Context 
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Physician Prescribing Behaviour 
Change Influence  
 
A.2.3 Selection Criteria  
Table A-4 Scope of systematic review 
Focus The focus of the review is on direct-to-physician pharmaceutical promotion and 
its influence on physician prescription behaviour. 
Source: knowledge must be produced by organizations adhering to accepted 
academic methods of inquiry and be research based.  
Content:  knowledge must be generated following academically accepted 
methodologies and aligned with appropriate epistemologies.  
Time Frame Searches will be conducted from 1980 onwards as this denotes the time from 
which modern regulation of promotion of medicines was instituted.  Literature 
earlier than this will be included if cross referenced within the original search 
frame. 
Language 
English only (UK and US) 
Discipline 
The review will examine the management, marketing, health economics, 
psychology and medical literature. List is not exhaustive and flexibility will be 
key to extract available information.  
 
Stage 1: Selection by Title and Abstract 
Papers will be selected if: 
 They address aspects:  
o Frameworks and theoretical underpinnings of physician decision 
behaviour having a bearing on prescription behaviour 
o Factors and interventions that influence physician decision 
behaviour 
Stage 2: Selection by Full text 
Documents selected at stage 1 will undergo a second selection stage with the 
following criteria: 
 Conceptual overview: papers included will be those that address the key 
issues, framework and theoretical underpinnings of physician 
prescription behaviour. 
 Review of factors influencing physician prescription behaviour: Papers 
exploring factors under the influence of the pharmaceutical industry 
having a bearing on physician decision behaviour when prescribing will 




A.2.4 Quality Appraisal Criteria 
Quality Appraisal criteria has been adapted from (Tranfield, Denyer, & Smart 
2003). 
Table A-5 Systematic review quality criteria 
 High  Medium Low Not 
applicable 
Theory  Well defined 
theory/framework 
Fairly well defined 
theory/framework 
Insufficient 
definition of  
theory/framework 
Element not 
applicable to paper 














applicable to paper 
Alignment of 
concepts and ideas 
Concepts and ideas 
are fully aligned  
Concepts and ideas 
are partially  aligned  
Not enough 
information to 
assess alignment  
Element not 
applicable to paper 






interpretation of data.  
Systematic 
collection, analysis 
and interpretation of 








applicable to paper 
Conclusions Fully aligned to theme 







Partially aligned to 
theme of paper. 






evidence is clear 
Conclusions not 
in alignment with 






















unclear and not 
significant. 
Element not 
applicable to paper. 
Quality appraisal criteria will be applied to and documented for all literature 
selected for inclusion at stage 2. Only literature appraised as being of high and 
medium quality will be included in the review. Furthermore, non peer reviewed 
literature will be appraised by a second reviewer (Dr. Javier Marcos) and 
judgement on reputability of source will be made.  Only non-peer reviewed 
literature from a reputable source, such as academic and government institutions, 
having passed the quality appraisal criteria by the second reviewer will be 
included in the review. The review panel will serve as the final decision authority 
for all literature to be included in the review.  
A.2.5 Descriptive Analysis and data Extraction Form   
The following data will extracted from the studies and input into EndNote X4 and 
subsequently into Microsoft Excel 2010 and NVIVO 8.  
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Table A-6 Data extraction form 
Aspects Fields 
Citation information 1. Author 
2. year 
3. title of paper (book) 




8. Page numbers 
9. URL (if web pages) 
10. Location of item – location of the electronic/hard 
copy 
Purpose 11. A brief description of the aim and objectives of the 
study 
Operationalization: 12. Measures used and operationalization of variables 
in the study. 
Content of the study 13. Variables/Interventions 
14. Primary and secondary endpoints 
15. Outcomes 
Study details 16. Academic/ practitioner/policy 
17. Methods of data collection 
18. Sample size and type of sample 
19. Methods of data analysis 
20. Theoretical frameworks mentioned  
Study context 21. Country/Region 
22. Regulatory conditions 
23. Type of organization (payer, provider, delivery) 
Key findings 24. Brief summary of the main conclusions reached 
and research gaps identified 
Subfield of study 25. Indicate the sub-area of study of the paper.  
Keywords 26. Relevant keywords and descriptors of the study 
A.2.6 Synthesis and Analysis 
After extracting the data for the descriptive analysis, the studies will be analysed 
in depth using the Wallace and Wray framework (Wallace and Wray 2006). 
Captured relevant information will be imported and coded in NVIVO 8. Emerging 
themes will be identified and grouped into dimensions following and inductive 
analysis approach.  
The following table summarizes some principles of good synthesis methods and 
how the synthesis strategy of this systematic review will meet these principles. 
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Table A-7 Principles of good synthesis  
Principles Strategy: Approach and methods 
Synthesis method appropriate 
to research 
4. Explore and map the key issues, frameworks and 
theoretical underpinnings of physician decision 
behaviour having a bearing on prescription behaviour 
5. Investigate factors that influence physician decision 
behaviour, 
6. Investigate contexts under which these factors 
influence physician decision behaviour. 
Cope with diffuse and 
heterogeneous data 
Summaries of the studies following the Wallace and Wray 
framework will be import into NVIVO 8 facilitating handing of 
diffuse and heterogeneous data.  
Transparency and detail of 
content allowing reader to 
adequately gauge quality of 
method, data and conclusion 
Transparent and exhaustive referencing of material included 
in the review will allow the reader to interpret and validate the 
conclusions of the review.  
Ensure audit trail Studies included and excluded from the review will be 
reported. Comprehensive descriptive analysis tables and 
coding in NVIVO 8 will provide audit trials. 
 
A.2.7 Dissemination of the Review and Further Research  
The aim of this review is to fulfil the DBA requirements at the Cranfield School of 
Management. The review will be updated on an ongoing basis using an automatic 
alert from the British Library. Identified literature titles will be added once the final 
search is completed.   
A.2.8 Project Plan 
The review includes several stages and will be conducted during the period 
spanning from protocol approval (late 2010) to final submission in June 2011.  
Work will only commence obtaining necessary protocol and ethical approval. 
Consultation is planned at various points during the review period and will take 
the form of monthly progress reviews with Dr. Javier Marcos. A face-to-face 
meeting with the panel will be planned during the course week in February 2011. 
Further, face-to-face meeting will be planned as required. First draft will then be 
circulated among the panel members in May 2011, before final submission by 





Table A-8 Systematic review project plan 
Stage   Start  End  
Stage 1 Preparing the review  27.09.2010 
Map the field  27.09.2010 




Identify and evaluate papers   
Systematic search 15.11.2010 15.12.2010 




Data extraction/synthesis   
Data extraction 15.12.2010 31.01.2011 




Reporting   
Work in progress submission   17.01.2011 
Work in progress review  31.01.2011 03.02.2011 
Final Draft paper  01.05.2011 




Utilizing the findings   
Informing the research 04.07.2011 07.07.2011 




Table A-9 Systematic review source details 




 Web of Science 




 Cochrane Trials Database 
Metasearch engines  Complete Planet HTUwww.completeplanet.comUTH.  
 Dogpile: HTUwww.dogpile.comUTH  
 IxQuick HTUhttp://ixquick.comUTH  
 Metacrawler. HTUwww.metacrawler.comUTH  
 Vivisimo. HTUhttp://vivisimo.comUTH.  
Internet. Search 
engines 
 Google. HTUwww.google.comUTH  
 Google Scholar. scholar.google.com  
 Adobe pfd online HTUhttp://searchpdf.adobe.comUTH  
 Scirus HTUwww.scirus.comUTH   
 Teoma: HTUwww.teoma.comUTH.  
Subject gateways  Bized: HTUwww.bized.ac.ukUTH  
 SOSIG: HTUwww.sosig.ac.ukUT 
 BUBL HTUhttp://bubl.ac.ukUTH  
 Virtual LRC  
Grey literature  SIGLE: International System for Grey Literature.  
References  References suggested by the review panel and/or 
knowledgeable researchers and/or practitioners  
 List of references from selected papers 
 Personal library (850 books and articles) 
Available 
bibliographies 
A focused search to browse for bibliographies about influence on 
physician prescribing behaviour will be done and relevant 
bibliographies retrieved.  
Manual searches of 
specific journals 
 International Journal of Research in Marketing 
 Journal of Marketing 
 Journal of Law and Economics 
 Social Science Medicine 
 The Academy of Management Review 
 Marketing Research 
 Medical Decision Making 
 Management Science 
 Journal of Advertising Research 
 JAMA 
 BMJ 
Thesis  Index to thesis 
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Table A-10 Systematic review search strings 
Search String 
1 Physician AND (decision OR behaviour OR ) AND prescr*  
2 Physician AND (price OR price sensitivity OR promotion OR detailing 
OR field force OR promotional material OR  gifts OR honoraria OR 
meals OR travel OR conference) 
3 Physician AND presc* AND (industry OR pharmaceutical OR 
pharmaceutical industry) 
4 Physician AND presc* AND (therapeutic area OR promotional 
instrument OR education OR promotion OR peers OR colleagues OR 
ethics OR ethical OR legislation OR regulatory OR measures OR 
control OR attributes OR product) 
5 Prescribing AND (public policy OR quality OR safety OR 
reimbursement OR finance OR payment OR efficacy OR welfare OR 
optimality OR competition OR demand) 
6 Prescr* AND medicines AND physician AND (information OR 
information asymmetry OR persuasion OR knowledge OR know why 
OR know how OR research OR development OR knowledge 
management) 
7 (Influence OR persuasion) AND (source OR message OR receiver OR 
context) 
8 Prescr* AND (Medical decision OR medical decision making OR 
heuristics OR shared decision OR theory OR framework OR intention 
OR attitude or Choice) 




Table A-11 Journals included in the review 






Acad Emerg Med 1 .6 .6 .6
Acta Psychiatr Scand 1 .6 .6 1.2
Am J Ind Med 1 .6 .6 1.9
Am J Manag Care 3 1.9 1.9 3.7
Am J Med 2 1.2 1.2 5.0
Am J Med Qual 1 .6 .6 5.6
Am J Med Sci 1 .6 .6 6.2
Am J Psychiatry 1 .6 .6 6.8
American Journal of Hosital 
Pharmacy 
1 .6 .6 7.5
American Journal of Public 
Health 
1 .6 .6 8.1
Ann Emerg Med 1 .6 .6 8.7
Ann Intern Med 1 .6 .6 9.3
Ann Pharmacother 3 1.9 1.9 11.2
Arch dermatological 
research 
1 .6 .6 11.8
Arch Intern Med 5 3.1 3.1 14.9
Australian Journal of Rural 
health 
1 .6 .6 15.5
BMC Health Service 
Research 
4 2.5 2.5 18.0
BMC Public Health 1 .6 .6 18.6
BMJ 7 4.3 4.3 23.0
Br J Clin Pharmacol 2 1.2 1.2 24.2
Br J Gen Pract 6 3.7 3.7 28.0
Chochrane Database Syst 
Rev 
2 1.2 1.2 29.2
Clin Drug Investig 1 .6 .6 29.8
Clin Microbiol Infect 1 .6 .6 30.4
Clin Pharmacology & 
Therapeutics 
1 .6 .6 31.1
CMAJ 1 .6 .6 31.7
Consult Pharm 1 .6 .6 32.3
Diabetes Care 1 .6 .6 32.9
Dis Manag 1 .6 .6 33.5
Eur J Clin Pharmacol 2 1.2 1.2 34.8
Euro Surveil 1 .6 .6 35.4
European Journal of Clinical 
Pharmacology 
1 .6 .6 36.0
European Psychiatry 1 .6 .6 36.6
European Respiratory 
Journal 
1 .6 .6 37.3
Fam Pract 4 2.5 2.5 39.8
Fundamental and Clinical 
Pharmacology 
1 .6 .6 40.4
Health Economics 1 .6 .6 41.0
Health Mark Q 2 1.2 1.2 42.2
Health Policy 1 .6 .6 42.9
Health care Policy 1 .6 .6 43.5
Inflammatroy Bowl Disease 1 .6 .6 44.1
Int J Med Inform 1 .6 .6 44.7
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International Journal of 
Cardiology 
1 .6 .6 45.3
International Journal of 
Clinical Pharmacy and 
Therapeutics 
1 .6 .6 46.0
International Journal of 
Pharmaceutical and health 
Care Marketing 
1 .6 .6 46.6
International Journal of 
Pharmaceutical Medicine 
1 .6 .6 47.2
International Journal of 
Technology Assessement in 
Health Care 
1 .6 .6 47.8
J Am Board Fam Pract 1 .6 .6 48.4
J Am Med Inform Assoc 2 1.2 1.2 49.7
J Antimicrob Chemother 2 1.2 1.2 50.9
J Cancer Educ 1 .6 .6 51.6
J Clin Epidemiol 1 .6 .6 52.2
J Clin Pharm Ther 2 1.2 1.2 53.4
J Eval Clin Pract 1 .6 .6 54.0
J Gen Intern Med 1 .6 .6 54.7
J Health Serv Rec Policy 1 .6 .6 55.3
J Manag Care Pharm 1 .6 .6 55.9
J Palliat Med 1 .6 .6 56.5
J Pharm Technol 1 .6 .6 57.1
J Scand Prim Health Care 1 .6 .6 57.8
JAMA 3 1.9 1.9 59.6
Jorunal of Clinical 
Epdiemiology 
1 .6 .6 60.2
Journal of Advertising 
Research 
1 .6 .6 60.9
Journal of Clinical 
Pharmacy and Therapeutics 
1 .6 .6 61.5
Journal of Economics & 
Management Strategy 
2 1.2 1.2 62.7
Journal of Evaluation in 
Clinical Practice 
1 .6 .6 63.4
Journal of Evaluation of 
Clinical Practice 
3 1.9 1.9 65.2
Journal of Health 
Economics 
2 1.2 1.2 66.5
Journal of Law and 
Economics 
1 .6 .6 67.1
Journal of Marketing 1 .6 .6 67.7
Journal of Marketing 
Research 
1 .6 .6 68.3
Journal of Medical 
Education 
1 .6 .6 68.9
Journal of Medical 
Marketing 
1 .6 .6 69.6
Journal of Pharmaceutical 
Marketing & Management 
3 1.9 1.9 71.4
Journal of the American 
Geriatrics Society 
1 .6 .6 72.0
Journal of the Royal Society 
of Medicine 
1 .6 .6 72.7
Management Science 3 1.9 1.9 74.5
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Market Lett 1 .6 .6 75.2
Med Care 3 1.9 1.9 77.0
Med Decis Making 2 1.2 1.2 78.3
Medical Journal of Australia 1 .6 .6 78.9
Medinfo 1 .6 .6 79.5
NJEM 1 .6 .6 80.1
Osteoporosis Int 1 .6 .6 80.7
P&T 1 .6 .6 81.4
Pain 1 .6 .6 82.0
Pain Med 1 .6 .6 82.6
Pediatrics 2 1.2 1.2 83.9
Pharmacoeconomics 1 .6 .6 84.5
Pharmacoepidemiol Drug 
Saf 
5 3.1 3.1 87.6
Pharmacy World & Science 1 .6 .6 88.2
PLoS Med 1 .6 .6 88.8
PLoS One 1 .6 .6 89.4
Preventive Medicine 1 .6 .6 90.1
Psychol Med 1 .6 .6 90.7
Qual Saf Health Care 2 1.2 1.2 91.9
Scand J Prim Health Care 1 .6 .6 92.5
Singapore Medical Journal 1 .6 .6 93.2
Soc Sci Med 1 .6 .6 93.8
Social Sci Med 2 1.2 1.2 95.0
South Med J 1 .6 .6 95.7
Stroke 1 .6 .6 96.3
The American Journal of 
Medicine 
1 .6 .6 96.9
The European Journal of 
General Practice 
1 .6 .6 97.5
The European Journal of 
Health Economics 
1 .6 .6 98.1
The Eurpoean Journal of 
Public Health 
1 .6 .6 98.8
The Journal of Indiustrial 
Economics 
1 .6 .6 99.4
Wiener Klinische 
Wochenschrift 
1 .6 .6 100.0




A.3 Systematic review data extraction results 
The data extraction table is quite extensive more than 50 000 words and over 
880 pages. For practical reasons I have therefore chosen to only include a 
facsimile of the table in this appendix, so that the reader can get a feeling with 
the way the data has been captured and recorded. The facsimile shows how data 
from each included study has been captured and organized according to the 
structure of the data capture table, please refer to Appendix F for details. The full 
table is available upon request in the following formats: doc, pdf and xls.  
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Appendix B PROJECT TWO 
This section contains the appendices for project two of the thesis. 
B.1 Protocol 
B.1.1 Background 
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, it is widely 
recognized that because medical decisions have an impact on patients’ health, 
they should be of high quality (Klein, 2005). 
There appears to be consensus that decision making in medicine is made under 
uncertainty (Bornstein and Emler, 2001, Elstein, 1999, Elstein and Schwarz, 
2002, Payne et al., 1993, Reyna and Rivers, 2008, Spring, 2008). A systematic 
review conducted prior to the present project revealed that no general theory of 
medical decision has been formulated, but the theory of reasoned action is the 
most studied theoretical framework informing on the topic of physician’s decision 
behaviour (Reyna, 2008). Given the complexities of medical decision making and 
that no grand theoretical framework exists, deciding how to decide is central 
(Payne et al., 1993). Despite being highly trained, doctors are prone to making 
mistakes and cognitive biases may detract from the use of logical and statistical 
decision heuristics (Hershberger et al., 1994). In summary, there is a lack of 
contextually sensitive evidence informing medical decision processes.  
A report from the Institute of Medicine has documented that close to one million 
people per year are injured and close to one hundred thousand people a year 
dies as a result of preventable medical errors (Kohn et al., 1999). As a 
consequence, standardization of the provision of care in hospitals has come into 
greater focus. Implementing approaches to implement more systematically 
compliance with guidelines can help reduce variation in core processes of 
organizations (Flynn et al., 1994) and the same increase the quality of health care 
provided (Leape, 1994).  
The focus on quality of health care provision focuses on two main components. 
First, improvement of clinical quality where clinical quality refers to performance 
relative to process of care performance measures which are represented by 
clinical protocols of best practice to achieve high levels of patient safety 
(Chandrasekaran et al., 2012). Second, experiential quality is represented by the 
quality of care as experienced by the patient (Donabedian, 1988). It focuses on 
how care is provided and is distinct from the clinical quality as it is focused on 
what is provided. 
Tension between the two paths may occur when hospital management try to 
balance the two; as focus on clinical quality can reduce variation and focus on 
experiential quality increase variation(Chandrasekaran et al., 2012).  Clinical 
quality has been shown to be closely linked to experiential quality (Blackwell, 
1973, Butler et al., 2002, Camron, 1996) and vice versa. Thus, it is argued that 
the quality of care is dependent on both clinical- and experiential quality.  
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B.1.2 Justification for the Study: Findings from Systematic 
Literature Review 
Though a good amount of research exists on outcomes of medical care, this study 
is justified, among others for the following reasons: 
 
Lack of grand medical Decision Theory 
Medical decision making has been given due attention due to the fact that such 
decisions may have a profound impact on patients’ health. Although there is wide 
agreement that medical decisions are made under uncertainty, as of yet, no grand 
theory of medical decision making exists (Reyna & Rivers 2008). Deciding how 
to decide is therefore important (Payne, Bettman, & Johnson 1993). This was a 
key finding of the systematic review preceding this study.  
 
Overall lack of information regarding outcomes  
It is widely recognized that because medical decisions have an impact on patients’ 
health, they should be of high quality (Klein, 2005). Factors influencing physician 
prescribing behaviour have been widely stated, but the linkage between these factors 
and evidence of how and under which circumstances (contexts) influence is exerted 
remains unanswered (Bornstein and Emler, 2001, Bradley, 1991). Furthermore, 
effect on patients’ health of any intervention designed to affect physician 
decisions is sadly lacking (Bornstein & Emler 2001;Bradley 1991;Smith 1977).   
 
The need for understanding how factors influence decision behaviour 
There is a wide body of evidence informing on the topic of influence and 
persuasion (O'Keefe 2002), but very little on effect in the context of physician 
prescribing behaviour (Lambert et al. 1997;O'Keefe 2002). Furthermore, there is 
a lack of contextual evidence and understanding of how factors affect physician 
decisions.  
Overall, the above findings mean that factors influencing physician decision 
behaviour may impact quality of the health care provided. It is therefore important 
to understand how and what role the physician play in determining the quality of 
health care provision. 
B.1.3 Study Panel 
The study panel will consist of the primary investigator (Yngve Mikkelsen, MD), 
his lead supervisor (Dr. Javier Marcos), a senior academic supervisor (Professor 
Hugh Wilson) and senior academic supervisor (Professor Simon Knox). In 
addition, other academics with which the researchers have contact and are 
knowledgeable in the field may be consulted to discuss the approach and findings 
of the present study.  
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Table B-1 Study panel for project two 
Person Role / Title and organization 
Yngve Mikkelsen MD Researcher, doctoral student, Cranfield School of Management 
Dr. Javier Marcos Lead supervisor, Lecturer, Cranfield School of Management 
Professor Simon Knox Senior supervisor, Professor, Cranfield School of Management 
Professor Hugh Wilson  Senior supervisor, Professor, Cranfield School of Management 
B.1.4 Aims and Objectives  
This study contains two separate parts addressing separate research questions 
designed to fulfil the requirements for empirical project two (P2) and three (P3) 
for the DBA at Cranfield School of Management. For practical purposes data 
collection for both P2 and P3 will take place simultaneously with approximately 
30 individual physicians. The projects will be analysed and reported separately 
as highlighted in the Project Plan section on page 10 in this document. 
The aim of this project is to gain an in depth understanding of how physicians 
frame quality of health care delivery, identify enablers and barriers for provision 
of quality health care by physicians and describe the perceived role of physicians 
in balancing clinical and experiential quality while delivering health care. 
Specifically the project will: 
- Identify and categorize key constructs physicians have in mind to 
understand and deliver health care when conducting clinical (with the 
patient) work 
- Identify enablers and barriers for provision of quality health care as 
perceived by physicians 
- Identify how physicians balance clinical and experiential quality when 
providing health care 
Taking on a physician perspective in a hospital setting I therefore propose the 
following research question (RQ):  
RQ: How do physicians perceive quality of health care delivery in a hospital 
setting? 
Little or no good quality data exists addressing such issues, making quantitative 
analysis as basis for further understanding of the phenomenon impractical. So, 
in order to gain a better understanding of how physicians frame quality of health 
care provision, a qualitative approach was chosen. With this in mind, possible 
methods for gathering data was explored (list not exhaustive): interviews (face-
to-face, telephone, e-mail), focus groups, comparison of records (reports, 
academic articles, etc.), case studies, and observation of phenomena in its 
natural environment.  
In order to answer RQ I have chosen to adopt the methodology of repertory grid 
as first outlined by Kelly (1955).  
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B.1.5 The Context of the Research 
The hospital in question is divided into separate divisions focusing on different 
therapy areas. Given the difference in focus there might be differences in 
perspectives between the divisions. Therefore, a decision to include several 
divisions was made. The method considered most suitable, ensuring both 
detection of potential contrasts between the divisions and extract the most 
valuable information, was repertory grid.  
B.1.6 Scope of the Study 
Table B-2 Scope of project two 
Focus The focus of the study is on how physicians frame health care 
service quality and what are the enablers and barriers for 
review  
Source: physician, university hospital, across specialties  
Time Frame The study will be conducted during the second half of 2012. 
Geography Norway, Oslo area 
Discipline The study will focus on hospital physicians across specialties 
at a university hospital. 
B.1.7 Methodology 
 
Repertory grid technique 
The interviews will be conducted using the repertory grid technique based on 
Kelly’s Personal Construct Theory (Kelly, 1955). This technique involves a form 
of structured interviews and has been found to be a powerful tool in management 
research (Goffin, 2002). Furthermore, the technique is useful for limiting jargon 
and social desirability (Goffin, 2002, Szwejczewski et al., 2005, Lemke et al., 
2011). 
The operationalization closely follows Goffin (2002).Two basic methods for 
selecting elements exist: supplied and elicited. Supplied elements are provided 
by the researcher, whereas, elicited elements are provided by the respondent. In 
addition, there are several rules for selecting supplied or elicited elements: 
 Elements must be discrete (Stewart and Stewart, 1981)  
 Elements must be homogeneous (Easterby-Smith, 1980) 
 Elements must not be evaluative (Stewart and Stewart, 1981) 
 Elements should be representative of the area to be investigated (Beail, 
1985, Easterby-Smith, 1980) 
Reger (1990) proposes three main reasons for why a researcher may want to 
supply elements. Firstly, the researcher may wish to learn more about a given set 
of elements from various respondents. Secondly, theory may guide the choice of 
elements. Finally, the researcher may wish to compare responses within a group 
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or across groups. The later instance will require a uniform set of elements to make 
cross group comparisons possible. Elements will be elicited from the respondents 
with the following question: 
Can you please think of two patient encounters (please keep names 
anonymous) where quality of health care provision was excellent, two 
where quality of health care provision was medium and two where quality 
of health care delivery was poor? 
The respondent will be asked to write the elicited elements (anonymous patient 
encounters) on randomly numbered cards, including a brief description of each 
element (a few key descriptors or keywords).   
Using the triad method from (Kelly, 1955, Kelly, 1963) as described by (Fransella 
et al., 2003) the interviewer will present the respondent with three cards asking:  
“How are two of these similar and different from the third in terms of quality 
of health care delivery?”  
The triads will be chosen according to a preselected order and the results will be 
captured on a data capture sheet (repertory grid) by the researcher (see 
Appendix A: Repertory Grid). Each captured response resulted in a construct and 
a construct pole. The construct pole will be elicited by asking what the respondent 
feels is the opposite of the construct. 
After the meaning of the constructs has been discussed with the respondent, the 
respondent will be asked to rate all elements on a five-point Likert scale 
(Fransella et al., 2003) where one represents the construct and five represents 
the construct pole.  
The process is repeated by presenting the respondent with another set of three 
cards restating the original question. The respondents will be encouraged not to 
repeat constructs which had already been elicited. This process will continue until 
further constructs can no longer be elicited or the time limit of 60 minutes expires.  
At the end of the interview the respondent will be asked to grade the elicited 
constructs on a five-point Likert scale with the following poles: 
Enabler  –  Barrier 
Clinical quality  –  Experiential quality 
This last step is to ensure capture of each individuals understanding of the 
phenomenon of interest (Jankowicz, 2004 p. 170-71). 
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B.1.8 Study: Administrative phase 
 
Ethical approval 
Ethical approval in accordance with Cranfield University and Akershus University 
Hospital policy (internal approval by the privacy ombudsman) will be obtained 
before study start in order to ensure appropriate management of data and 
maintenance of privacy. The project is not considered to be within the scope of 
“Helseforskningsloven” (Norwegian research legislation) and will therefore not be 
submitted to the regional ethical committee (Regional Etisk Kommite) in Norway.  
 
Selection of study subjects 
Physicians across the five clinical divisions of a university hospital in the Oslo 
area in Norway will be invited to participate. The interviews will be formally 
booked using Microsoft Outlook 2007, including information about background, 
confidentiality and use of a tape recorder. Acceptance of interview participation 
will also be recorded in Microsoft Outlook.   
The number of recruited individuals will depend on the point at which theoretical 
saturation is achieved (approximately 30 individuals expected). 
The criteria to invite physicians to participate in the study are: 
 Physicians in clinical practice   
o Employed by Akershus University Hospital at the time of the study 
 Physicians not in administrative roles 
 Physicians willing to participate in the study 
 
Informed consent 
Informed consent will be sought from study subjects prior to inclusion and 
recorded in writing (see Appendix C: Written Consent Form) and on voice 
recorder. 
B.1.9 Study: Conduction phase 
 
Pilot 
On the basis of the research objective, an interview guide was developed (see 
Appendix B: Interview Guide) and subjected to evaluation and feedback from 
supervisor and course leader, before amendments were made.  The interview 
guide will be piloted (3-4 interviews) and revised in accordance with feedback 
provided and personal learning’s during the pilot stage. Revision of the interview 
guide will be done in collaboration with the study panel.  
 
Data capture 
The interviews will be conducted in a suitable office behind closed doors Q3-4 
2012; acceptance of tape-recorder use will be recorded, as will the rest of the 
interview as per interview guide, using an Olympus Digital Voice Recorder DM-
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550.  During the interview data will be captured on the data capture sheet 
designed for the purpose (see Appendix A: Repertory Grid).  
After the interview is completed the recording will be transcribed by the 
researcher. Only quotes to be used in the final report will be translated for 
meaning by the researcher as these best suites the purpose of the project.  
 
Anonymization  
Data will be anonymized by the researcher using a key. Only the researcher will 
have access to the key.  
Data storage 
Data will be stored securely (locked in a safe) to ensure that no unintended 
access to data takes place. All data will be destroyed after legislation or 
contractual requirements expire, at the latest after 10 years.  
B.1.10 Analysis phase –Interview part one 
Qualitative and quantitative data captured on pre-prepared grids, and tape 
recording (Olympus DM-550 digital recorder) of the interviews and works shops, 
and transcribed recordings in Norwegian will be used for analysis. Data analysis 
will follow (Goffin et al., 2006) and also included elements from Lemke et al. 
(2011). 
 
Standardization of constructs 
The grids will be examined by the researcher to identify repetition of constructs. 
The grids will be further examined for constructs having the same meaning.  
 
Categorization of constructs 
The resulting standardized constructs will be categorized in workshop with the 
respondents. Both categories and meanings of the categories will be elicited 
during the workshops.  
The resulting categories with meaning from the workshop will be given to a 
scholar who will be asked to categorize the standardized constructs. The result 
will be discussed and the categories revised for content and meaning. The result 
will be compared to the one from the workshop in order to calculate an interrater 
variability index. The process will be repeated until an acceptable agreement is 
achieved (Jankowicz, 2004 p. 161). 
 
Identification of key constructs 
The most important constructs will be identified using frequency count and 
average normalized variability following the methodology of Lemke et al. (2003) 
and Goffin et al. (2006). The threshold for key construct is set at 25 % responder 
mention (Lemke et al., 2003). Average normalized variability will be calculated 
using Idogrid 2.4 and SPSS 19.1.  
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B.1.11 Project Plan 
The study includes several stages and will be conducted during the period 
spanning from protocol approval (mid 2012) to final submission in November 
2012 (DBA P2)P3).  Work will only commence obtaining necessary protocol and 
ethical approval. Consultation is planned at various points during the review 
period and will take the form of monthly progress reviews with Dr. Javier Marcos. 
A face-to-face meeting with the panel was held on the 4th July 2012. Further, 
face-to-face meeting will be planned as required. First draft of P2 will be circulated 
among the panel members in October 2012, before final submission by 
November 2012 
B.1.12 Dissemination of the Review and Further Research  
The aim of this study is to fulfil the DBA requirements at the Cranfield School of 
Management. The study will adapted for publication in academic and practitioner 
journals.   
B.1.13 Interview Guide 
 
Personal statement/ introduction 
First, thank you so much for agreeing to conduct this interview. 
 
I am a student at Cranfield School of Management, Cranfield University, UK I am 
pursuing a doctorate in business administration which focus is investigating the 
factors that influence physician’s decisions and work and their influence on the 
quality of health care delivery.  Your perspectives on this subject will provide 
valuable insight to this research.   
 
I would like to tape record this interview to enable a rigorous analysis of the data 
and to enhance the reliability of the methods.  Would this be OK for you? Your 
answers will be confidential and the identity of participants in this study kept 
strictly anonymous. Also your participation in this study is totally voluntary.  
 
I am not looking for any particular answer, but just you views and opinions on a 
number of areas. Please feel free to ask me to clarify any question you do not 
understand.  
 
The interview will last approximately 90 minutes and has two parts. I will outline 




This is a structured interview where I am interested in understanding how 
physicians frame quality of health care provision in your own terms, and not to 




First you will be asked to provide six cases (elements), two representing excellent 
quality, two representing medium quality and two representing low quality. 
 
You will then be asked to make a series of systematic comparison of different 
elements related to clinical and experiential quality. In addition you will be asked 
to rate your response on a scale from 1 – 5. 
 
I will be taking some notes as we go and capture your responses on a data 
capture sheet designed for this purpose. 
 
This part of the interview will not last more than 60 minutes. Any questions before 
we start? 
B.1.14 Written consent form in Norwegian 
Forespørsel om å delta i forskningsprosjektet «Legers 
forståelse av kvalitet av helsetjenester» 
I forbindelse med min doktorgrad holder jeg nå på med et forskningsprosjekt. 
Temaet for studien er kvalitet i helsetjenesten, og jeg skal gjennomføre en 
eksplorativ undersøkelse for å kartlegge hvordan leger legger rammer for 
kvalitet av helsetjenesteleveranser, og hvilke faktorer som motvirker eller 
medvirker til kvalitet av helsetjenesteleveranser. 
For å finne ut av dette, ønsker jeg å intervjue ca. 30 leger ved AHUS. 
Spørsmålene vil dreie seg om din forståelse av kvalitet i helsetjenesten. Som en 
del av studien vil jeg også forsøke å finne ut noe om hvilke faktorer som 
medvirker eller motvirker kvalitet av helsetjenesteleveranser fra et 
legeperspektiv. 
Jeg vil bruke båndopptaker og ta notater mens vi snakker sammen. Intervjuet vil 
ta omtrent en 60 minutter, og vi blir sammen enige om tid og sted.  
 
Det er frivillig å være med og du har mulighet til å trekke deg når som helst 
underveis, uten å måtte begrunne dette nærmere. Dersom du trekker deg vil 
alle innsamlede data om deg bli anonymisert. Opplysningene vil bli behandlet 
konfidensielt, og ingen enkeltpersoner vil kunne gjenkjennes. Opplysningene 
anonymiseres og opptakene slettes når studien er ferdig, innen utgangen av 
2012.  
 
Dersom du har lyst å være med på intervjuet, er det fint om du skriver under på 
den vedlagte samtykkeerklæringen.  
 
Hvis det er noe du lurer på kan du ringe meg på +47 94987760, eller sende en 
e-post til yngve.mikkelsen@ahus.no. Du kan også kontakte min veileder Dr. 
Javier Marcos ved Cranfield School of Management, telefonnummer +44 
1234751122 .  
 




Med vennlig hilsen  
Yngve Mikkelsen 




Jeg har mottatt skriftlig informasjon og er villig til å delta i studien.  
 
Signatur …………………………………. Telefonnummer ………………………….. 
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they do not. 
This is a 
group of 
people 
requiring a lot 
of energy from 
us in order to 
make sure 
they come 
and get the 
necessary 
treatment." 
2 14,27 L No 
2 Disease 
state 















veins. I felt it 
was important 






signs of heart 





































"It was very 













had a poorly 
developed 
vocabulary 





to disease. It 
was very 
difficult to get 
through to 
him." 















































do what is 
necessary in 
order to solve 
the issue at 
hand. In other 
words, 
competency is 
not a state, 






are present in 
order to solve 
a given 




came to the 
ER 
complaining of 
a tight chest. It 
was early in 
my career as 
a physician 
and I was 
inexperienced. 
I figured it 
must be a 
myocardial 
infarction and 
did not involve 
the consultant. 





the patient got 
worse. Finally, 






6 10,76 H No 























y, but not so 
concerned 
with the risk of 
the disease." 
5 11,52 M No 






be more or 
less confident 
















perform, but I 
was confident 














1 9,76 M No 
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agree to the 
treatment. I 




5 12,8 L No 





















may also be 
affected. 
“This patient 
had been to 












to do. When 
he came to 









He died two 
weeks later 
and ….” 
11 12,22 M Yes 















"The ER is not 
very effective, 
the nurse and 
physician see 
the patient at 
different times 




much better if 
we were there 




easily and the 
patient would 

















is central to 





















had a high 
social status 
and it made it 
easy to 
communicate. 
I think this 
was important 
12 13,05 H Yes 
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It has also 
helped in the 
follow-up. At 










have done.”  
12 Decision 
base 
Academic Flexible Decisions 
base: is 
related to 
























use of all the 
questionnaire 
tools we use. 
It is important 
for me to be 




















related to the 







"I think that if 
a disease has 
a high chance 
of a fatal 




effort is given 
to the patient." 
8 8,75 L No 

















"I feel lucky as 
I still have the 
possibility to 
decide for how 
long I will treat 
my patients. 
Some will only 




some even up 
to five years." 



















related to the 






"Due to delay 
in diagnosis 




save his life." 
17 12,86 H Yes 
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be more or 
less effective 































cure is not 
available and 
then it is 
important to 
set therapy 
targets in line 
with what is 
the patient’s 
interest." 
10 13,8 M Yes 



















came to the 
ER after a 
fight at a local 








full that night, 
but I managed 
to get the 
patient a bed 





the night I 
went to check 
on the patient 
and found him 
in a deep 











and died on 
the operating 
table. This is a 
case that has 
been with me 
for years and 








my gut feeling 
















fact that one 
physician is in 
charge of the 
care of the 
patient. 
"I think this 
patient would 
have had a 
better 
outcome if I 
would have 
had the full 
responsibility. 
The problem 






advice. If I 
would have 










the poor boy 
died." 
7 11,97 M Yes 



























7 10,04 M No 












"If the patient 
is interesting, 
out of the 
ordinary, I will 
pay more 
attention and 








3 12,5 H No 





an effort to 
improve the 











































has been in 






for her care I 
thought I 
could make a 
difference. It is 
very difficult to 






spent so much 
time and effort 
trying to help. 
I felt so angry 
and 
disappointed" 


























use of force 
may be 
legitimate in 
order to save 















they do not. 
This is a 
group of 
people 
requiring a lot 
of energy from 
us in order to 
make sure 
they come 
and get the 
necessary 
treatment." 


















"...it is central 




If not the 
patient will not 




think this is 
one aspect of 
patient-delay." 

















get a good 
alliance with 
the patient 


































had to pull 
information 
out of the 
patient. It was 
difficult find a 
rational 
explanation 





past 20 years 
with the same 
complaint." 










the feeling of 
obligation to 
follow a 
course or take 
action in order 
to prevent the 
loss of health 
or improve 
health. 
"I think this 
patient would 
have had a 
better 
outcome if I 
would have 
had the full 
responsibility. 
The problem 






advice. If I 
would have 










the poor boy 
died." 





























had to pay 
special 
attention to 
the quality of 
everything 
that that I did. 
Nothing 
escaped the 
scrutiny of the 
patient." 

















was left in the 






take care of 
and some had 
































































to treat or 


















apy, but not 
so 
concerned 











































and told him 
to come 
back in a 
few days if 
he was not 
better. He 



























































this point he 
was dying 
and therapy 
at this point 











Table B-4 Full listing 
Int 
ID 


















1 1 Time Long treatment 
period 
1 2 5 3 1 1 Short treatment 
period 
3 






Stable alliance with 
patient 




1 4 Decision base Clear academic 
foundation and 
methodology 








3 3 3 1 5 2 Patient activate 
positive transfer 
2 
1 6 Patient driven Accept and 
understanding of past 
2 4 2 5 1 3 Focus on 
present 
3 
1 7 Context Family context 
important 
2 2 2 4 2 2 Family context 
not important 
2 
1 8 Effect of 
therapy 
Effect of intervention 
is important 




2 1 Acute disease Acute disease 5 2 1 1 5 2 Chronic disease 1 
2 2 Intervention Acute technical 
intervention (somatic 
Dx) 




2 3 Resource 
utilization 




Continuous empathy 3 2 1 1 4 2 Passing 
empathy 
3 
2 5 Competency Requires high quality 4 2 1 1 4 2 Requires less 
quality 
2 
2 6 Context Legal right to health 
care 
4 1 1 1 5 3 No legal right to 
health care 
5 
2 7 Effect of 
therapy 
Effect of intervention 
is important 




2 8 Competency Specialty knowledge 2 4 3 3 4 3 General 
knowledge 
2 
2 9 Communication Communication with 
patient is important 
1 1 5 4 3 2 Communication 
with patient is 
less important 
1 
2 10 Information High degree of 
comparent 
information 




3 1 Competency Experience and 
knowledge 
3 5 2 2 5 2 Experience and 
action 
1 
3 2 Responsibility Did what I should 
have done 
1 1 2 1 4 4 Did not do what 
I should have 
done 
2 
3 3 Intervention Acute action 1 1 5 5 1 1 Follow up 3 
3 4 Disease 
severity 
Severe disease 1 4 1 4 4 2 Less severe 
disease 
4 
3 5 Competency Previous experience 1 1 2 1 4 5 No previous 
experience 
2 
3 6 Responsibility Attentive and 
catching the problem 




3 7 Responsibility Full responsibility 1 4 2 1 5 5 Shared 
responsibility 
4 
3 8 Resource 
availability 
High need for time 
and resources 




4 1 Communication Collect information in 
order to provide care 
3 2 4 2 2 2 Give information 
in order to care 
1 
4 2 Time Enough time 2 4 1 2 2 5 Not enough time 2 
4 3 Responsibility Interest in the patient 
and presenting 
problem 
2 1 1 4 3 2 Lack of interest 




4 4 Responsibility My responsibility 2 2 1 3 4 3 Who's 
responsibility? 
1 
4 5 Complexity  Complex medical 
problem and context 





4 6 Coordination 
and logistics 
High degree of 
coordinated care 




4 7 Context Involvement of close 
family 
1 2 1 4 4 1 No involvement 
of close family 
2 
4 8 Decision base Decision made on the 
basis of high degree 
of certainty 
2 3 1 3 4 4 Decision made 
on the basis of 
low degree of 
certainty 
1 
4 9 Communication Easy to get through 
to patient 




4 10 Continuity Disrupted treatment 2 1 4 3 4 3 Non-disrupted 
treatment 
3 
5 1 Early diagnosis 
and treatment 
Correct diagnosis and 
resolution 




5 2 Effect of 
therapy 
Good response to 
treatment 
5 5 5 2 1 5 No response to 
treatment 
1 
5 3 Patient driven High degree of 
patient engagement 




5 4 Communication Interactive 
communication 
5 1 1 5 1 2 Unilateral 
communication 
1 
5 5 Coordination 
and logistics 
Thorough process 5 1 4 3 1 4 Less thorough 
process 
1 
5 6 Complexity  Complex experience 
based approach 
2 1 2 3 5 3 Methodological 
approach 
1 
5 7 Clear 
presenting 
problem 
Concrete reason for 
contact with health 
care 
4 3 4 1 2 3 Diffuse reason 
for contact with 
health care 
3 




2 2 4 1 5 4 Not so effective 
treatment 
2 
6 2 Competency Correct interpretation 
of investigation 
results 





6 3 Resource 
utilization 
Quality of treatment 
and diagnostics 
above normal 





6 4 Responsibility Take personal 
responsibility 




6 5 Clear 
presenting 
problem 
Concrete reason for 
contact with health 
care 
4 3 4 1 2 3 Diffuse reason 
for contact with 
health care 
3 
6 6 Context Public health care 4 1 3 2 5 5 Private health 
care 
2 
6 7 Patient driven High level of patients' 
ability to interpret 
symptoms 





6 8 Disease 
severity 
Situation with high 
priority 
2 2 3 1 5 3 Situation with 
low priority 
2 
7 1 Patient driven Patient responsible 
for own situation 




7 2 Complexity  Complex and serious 
consequence of 
disease 





7 3 Communication Easy to understand 
what the patient 
wants 





7 4 Patient driven Patient wants 
resolution 
2 2 1 1 5 4 Patient has 
given up 
2 
7 5 Patient driven Patient knows a lot 
about own disease, 
system and what can 
influence course 
2 3 1 1 4 4 Patient knows 
little about own 
disease.... 
2 
7 6 Patient activate 
transfer 
Dependent on frames 2 2 5 1 1 5 Independent of 
frames 
3 
7 7 Patient activate 
transfer 
High degree of abuse 
potential 
2 2 4 5 1 1 Low degree of 
abuse potential 
2 
7 8 Communication Easy to get through 
to patient 





7 9 Competency High degree of 
understanding about 
biological gender 
differences and its 
impact on 
communication 





its impact on 
communication 
2 
















5 1 4 4 1 1 Low resource 
utilization 
3 








8 4 Patient activate 
transfer 
Positive patient give 
positive physician 
feeling 




8 5 Resource 
availability 
Available resources 4 1 4 4 1 1 Lack of 
resources 
4 




1 2 4 3 5 1 Unhealthy 
patient lifestyle 
5 
9 1 Communication Conversation with 
high degree of 
common 
understanding 
1 2 4 4 5 5 Conversation 




9 2 Continuity Continuity in 
physician services 




9 3 Time Enough time for 
patient and family 




9 4 Resource 
availability 
Resource balance 5 3 1 1 5 4 Resource 
imbalance 
2 
9 5 Continuity Patient followed over 
long time 
1 4 3 4 5 5 Patient followed 
over short time 
4 
9 6 Competency Correct competencies 
in physician services 





9 7 Patient 
adherence 
High degree of 
patient adherence 




9 8 Responsibility Full responsibility 1 1 3 3 5 5 Part 
responsibility 
2 
9 9 Competency Correct level of 
diagnostics 
1 2 3 1 5 5 Improper level 
of diagnostics 
1 
10 1 Patient activate 
transfer 
High degree of 
engagement 
1 3 1 4 1 2 Low degree  of 
engagement 
1 
10 2 Information High level of 
information available 
1 1 1 3 2 1 Lack of 
information 
2 
10 3 Continuity Continuity in 
physician services 













10 5 Competency Available 
competencies 
1 3 2 4 3 2 Lack of 
competencies 
2 
10 6 Resource 
availability 
Control of diagnostic 
resources 




10 7 Comorbidity Low degree of 
comorbidity 
1 2 3 5 1 2 High degree of 
comorbidity 
2 












11 2 Patient driven Rational patient 4 4 3 1 3 5 Irrational patient 3 
11 3 Clear 
presenting 
problem 
Symptoms related to 
disease 
4 1 4 2 5 1 No symptom of 
disease 
2 
11 4 Communication Patient with rich 
language 









relationship is based 
on long term relation 
1 5 2 4 2 2 Patient-
physician 
relationship is 
based on short 
term relation 
2 
11 6 Disease 
severity 
Patient is severely ill 2 2 1 1 4 1 Patient is not so 
ill 
1 
11 7 Patient 
adherence 
High degree of 
patient compliance 




11 8 Patient activate 
transfer 
High degree of abuse 4 1 3 1 2 5 No abuse 3 
11 9 Clear 
presenting 
problem 
Patient presents with 
clear problem 













12 2 Risk Complications free 
treatment 




12 3 Information Previous history of 
disease influence 
choice of diagnostics 
to a high degree 
1 2 4 5 5 5 Previous history 
of disease 
influence choice 
to a lesser 
extent 
4 
12 4 Competency High level of own 
experience 
4 1 1 4 1 1 Low level of own 
experience 
2 









12 6 Acute disease Acute disease 1 1 1 1 5 1 Chronic disease 5 
12 7 Patient driven Patient wants 
resolution 
2 2 1 1 5 4 Patient has 
given up 
2 
12 8 Time Enough time 3 3 2 5 3 1 Limited time 1 
13 1 Early diagnosis 
and treatment 
Early diagnosis 4 1 3 3 4 1 Delayed 
diagnosis 
1 
13 2 Communication Good communication 
with patient and 
family 
4 5 1 5 5 1 Lack of 
communication 
with patient and 
family 
1 




















Good alliance with 
patient and family 
5 5 1 4 4 1 Poor alliance 
with patient and 
family 
1 









13 7 Communication Simple interaction 
with patient 




14 1 Effect of 
therapy 
Effective treatment 1 1 4 3 5 5 Less effective 
treatment 
1 
14 2 Risk Fear governs patient 
choice 




14 3 Patient 
adherence 
High degree of 
adherence 
1 1 2 4 5 4 Low degree of 
adherence 
1 









14 5 Early diagnosis 
and treatment 
Early diagnosis 1 1 1 3 5 5 Delayed 
diagnosis 
1 
14 6 Continuity High degree of 
continuity 
4 5 2 2 2 3 Lacking 
continuity 
2 
14 7 Competency Highly competent 
staff 
2 4 4 3 1 1 Less competent 
staff 
2 
14 8 Correct 
interpretation 
Correct diagnosis 2 2 4 1 2 5 Diagnosis not 
clear 
1 
15 1 Complexity  Complex presenting 
problem 





15 2 Correct 
interpretation 
Correct diagnosis 2 2 4 1 2 5 Diagnosis not 
clear 
1 










15 4 Complexity  Complicated 
treatment regimen 




15 5 Resource 
availability 
Control of diagnostic 
resources 














15 7 Competency Competency 
dependent to a high 
degree 
2 1 1 1 3 5 Competency 
dependent to a 
lesser extent 
1 
16 1 Disease 
severity 
Grave disease and 
consequence for 
patient 





16 2 Early diagnosis 
and treatment 
Quick diagnostics 3 1 2 1 5 3 Delayed 
diagnostics 
2 
16 3 Effect of 
therapy 
Predictable effect of 
treatment 




16 4 Patient driven Patient expectations 
met 













16 6 Coordination 
and logistics 
Many people involved 
- complex logistics 
2 1 4 1 1 1 Few people 




16 7 Continuity Continuity in 
physician services 








16 9 Team approach High degree of 
cooperation between 
HCP 




17 1 Effect of 
therapy 
Optimal treatment 2 2 5 1 2 1 Suboptimal 
treatment 
1 
17 2 Complexity  High degree of 
complexity 
1 3 3 1 4 2 Low degree of 
complexity 
4 
17 3 Complexity  Complicated 
therapeutic regimen 












17 5 Effect of 
therapy 
Effective treatment 3 2 5 1 2 2 Ineffective 
treatment 
4 




2 1 3 1 1 1 Competency 




17 7 Coordination 
and logistics 
Cooperation with 
others to increase 
competency level 
4 5 4 1 5 4 Manage by self 2 
18 1 Competency Clinical experience 1 2 5 1 4 5 Lacking clinical 
experience 
1 
18 2 Correct 
interpretation 
Therapy matched to 
presenting problem 





18 3 Team approach Team approach to 
diagnosis and 
therapy 





18 4 Competency High degree of 
situational confidence 




18 5 Time Enough time 4 4 1 1 1 5 Lacking time 3 
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18 6 Information Information is central 
to therapy 
3 5 1 2 1 5 Information not 
needed 
1 
18 7 Intervention Technical intervention 1 1 5 2 5 1 Human 
approach 
3 








18 9 Early diagnosis 
and treatment 
Early diagnosis 1 2 5 4 2 2 Delayed 
diagnosis 
1 
19 1 Early diagnosis 
and treatment 
Early diagnosis 1 2 5 4 2 2 Delayed 
diagnosis 
1 
19 2 Effect of 
therapy 
Correct treatment for 
medical condition 





19 3 Acute disease Acute disease with 
dramatic symptoms 




19 4 Comorbidity Low degree of 
comorbidity 
1 2 3 5 1 2 High degree of 
comorbidity 
2 




5 4 3 1 5 5 No experience 









2 2 5 4 1 1 Resources and 
relevant 
competency not  
available 
1 
19 7 Competency Highly competent 
staff 
2 4 4 3 1 1 Less competent 
staff 
2 
19 8 Effect of 
therapy 
Short duration of 
therapy 
4 3 3 3 4 2 Long duration of 
therapy 
2 
20 1 Early diagnosis 
and treatment 
Early involvement 2 1 5 3 1 1 Delayed 
involvement 
2 












20 4 Continuity Few physicians 
involved 
2 1 5 4 1 1 Many physicians 
involved 
1 
20 5  High level health care 2 1 2 2 5 4 Lowe level 
health care 
3 
20 6 Complexity  High level of 
complexity 
2 1 5 2 1 1 Low level of 
complexity 
1 




1 1 1 1 5 4 No opportunity 
for follow-up 
2 




1 1 1 1 4 5 All possibilities 
not utilized 
2 




to resolve problem 
1 1 2 1 4 4 Necessary 








1 1 1 1 5 3 Diagnostic tools 
not available 
2 
21 1 Information Extensive information 
about previous 
history available 





21 2 Time Enough time for 
evaluation 
1 1 1 1 5 1 Lack of time for 
evaluation 
1 
21 3 Responsibility Fully responsibility for 
patient care 








1 1 2 2 5 2 Lacking medical 
evaluation 
1 
21 5 Correct 
interpretation 
Quality of evaluation 
is high 
1 1 2 1 5 4 Quality of 
evaluation is low 
1 
21 6 Team approach Team approach 1 1 2 1 5 2 Individual 
approach 
1 
21 7 Early diagnosis 
and treatment 
Early diagnosis 1 2 5 4 2 2 Delayed 
diagnosis 
1 
21 8 Patient activate 
transfer 
Patient is demanding 1 2 1 4 3 4 Patient is not 
demanding 
4 
22 1 Continuity Continuity in 
physician services 




22 2 Effect of 
therapy 
Treatment with effect 
on disease 





22 3 Early diagnosis 
and treatment 
Highly competent 
staff involved early 





22 4 Coordination 
and logistics 
Everything went 
according to plan 
1 1 3 2 3 1 Everything did 
not go according 
to plan 
2 
22 5 Early diagnosis 
and treatment 
Quick diagnosis and 
treatment 




22 6 Competency High degree of 
experience 






High degree of trust 1 2 2 3 2 2 Lacking trust 2 
22 8 Time Enough time 2 1 3 1 1 4 Lacking time 3 









23 2 Acute disease Acute and severe 
disease 




23 3 Time Enough time 3 1 4 4 1 1 Limited time 1 
23 4 Comorbidity Patient care not 
limited by 
comorbidities 




23 5 Correct 
interpretation 
Quality diagnosis 3 2 1 2 1 5 Limited 
diagnosis 
2 
23 6 Responsibility Full responsibility 5 3 4 4 2 1 Shared 
responsibility 
2 
23 7 Early diagnosis 
and treatment 
Early diagnosis 5 2 1 3 4 5 Delayed 
diagnosis 
1 
23 8 Patient activate 
transfer 






High degree of trust 4 2 2 3 1 2 Lacking trust 3 
24 1 Competency Specialist 
competency required 




24 2 Early diagnosis 
and treatment 
Early diagnosis 1 2 1 3 4 5 Delayed 
diagnosis 
1 









24 4 Disease 
severity 
Serious disease 1 2 2 1 1 3 Less serious 
disease 
3 
24 5 Time Enough time 1 1 1 2 4 4 Pressed for time 2 
24 6 Patient activate 
transfer 
Positive transfer 3 3 1 3 2 2 Negative 
transfer 
3 








24 8 Disease 
severity 
Severe symptoms of 
disease 
1 1 3 2 4 3 Mild symptoms 
of disease 
4 
24 9 Communication Easy to communicate 
with patient 




24 10 Early diagnosis 
and treatment 
Early treatment 1 2 2 3 4 5 Delayed 
treatment 
1 
25 1 Early diagnosis 
and treatment 
Early diagnosis and 
treatment 




25 2 Acute disease Acute disease 1 5 4 2 4 3 Chronic disease 2 
25 3 Competency Highly competent 2 5 1 2 2 2 Lacking 
commence 
1 
25 4 Patient 
adherence 
Patient willing to 
participate in therapy 








High degree of trust 5 3 2 1 2 2 Lacking trust 2 
25 6 Continuity High degree of 
continuity 
4 5 2 2 2 3 Lacking 
continuity 
2 
25 7 Disease 
severity 
Severe symptoms of 
disease 




26 1 Communication Good communication 
with patient 




26 2 Early diagnosis 
and treatment 
Early diagnosis and 
treatment of 
complications 





26 3 Continuity Continuity in 
treatment - few 
physicians involved 





26 4 Acute disease Acute disease 5 5 1 3 5 5 Chronic disease 3 
26 5 Patient activate 
transfer 
Patient is demanding 1 2 1 4 3 4 Patient is not 
demanding 
4 
26 6 Early diagnosis 
and treatment 
Early diagnosis of 
primary disease 




26 7 Resource 
utilization 
High level of health 
care 
1 1 2 3 3 5 Low level of 
health care 
2 
26 8 Coordination 
and logistics 
High degree of 
cooperation between 
physician and nurses 
1 1 2 2 1 5 Parallel paths 2 
26 9 Resource 
availability 
High level of policlinic 
follow up 




26 10 Competency More supervision of 
junior doctors 




27 1 Acute disease Acute disease 5 2 1 1 5 2 Chronic disease 1 
27 2 Intervention Acute technical 
intervention (somatic 
Dx) 








Continuous empathy 3 2 1 1 4 2 Passing 
empathy 
3 
27 5 Resource 
availability 
Requires high quality 4 2 1 1 4 2 Requires less 
quality 
2 
27 6 Context Legal right to health 
care 
4 1 1 1 5 3 No legal right to 
health care 
5 
27 7 Effect of 
therapy 
Effect of intervention 
is important 




27 8 Competency Specialty knowledge 2 4 3 3 4 3 General 
knowledge 
2 
27 9 Communication Communication with 
patient is important 
1 1 5 4 3 2 Communication 
with patient is 
less important 
1 
27 10 Information High degree of 
comparent 
information 







Table B-5 Repertory Grid 
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Table B-6 Theoretical saturation 
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Table B-7 Key constructs 
D Construct 
Label 























"It was very easy 
to get contact with 
this patient. The 
patient had a good 
understanding of 
his condition and 
was able to 
communicate his 
symptoms clearly. 
This other patient 
had a poorly 
developed 
vocabulary and did 
not understand 
that the symptoms 
were related to 
disease. It was 
very difficult to get 
through to him." 
12 13,37 H 
9 Continuity More continuity Less continuity Continuity: is 
related to how 
many physicians 
or other health 
care workers are 











may also be 
affected. 
“This patient had 
been to several of 
my colleagues with 
stomach pain for 
months. A few 
tests had been 
done and the 
patient repeatedly 
sent home without 
further to do. When 
he came to me I 
ordered a 
computer 
tomography of the 





died two weeks 
later and ….” 













necessary for a 
team approach 
and its synergies 
of effect. 
"The ER is not very 
effective, the nurse 
and physician see 
the patient at 
different times and 
ask the same 
questions. It would 
be much better if 
we were there at 
the same time. 
Information would 
flow easily and the 
patient would not 
have to answer the 
same question 
twice." 













central to the 
process of 
diagnosing and 




patient was a 
young boy with 
down syndrome. I 
was dependent on 
his parent’s 
information to 
make a correct 
diagnosis. 
Fortunately, his 
parents had a high 
social status and it 
made it easy to 
communicate. I 
think this was 




diagnosis. It has 
also helped in the 
follow-up. At the 
12 13,05 H 
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time I had two 
such patients with 
genetic heart 
disorders and they 
both lived 10-15 


















and treatment is 
related to the 






"Due to delay in 
diagnosis this 
patient did not 
receive the therapy 
needed to save his 
life." 









Effect of therapy: 
therapy can be 









effect. In some 
cases the 
symptomatic 
effect may be 
just as important 
dependent on 







"...intensive care is 
about two things: 
cure and palliation. 
Sometimes a cure 
is not available and 
then it is important 
to set therapy 
targets in line with 
what is the 
patient’s interest." 
10 13,8 M 
1
7 










similar events or 
cases. 
"The patient came 
to the ER after a 
fight at a local bar. 
He was not 
conscious and the 
consultant did not 
come to see the 
patient. The 
hospital was full 
that night, but I 
managed to get 
the patient a bed 
on a ward. I felt 
uneasy about the 
whole thing. Later 
during the night I 
went to check on 
the patient and 
found him in a 
deep coma. A Ct 
was requested and 
an intracranial 
bleeding was 
found. The patient 
was flown by 
helicopter to the 
nearest trauma 
centre and died on 
the operating table. 
This is a case that 
has been with me 
for years and my 
lack of experience 
made me accept 
the cursory advice 
from the consultant 
even though my 
8 11,96 H 
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No responsibility Full 
responsibility: 
denotes the fact 
that one 
physician is in 
charge of the 
care of the 
patient. 
"I think this patient 
would have had a 
better outcome if I 
would have had 
the full 
responsibility. The 
problem was that I 
felt like a 
consultant without 
full responsibility 
and gave advice. If 
I would have had 
all the information 
and been involved 
from the beginning 





poor boy died." 
















"The patient was 
left in the ER for 12 
hours without care. 
There were simply 
too many patients 
to take care of and 
some had to wait a 
really long time. 
Longer than what 
is acceptable." 











use of resources 














"This patient got 
more than what 





tried. In other 
words, the health 
care system had 
no more resources 
available that could 
be used." 
8 15,83 L 
3
3 
Time More time Less time Time: available 
time is important 
in order to do 
what is 
necessary. Time 
available is often 
determined by 
patients/physicia
ns per time unit. 
"During a hectic 




initial echo of the 
heart only paid 
attention to the 
replacement valve 
and not to the 
whole heart. Only 
two months later, 
after looking at the 
recorded echo film, 
was I evident that 
the left ventricle 
was barely moving. 
At this point he 
was dying and 
therapy at this 
point did not have 
any effects. He 
died shortly 
thereafter." 
9 13,25 M 
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Table B-11 Frequency of nodes and references by interview 
Name Nodes References
Interview 1 62 121
Interview 2 61 103
Interview 3 51 88
Interview 4 62 126
Interview 5 56 111
Interview 6 66 123
Interview 7 49 84
Interview 8 47 84
Interview 9 64 118
Interview 10 58 95
Interview 11 45 81
Interview 12 60 100
Interview 13 56 88
Interview 14 56 96
Interview 15 52 85
Interview 16 59 92
Interview 17 42 63
Interview 18 48 73
Interview 19 68 104
Interview 20 70 118
Interview 21 49 84
Interview 22 60 101
Interview 23 54 91
Interview 24 75 133
Interview 25 91 182
Interview 26 67 143
Interview 27 62 101












Appendix C PROJECT THREE 
C.1 Protocol 
C.1.1 Background 
It has been widely recognized that access to medical interventions necessitates 
physician initiative and concurrence (McGuire, 2001). Furthermore, it is widely 
recognized that because medical decisions have an impact on patients’ health, 
they should be of high quality (Klein, 2005). 
There appears to be consensus that decision making in medicine is made under 
uncertainty (Bornstein and Emler, 2001, Elstein, 1999, Elstein and Schwarz, 
2002, Payne et al., 1993, Reyna and Rivers, 2008, Spring, 2008). A systematic 
review conducted prior to the present project revealed that no general theory of 
medical decision has been formulated, but the theory of reasoned action is the 
most studied theoretical framework informing on the topic of physician’s decision 
behaviour (Reyna, 2008). Given the complexities of medical decision making and 
that no grand theoretical framework exists, deciding how to decide is central 
(Payne et al., 1993). Despite being highly trained, doctors are prone to making 
mistakes and cognitive biases may detract from the use of logical and statistical 
decision heuristics (Hershberger et al., 1994). In summary, there is a lack of 
contextually sensitive evidence informing medical decision processes.  
A report from the Institute of Medicine has documented that close to one million 
people per year are injured and close to one hundred thousand people a year 
dies as a result of preventable medical errors (Kohn et al., 1999). As a 
consequence, standardization of the provision of care in hospitals has come into 
greater focus. Implementing approaches to implement more systematically 
compliance with guidelines can help reduce variation in core processes of 
organizations (Flynn et al., 1994) and the same increase the quality of health care 
provided (Leape, 1994).  
The focus on quality of health care provision focuses on two main components. 
First, improvement of clinical quality where clinical quality refers to performance 
relative to process of care performance measures which are represented by 
clinical protocols of best practice to achieve high levels of patient safety 
(Chandrasekaran et al., 2012). Second, experiential quality is represented by the 
quality of care as experienced by the patient (Donabedian, 1988). It focuses on 
how care is provided and is distinct from the clinical quality as it is focused on 
what is provided. 
Tension between the two paths may occur when hospital management try to 
balance the two; as focus on clinical quality can reduce variation and focus on 
experiential quality increase variation (Chandrasekaran et al., 2012).  Clinical 
quality has been shown to be closely linked to experiential quality (Blackwell, 
1973, Butler et al., 2002, Camron, 1996) and vice versa. Thus, it is argued that 
the quality of care is dependent on both clinical- and experiential quality.  
 372 
C.1.2 Justification for the Study: Findings from Systematic 
Literature Review 
Though a good amount of research exists on outcomes of medical care, this study 
is justified, among others for the following reasons: 
 
Lack of grand medical Decision Theory 
Medical decision making has been given due attention due to the fact that such 
decisions may have a profound impact on patients’ health. Although there is wide 
agreement that medical decisions are made under uncertainty, as of yet, no grand 
theory of medical decision making exists (Reyna & Rivers 2008). Deciding how 
to decide is therefore important (Payne, Bettman, & Johnson 1993). This was a 
key finding of the systematic review preceding this study.  
 
Overall lack of information regarding outcomes  
It is widely recognized that because medical decisions have an impact on patients’ 
health, they should be of high quality (Klein, 2005). Factors influencing physician 
prescribing behaviour have been widely stated, but the linkage between these factors 
and evidence of how and under which circumstances (contexts) influence is exerted 
remains unanswered (Bornstein and Emler, 2001, Bradley, 1991). Furthermore, 
effect on patients’ health of any intervention designed to affect physician 
decisions is sadly lacking (Bornstein & Emler 2001;Bradley 1991;Smith 1977).   
The need for understanding how factors influence decision behaviour 
There is a wide body of evidence informing on the topic of influence and 
persuasion (O'Keefe 2002), but very little on effect in the context of physician 
prescribing behaviour (Lambert et al. 1997;O'Keefe 2002). Furthermore, there is 
a lack of contextual evidence and understanding of how factors affect physician 
decisions.  
Overall, the above findings mean that factors influencing physician decision 
behaviour may impact quality of the health care provided. It is therefore important 
to understand how and what role the physician play in determining the quality of 
health care provision. 
C.1.3 Study Panel 
The study panel will consist of the primary investigator (Yngve Mikkelsen, MD), 
his lead supervisor (Dr. Javier Marcos), a senior academic supervisor (Professor 
Hugh Wilson) and senior academic supervisor (Professor Simon Knox). In 
addition, other academics with which the researchers have contact and are 
knowledgeable in the field may be consulted to discuss the approach and findings 
of the present study.  
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Table C-1 Study panel for project three 
Person Role / Title and organization 
Dr. Javier Marcos Lead supervisor, Lecturer, Cranfield School of Management. 
Professor Simon Knox Senior supervisor, Professor, Cranfield School of Management
Professor Hugh Wilson  Senior supervisor, Professor, Cranfield School of Management
C.1.4 Aims and Objectives  
This study contains two separate parts addressing separate research questions 
designed to fulfil the requirements for empirical project three (P3) for the DBA at 
Cranfield School of Management. For practical purposes data collection for P3 
will take place on the same day as data collection for P2 from approximately 30 
individual physicians. The projects will be analysed and reported separately as 
highlighted in the Project Plan section on page 376. 
The aim of this project is to gain an in depth understanding of how physicians 
frame quality of health care delivery, identify enablers and barriers for provision 
of quality health care by physicians and describe the perceived role of physicians 
in balancing clinical and experiential quality while delivering health care. 
Specifically the project will: 
- Identify and categorize key constructs physicians have in mind to 
understand and deliver health care when conducting clinical (with the 
patient) work 
- Identify enablers and barriers for provision of quality health care as 
perceived by physicians 
- Identify how physicians balance clinical and experiential quality when 
providing health care 
Taking on a physician perspective in a hospital setting I therefore propose the 
following research question (RQ):  
RQ 1: How do physicians perceive quality of health care delivery in a hospital 
setting? 
RQ 2: What are the perceived enablers and barriers of quality health care delivery 
by physicians in a hospital setting? 
Little or no good quality data exists addressing such issues, making quantitative 
analysis as basis for further understanding of the phenomenon impractical. So, 
in order to gain a better understanding of how physicians frame quality of health 
care provision, a qualitative approach was chosen. With this in mind, possible 
methods for gathering data was explored (list not exhaustive): interviews (face-
to-face, telephone, e-mail), focus groups, comparison of records (reports, 
academic articles, etc.), case studies, and observation of phenomena in its 
natural environment.  
Both RQs will be addressed using semi structured interviews employing 
projective technique.   
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C.1.5 The Context of the Research 
The hospital in question is divided into separate divisions focusing on different 
therapy areas. Given the difference in focus there might be differences in 
perspectives between the divisions. Therefore, a decision to include several 
divisions was made. The method considered most suitable, ensuring both 
detection of potential contrasts between the divisions and extract the most 
valuable information, was repertory grid.  
C.1.6 Scope of the Study 
Table C-2 Scope of project three 
Focus The focus of the study is on how physicians frame health care 
service quality and what are the enablers and barriers for review 
Source: physician, university hospital, across specialties  
Time Frame The study will be conducted during the second half of 2012. 
Geography Norway, Oslo area 
Discipline The study will focus on hospital physicians across specialties at 




Semi-structured interviews will be used in order to elicit information from the 
participants’ about the phenomenon in question. The methodology closely follows 
that described by Kvale and Brinkmann (2009) p. 97-141 
 
Projective approaches 
Projective techniques and selection of episodes / cases will be used to help elicit 
participants’ view of the phenomenon in question. The methodology is suitable 
for eliciting information that the participants’ may not be explicitly conscious of 
(Mason, 1950). For instance, participants will be asked what they would do 
differently if conditions were ideal. 
Furthermore, the realist synthesis methodology suggested by Pawson et al. 
(2004) where focus is on gaining insights from the respondent perspective about 
the relationship between context, intervention, mechanism and outcomes,. 
C.1.8 Study: Administrative phase 
 
Ethical approval 
Ethical approval in accordance with Cranfield University and Akershus University 
Hospital policy (internal approval by the privacy ombudsman) will be obtained 
before study start in order to ensure appropriate management of data and 
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maintenance of privacy. The project is not considered to be within the scope of 
“Helseforskningsloven” (Norwegian research legislation) and will therefore not be 
submitted to the regional ethical committee (Regional Etisk Kommite) in Norway.  
 
Selection of study subjects 
Physicians across the five clinical divisions of a university hospital in the Oslo 
area in Norway will be invited to participate. The interviews will be formally 
booked using Microsoft Outlook 2007, including information about background, 
confidentiality and use of a tape recorder. Acceptance of interview participation 
will also be recorded in Microsoft Outlook.   
The number of recruited individuals will depend on the point at which theoretical 
saturation is achieved (approximately 30 individuals expected). 
The criteria to invite physicians to participate in the study are: 
 Physicians in clinical practice   
o Employed by Akershus University Hospital at the time of the study 
 Physicians not in administrative roles 
 Physicians willing to participate in the study 
 
Informed consent 
Informed consent will be sought from study subjects prior to inclusion and 
recorded in writing (see Appendix C: Written Consent Form) and on voice 
recorder. 
C.1.9 Study: Conduction phase 
 
Pilot 
On the basis of the research objective, an interview guide was developed (see 
Appendix B: Interview Guide) and subjected to evaluation and feedback from 
supervisor and course leader, before amendments were made.  The interview 
guide will be piloted (3-4 interviews) and revised in accordance with feedback 
provided and personal learning’s during the pilot stage. Revision of the interview 
guide will be done in collaboration with the study panel.  
 
Data capture 
The interviews will be conducted in a suitable office behind closed doors Q3-4 
2012; acceptance of tape-recorder use will be recorded, as will the rest of the 
interview as per interview guide, using an Olympus Digital Voice Recorder DM-
550.   
After the interview is completed the recording will be transcribed by the 
researcher. Only quotes to be used in the final report will be translated for 





Data will be anonymized by the researcher using a key. Only the researcher will 
have access to the key.  
 
Data storage 
Data will be stored securely (locked in a safe) to ensure that no unintended 
access to data takes place. All data will be destroyed after legislation or 
contractual requirements expire, at the latest after 10 years.  
C.1.10 Analysis phase  
An open coding approach was chosen for this project as it is well suited for 
understanding phenomena (Kvale and Brinkmann, 2009).  
Transcript of the first interview will be studied in detail and concepts identified line 
by line. The concepts will be given rudimentary codes in the margin of the written 
transcript. These codes will be compared to new codes from the next transcript, 
continuously going back and forth comparing the data. The process will be 
repeated until all transcripts have been conceptualized.  
During the process, concepts will be merged into new concepts, grouped into 
categories, and finally labelled as tentative categories. Using the tentative 
categories as a guide, transcripts and interview notes will be revisited establishing 
the final categorical coding reflecting a cognitive map of how physicians frame 
quality in health care service delivery, and physician enablers & barriers.   
The categories will then be probed for properties and dimensions by going back 
and forth comparing data from transcripts, interview notes and re-listening to the 
recordings for additional data granularity. The resulting coding structure consists 
of four levels consisting of: category, sub-category, property and dimension. 
Evolution of the coding process will be tracked in Microsoft Excel 2010 using 
progressive sheets, resulting in a detailed coding log. NVivo 10 will be used for 
final text analysis and coding. 
C.1.11 Project Plan 
The study includes several stages and will be conducted during the period 
spanning from protocol approval (mid 2012) to final submission in May 2013.  
Work will only commence obtaining necessary protocol and ethical approval. 
Consultation is planned at various points during the review period and will take 
the form of monthly progress reviews with Dr. Javier Marcos. A face-to-face 
meeting with the panel was held on the 4th July 2012. Further, face-to-face 
meeting will be planned as required First draft of P3 will be circulated among 




C.1.12 Dissemination of the Review and Further Research  
The aim of this study is to fulfil the DBA requirements at the Cranfield School of 
Management. The study will adapted for publication in academic and practitioner 
journals.    
C.1.13 Interview Guide 
Personal statement/ introduction 
First, thank you so much for agreeing to conduct this interview. 
 
I am a student at Cranfield School of Management, Cranfield University, UK I am 
pursuing a doctorate in business administration which focus is investigating the 
factors that influence physician’s decisions and work and their influence on the 
quality of health care delivery.  Your perspectives on this subject will provide 
valuable insight to this research.   
 
I would like to tape record this interview to enable a rigorous analysis of the data 
and to enhance the reliability of the methods.  Would this be OK for you? Your 
answers will be confidential and the identity of participants in this study kept 
strictly anonymous. Also your participation in this study is totally voluntary.  
 
I am not looking for any particular answer, but just you views and opinions on a 
number of areas. Please feel free to ask me to clarify any question you do not 
understand.  
 
The interview will last approximately 90 minutes and has two parts. I will outline 




I expect this part of the interview will last about 30 minutes. I will now give you a 
brief outline of the interview. 
1. First, I will ask general  questions about how you view the provision of 
health care 
a. Please feel free to elaborate or illustrate in any way you want  
b. When I may ask follow up questions to gain a clearer understanding 
of your views 
2. Third, I would like to gain your insights about ways in which quality of 
health provision may be enhanced.  
 
I will also take some notes as we go.  




Please tell me, how you would describe Quality of Health Care provision 
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I see…. Please tell me more; what does quality of health care service mean to 
you? 
 
How do you assess quality of health care? 
 
Perceived enablers of quality of health care  
1º Q: You’ve described your view of quality health care provision which I 
appreciate. I’d like to ask you 
- what gets facilitates YOU delivering quality of health care 
- I see, what other enablers you see in helping you deliver quality health 
care? 
 
Please describe the cases provide in part one of the interview that represent a 
patient encounter where the quality of service was excellent.  
- what was the Context 
- what did you and/or your service do (Intervention) 
- what was the Outcome 
- what were the factors (in other words Mechanisms) that contributed to 
such outcome? 
 
Perceived barriers of quality of health care  
2º Q: You’ve described your view of quality health care provision which I 
appreciate. I’d like to ask you 
- what gets in the way (or precludes) for YOU from delivering quality of 
health care 
- I see, what other barriers you see in preventing you from delivering quality 
health care? 
You’ve mentioned X, Y, Z. Let’s imaging that those constrains/barriers did not 
exist… 
 
What would you do differently? 
 
Please describe the cases provide in part one of the interview that represent a 
patient encounter where the quality of service was not satisfactory.  
- what was the Context 
- what did you do (Intervention) 
- what was the Outcome 
- what were the factors (in other words Mechanisms) associated with such 
outcome? 
 
2º Q: What do you mean by? 
Please explain further. 
Can you elaborate further?  
In your answer you mentioned…. 
 
Concluding 




I would also like to ask you, what is your experience of this interview? 
C.1.14 Samtykkeerklæring (Written consent form in Norwegian) 
Forespørsel om å delta i forskningsprosjektet «Legers forståelse 
av kvalitet av helsetjenester» 
I forbindelse med min doktorgrad holder jeg nå på med et forskningsprosjekt. 
Temaet for studien er kvalitet i helsetjenesten, og jeg skal gjennomføre en 
eksplorativ undersøkelse for å kartlegge hvordan leger legger rammer for 
kvalitet av helsetjenesteleveranser, og hvilke faktorer som motvirker eller 
medvirker til kvalitet av helsetjenesteleveranser. 
For å finne ut av dette, ønsker jeg å intervjue ca. 30 leger ved AHUS. 
Spørsmålene vil dreie seg om din forståelse av kvalitet i helsetjenesten. Som en 
del av studien vil jeg også forsøke å finne ut noe om hvilke faktorer som 
medvirker eller motvirker kvalitet av helsetjenesteleveranser fra et 
legeperspektiv. 
Jeg vil bruke båndopptaker og ta notater mens vi snakker sammen. Intervjuet vil 
ta omtrent en 30 minutter, og vi blir sammen enige om tid og sted.  
 
Det er frivillig å være med og du har mulighet til å trekke deg når som helst 
underveis, uten å måtte begrunne dette nærmere. Dersom du trekker deg vil 
alle innsamlede data om deg bli anonymisert. Opplysningene vil bli behandlet 
konfidensielt, og ingen enkeltpersoner vil kunne gjenkjennes. Opplysningene 
anonymiseres og opptakene slettes når studien er ferdig, innen utgangen av 
2012.  
 
Dersom du har lyst å være med på intervjuet, er det fint om du skriver under på 
den vedlagte samtykkeerklæringen.  
 
Hvis det er noe du lurer på kan du ringe meg på +47 94987760, eller sende en 
e-post til yngve.mikkelsen@ahus.no. Du kan også kontakte min veileder Dr. 
Javier Marcos ved Cranfield School of Management, telefonnummer +44 
1234751122 .  
 
Studien er godkjent av Forskningsenheten ved AHUS og Cranfield School of  
Management. 
 
Med vennlig hilsen  
Yngve Mikkelsen 




Jeg har mottatt skriftlig informasjon og er villig til å delta i studien.  
 
Signatur …………………………………. Telefonnummer ………………………….. 
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Table C-3 NVIVO screen shot 
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Table C-4 Word frequency of the 100 most common words 





add 3 130 0,29 add, brings, contributed, contributing, sums, supply, total, 
totally 
admitted 8 206 0,46 accept, acceptable, acceptance, accepted, accepts, 
acknowledge, acknowledged, admit, admitted, admitting, 
allow, allowed, confess, hold, holds, include, included, 
includes, including, take, takes, taking, true 
also 4 172 0,65 also 
anything 8 158 0,59 anything 
available 9 158 0,26 access, accessible, availability, available, help, helped, 
helpful, helping, helps 
back 4 124 0,29 back, backing, backward, cover, covered, covering, covers, 
fund, funding, funds, game, hinder, hinders, reared, second, 
secondly, support, supported, supporter, supporting, 
supportive, supports 
better 6 111 0,36 advance, advanced, amended, amending, best, better, 
breaks, improve, improved, improvement, improving 
call 4 84 0,23 address, addressed, addressing, anticipation, call, called, 
calling, calls, career, crying, name, phone, phones, 
predictability, predictable, predicted, promise, ring, rings, 
shout, songs, visit, visiting, visits 
care 4 722 1,75 aid, aides, aiding, attention, attentive, care, cared, carefully, 
caring, charge, concerned, concerns, deal, dealing, deals, 
fear, handled, like, liked, likely, maintenance, manage, 
managed, management, manager, manages, managing, 
measurable, measure, measured, measurement, measures, 
measuring, tend, wish, wished, worry 
case 4 343 0,90 case, cases, cause, caused, causes, causing, event, events, 
example, examples, face, faces, facing, font, instance, 
slipped, subject, subjective, suit, type, types 
close 5 150 0,23 close, closed, closely, closing, complete, completely, 
conclude, concluded, conclusion, end, ended, ending, ends, 
final, finally, finish, finished, last, lasted, tight 
colleagues 10 65 0,24 colleague, colleagues 
communication 13 112 0,36 communicate, communicated, communicating, 
communication, community, convey, national, pass, passed, 
passing 
competency 10 100 0,35 capability, capable, competencies, competency, competent 
condition 9 134 0,29 check, condition, conditions, consideration, learn, learned, 
learning, learns, qualified, shape, shaped, status, term, terms, 
train, trained, training 
context 7 88 0,27 context, set, setting 
day 3 167 0,48 day, days, year, years 
delivering 10 181 0,55 deliver, delivered, delivering, present, presented, presenting, 
presents, rescue, return, returned, save, saving 
department 10 211 0,28 asleep, department, departments, go, going, gone, leave, part, 
parted, parts, section, start, started, starting, starts, varied, 
varies, varying 
diagnosis 9 114 0,40 diagnose, diagnosed, diagnoses, diagnosing, diagnosis 
different 9 172 0,64 conflict, conflicting, conflicts, differ, difference, differences, 
different, differently, differing, otherwise 
difficult 9 68 0,25 difficult, difficulty, hard 
done 4 76 0,29 done 
else 4 148 0,56 else 
enough 6 90 0,30 adequate, adequately, enough, sufficient 
example 7 142 0,25 example, examples, exercise, exercising, illustrate, instance, 
model, represent, representative, representing, represents 
experience 10 567 1,27 experience, experienced, experiences, experiencing, 
experiment, feel, feeling, feelings, feels, get, gets, getting, 
know, knowing, knows, live, lived, lives, living, receive, 
received, receiving, see, seeing, sees 
facilitates 11 123 0,34 alleviated, facilitate, facilitated, facilitates, facilitating, 
facilitators, help, helped, helpful, helping, helps 
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factors 7 67 0,23 agent, element, elements, factor, factors, gene 
feel 4 216 0,32 belief, feel, feeling, feelings, feels, find, finding, findings, 
finger, flavour, impression, look, looked, looking, looks, 
opinion, palpated, palpation, sense, spirit, touch, touched, 
touching 
focus 5 99 0,24 centre, concentrate, concentration, direct, directed, direction, 
directly, focal, focus, focused, focusing, stress, stressed 
get 3 692 0,83 aim, amazing, arrest, arrive, arrived, beating, become, 
becomes, becoming, begin, beginning, brings, catch, cause, 
caused, causes, causing, come, comes, coming, convey, 
develop, developed, developing, development, draw, drive, 
drives, find, finding, findings, fix, generate, generated, 
generates, generating, get, gets, getting, go, going, growing, 
grows, let, make, makes, making, mother, pose, produce, 
produced, producer, producing, receive, received, receiving, 
start, started, starting, starts, suffer, suffered, suffering, 
suffers, take, takes, taking 
give 4 255 0,32 applies, apply, big, breaks, collapsed, contributed, 
contributing, dedicated, establish, established, establishing, 
feed, generate, generated, generates, generating, give, gives, 
giving, granted, hand, hands, leave, open, opened, opening, 
pass, passed, passing, present, presented, presenting, 
presents, reaching, return, returned, sacrifice, spring, throw, 
throws 
going 5 297 0,31 belongings, breaks, die, died, dies, dying, endure, exited, 
extend, extended, extending, fail, failed, failing, fit, fits, go, 
going, last, lasted, lead, leading, leave, live, lived, lives, living, 
loss, move, moved, moving, offer, offered, offers, pass, 
passed, passing, proceed, run, running, sound, sounds, start, 
started, starting, starts, survival, survived, travel, travelled, 
travels, turn, turned, turning, turns, x 
good 4 849 2,05 beneficial, dependencies, dependent, depending, effect, 
effective, effectively, effects, estimate, expert, experts, full, 
good, healthy, honest, just, practical, practice, respect, 
respected, respectful, right, rightly, safe, secure, secured, 
security, serious, seriously, skill, skilled, skills, sound, sounds, 
thorough, tidy, upright, well 
health 6 282 0,72 health, well 
healthcare 10 120 0,45 healthcare 
hospital 8 111 0,42 hospital, hospitals 
however 7 128 0,38 however, still, yet 
important 9 502 1,20 consequence, consequences, consequent, consequently, 
implication, implications, importance, important, mean, 
meaning, means, moment 
indicated 9 116 0,23 argued, design, designed, indicate, indicated, indicates, 
indicating, indication, indicative, indicator, indicators, point, 
points, read, reading, show, showed, shows, signals, suggest, 
suggested, suggestion 
information 11 125 0,43 conversation, conversations, conversion, data, inform, 
information, informed, informing, loose, sources 
interviewee 11 714 2,68 interviewee 
interviewer 11 885 3,18 consult, consultation, consultations, consulted, consulting, 
interview, interviewer, question, questionable, questioned, 
questioning, questions 
know 4 191 0,33 acknowledge, acknowledged, banging, bed, beds, fucking, 
intention, know, knowing, knowledge, knows, learn, learned, 
learning, learns, letter, love, recognise, recognised, 
recognising, wisely 
level 5 167 0,40 charge, degree, degrees, equal, equality, equally, equals, 
even, evening, level, levels, point, points, stage, stories, story 
like 4 222 0,40 comparable, compare, compared, like, liked, likely, potential, 
potentially, probabilities, probability, probably, similar 
lot 3 258 0,60 band, deal, dealing, deals, draw, load, lot, lots, luck, mess, 
much, score, scored, scoring, set, setting 
make 4 410 0,51 build, building, builds, cause, caused, causes, causing, clear, 
clearly, constructive, create, created, creates, creating, draw, 
establish, established, establishing, fix, form, formed, gain, 
gained, give, gives, giving, hit, hits, hold, holds, make, makes, 
making, name, preparation, prepare, prepared, produce, 
produced, producer, producing, reaching, ready, realise, 
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realised, score, scored, scoring, shit, stool, take, takes, taking, 
throw, throws, urine 
managed 7 167 0,24 achieve, achieved, cope, deal, dealing, deals, direct, directed, 
direction, directly, director, handled, manage, managed, 
management, manager, manages, managing, supervised, 
supervising, supervision 
many 4 65 0,24 many 
may 3 104 0,39 may 
mean 4 441 0,65 agencies, base, based, close, closed, closely, closing, 
humble, implies, intended, mean, meaning, means, pregnant, 
substances, tight, way, ways 
measure 7 243 0,42 amount, amounts, beating, calculate, calculated, evaluate, 
evaluated, evaluating, evaluation, evaluations, measurable, 
measure, measured, measurement, measures, measuring, 
quantity, standard, standards, stepped, valuation, value, 
values 
medical 7 128 0,48 medical, medically, medication, medications, medicine, 
medicines 
mentioned 9 127 0,32 acknowledge, acknowledged, mention, mentioned, 
mentioning, name, note, noted, notes, observable, 
observation, observations, observe, observed, refer, referred, 
referring 
must 4 70 0,26 must 
necessary 9 99 0,33 essential, necessary, require, requirement, requirements, 
requires, requiring 
need 4 377 0,87 ask, asked, asking, asks, demand, demanded, demands, 
involve, involved, involvement, involves, involving, motivate, 
motivated, motivation, necessarily, need, needed, needing, 
needs, require, requirement, requirements, requires, requiring, 
take, takes, taking, want, wanted, wants 
next 4 108 0,29 follow, followed, following, follows, future, next, succeed 
now 3 155 0,40 direct, directed, direction, directly, immediate, immediately, 
now, present, presented, presenting, presents, today 
nurses 6 78 0,28 hold, holds, lactate, nurse, nurses, nursing 
one 3 139 0,51 1, ace, one, ones, single 
order 5 192 0,30 arrange, consisting, consists, dictated, governance, 
government, logic, logical, order, ordered, place, placed, 
places, placing, prescribed, put, putting, range, rate, rates, 
regular, regularly, regulated, regulations, saying, society, tell, 
tells 
outcome 7 277 0,61 consequence, consequences, consequent, consequently, 
effect, effective, effectively, effects, event, events, issue, 
issues, outcome, outcomes, result, resulted, resulting, results, 
terminal 
patient 7 952 3,57 patient, patients 
person 6 88 0,28 individual, individuals, mortality, person, personal, personality, 
personally, pose, someone, soul 
physician 9 192 0,72 doctor, doctors, physician, physicians 
place 5 225 0,26 aim, direct, directed, direction, directly, home, identified, 
identify, identifying, invest, investment, local, located, location, 
place, placed, places, placing, point, points, pose, position, 
positive, positively, positives, post, put, putting, send, set, 
setting, space, spot, target, targeted, targets 
positive 8 131 0,27 advantages, attitude, attitudes, confidence, confident, confirm, 
confirmed, confirming, convince, located, location, 
perspective, position, positive, positively, positives, posture, 
prescribed, side, sides, state, stated, status, view, viewed, 
views 
possible 8 126 0,42 maybe, open, opened, opening, possibility, possible, possibly, 
potential, potentially, theory 
prevents 8 90 0,30 hinder, hinders, keep, keeping, keeps, prevent, preventable, 
prevented, preventing, prevents 
problem 7 128 0,41 job, jobs, problem, problems 
procedures 10 150 0,27 function, functioning, functions, operate, operated, operating, 
operation, operative, procedure, procedures, process, 
processes, routine, routines 
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providing 9 130 0,40 allow, allowed, leave, offer, offered, offers, provide, provided, 
provides, providing, supply 
quality 7 566 2,11 choice, choices, qualities, quality 
quite 5 129 0,35 department, departments, quite, rather, stop, stopped, stops 
related 7 182 0,32 associated, association, comparable, compare, compared, 
concerned, concerns, congress, congresses, connected, 
connecting, connection, deal, dealing, deals, link, linked, 
pertaining, refer, referred, referring, relate, related, relation, 
relations, relatively, tell, tells, touch, touched, touching 
resources 9 98 0,36 imagine, resource, resources 
right 5 276 0,47 appropriate, appropriately, compensate, correct, corrected, 
correction, correctly, just, justifiable, laws, power, properly, 
rectified, rectify, right, rightly, true, truly 
satisfied 9 154 0,46 comfort, comfortable, filling, fulfill, meet, meeting, meetings, 
meets, satisfied, satisfy, satisfying, solid, square 
see 3 469 0,62 assurance, assure, attend, attended, catch, check, consider, 
considered, considering, control, controlled, controlling, 
controls, date, determine, determines, determining, discover, 
discovered, ensure, ensured, ensuring, examination, examine, 
examined, examining, figure, find, finding, findings, hear, 
imaging, insurance, interpret, interpretation, interpreted, learn, 
learned, learning, learns, look, looked, looking, looks, meet, 
meeting, meetings, meets, picture, pictures, project, 
projection, projects, realise, realised, regard, regarding, 
regards, see, seeing, sees, understand, understanding, 
understands, view, viewed, views, visit, visiting, visits, 
watching 
services 8 383 1,14 availability, available, help, helped, helpful, helping, helps, 
serve, served, service, services, serving 
situation 9 173 0,32 fix, located, location, office, officer, offices, place, placed, 
places, placing, position, positive, positively, positives, post, 
set, setting, situation, situations, spot 
something 9 143 0,54 something 
system 6 177 0,46 arrange, order, ordered, organ, organisation, organisational, 
organise, organised, organising, system, systematic, 
systematically, systemic, systems 
take 4 426 0,43 accept, acceptable, acceptance, accepted, accepts, aim, 
assume, brings, carried, carries, carry, choose, consider, 
considered, considering, contains, convey, deal, dealing, 
deals, direct, directed, direction, directly, drive, drives, 
engage, engaged, engagement, exact, exactly, filling, film, 
hiring, hold, holds, issue, issues, lead, leading, learn, learned, 
learning, learns, pick, proceed, read, reading, removed, 
removes, return, returned, studied, studies, study, take, takes, 
taking, train, trained, training 
test 4 112 0,27 exam, examination, examine, examined, examining, run, 
running, screen, test, testing, tests, tried, try, trying 
things 6 190 0,68 matter, matters, thing, things 
think 5 591 1,31 believe, believed, believing, cerebral, consider, considered, 
considering, guess, imagine, intellect, intelligence, intelligent, 
intended, mean, meaning, means, reason, reasonable, 
reasons, remember, remembering, supposed, think, thinking, 
thinks, thought, thoughts 
time 4 343 1,29 clock, time, times, timing 
treatment 9 231 0,80 discuss, discussed, discussing, discussion, discussions, 
handled, intervention, interventional, treatment, treatments 
two 3 65 0,24 2, two 
use 3 186 0,43 applies, apply, employed, employing, enjoy, enjoyable, 
enjoyed, enjoys, exercise, exercising, function, functioning, 
functions, habits, practical, practice, purpose, purposes, role, 
roles, use, used, useful, using, utilisation, utilise, utilised, 
utilization 
waiting 7 153 0,26 awaiting, delay, delayed, delaying, delays, expect, 
expectancy, expectation, expectations, expected, hold, holds, 
look, looked, looking, looks, wait, waiting 
way 3 147 0,24 direct, directed, direction, directly, manner, path, paths, room, 
rooms, style, way, ways 
whether 7 77 0,29 whether 
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words 5 91 0,25 book, books, discuss, discussed, discussing, discussion, 
discussions, formulate, intelligence, intelligent, language, 
news, speech, word, words 
work 4 570 1,08 act, acted, acting, brings, employed, employing, exercise, 
exercising, form, formed, function, functioning, functions, go, 
going, influence, influenced, influencing, make, makes, 
making, operate, operated, operating, operation, operative, 
played, process, processes, run, running, shape, shaped, 
solve, solved, solving, sour, studied, studies, study, turn, 
turned, turning, turns, work, worked, working, works 
yes 3 85 0,32 yes 
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Table C-6 Word frequency tree map 
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Table C-7 Distribution of nodes (categories) and references by interview 
respondent 
Name Nodes References
Interview 1 62 121
Interview 2 61 103
Interview 3 51 88
Interview 4 62 126
Interview 5 56 111
Interview 6 66 123
Interview 7 49 84
Interview 8 47 84
Interview 9 64 118
Interview 10 58 95
Interview 11 45 81
Interview 12 60 100
Interview 13 56 88
Interview 14 56 96
Interview 15 52 85
Interview 16 59 92
Interview 17 42 63
Interview 18 48 73
Interview 19 68 104
Interview 20 70 118
Interview 21 49 84
Interview 22 60 101
Interview 23 54 91
Interview 24 75 133
Interview 25 91 182
Interview 26 67 143
Interview 27 62 101















Evaluation Feedback Level of feedback and ability to change based on 
feedback received 
High - Low 
Measures Being able to objectively measure  High - Low 
Intervention Diagnosis Ability to make a correct diagnosis without delay High - Low 
Treatment Ability to give appropriate treatment without delay or 
undue risk to patients 
High - Low 
Procedure Ability to perform procedure correctly High -Low 
Communication Quality of communication High - Low 
Mechanism Time Availability of time to do what is necessary High - Low 
Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High - Low 
Diagnostics Ability to correctly diagnose patients without delay High - Low 
Treatment Ability to correctly treat patients without delay High - Low 
Resources Availability of necessary technical, building and 
human resources 
High - Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High - Low 
Physician attitude Ability to show and real interest and level of curiosity High - Low 
Patient Willingness to cooperate and adhere to medical 
advice given  
High - Low 
Barriers Availability of time Having enough time to do what is necessary High – Low 
Resource 
availability 
Adequate resources available High – Low 
Competency  Level of competency available on the personal level High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Enablers Evaluation Ability to evaluate  High – Low  
Time Availability of time to do what is necessary High – Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High – Low 
Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Physician Physician attitude High – Low 
Patient Willingness to cooperate and adhere to medical 
advice given 
High – Low 
Diagnostics Ability to correctly diagnose patients without delay High – Low 
Treatment Ability to correctly treat patients without delay High – Low 
Quality Communication Ability to communicate, get and give necessary 
information in a tailored manner 
High – Low 
Resources Adequate resources available High – Low 
Competency Availability of necessary competency (knowledge, 
experience and skill) 
High – Low 
Diagnostics Ability to correctly diagnose patients without delay High – Low 
Treatment Ability to correctly treat patients without delay High – Low 
Patient Willingness to cooperate and adhere to medical 
advice given 
High – Low 
Physician Physician attitude High – Low 
Organization Organization of work that support delivery of health 
care 
High – Low 
Evaluation Ability to evaluate and learn High – Low 
Continuity Level of continuity of care High – Low 




Table C-9 Enablers and barriers 
Barriers and enablers 
Category Sub-category Property Dimension Ref # * Sample quote Elements 
Barriers Time Having 
enough time to 
do what is 
necessary 
High – Low 21 “…often I feel it’s about not 
having enough time which could 
be caused by a combination of 
factors, one being that we have 
a lot of patients and therefore 
more patients per physician, 
both admitted and outpatients.” 
Structure 




High – Low 35 “…well, it may be worthwhile 
mentioning resource access, 
well, actually that’s also very 
important, one of the patients we 
have discussed earlier was 
definitely an example of lack of 
resources, as he did not get 
access to a respirator, was 
placed in the hallway of a 
hospital and died.” 
Structure 





High – Low 10 “…lack of knowledge and skills, 
lack of competency. I will have to 
define competency. The problem 
is we need to sort of often walk 
through the door. We can sit 
down and read. But the lack of 








High – Low 23 “The economic model increases 
the demands for reporting to 
satisfy the bureaucracy. This 
detracts from good quality health 
care services. “ 
Structure 
Enablers Evaluation Ability to 
evaluate  
High – Low  5 “…evaluation of effect and follow 
up…” 
Process 
Time Availability of 
time to do 
what is 
necessary 
High – Low 22 “…often I feel it’s about not 
having enough time which could 
be caused by a combination of 
factors, one being that we have 
a lot of patients and therefore 
more patients per physician, 
both admitted and outpatients.” 
 






High – Low 52 “…lack of knowledge and skills, 
lack of competency. I will have to 
define competency. The problem 
is we need to sort of often walk 
through the door. We can sit 
down and read. But the lack of 
competency in general, is a 
barrier.” 
Structure 
Communication Ability to 
communicate, 





High – Low 22 “…it’s mostly about me listening 
and I am able to pose good 
questions, and that I am very 








High – Low 36 “The economic model increases 
the demands for reporting to 
satisfy the bureaucracy. This 
detracts from good quality health 




High – Low 42 “Being professionally curious 
and interested is important, the 
moment you stop being curious 
and believe you know everything 
you have lost.” 
Process 





High – Low 2 “…good compliance at the 
patient level, she complied and 
took medicines.” 
Process 





High – Low 2 “…the combination of an early 
diagnosis and treatment, close 
monitoring and a competent 
team around her were key 
success factors for a positive 
outcome.” 
Process 
Treatment Ability to 
correctly treat 
High – Low 3 “…continuity in the treatment so 





back in order to evaluate 
whether the treatment is 
effective and if the patient is 
satisfied or not, and allow for 
correction of emerging issues.” 
* Ref # = number of references 
 
















































































































































































































































































Table C-12 Patient cases - High quality 





1 Single-parent, social and 
personality related problems, does 
not hold down a job, lives with 
parents 
Support from next of 
kin 
Support from social 
services 
Back to work full time 
Lives by her self 
Direct and honest 
communication 
 
2 Chronic pain patient Good communication 
Respect 
Cured Took the patient seriously 
Provided injection therapy 
3 GP calls to discuss child with large 
tonsils, something seems not right, 
turn out to be an aggressive for of 
lymphoma 
Attitude 
Attention to detail 
Child survived Asked GP to send the patient 
the next day 
Examined the child and took 
tests 
Referred for treatment 
4 Female patient admitted and 
diagnosed and treated for 
meningitis, something felt wrong  
and it turned out to be an epidural 
abscess 
Short-cuts taken by 
admitting physician 
Experience – having 
seen a similar case 
earlier 
Patient was operated 
and discharged a few 
days later without 
problems 
Good case history 
Did not buy the initial story 
5 Young female patient referred for 
evaluation, she did not function at 




Patient became well Diagnose vitamin D deficiency 
from case history 
Prescribe vitamin D 
6 Older female patient, in her 70’s, 
admitted due to poor general 
condition, physical examination 
revealed a swollen lymph node, CT 
showed stomach cancer and she 
was scheduled for surgery 2 days 
later, postoperative period was 
uncomplicated, she died after 6 







Patient died after 
about 6 months due 
to metastatic cancer 
Diagnostic workup 
Surgery 
7 Family of two adults and two 
children. Two traumatic events, 
first, car accident where father gets 
injured and suffers from shoulder 
pain, second, wife gets ankle 






Both parents and 
children cope well 
Support when needed 
Pushed for action 
8 Sailor collapsed on a ship outside 
of  Nigeria, was found to be 
severely hypoxic, flown back to 
Norway for further investigation, 
referred for lung transplant but 
denied due to lack of a firm 
diagnosis 
Considering the option 
of a shunt 
Correct diagnosis 
Surgical correction is 
to be attempted 
Suggest that further investigation 
should look for a shunt 
9 Female patient presenting with 
abdominal pain, gastroscopy 
showed a small ulceration, but pain 





Everything worked out 
Patient was well 
taken care off 
Evaluation of patient, treatment 
and referral to nephrologist 
10 Female patient admitted during a 
weekend with a myocardial 
infarction and heart failure, 
echocardiography showed that she 
was dehydrated, she was given 
fluids and medicines to aid her 
failing heart,   
Access to competent 
staff and equipment 








improved from 30 to 
50% 
Echocardiographic evaluation 
11 Girl referred from haematology to 
infectious disease outpatient ward 
due to low platelet count, liver 
cirrhosis was discovered and 
hepatitis-c diagnosed, life-saving 
treatment was given 





Patient is alive and 
virus free 
Decide to use the resource and 
take the risk of interferon 
treatment 
12 75 year old male patient with 
unsteady gait due to CNS gliosis 
admitted due to syncope, 
diagnosed with atrial flutter and 
observed on telemetry 
Access to competent 
physicians and 
equipment 
Discharged in good 
health 
Evaluated patient with 
echocardiography 
Prescribed pacemaker 
13 Female patient that since childhood 
had become unwell upon physical 
exertions and infections, she came 
without a diagnosis even though 
she had been to see countless 
physicians for her problem 




Patient is well when 
she sticks to special 
diet 
Understand what could be the 
cause and establish a diagnosis 
14 Patient had previously been treated 
for breast and lung cancer and felt 
that she was cured, came to 
colonoscopy and a biopsy was 
taken from a suspect area 
Quick answer to 
patients concerns 
No new cancer 
detected 
Informed the patient very quickly 
about the results 
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15 A young female patient admitted 
with symptoms of septicaemia, she 
had chills and tentatively she was 
diagnosed with a urinary tract 
infection, the question was whether 
she was pregnant or not,  
antibiotics were started and she 
became better the next day 
Young patient that can 
tolerate a lot 
 
Discharged in good 
health 
Established a diagnosis 
Initiated treatment 
Checked baby with ultrasound 
16 Male patient in his 40s, gained 
weight and felt out of shape, started 
to exercise, administered anabolic 




Patient understood the 




His lung condition 
resolved 
Established diagnosis 
Treated his condition and follow-
up 
17 Male patient that had been 
operated for CNS lymphoma, came 
for control and was asked about his 
prognosis by the controlling 
physician, the patient did not 
expect the question and became 
anxious 
Lack of competency 





Patient was satisfied 
with information  
Patient is doing well 
Informed the patient 
Gave honest and relevant 
information in the right dose 
18 Patient admitted to medical ICU 
with slow heart rate, he was given 
electric shock 5 times during the 
night and was anxious the next 




Patient discharged in 
good health 
Identify episodes of ventricular 
tachycardia 
Implant pacemaker 
19 Abnormal heart rhythm during 
syncope and would wake up when 
normal rhythm returned, he was 
given a temporary pacemaker and 
a permanent one was implanted a 
few days later.  and tendency for 
syncope, admitted to ICU and 
observed, he had  
Patient came to the 
right place at the right 
time 
Resources and 
competent staff were 
available 
Patient discharged in 
good health 
Pacemaker implanted 
20 3-year old patient admitted, he did 
not want to walk and had back 
pain, MRI scan showed possible 
two tumours, he was diagnosed 
with an aggressive for of 
myelogenic leukaemia  
Available diagnostic 
modalities 





started very quickly 
Patient died Established diagnosis quickly 
Started correct treatment quickly 
21 Patient presenting with a serious 
depression and suicidal thoughts, 
patient was admitted acutely for 
evaluation 
Quality of alliance with 
patient 
Information quality was 
important 
Patient became well Designed process and course of 
treatment 
22 Mature male patient admitted o ICU 
with pneumococcal pneumonia, 
aggressive diagnosis revealed that 
the patient had cancer with 
metastasis as well, intensive 
treatment was successful and 
patient was discharged, but 
condition deteriorated after 3-4 
months due to the cancer 
Communication and 
information to next of 
kin 







Aggressive therapy and 
adherence to therapy 
23 Older female patient admitted at 
night with symptoms of shock, low 
blood pressure and unconscious, 
shock therapy was given in ICU 
and uro-sepsis was diagnosed and 
treated 
Access to necessary 
resources 
Specialty support 
Did not give up even 
though situation 
appeared hopeless 
Discharged after a 
few days with a 
nephrostomy, in 
good health 
Initial shock therapy 
Antibiotics for septicaemia 
Nephrostomy 
24 Female patient in her 40s, had 
problems keeping herself awake 
since 16 years of age, would fall 
asleep during conversations, little 





Interest in the patient 
and problem 
Diagnosed with 
narcolepsy and given 
appropriate treatment 
Established a tentative diagnosis 
Referred to neurologist for 
confirmation and therapy 
25 Female patient with genetic heart 
disease (Eisenmenger and shunt), 
patient was given a back pack with 
oxygen, experimental treatment, 
her condition improved and she 
lived 15 years longer than 
expected. 
Close contact and good 
communication with 
parents 
Willing to take the risk 
(experiment) 
Being interested in the 
patient and the problem 
Competent team 
Patient lived 15 years 
longer than expected 
Experimental therapy with 
oxygen 
Good communication 
26 Patient with COPD admitted with 
respiratory distress, it appeared to 
be an inspiratory problem, after 
inspection a foreign body was 
located and removed freeing the 
compromised airway, patient would 
have died a few minutes later if 
intervention had not been done 
Experience 
Interest in the problem 
and patient 
Patient discharged in 
good health 
Removed foreign body causing 
blocked airways 
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27 Male patient in his early 60’s 
admitted in the middle of the night, 
he was known to be a heavy 
drinker and smelled of alcohol, 
reduced consciousness, spinal 
puncture was done and it showed 
meningitis, antibiotics started and 
















Medical outcome Clinical intervention
1 Paediatric psychiatry patient 
admitted with restraints, changes 
between nice behaviour and self-
destructive behaviour 
Transfer of negative 
feelings 
Patient is fully 
institutionalized 
Therapy for six months 
including medication and 
the use of restraints 
2 Female patient with clear 
expectation of what treatment she 
needed 
Lack of time 
Information from next of 




Prescription of a controlled 
substance 
3 Urologic patient with re-bleeding 
after surgery, need reoperation and 
was given an epidural, patient got 
cardiac arrest  
Lack of experience 
Sub-optimal pain 
management? 
Patient died Epidural anaesthesia 
4 Multi-morbid patient, undergone 
aortic valve replacement surgery, 
infiltrates on both lungs, CT 
showed abscess 
Samples taken, but 
forgotten to send for 
analysis 
Poor follow up by  
physicians 
Lack of continuity 
Still in ICU getting 
treatment and slowly 
getting better 
Asked: what is going on and 
ordered CT 
Prescribed antibiotics 
5 Male patient in his 40s, condition 
varying between not being able to 
get out of bed to being able to do 





Wheel chair bound 
Unresolved diagnosis 
Diagnostic work-up 
6 Male patient in his 50’s, previous 
history of malignant melanoma 
more than 5 years back, swollen 
lymph node on the neck, had a 
sore throat as primary symptom,  
Did not take condition 
seriously 
 
Lack of experience 
Delayed diagnosis and 
treatment of metastatic 
cancer 
Patient died 
Diagnostic work-up on 
primary symptom 
Asked patient to return if not 
better 
7 Older woman followed for 20 years 
or so, well regulated diabetes, 
active life with walks, husband is 
caretaker and initiators, and 
husband gets sick and dies. 
Her world disappeared 
when her husband died 
Patient dies at the age 
of 85, 3 months after 
husband dies 
Treated her diabetes 
8 65 year old male admitted with 
pneumonia, initially give 
appropriate antibiotic treatment and 
chest drain,  
Discharged too early 
initially 
Active treatment was too 
short 
Outpatient control with X-
ray not done according t 
plan  
Alive with fibro-thorax 
and can no longer work 
Prolonged therapy upon 
readmission 
9 Older female patient admitted with 
epigastric pain, observed and 
discharged after two negative 
troponin tests. Pain did not go away 
and readmitted, pain upon 
palpation of the liver, ultrasound 
showed gallstones 





and patient doing well 
Order ultrasound and 
control after discharge 
10 Patient admitted during the summer 
and referral papers did not mention 
that he used B-blocker, this was not 
noticed and he was discharged 
without. He was readmitted due to 
unstable heart rhythm 
No system for medication 
follow-up 
Admitting physician did 
not question current 
treatment 
Patient did not question 
change in medication 
 
Patient is alive and well Evaluate ICD readout and 
reinstate B-blocker 
11 Female outpatient with friend, 
diffuse case history, weight loss 
and slightly elevated CRP, had 
been given a hemochromatosis 
diagnosis, ordered CT and 
scheduled control in one month, 
missed the elevated ANA on lab 
results, had to tidy up mess with 
new referral 
Diffuse case history 
Transfer of negative 
feelings from patient and 
accompanying friend 
Rushed consultation 
Missed lab result 
Patient was given 
correct treatment and is 
doing well 
Patient referred for Lupus 
treatment at centre of 
excellence 
12 Older male patient admitted acutely 
with chest and back pain, 
ultrasound was done to exclude 




aorta dissection, no dissection 
detected and anticoagulants were 
given, condition did not improve 
and patient was transferred to 
another hospital for rescue. 
Referred to another hospital 
for rescue 
13 Male patient in his 40s admitted 
during a busy weekend, he had a 
cerebral infarction earlier the same 
year and was a bit reduced, CT 
was initially negative for a brain 
haemorrhage, however, upon re-
examination it showed a huge 
bleeding at the base of the brain 
Lack of radiology  
competency  
Lack of communication 
about findings 
No MRI available 
Patient died after an 
unsuccessful surgical 
attempt to save his life 
CT results were not 
communicated to 
neurologist 
14 Male patient in his 70s afraid of 
contacting physicians, he had 
change in stool pattern, faecal 
blood and weight loss 
Patient delay Advanced cancer with 
very poor prognosis 
Patient cancelled many 
appointments for 
colonoscopy 
15 Older female patient admitted with 
diffuse pain,  colonoscopy and CT 
was ordered, delay in diagnostic 
procedures, no clear diagnosis 
established, transferred t lower 
level of care facility, condition 
slowly improved over time 
Difficult to choose level of 
intervention 






slowly over time 




Order diagnostic procedures 
and tests 
16 26 year old male patient that had 
been living in Sweden for the last 4 
years, he was very ill and could not 
stand upright, x-rays of his lungs 
showed huge destructions due to 
TBC, he also had pneumothorax,  
he had tachycardia, but due to 
infection no further examinations 
were done before it was too late. 
The cardiologist found out that he 
had a genetic heart condition, and 
that most patients would die before 
they were 30.  
TBC anxiety delayed 
diagnosis 
No enough information 
about the cause of his 
condition 
 
Patient died Discussion of his case 
17 Female patient with blood cancer, 
gentamycin was not given as a 
starter dose, the physician that saw 
the patient the next day took for 
granted that gentamycin was dosed 
for the following days,  
Gentamycin not dosed 
correctly 
Septicaemia not detected 
early enough 
Accepting the evaluation 
of supporting service at 
face value 
Patient died Mistake discovered too late 
18 Older patient with high heart rate 
due to atrial fibrillation, electro 
conversion was considered, but 
physician decided against, Ca-
blocker was given and BP dropped 
and patient died. 





Calcium blocker was given 
19 Female patient in her 70s with 
aortic stenosis identified during a 
routine control, she was supposed 
to come for a control after a year, 
but had fallen out of the system. 
She was admitted because she 
was short of breath, placed on the 
pulmonology ward and waited 5-6 
days before transfer to cardiology 
where echocardiography was done 
medication changed, she felt a bit 
better after that, cardiac arrest the 
next day. 
ACE inhibitors were given 
when it was 
contraindicated 
Condition not properly 
evaluated due to lack of 
resources and time 
Cardiac arrest 
Patient died 
Evaluated and changed 
treatment regimen while 
patient was on the 
cardiology ward. 
20 65 year old male patient presents in 
the ER with chest pain, pain in 
chest upon palpation, ECG not very 
specific, the patient was sent home 
Lack of experience 
Lack of competency 
Did not want to burden 
the cardiology ward 
Patient was admitted 
the following day with 
myocardial infarction 
Missed the diagnosis 
21 Male patient that had been drinking 
alcohol, engaged in a fight at a 
local disco, admitted to hospital and 
CT was delayed, patient was 
comatose but it was considered a 
cause of drinking and not fighting, 
CT showed brain haemorrhage, 
transferred to neurosurgery and 
died on the operating table 
Patient was not admitted 
directly to neurosurgery 
Delayed diagnosis 
Delayed treatment 
Patient died on the 
operating table 
Delayed diagnosis and 
treatment 
22 Middle aged falls and hits the head, 
surgical evacuation of hematoma, 
transferred to ICU with pneumonia, 
treated and transferred to the ward 
with a cannula, inappropriate care 
Inexperienced physicians 
in ICU 
Inappropriate care of 
cannula 
Patient back in ICU 
after 9 weeks 
Set treatment target in ICU 
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of cannula cause patient to be 
readmitted to ICU 
Limits for treatment set in 
ICU were cancelled 
without consideration 
23 Patient with many symptoms and 
diseases, he presented with two 
distinct problems, but only one was 
treated 
Lack of capacity 
Physician focus on what 
they are good at and do 
not take the time to focus 
on problems outside their 
speciality 
Patient discharged 
without resolution and 
readmitted shortly 
thereafter 
Focus on one out of two 
medical problems only 
24 Male patient in his 50s with flue like 
symptoms, soreness in the chest, 
possibly after crab fishing, slight 
fever, given penicillin in case of 
pneumonia and asked to call back 
if not better, he did not get better, 
increasingly ill and loss of blood 
pressure, admitted to the local 
hospital, endocarditis was 
diagnosed and transferred to 
another hospital for heart surgery, 
patient died on the operating table. 
Missed diagnosis 
Lack of experience 
Did not take symptoms 
seriously 
Patient died Patient not admitted initially 
25 Male patient with widespread 
coronary disease, admitted due to 
an abdominal aortic aneurysm and 
scheduled for operation, coronary 
artery disease was deemed more 
important and he was operated with 
by-pass, operation was a success, 
but patient suffered re-bleeding and 
needed to be re-operated and 
suffered a myocardial infarction 
during the second operation,. 
Operated in April and 
echocardiography control in May, 
came for a second control in June 
and it was then that the MI was 
noticed. The MI was overlooked 
initially and during the control, the 
echocardiography film was very 




Narrow focus due to lack 
of time 
Patient died Diagnosis overlooked 
26 Male patient in his 20s presented 
with knee pain after a trauma 
during a hike in the forest, initially 
treated with NSAIDs and asked to 
come back if not better, he did not 
get better and came back 3 days 
later, aspiration from the knee was 
bloody indicating a fracture-rays 
were ordered and confirmed a tibia 
fracture involving the knee joint 
Lack of time 
Lack of experience 
Lack of radiology service 
Did not do a full 
examination 
 
Knee arthritis Diagnosis overlooked 
27 Female patient in her early 20’s 
admitted for evaluation of epilepsy 
with focus on possible surgery, 
medication was reduced to provoke 
seizure, she had a seizure in the 
bathroom, hit her head and got 
bruises and cuts 
No one followed her to 
the bathroom 
Nor surveillance in 
bathroom 
Bathroom facilities not 
adequately padded 
Bruises and cuts in the 
face due to trauma in 
connection with 
epileptic seizure 
Reduction in medication to 
provoke seizure 
Table C-14 Coding for patient cases 















1 Mental  Acute Clear No Communication 
Therapy 
Improved Social support High quality 
2 Physical Chronic Clear No Communication 
Procedure 























6 Physical Acute Clear Yes Diagnostics 
Therapy 
Procedure 



















9 Physical Acute Diffuse No Diagnostics 
Therapy 
 














11 Physical Acute Diffuse Yes Diagnostics 
Therapy 





























































































22 Physical Acute Clear Yes Communication 
Diagnostics 
Therapy 




























25 Physical Chronic Clear Yes Therapy 
Communication 




























28 Mental  Chronic Clear Yes Diagnostics 
Therapy 
 








29 Physical Chronic Clear No Diagnostics 
Procedure 















31 Physical Acute Clear Yes Diagnostics 
Therapy 
 









32 Physical Chronic Diffuse No Diagnostics Worse Failed 
diagnostics 
Low quality 
33 Physical Acute Clear Yes Diagnostics 
Therapy 


























37 Physical Acute Clear No Diagnostics 
Therapy 






38 Physical Acute Diffuse No Diagnostics 
Therapy 
 
Improved Transfer of 
negative 
feelings 




39 Physical Acute Clear Yes Diagnostics 
Therapy 
Procedure 





40 Physical Chronic Diffuse Yes Diagnostics 
Therapy 



















43 Physical Acute Clear Yes Diagnostics  
Therapy 





44 Physical Acute Clear Yes Diagnostics 
Therapy 








45 Physical Acute Clear Yes Diagnostics 
Therapy 




46 Physical Acute Clear Yes Diagnostics  
Therapy 
Death Lack of 
resource 














48 Physical Acute Clear Yes Diagnostics 
Therapy 




















































Table C-15 Sub-categories of quality 
Quality  




Communication Ability to communicate, get and give 
necessary information in a tailored manner 
High – Low 12 20 
Time Availability of time to do what is necessary High – Low 6 8 
Resources Adequate resources available High – Low 8 12 
Competency Availability of necessary competency 
(knowledge, experience and skill) 
High – Low 20 50 
Diagnostics Ability to correctly diagnose patients without 
delay 
High – Low 10 13 
Treatment Ability to correctly treat patients without 
delay 
High – Low 13 23 
Patient Willingness to cooperate and adhere to 
medical advice given 
High – Low 14 26 
Physician Physician attitude High – Low 13 27 
Organization Organization of work that support delivery of 
health care 
High – Low 22 39 
Evaluation Ability to evaluate and learn High – Low 9 22 
Continuity Level of continuity of care High – Low 2 3 
Patient 
satisfaction 




Table C-16 Summary of quality sub-categories by quality elements 
Elements of quality  





Communication Ability to communicate, get 
and give necessary 
information in a tailored 
manner 
High – Low 12 20 Process 
Resources Adequate resources 
available 
High – Low 15 20 Structure 
Competency Availability of necessary 
competency (knowledge, 
experience and skill) 
High – Low 20 50 Structure 
Diagnostics Ability to correctly diagnose 
patients without delay 
High – Low 10 13 Process 
Treatment Ability to correctly treat 
patients without delay 
High – Low 13 23 Process 
Patient Willingness to cooperate 
and adhere to medical 
advice given 
High – Low 14 26 Process 
Physician Physician attitude High – Low 13 27 Process 
Organization Organization of work that 
support delivery of health 
care 
High – Low 24 41 Structure 
Evaluation Ability to evaluate and learn High – Low 9 22 Outcome 
Patient 
satisfaction 
Level of experiential quality  High – Low 19 31 Outcome 
Table C-17 Elements by frequency of respondents and references 
Element Respondents (cumulative) References Ratio (Ref/Res)
Structure 57 109 1,91 
Process 64 112 1,75 
Outcome 28 53 1,89 
Table C-18 Evaluation 
Evaluation 
Sub-category Property Dimension Respondents References Example quote 
Feedback Level of 
feedback and 




High - Low 13 21 “It’s largely based on direct 
feedback from patients, with 
this satisfied or not satisfied.  
No matter what happened, if 
there are satisfied I feel that I 
have done some good.” 
Measures Being able to 
objectively 
measure  
High - Low 21 50 “ …we stopped measuring, 
because the measures 
showed an adherence rate of 
about 92%, and there was 
always a good reason why 
the last 8% did not use the 
medication according to 
guidelines, for example the 





Table C-19 Influencers of quality 
Influencers of quality 
Sub-category Property Dimension Ref #* Example quotes Element 
Time Availability of 
time to do what 
is necessary 
High - Low 28 “I had a lot of patients waiting in a 
waiting room and felt stressed due 
to lack of time; I didn’t spend 
enough time to evaluate the patient 
properly and missed the 
diagnosis.” 
Structure 
Communication Ability to 
communicate, 
get and give 
necessary 
information in a 
tailored manner 
High - Low 32 “I think that the fact that they have 
been very explicit in what they need 
has made it easy to be their 
physician and give them the 
support that they needed.” 
Process 





High - Low 23 “Due to very aggressive 
diagnostics, we discovered that this 
patient has a cancer with 
metastasis.” 
Process 




High - Low 6 “I didn’t diagnose the patient 
correctly and started inappropriate 
treatment which may have masked 
the symptoms. When I realised the 
patient was getting worse I 
contacted a more senior physician, 
a cardiologist, and he could make 
the correct diagnosis and start 
appropriate treatment but it was too 
late.” 
Process 






High - Low 14 “…the patient came to the right 
place at the right time, there were 
available resources and time was 
available ensuring good quality 
treatment and information.”  
Structure 






High - Low 19 “I think the most important other 
factor was my previous experience 




Ability to show 
and real interest 
and level of 
curiosity 
High - Low 12 “First, you need to respect the 
patient and the patient’s 
experience of his problem. 
Second, you need to respect the 
patient as an equal with respect to 
yourself. You need to believe that 
people are equal. This belief 
needs to be rooted deep in your 
soul. However, sometimes it may 
be very difficult. “ 
Process 





High - Low 7 “...demanding patients create 
negative feelings and I fear I may 
give suboptimal therapy due to this 
fact...” 
Process 
* Ref # = number of references 
 
 
